data_6rh6_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6rh6 _Structure_validation_residue.Date_analyzed 2019-08-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' H ' ' A' ' 86' ' ' THR . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 85' ' ' VAL . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 86' ' ' THR . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.406 ' H ' HG21 ' A' ' 85' ' ' VAL . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 . . . . . 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.445 ' H ' HG21 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 CA-C-O 121.125 0.291 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG21 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.472 ' H ' HG21 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.169 0.509 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.517 0.675 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.489 ' H ' HG21 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.463 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG21 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.44 ' H ' HG21 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 121.56 0.533 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 HG21 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.425 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.966 0.889 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG21 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.843 0.83 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 N-CA-C 113.677 0.231 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 86' ' ' THR . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.435 ' H ' HG21 ' A' ' 85' ' ' VAL . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG21 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG21 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.548 0.69 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 86' ' ' THR . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 85' ' ' VAL . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 . . . . . 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 120.283 -0.176 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 HG21 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.458 ' H ' HG21 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 . . . . . 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.939 0.876 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.428 HG21 ' H ' ' A' ' 86' ' ' THR . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.428 ' H ' HG21 ' A' ' 85' ' ' VAL . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.69 0.757 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 55' ' ' THR . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 53' ' ' GLY . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 HG21 ' H ' ' A' ' 86' ' ' THR . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.417 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 . . . . . 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 55' ' ' THR . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 53' ' ' GLY . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.441 ' H ' HG21 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 122.067 0.936 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' H ' ' A' ' 86' ' ' THR . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 85' ' ' VAL . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' H ' ' A' ' 86' ' ' THR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.441 ' H ' HG21 ' A' ' 85' ' ' VAL . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.473 ' H ' HG21 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.409 HG21 ' H ' ' A' ' 86' ' ' THR . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.409 ' H ' HG21 ' A' ' 85' ' ' VAL . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.464 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.867 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.9 p -74.23 153.17 88.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.69 1.196 . . . . 0.0 112.829 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 160.58 48.92 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.302 2.668 . . . . 0.0 112.714 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.17 -27.67 68.87 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.15 0.98 . . . . 0.0 113.455 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.9 m -124.35 127.19 47.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.889 1.676 . . . . 0.0 110.103 170.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.49 131.05 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.414 1.086 . . . . 0.0 110.834 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.34 32.69 3.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.121 2.169 . . . . 0.0 111.88 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m 57.71 41.56 25.08 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.026 1.73 . . . . 0.0 113.302 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.99 173.63 7.64 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.281 1.832 . . . . 0.0 112.382 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.11 58.56 2.04 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.022 1.329 . . . . 0.0 111.823 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.67 33.25 0.2 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.978 1.711 . . . . 0.0 113.973 -174.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -81.4 178.86 8.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.777 1.231 . . . . 0.0 113.495 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.07 127.18 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.384 2.274 . . . . 0.0 108.57 165.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.48 166.89 17.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -118.27 -46.18 2.61 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.99 1.716 . . . . 0.0 113.654 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.32 91.97 1.82 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.283 1.039 . . . . 0.0 111.805 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 t -88.37 164.11 15.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.067 164.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.34 -24.23 11.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.231 1.813 . . . . 0.0 115.46 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -110.55 -4.0 15.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.664 1.586 . . . . 0.0 114.502 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.14 -111.21 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.799 1.666 . . . . 0.0 111.628 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' H ' ' A' ' 86' ' ' THR . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 85' ' ' VAL . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -85.28 145.02 27.74 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.36 -1.74 58.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.68 8.14 85.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.11 1.338 . . . . 0.0 115.269 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.5 p -121.57 13.37 10.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.345 1.458 . . . . 0.0 113.673 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.76 15.07 54.0 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.193 1.378 . . . . 0.0 113.828 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.19 162.21 33.18 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.026 1.73 . . . . 0.0 113.039 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -119.94 162.66 18.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.976 1.31 . . . . 0.0 113.973 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.77 -155.91 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt 58.25 25.06 12.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.222 1.409 . . . . 0.0 114.288 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 56.06 29.82 15.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.27 1.828 . . . . 0.0 114.363 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 124.603 1.161 . . . . 0.0 113.823 174.957 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -86.22 -43.03 13.3 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.31 1.044 . . . . 0.0 112.184 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 17.0 tt -159.82 168.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 109.14 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -125.33 125.76 43.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.17 -0.956 . . . . 0.0 111.167 164.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.1 m -140.05 50.48 1.73 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.755 1.622 . . . . 0.0 110.9 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -45.36 140.32 3.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.968 2.107 . . . . 0.0 113.526 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.31 120.51 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.241 1.02 . . . . 0.0 109.177 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.503 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.53 -28.37 0.03 OUTLIER Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.943 1.259 . . . . 0.0 114.853 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -66.45 -23.03 66.22 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.05 -35.9 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.873 1.669 . . . . 0.0 112.182 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.5 65.21 2.74 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.969 1.271 . . . . 0.0 113.108 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.22 -160.25 1.04 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -164.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -137.73 -56.74 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -137.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.361 1.864 . . . . 0.0 111.487 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 6.9 m -65.49 150.43 95.95 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.319 1.048 . . . . 0.0 112.755 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.82 -8.62 18.03 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.579 2.853 . . . . 0.0 113.724 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -127.94 -173.22 2.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.8 2.04 . . . . 0.0 112.062 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.1 m -58.88 -14.06 7.99 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.31 -23.52 62.52 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.601 1.091 . . . . 0.0 112.69 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.98 -15.31 55.66 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.6 p -82.34 -10.69 58.98 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -107.94 144.31 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.484 1.914 . . . . 0.0 110.952 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -118.58 -5.73 10.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.332 1.453 . . . . 0.0 113.344 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.15 22.84 7.91 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -114.71 178.55 4.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -163.81 132.42 3.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.411 1.884 . . . . 0.0 109.006 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.29 170.96 18.57 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -130.06 -37.12 1.5 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.826 1.65 . . . . 0.0 113.451 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.05 18.34 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.985 0.914 . . . . 0.0 112.157 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -83.83 -2.2 55.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -130.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -135.58 -78.19 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.385 1.074 . . . . 0.0 109.799 162.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.71 -3.77 11.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.499 1.919 . . . . 0.0 113.676 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.07 2.35 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.35 1.928 . . . . 0.0 110.038 -169.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.59 146.94 24.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.98 -2.33 58.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.89 11.97 84.65 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.752 1.168 . . . . 0.0 115.305 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.253 6.4 t -129.6 29.42 5.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.284 1.434 . . . . 0.0 112.885 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.89 56.36 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.436 1.494 . . . . 0.0 113.972 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -142.42 171.12 14.49 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.362 1.465 . . . . 0.0 113.735 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m -124.99 159.55 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.852 1.661 . . . . 0.0 113.272 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -164.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 61.11 31.56 19.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 157.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . 0.25 8.8 mp0 54.56 31.27 14.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.664 1.985 . . . . 0.0 114.925 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.704 1.202 . . . . 0.0 113.361 172.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -115.73 13.06 16.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.104 1.361 . . . . 0.0 113.748 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.94 130.13 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.105 . . . . 0.0 110.072 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -83.27 148.89 27.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.116 1.366 . . . . 0.0 113.152 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -92.63 59.65 3.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.1 1.36 . . . . 0.0 113.457 -164.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -43.93 144.97 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.026 1.73 . . . . 0.0 113.868 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.32 131.36 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.334 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.408 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.87 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.435 -1.711 . . . . 0.0 113.561 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -67.47 -20.6 65.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.288 1.435 . . . . 0.0 114.721 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.3 tp -128.54 -42.44 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -171.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.13 30.72 56.8 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.223 0.916 . . . . 0.0 114.772 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -93.3 0.08 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.992 2.117 . . . . 0.0 115.082 -168.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -71.71 146.2 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.292 2.637 . . . . 0.0 111.854 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.1 2.16 . . . . 0.0 111.504 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 45.9 m -66.59 144.13 98.48 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.309 1.044 . . . . 0.0 112.663 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.43 -13.78 36.06 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.588 2.858 . . . . 0.0 114.59 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -82.84 -7.38 59.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 114.015 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 150.6 31.26 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.303 1.041 . . . . 0.0 112.462 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.87 -17.48 61.52 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 113.389 170.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.91 -7.05 56.22 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -81.83 -10.25 59.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.49 172.54 12.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.761 1.624 . . . . 0.0 113.349 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.55 87.92 5.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.599 1.16 . . . . 0.0 108.459 166.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 44.57 1.0 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.011 1.324 . . . . 0.0 112.78 -167.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -89.96 -178.34 5.44 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.105 1.362 . . . . 0.0 113.584 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.44 132.16 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.923 2.089 . . . . 0.0 108.947 161.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.35 172.55 14.44 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -132.84 -40.03 0.96 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.473 1.509 . . . . 0.0 113.78 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.86 22.91 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.642 0.777 . . . . 0.0 112.25 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -85.39 3.43 40.01 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -131.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.3 -40.8 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 0.0 113.117 164.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.22 -51.36 0.53 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.129 1.772 . . . . 0.0 111.621 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.88 -120.02 1.34 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.432 1.491 . . . . 0.0 110.478 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 86' ' ' THR . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.406 ' H ' HG21 ' A' ' 85' ' ' VAL . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -102.5 148.15 25.87 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.85 -5.0 59.33 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 4.35 89.68 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.07 1.319 . . . . 0.0 115.37 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.5 p -109.18 12.61 24.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.597 1.559 . . . . 0.0 113.363 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.34 53.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.388 1.47 . . . . 0.0 113.884 -172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -130.02 167.69 17.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.822 1.649 . . . . 0.0 113.629 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -124.32 158.59 32.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.893 1.677 . . . . 0.0 113.026 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.08 -163.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.4 tptp 60.2 19.13 8.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.706 1.603 . . . . 0.0 115.193 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 52.97 29.13 7.42 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.383 1.873 . . . . 0.0 114.398 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.838 1.255 . . . . 0.0 113.931 176.017 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.704 0.287 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -76.16 -21.43 56.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.447 1.099 . . . . 0.0 112.289 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 54.7 mt -80.01 143.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 110.23 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.8 p -65.59 166.67 10.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.187 1.395 . . . . 0.0 113.22 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 23.4 m -77.24 40.82 0.28 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.52 1.528 . . . . 0.0 113.64 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.21 163.21 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.129 2.172 . . . . 0.0 114.119 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.04 117.93 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.07 1.348 . . . . 0.0 109.316 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.435 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.04 -13.42 0.05 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.405 2.431 . . . . 0.0 113.641 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -69.85 -15.95 63.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.301 2.24 . . . . 0.0 114.988 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -145.31 -35.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.72 43.53 75.01 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 123.969 0.795 . . . . 0.0 113.851 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.67 -142.86 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.441 2.296 . . . . 0.0 113.916 -170.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -137.21 -174.25 3.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.231 1.812 . . . . 0.0 112.936 -150.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.928 1.291 . . . . 0.0 113.339 168.317 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.9 p -74.22 153.2 88.3 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.33 147.61 66.0 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.348 2.699 . . . . 0.0 112.34 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -151.72 155.43 38.27 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.964 1.306 . . . . 0.0 111.616 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.1 m -59.3 -16.39 21.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.582 1.553 . . . . 0.0 114.967 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.58 -7.83 5.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 -12.23 2.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.818 1.647 . . . . 0.0 115.161 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.3 p -73.53 -17.44 61.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.832 1.253 . . . . 0.0 113.777 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -87.75 140.67 29.28 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.703 1.601 . . . . 0.0 109.866 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.55 -9.64 15.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.853 1.261 . . . . 0.0 113.389 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 51.77 43.73 29.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.266 1.826 . . . . 0.0 115.237 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -138.92 -179.57 5.91 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.996 -1.065 . . . . 0.0 112.678 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.53 135.45 5.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.757 2.023 . . . . 0.0 108.325 161.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.2 161.6 20.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -111.45 -28.23 8.27 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.326 1.45 . . . . 0.0 114.877 169.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.22 104.82 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.671 0.789 . . . . 0.0 111.577 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 161.6 17.92 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.007 0.923 . . . . 0.0 110.362 158.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.62 -17.99 64.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.145 -0.972 . . . . 0.0 112.98 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -88.16 -15.26 36.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.999 1.32 . . . . 0.0 113.302 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.26 -101.55 0.79 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.246 1.403 . . . . 0.0 111.003 -168.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.445 ' H ' HG21 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.553 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.22 155.89 17.68 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -86.15 -13.64 46.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 168.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.87 5.71 85.98 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.041 1.305 . . . . 0.0 114.843 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.4 p -114.56 18.12 16.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.745 1.618 . . . . 0.0 113.544 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.12 16.29 59.52 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.999 1.285 . . . . 0.0 113.946 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -135.48 174.25 10.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.077 1.751 . . . . 0.0 112.871 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -144.09 160.19 41.33 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -160.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 tptp 59.0 18.88 6.66 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.404 1.881 . . . . 0.0 115.564 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.78 28.62 6.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.512 1.925 . . . . 0.0 114.641 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 177.113 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.656 0.265 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -142.32 163.6 32.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.207 1.403 . . . . 0.0 112.457 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.9 mt -70.42 141.49 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.11 1.364 . . . . 0.0 109.973 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 p -121.7 138.68 54.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.232 1.413 . . . . 0.0 111.915 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 58.6 m -87.59 46.98 1.44 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.887 1.275 . . . . 0.0 113.376 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -47.67 142.24 4.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.289 2.235 . . . . 0.0 113.534 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.0 124.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.857 0.836 . . . . 0.0 109.993 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.553 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -168.83 -15.95 0.02 OUTLIER Glycine 0 CA--C 1.539 1.588 0 C-N-CA 127.39 2.424 . . . . 0.0 113.461 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -68.63 -14.21 62.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.041 2.137 . . . . 0.0 114.751 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 tp -146.07 -40.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.917 1.287 . . . . 0.0 113.251 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.0 70.73 1.3 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.411 1.005 . . . . 0.0 112.569 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.38 -159.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -137.17 -60.23 0.68 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.659 -1.276 . . . . 0.0 114.345 -136.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.872 1.669 . . . . 0.0 111.808 -171.415 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.74 147.34 99.06 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.81 -19.64 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.21 2.607 . . . . 0.0 113.614 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.53 158.7 43.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.142 1.777 . . . . 0.0 110.385 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.5 t -75.19 150.16 38.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 112.474 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm -127.52 16.14 7.05 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.933 1.693 . . . . 0.0 112.529 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 128.3 35.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.179 0.99 . . . . 0.0 111.98 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.3 p -80.07 -17.77 51.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.874 1.67 . . . . 0.0 114.048 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.4 141.85 35.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.643 1.977 . . . . 0.0 110.836 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.61 -4.72 10.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.669 1.588 . . . . 0.0 113.111 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 56.32 33.4 22.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.773 2.029 . . . . 0.0 115.897 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -134.34 -178.34 5.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.96 129.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.361 1.864 . . . . 0.0 108.895 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.26 158.05 19.96 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -103.01 -27.03 12.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.459 1.504 . . . . 0.0 114.689 167.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.29 106.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.753 1.221 . . . . 0.0 109.42 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 t -90.48 164.6 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.62 1.168 . . . . 0.0 111.283 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -34.93 11.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.132 2.173 . . . . 0.0 115.412 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -129.45 93.4 3.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.645 1.578 . . . . 0.0 107.374 165.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.94 -96.31 0.1 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.043 1.306 . . . . 0.0 113.78 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -78.36 127.61 32.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.51 10.75 21.66 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -162.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.77 85.62 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.025 1.298 . . . . 0.0 115.806 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -131.87 25.67 4.65 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.728 1.264 . . . . 0.0 113.747 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.2 55.92 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 124.365 0.983 . . . . 0.0 113.547 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -142.06 174.83 10.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.623 1.969 . . . . 0.0 111.945 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -123.99 154.24 40.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.25 1.02 . . . . 0.0 112.158 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.431 HH22 ' P ' ' B' ' 156' ' ' TPO . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -156.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 60.33 17.18 6.86 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 52.91 29.96 8.53 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.379 1.872 . . . . 0.0 113.945 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.11 1.764 . . . . 0.0 114.465 -178.459 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.251 0.072 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.45 157.66 43.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 112.513 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 68.5 mt -129.39 138.96 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.194 1.798 . . . . 0.0 108.308 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 42.2 p -139.36 148.19 42.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.2 m -118.01 49.07 1.29 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.325 1.85 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -45.03 142.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.442 2.697 . . . . 0.0 114.666 -162.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.36 126.35 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.986 0.898 . . . . 0.0 111.033 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.575 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.24 -24.05 0.02 OUTLIER Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.802 1.667 . . . . 0.0 113.568 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.62 -27.74 65.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.23 -37.33 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.24 61.49 3.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.313 0.959 . . . . 0.0 112.772 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.53 -164.92 1.53 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 113.093 -164.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.369 30.8 mmt180 65.75 28.07 11.06 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 127.422 2.289 . . . . 0.0 114.286 169.133 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.3 m -138.54 149.81 63.94 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.169 1.388 . . . . 0.0 111.817 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.44 159.82 35.82 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.695 2.93 . . . . 0.0 113.787 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.54 -19.79 65.83 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.173 0.989 . . . . 0.0 113.383 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -63.44 -8.4 9.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.235 1.414 . . . . 0.0 114.738 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtm -55.26 -24.7 29.39 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.536 -1.352 . . . . 0.0 112.914 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.98 -16.51 60.63 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.7 p -122.64 -9.17 8.44 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.417 1.487 . . . . 0.0 114.065 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.9 156.16 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.802 2.041 . . . . 0.0 112.88 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.64 53.44 0.71 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.607 1.963 . . . . 0.0 111.514 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.51 45.71 0.5 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.483 2.313 . . . . 0.0 112.279 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.3 175.75 10.37 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.054 -1.029 . . . . 0.0 113.149 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.26 129.4 1.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.896 2.078 . . . . 0.0 109.241 165.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.38 159.31 36.43 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -112.82 -28.62 7.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.248 1.419 . . . . 0.0 114.768 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.31 106.33 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.891 0.876 . . . . 0.0 111.454 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -82.45 156.98 23.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.005 0.922 . . . . 0.0 110.467 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -8.61 53.62 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.156 0.982 . . . . 0.0 113.229 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -41.37 7.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.031 1.733 . . . . 0.0 110.407 171.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.09 -77.97 0.17 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.295 1.426 . . . . 0.0 111.832 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG21 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.472 ' H ' HG21 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.583 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -73.82 129.72 38.48 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -86.52 3.9 42.18 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.87 -0.43 78.1 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.577 1.56 . . . . 0.0 115.597 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.2 p -112.79 14.15 19.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.522 1.529 . . . . 0.0 113.295 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.31 15.7 54.94 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.27 1.414 . . . . 0.0 113.95 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -134.34 172.28 13.1 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.258 1.823 . . . . 0.0 112.792 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p -108.7 152.13 25.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 111.871 167.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -157.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 56.86 24.87 9.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.708 1.603 . . . . 0.0 114.784 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 54.46 31.45 14.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 114.529 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.862 1.265 . . . . 0.0 113.782 173.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.68 158.62 28.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.006 0.922 . . . . 0.0 112.5 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.7 tp -144.35 158.92 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.769 1.628 . . . . 0.0 110.713 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -76.8 151.44 35.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.546 1.138 . . . . 0.0 112.749 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -83.7 49.91 1.7 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.498 1.519 . . . . 0.0 113.862 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.17 156.03 7.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.743 2.017 . . . . 0.0 113.135 -172.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . 0.535 HG13 ' H ' ' A' ' 88' ' ' SER . 3.8 t -62.13 136.42 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.583 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.93 -20.09 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 CA-C-N 113.369 -1.742 . . . . 0.0 113.393 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -65.07 -16.99 64.07 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.595 1.558 . . . . 0.0 114.664 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.41 -39.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.09 63.7 3.33 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.456 1.027 . . . . 0.0 113.05 167.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -146.54 170.5 16.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -155.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -169.25 -50.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.307 2.243 . . . . 0.0 110.184 156.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.147 2.179 . . . . 0.0 111.635 179.686 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.3 m -140.2 157.72 68.3 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 125.337 1.455 . . . . 0.0 111.848 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.88 141.95 98.6 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.392 2.728 . . . . 0.0 113.695 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -153.72 161.05 42.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.34 1.456 . . . . 0.0 110.935 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.0 m -73.69 132.35 42.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.92 0.888 . . . . 0.0 110.896 170.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -110.42 -6.39 14.96 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.43 60.39 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.3 m -77.36 -26.71 52.23 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.598 1.559 . . . . 0.0 113.916 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.06 157.76 43.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.927 1.691 . . . . 0.0 111.468 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.5 54.07 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.029 1.732 . . . . 0.0 110.686 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.46 115.42 22.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 0.0 110.331 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.0 -176.51 5.8 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.073 1.349 . . . . 0.0 112.058 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.22 136.27 6.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.021 1.728 . . . . 0.0 109.207 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.2 158.29 20.15 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -104.42 -25.06 12.97 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.501 1.52 . . . . 0.0 114.439 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.02 104.65 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.507 1.123 . . . . 0.0 110.288 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -91.41 162.82 14.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.606 1.162 . . . . 0.0 111.235 167.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -24.27 56.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.754 2.022 . . . . 0.0 115.143 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -108.75 -0.86 19.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.441 1.496 . . . . 0.0 114.045 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.43 -92.1 0.34 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.837 1.684 . . . . 0.0 110.751 -170.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.489 ' H ' HG21 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.26 147.73 22.66 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -88.27 0.38 56.19 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.47 13.47 83.19 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.77 1.176 . . . . 0.0 115.435 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -134.6 28.32 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.681 1.193 . . . . 0.0 113.541 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.78 17.91 55.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.213 1.387 . . . . 0.0 113.939 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -142.05 172.87 12.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.722 1.609 . . . . 0.0 113.173 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -149.17 161.76 41.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -168.32 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 tptt 57.02 20.49 5.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.932 1.693 . . . . 0.0 115.273 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.27 30.04 7.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.226 1.81 . . . . 0.0 114.576 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.496 0.188 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -125.18 35.99 4.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.226 1.411 . . . . 0.0 112.07 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.0 mt -74.72 136.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.563 1.145 . . . . 0.0 109.92 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 41.6 p -135.39 164.87 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.522 1.529 . . . . 0.0 112.34 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.61 46.6 0.88 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.847 1.659 . . . . 0.0 115.039 -170.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -58.61 150.78 22.23 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.124 2.17 . . . . 0.0 112.766 -174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . 0.459 HG13 ' H ' ' A' ' 88' ' ' SER . 3.1 t -62.48 132.32 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.863 0.865 . . . . 0.0 110.561 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.624 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -162.5 -13.26 0.03 OUTLIER Glycine 0 CA--C 1.54 1.622 0 C-N-CA 127.721 2.581 . . . . 0.0 113.385 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.02 -17.67 62.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.002 2.121 . . . . 0.0 115.245 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.0 tt -123.86 -39.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.429 1.092 . . . . 0.0 113.44 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.86 67.69 1.82 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.437 1.017 . . . . 0.0 112.574 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -147.51 163.22 37.24 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -159.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.03 -48.99 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.976 2.11 . . . . 0.0 109.559 159.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.067 2.147 . . . . 0.0 111.482 168.291 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.4 m -136.59 150.96 71.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.246 1.419 . . . . 0.0 111.834 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.31 -19.19 22.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.32 2.68 . . . . 0.0 113.731 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -143.37 161.55 38.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.251 1.82 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.9 t -148.25 150.86 34.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.916 1.286 . . . . 0.0 112.216 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt -116.35 12.39 15.28 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.495 1.518 . . . . 0.0 112.721 171.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.18 -28.57 38.71 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 113.521 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.0 p -94.55 -24.36 17.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.107 1.363 . . . . 0.0 113.897 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 10.0 tp10 -154.3 142.31 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.978 2.111 . . . . 0.0 109.765 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.0 -10.91 56.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.282 1.033 . . . . 0.0 113.407 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 6.5 mm-40 50.11 44.87 25.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.91 2.084 . . . . 0.0 114.071 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -101.16 -171.05 1.93 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.684 1.994 . . . . 0.0 112.36 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.64 130.01 1.94 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.454 1.901 . . . . 0.0 108.823 157.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 161.99 19.71 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -111.6 -23.62 10.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.183 1.793 . . . . 0.0 114.433 166.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.34 95.15 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.085 1.354 . . . . 0.0 108.777 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.8 t -80.34 -48.96 12.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -167.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -165.6 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.431 1.492 . . . . 0.0 110.973 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -83.99 -31.16 25.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.52 -124.43 0.73 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.683 1.611 . . . . 0.0 111.608 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.463 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -77.25 141.96 39.75 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.41 -0.8 57.32 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.365 0.666 . . . . 0.0 112.743 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.69 81.69 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.074 1.321 . . . . 0.0 115.29 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -137.19 30.23 2.71 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.734 1.254 . . . . 0.0 113.307 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.72 19.31 58.32 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 125.111 1.339 . . . . 0.0 113.793 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.34 161.0 40.67 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.97 1.708 . . . . 0.0 112.658 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -132.92 159.38 40.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.04 -162.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 tptt 58.16 22.38 9.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.204 1.802 . . . . 0.0 115.019 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 53.04 29.19 7.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.088 1.755 . . . . 0.0 114.041 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.972 1.309 . . . . 0.0 113.976 174.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -83.14 -13.44 55.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.53 1.132 . . . . 0.0 112.963 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.8 mt -75.67 138.94 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.696 1.198 . . . . 0.0 110.119 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.99 154.29 41.93 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.485 1.114 . . . . 0.0 112.722 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 82.1 p -150.86 17.62 0.78 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -164.63 166.75 19.88 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.806 2.042 . . . . 0.0 115.159 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.12 124.62 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 149.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.41 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.81 -13.56 0.04 OUTLIER Glycine 0 CA--C 1.541 1.659 0 C-N-CA 127.239 2.352 . . . . 0.0 113.383 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.37 -16.79 61.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.35 2.26 . . . . 0.0 115.157 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.9 tt -140.44 -33.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.23 32.89 57.68 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.94 0.781 . . . . 0.0 114.605 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -158.45 0.67 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.707 1.603 . . . . 0.0 113.786 -168.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -138.03 -161.94 1.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.024 1.729 . . . . 0.0 111.397 -143.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.786 1.234 . . . . 0.0 113.541 168.589 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 36.9 m -67.48 150.51 97.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.517 1.127 . . . . 0.0 113.073 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.13 166.92 25.15 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.58 2.853 . . . . 0.0 112.686 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -69.56 -19.37 63.68 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.2 m -133.04 133.47 43.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.738 1.615 . . . . 0.0 110.817 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -108.25 1.84 22.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.55 120.83 22.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.954 1.302 . . . . 0.0 111.228 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -81.92 54.12 2.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.699 1.6 . . . . 0.0 111.916 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.72 147.7 48.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.884 1.274 . . . . 0.0 112.243 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.65 31.45 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.521 1.928 . . . . 0.0 113.144 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.21 130.63 40.67 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.732 -1.23 . . . . 0.0 110.769 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -152.18 178.49 9.43 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.0 135.74 4.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.122 2.169 . . . . 0.0 108.355 161.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.53 164.93 27.92 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -123.99 -26.39 4.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.75 1.62 . . . . 0.0 114.775 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.85 104.19 1.03 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.787 0.804 . . . . 0.0 112.408 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.7 t -84.47 160.09 20.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.134 0.974 . . . . 0.0 109.498 153.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -18.5 65.41 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.938 -1.102 . . . . 0.0 112.009 169.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -82.38 -16.23 49.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.375 1.47 . . . . 0.0 112.84 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.55 -101.32 0.92 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.488 1.518 . . . . 0.0 111.114 -171.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -97.28 146.05 25.51 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.66 -4.43 57.76 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.56 6.39 87.45 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.166 1.365 . . . . 0.0 115.098 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.7 p -114.24 4.49 15.5 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.591 1.556 . . . . 0.0 113.592 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.8 54.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.652 1.596 . . . . 0.0 113.952 -172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -109.69 175.73 5.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.581 1.553 . . . . 0.0 113.409 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p -141.86 165.64 26.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.91 -163.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt 63.59 30.89 14.93 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 157.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 56.93 25.19 10.26 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.681 1.993 . . . . 0.0 115.472 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.012 1.325 . . . . 0.0 113.577 169.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.725 0.297 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -135.94 165.83 24.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.036 1.734 . . . . 0.0 111.048 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.65 158.6 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.379 1.472 . . . . 0.0 111.393 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.9 p -62.34 142.39 57.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.696 1.199 . . . . 0.0 112.448 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 71.2 m -130.39 70.08 1.45 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.918 1.287 . . . . 0.0 111.568 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.21 145.4 2.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.338 1.855 . . . . 0.0 114.479 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.56 124.43 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.489 1.116 . . . . 0.0 109.256 -173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.407 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.68 -26.54 0.02 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.688 1.613 . . . . 0.0 114.433 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -72.88 -29.53 63.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.97 -34.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.65 1.18 . . . . 0.0 112.531 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.42 31.81 62.91 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.573 1.083 . . . . 0.0 114.673 166.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -105.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.82 2.048 . . . . 0.0 114.271 -163.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -69.79 126.92 31.14 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.772 2.029 . . . . 0.0 111.131 -173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.888 2.075 . . . . 0.0 113.887 -160.025 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 22.2 m -67.58 148.78 98.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.34 1.056 . . . . 0.0 112.982 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.77 154.29 73.53 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.184 2.589 . . . . 0.0 112.129 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.8 t30 50.4 45.91 25.76 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.554 1.542 . . . . 0.0 113.36 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -66.28 155.41 37.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.413 1.085 . . . . 0.0 112.88 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mtp -80.6 62.14 4.56 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.553 1.541 . . . . 0.0 112.639 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.68 -13.2 29.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.707 1.203 . . . . 0.0 113.864 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.1 p -81.32 -7.02 59.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.981 2.112 . . . . 0.0 114.176 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -59.45 147.27 37.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.944 1.298 . . . . 0.0 112.562 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.96 34.88 0.15 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.918 2.087 . . . . 0.0 112.991 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.0 134.54 49.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 110.32 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.77 178.67 9.63 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.41 133.53 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.254 2.222 . . . . 0.0 108.312 168.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.6 165.75 13.91 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.1 -24.93 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.971 1.708 . . . . 0.0 114.698 165.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.58 109.8 1.28 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.012 0.925 . . . . 0.0 110.349 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.4 p -119.47 169.59 9.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.302 1.441 . . . . 0.0 111.253 168.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -25.45 23.63 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -166.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -111.45 1.36 16.92 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.26 1.424 . . . . 0.0 114.717 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.29 -107.97 1.29 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.952 1.739 . . . . 0.0 111.125 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.494 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -81.49 128.13 33.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.9 0.29 51.61 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -163.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.6 89.12 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.613 1.578 . . . . 0.0 115.211 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.3 p -118.6 8.23 11.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.487 1.515 . . . . 0.0 113.533 -173.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.91 12.85 54.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.148 1.356 . . . . 0.0 113.96 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -127.99 176.46 7.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.804 1.642 . . . . 0.0 112.815 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m -118.25 155.34 30.74 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.369 1.068 . . . . 0.0 111.673 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.63 -163.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 60.78 16.87 7.13 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.475 1.91 . . . . 0.0 115.49 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 52.66 26.79 4.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.552 1.941 . . . . 0.0 114.425 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.379 1.071 . . . . 0.0 113.751 176.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.315 0.102 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -138.8 158.08 44.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.862 1.665 . . . . 0.0 111.692 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.14 132.67 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.489 1.516 . . . . 0.0 109.458 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -72.73 130.42 40.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.421 1.088 . . . . 0.0 112.334 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -95.03 44.26 1.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.749 1.22 . . . . 0.0 113.407 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -43.2 139.34 1.91 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.16 2.184 . . . . 0.0 114.4 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 4.1 p -61.34 118.1 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 109.406 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.494 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.68 -16.95 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.993 1.758 . . . . 0.0 114.158 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -73.4 -14.55 61.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.555 1.942 . . . . 0.0 114.678 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -146.56 -35.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.13 38.99 63.32 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.283 0.944 . . . . 0.0 113.893 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 -146.96 0.2 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.655 1.582 . . . . 0.0 113.51 -169.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -139.41 178.08 7.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -143.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.379 1.872 . . . . 0.0 113.503 175.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 51.0 p -73.58 155.14 89.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.731 1.213 . . . . 0.0 112.797 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.36 -20.89 20.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.053 2.502 . . . . 0.0 113.322 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -148.27 140.06 23.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.61 1.564 . . . . 0.0 110.986 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -74.63 -9.05 58.19 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -111.66 24.37 12.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.124 1.77 . . . . 0.0 112.999 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.02 135.82 57.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.454 1.121 . . . . 0.0 111.377 168.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.2 p -101.76 -12.08 18.62 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.72 162.66 29.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.24 90.52 4.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.601 1.16 . . . . 0.0 108.096 166.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 89.72 7.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.242 1.017 . . . . 0.0 110.328 -169.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -142.76 -176.67 4.97 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.878 1.271 . . . . 0.0 112.689 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.42 136.29 5.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.295 1.838 . . . . 0.0 108.541 163.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.09 165.74 21.35 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -116.29 -45.62 2.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.838 1.655 . . . . 0.0 113.592 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.2 100.78 2.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 112.221 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -93.77 162.06 14.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.943 1.297 . . . . 0.0 110.888 162.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -21.99 33.07 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 114.788 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -103.54 -7.93 20.46 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.186 1.395 . . . . 0.0 114.14 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.07 -107.92 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.662 1.601 . . . . 0.0 111.605 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG21 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.44 ' H ' HG21 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.559 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.2 140.35 29.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.35 -3.04 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 8.44 84.24 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.169 1.366 . . . . 0.0 115.094 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.0 p -119.95 18.69 12.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.552 1.541 . . . . 0.0 113.549 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 17.86 56.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.944 1.259 . . . . 0.0 113.838 -175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -134.21 171.23 14.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.258 1.823 . . . . 0.0 113.12 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m -128.45 157.77 40.18 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.266 1.426 . . . . 0.0 112.136 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -167.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 67.42 23.76 9.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 154.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 57.3 29.21 16.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.295 1.838 . . . . 0.0 115.446 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.182 1.393 . . . . 0.0 113.099 168.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -127.32 -39.93 1.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.173 1.789 . . . . 0.0 112.074 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 16.2 tt -67.75 169.98 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.273 1.429 . . . . 0.0 110.875 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.8 p -56.36 134.97 54.01 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.78 -1.2 . . . . 0.0 111.592 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.0 m -158.74 106.92 1.89 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.536 1.134 . . . . 0.0 110.354 -150.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -47.67 118.7 2.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 88' ' ' SER . 5.1 t -51.02 129.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.239 1.416 . . . . 0.0 111.726 -157.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.559 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -166.54 -12.43 0.03 OUTLIER Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.873 2.654 . . . . 0.0 113.299 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -71.3 -20.63 62.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.994 2.117 . . . . 0.0 115.141 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 18.6 tt -135.92 -40.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 41.27 73.95 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.925 0.774 . . . . 0.0 113.842 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -105.09 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.028 2.131 . . . . 0.0 113.327 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -61.91 113.31 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.249 2.62 . . . . 0.0 111.294 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.498 2.719 . . . . 0.0 113.807 178.364 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.6 t -68.55 140.62 92.38 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.762 0.825 . . . . 0.0 112.07 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.85 -16.38 54.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.236 2.624 . . . . 0.0 114.345 170.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.45 -51.1 7.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.365 1.066 . . . . 0.0 112.178 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 40.6 t -160.89 160.29 30.77 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 111.421 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm -67.98 -24.69 65.17 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.585 0.754 . . . . 0.0 112.016 166.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.19 -19.64 31.41 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.716 1.206 . . . . 0.0 113.901 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.1 p -84.06 85.4 7.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.242 1.017 . . . . 0.0 110.844 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -130.71 150.18 52.01 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 111.723 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.284 0.4 OUTLIER -90.84 25.64 2.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.336 1.854 . . . . 0.0 114.609 -174.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -46.03 126.62 7.66 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.2 1.8 . . . . 0.0 113.624 -175.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -150.17 -178.93 6.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.675 1.19 . . . . 0.0 113.445 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -164.17 132.5 3.56 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.233 2.213 . . . . 0.0 108.87 159.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.02 158.56 18.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -95.83 -40.56 9.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.853 2.061 . . . . 0.0 112.276 163.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.41 104.59 2.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.809 1.29 . . . . 0.0 109.954 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 t -100.53 177.6 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.841 -1.981 . . . . 0.0 111.266 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 122.98 19.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.16 0.984 . . . . 0.0 110.489 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.276 0.6 OUTLIER 61.16 24.75 14.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.998 2.119 . . . . 0.0 115.214 -173.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.6 -92.15 0.29 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.15 1.357 . . . . 0.0 113.956 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 HG21 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.425 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.434 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.19 129.9 35.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.09 1.14 29.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.121 1.369 . . . . 0.0 113.503 -167.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.68 13.0 65.77 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.382 1.467 . . . . 0.0 114.824 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.25 6.4 t -136.52 22.91 3.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.643 1.177 . . . . 0.0 113.551 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 22.86 50.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.9 1.238 . . . . 0.0 113.262 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -139.52 146.42 39.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.698 1.599 . . . . 0.0 112.029 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -92.63 154.41 18.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.104 0.865 . . . . 0.0 112.156 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -155.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.6 tptp 59.24 21.49 9.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.054 1.742 . . . . 0.0 114.911 174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 53.67 28.12 7.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.401 1.88 . . . . 0.0 114.477 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.414 1.086 . . . . 0.0 113.791 176.753 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.85 169.85 17.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.952 1.301 . . . . 0.0 112.523 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 77.9 mt -75.82 140.69 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 109.334 166.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -84.83 174.1 10.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.049 1.739 . . . . 0.0 113.042 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -75.93 44.19 0.3 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.456 1.902 . . . . 0.0 114.897 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.71 162.48 1.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 130.097 3.359 . . . . 0.0 114.435 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.91 118.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.434 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.33 -21.58 0.04 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.53 2.014 . . . . 0.0 112.998 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -72.2 -11.38 60.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.483 2.313 . . . . 0.0 114.605 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.25 -59.58 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.355 1.462 . . . . 0.0 110.805 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.76 35.2 19.93 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.961 1.267 . . . . 0.0 114.345 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.33 -156.7 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.35 1.86 . . . . 0.0 114.675 -169.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -135.88 -154.09 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.257 1.823 . . . . 0.0 111.76 -139.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.27 1.828 . . . . 0.0 113.164 171.504 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.9 m -67.37 148.89 98.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.371 1.068 . . . . 0.0 112.929 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.04 161.6 45.51 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.49 2.793 . . . . 0.0 112.775 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -73.09 163.88 27.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.212 1.005 . . . . 0.0 111.68 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 39.6 t -62.46 144.44 55.92 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.183 0.993 . . . . 0.0 112.282 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.46 0.53 45.88 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.733 1.213 . . . . 0.0 113.316 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.17 14.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.413 1.485 . . . . 0.0 114.873 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.1 p -76.2 -15.59 60.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.21 1.404 . . . . 0.0 113.676 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.63 150.64 20.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.098 1.759 . . . . 0.0 111.131 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.27 -46.71 89.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 40.82 45.27 2.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.276 2.23 . . . . 0.0 113.266 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -77.15 172.84 12.6 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -167.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -165.68 122.44 1.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.941 1.696 . . . . 0.0 108.735 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.01 171.44 10.44 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -123.83 -50.43 1.83 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.175 1.79 . . . . 0.0 113.556 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.64 107.81 4.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 122.318 1.056 . . . . 0.0 112.593 -167.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.6 p -106.66 169.26 8.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.405 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -16.44 59.07 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -103.13 -16.86 15.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.793 1.237 . . . . 0.0 113.439 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.09 -111.61 1.39 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.576 1.56 . . . . 0.0 111.591 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG21 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -84.7 141.02 30.88 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.64 -5.04 59.29 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 165.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 0.03 88.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.402 1.477 . . . . 0.0 115.19 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -109.24 12.14 25.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.306 1.442 . . . . 0.0 113.14 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.11 52.3 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.341 1.448 . . . . 0.0 113.79 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -132.5 152.71 51.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.964 1.706 . . . . 0.0 112.941 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m -124.42 157.21 35.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.393 1.077 . . . . 0.0 113.345 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.01 -158.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp 64.83 4.33 2.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 165.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 53.9 29.52 10.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.021 2.129 . . . . 0.0 114.599 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.004 1.722 . . . . 0.0 112.806 -176.908 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -71.02 140.15 50.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.097 0.959 . . . . 0.0 111.762 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.3 mt -85.96 134.91 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.646 1.179 . . . . 0.0 109.819 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.7 p -82.01 153.29 26.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.324 1.45 . . . . 0.0 113.067 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -78.84 49.66 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.66 1.584 . . . . 0.0 113.024 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -45.77 144.28 1.77 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.467 2.707 . . . . 0.0 114.949 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.87 142.13 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 166.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -131.42 7.06 5.63 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 114.732 -1.122 . . . . 0.0 114.287 -171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -150.62 -40.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -168.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 18.4 tt -90.65 -33.98 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -163.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.13 39.37 92.68 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 123.884 0.754 . . . . 0.0 113.472 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.67 -161.43 0.86 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 114.628 -165.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -138.77 -176.31 4.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -135.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 128.85 2.86 . . . . 0.0 114.826 -178.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 p -74.14 152.74 88.42 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.727 1.211 . . . . 0.0 112.921 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 152.97 62.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 112.698 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -78.61 153.91 30.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.235 1.014 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.7 t -153.81 147.22 24.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.389 1.476 . . . . 0.0 111.346 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -62.35 -18.56 61.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.419 1.088 . . . . 0.0 112.796 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.83 -1.04 29.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.87 1.268 . . . . 0.0 114.282 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -73.53 -9.88 59.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -142.73 167.36 22.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.19 1.396 . . . . 0.0 112.437 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.0 mt -82.63 52.25 2.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 112.037 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 31.63 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.973 1.309 . . . . 0.0 114.278 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -100.23 179.56 4.44 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -164.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.77 132.65 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.036 2.134 . . . . 0.0 108.399 163.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.61 155.45 24.28 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -99.33 -25.96 14.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.557 1.543 . . . . 0.0 114.16 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.81 102.82 0.79 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.895 1.278 . . . . 0.0 109.885 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -89.84 162.57 15.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.338 1.055 . . . . 0.0 111.479 170.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -21.94 14.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.356 2.262 . . . . 0.0 116.038 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -115.99 -0.18 12.86 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.463 1.505 . . . . 0.0 114.172 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.47 -93.96 0.3 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.789 1.662 . . . . 0.0 110.685 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.507 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -90.82 146.44 23.94 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.89 -2.88 58.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.89 89.8 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.122 1.344 . . . . 0.0 115.261 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -113.16 13.48 19.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.635 1.574 . . . . 0.0 113.355 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.7 14.01 53.84 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.356 1.455 . . . . 0.0 113.969 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -132.44 172.25 12.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.854 1.662 . . . . 0.0 113.537 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -120.27 158.67 26.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.97 1.708 . . . . 0.0 113.187 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -166.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 tptt 61.37 14.68 5.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.674 1.99 . . . . 0.0 115.325 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.46 25.37 6.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.235 2.214 . . . . 0.0 114.543 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 172.851 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 62.82 -43.17 0.19 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.065 2.946 . . . . 0.0 116.394 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 59.5 mt -129.19 134.7 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.073 1.749 . . . . 0.0 109.492 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.0 p -99.01 166.31 11.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.699 1.6 . . . . 0.0 112.586 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -80.54 45.62 0.79 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.2 1.4 . . . . 0.0 114.709 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -51.46 145.72 8.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.809 2.044 . . . . 0.0 112.554 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.24 124.94 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.627 0.727 . . . . 0.0 109.397 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.507 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.88 -31.59 0.02 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.311 1.434 . . . . 0.0 113.72 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -75.3 -19.11 59.85 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 mm -90.42 -52.33 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.391 1.077 . . . . 0.0 110.589 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.02 54.41 6.41 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.827 1.204 . . . . 0.0 112.65 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.64 -159.93 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.846 1.658 . . . . 0.0 111.392 -171.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.257 34.5 mmt180 52.92 60.6 3.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.095 1.758 . . . . 0.0 114.045 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 127.761 2.424 . . . . 0.0 114.618 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 41.6 m -66.79 149.09 98.57 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.459 1.103 . . . . 0.0 112.95 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.03 156.76 61.87 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.213 2.608 . . . . 0.0 112.562 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -79.72 -10.24 59.76 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 91.4 p -143.01 161.58 37.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.354 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp -83.92 41.84 0.83 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.464 1.506 . . . . 0.0 112.862 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.73 -16.38 60.96 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.0 p -88.02 -11.52 47.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.836 1.655 . . . . 0.0 114.07 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -95.52 158.08 15.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.9 1.68 . . . . 0.0 112.678 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.73 38.29 0.1 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.51 2.324 . . . . 0.0 112.534 172.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -69.44 135.34 50.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.683 1.593 . . . . 0.0 111.239 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.54 178.56 9.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.311 1.044 . . . . 0.0 113.158 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.57 133.18 4.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.176 2.19 . . . . 0.0 108.873 169.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.42 158.48 14.72 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -102.09 -23.25 14.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.07 105.35 0.9 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.26 1.024 . . . . 0.0 110.037 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 t -90.59 163.14 14.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 111.194 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -31.39 9.64 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.9 2.08 . . . . 0.0 115.23 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -128.41 84.9 2.28 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.788 1.635 . . . . 0.0 108.259 167.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.58 -93.69 0.1 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.943 1.735 . . . . 0.0 113.677 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 86' ' ' THR . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.435 ' H ' HG21 ' A' ' 85' ' ' VAL . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -77.06 141.85 40.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.13 -2.76 45.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.366 1.066 . . . . 0.0 112.26 167.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.77 1.69 87.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.409 1.957 . . . . 0.0 115.256 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.1 p -96.74 -15.26 21.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.449 1.099 . . . . 0.0 112.905 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.01 -20.22 13.1 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.169 1.842 . . . . 0.0 112.986 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -86.22 158.76 19.66 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.152 1.476 . . . . 0.0 112.539 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m -126.35 155.88 41.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -163.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 70.49 8.57 6.65 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 163.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.7 25.94 6.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.223 2.209 . . . . 0.0 114.499 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.884 1.674 . . . . 0.0 113.026 177.862 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.24 -17.58 48.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.705 1.202 . . . . 0.0 113.227 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.32 133.58 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.624 1.569 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -85.67 139.17 31.61 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.603 1.161 . . . . 0.0 113.338 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 46.3 m -81.88 57.37 3.43 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.263 1.825 . . . . 0.0 112.161 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -50.34 141.32 11.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.137 2.175 . . . . 0.0 114.598 -168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.2 139.72 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.543 1.137 . . . . 0.0 109.665 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.3 -8.63 0.52 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 126.343 1.925 . . . . 0.0 115.237 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.83 -27.09 3.38 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -173.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.2 tt -77.65 -34.96 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.482 1.492 . . . . 0.0 112.54 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.26 48.7 80.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.131 0.872 . . . . 0.0 112.6 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -147.45 0.25 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 111.988 -166.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.558 0.0 OUTLIER 63.27 -67.19 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.812 2.845 . . . . 0.0 114.203 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.868 1.667 . . . . 0.0 114.884 -170.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -151.39 178.99 1.34 Allowed Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 126.279 1.832 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -57.35 -22.84 51.73 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.391 2.061 . . . . 0.0 114.04 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -70.87 -27.74 64.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.097 0.959 . . . . 0.0 112.305 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 m -71.63 -9.4 58.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.021 1.329 . . . . 0.0 113.609 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.12 -9.21 58.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.554 1.142 . . . . 0.0 113.658 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.3 -13.29 60.41 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -81.55 75.71 8.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.725 1.21 . . . . 0.0 112.018 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -126.79 154.12 44.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.243 1.817 . . . . 0.0 111.721 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.98 35.28 0.1 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.947 2.099 . . . . 0.0 112.76 174.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -71.01 129.5 39.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.524 1.129 . . . . 0.0 110.562 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.403 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.2 p90 -146.76 177.01 9.43 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -167.6 127.87 1.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.249 2.22 . . . . 0.0 109.059 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.67 163.12 24.09 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -115.16 -27.7 7.2 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.529 1.532 . . . . 0.0 115.057 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.37 104.79 1.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.73 0.776 . . . . 0.0 111.876 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 t -96.28 162.9 13.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.978 1.311 . . . . 0.0 110.851 160.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -22.0 32.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.638 1.975 . . . . 0.0 114.871 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -104.51 -5.84 21.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.209 1.404 . . . . 0.0 114.123 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.5 -105.69 0.98 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.539 1.542 . . . . 0.0 111.489 -172.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG21 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG21 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -74.21 134.62 42.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -90.45 7.15 40.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.57 86.51 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.366 1.46 . . . . 0.0 115.683 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -118.39 15.26 13.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.485 1.514 . . . . 0.0 113.638 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.18 16.85 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.1 1.333 . . . . 0.0 113.814 -174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -136.77 174.34 10.72 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.249 1.82 . . . . 0.0 112.969 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -112.29 158.42 19.76 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.105 1.362 . . . . 0.0 112.998 168.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -157.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mmmp? 63.27 7.03 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 52.67 26.14 4.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 114.681 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.654 1.582 . . . . 0.0 114.683 -176.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -76.41 157.02 32.68 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.162 0.892 . . . . 0.0 111.91 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.2 tt -72.33 154.6 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.138 0.975 . . . . 0.0 112.156 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 47.5 p -134.24 151.04 51.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.519 1.528 . . . . 0.0 111.844 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 47.1 m -131.37 52.43 2.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.05 1.34 . . . . 0.0 112.055 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -50.12 135.68 20.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.421 1.888 . . . . 0.0 112.014 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 88' ' ' SER . 3.5 t -52.7 140.06 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.16 0.984 . . . . 0.0 111.603 -164.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.463 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -158.46 23.66 0.36 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 111.624 -2.535 . . . . 0.0 112.967 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -144.03 -37.87 0.32 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.0 tp -79.96 -34.51 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.2 0.909 . . . . 0.0 112.873 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.04 49.36 58.67 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.872 1.225 . . . . 0.0 113.521 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.13 -137.57 0.37 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.527 1.531 . . . . 0.0 113.247 -165.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 62.19 169.43 0.12 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.466 3.507 . . . . 0.0 113.794 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.295 1.838 . . . . 0.0 110.885 176.211 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 77.8 p -146.09 155.08 51.09 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.393 1.477 . . . . 0.0 112.118 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.15 -23.93 13.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.004 2.469 . . . . 0.0 113.354 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -151.98 152.05 31.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.196 1.798 . . . . 0.0 109.759 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.8 m -61.93 -20.82 64.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -95.89 -8.68 33.36 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.434 1.494 . . . . 0.0 113.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 -14.41 62.55 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.1 p -83.1 -10.06 58.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.485 1.514 . . . . 0.0 113.533 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -107.83 159.52 16.45 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.553 1.941 . . . . 0.0 111.648 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.56 49.75 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.727 1.611 . . . . 0.0 111.53 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.47 43.55 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.502 1.921 . . . . 0.0 112.903 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -84.82 178.37 7.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.357 1.063 . . . . 0.0 113.1 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.72 130.88 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.214 2.205 . . . . 0.0 109.14 163.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -83.4 163.41 14.82 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -110.3 -24.24 10.76 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.792 1.637 . . . . 0.0 114.573 165.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.37 105.63 0.99 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.162 0.985 . . . . 0.0 110.538 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.4 t -100.3 164.96 11.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.689 1.596 . . . . 0.0 111.494 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.06 -28.83 4.42 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.086 2.554 . . . . 0.0 116.66 -173.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -126.8 24.74 6.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.322 1.449 . . . . 0.0 114.902 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.02 -97.59 0.67 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.748 1.642 . . . . 0.0 112.501 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 86' ' ' THR . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 85' ' ' VAL . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.552 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -74.15 135.47 42.86 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.81 1.82 52.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.383 0.992 . . . . 0.0 113.478 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.04 -0.45 87.34 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.373 1.463 . . . . 0.0 115.699 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.3 p -113.34 14.27 19.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.42 1.488 . . . . 0.0 113.439 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.72 15.57 54.33 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.379 1.466 . . . . 0.0 113.971 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -135.28 174.24 10.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.146 1.779 . . . . 0.0 112.902 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -115.99 153.99 30.65 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 112.779 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.41 179.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 tptp 67.68 5.86 4.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 165.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 51.82 31.46 8.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.576 2.35 . . . . 0.0 114.388 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.132 1.373 . . . . 0.0 113.683 175.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -132.56 152.84 51.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.441 1.497 . . . . 0.0 111.126 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 80.6 mt -76.71 129.11 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.862 0.865 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 50.1 m -115.19 -2.75 12.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.796 2.039 . . . . 0.0 114.619 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m 61.94 30.79 18.18 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.882 3.273 . . . . 0.0 114.394 -166.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -59.25 160.96 5.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 129.386 3.074 . . . . 0.0 113.891 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -78.3 139.78 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 122.029 0.919 . . . . 0.0 109.31 157.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.552 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.4 -11.18 0.15 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 127.687 2.565 . . . . 0.0 114.784 168.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.5 -29.83 8.58 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.737 2.268 . . . . 0.0 116.256 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -81.37 -35.5 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.007 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.16 48.64 78.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.33 0.967 . . . . 0.0 112.901 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -162.05 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.933 2.093 . . . . 0.0 110.983 -169.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 59.01 -164.99 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.409 167.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.598 1.959 . . . . 0.0 110.936 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -67.99 149.17 98.29 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 112.999 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.04 167.22 26.7 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.525 2.817 . . . . 0.0 112.184 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.15 -29.65 69.91 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.61 0.764 . . . . 0.0 112.689 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.9 m -76.35 74.55 3.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.398 1.479 . . . . 0.0 111.108 171.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -63.23 -20.95 65.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.385 1.074 . . . . 0.0 113.845 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.75 137.56 54.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 149.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.7 p -100.05 -30.1 12.16 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.28 137.83 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.404 2.282 . . . . 0.0 113.243 -160.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.2 mt -112.02 -6.8 14.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.441 1.496 . . . . 0.0 113.001 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 48.77 56.63 7.38 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.676 1.991 . . . . 0.0 113.472 172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -123.65 -179.23 4.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.964 1.305 . . . . 0.0 113.319 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -166.94 134.84 2.58 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.822 2.049 . . . . 0.0 108.256 163.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.2 162.09 20.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -110.48 -28.09 8.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.529 1.532 . . . . 0.0 114.675 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.51 105.78 0.97 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.742 0.782 . . . . 0.0 111.66 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -88.86 155.99 19.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.458 1.103 . . . . 0.0 109.584 156.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -20.2 66.37 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.819 -1.175 . . . . 0.0 113.147 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.67 -10.81 47.19 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.118 1.367 . . . . 0.0 113.345 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.47 -99.11 0.54 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 126.606 2.051 . . . . 0.0 111.385 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -76.87 135.67 38.85 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.06 -18.2 47.46 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.219 -0.926 . . . . 0.0 113.329 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.56 86.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.974 1.273 . . . . 0.0 115.02 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.4 p -107.61 15.03 25.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.293 1.437 . . . . 0.0 113.271 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.6 16.58 54.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.083 1.325 . . . . 0.0 113.852 -173.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -136.35 175.08 9.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.171 1.789 . . . . 0.0 112.689 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -132.03 154.33 49.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.414 1.086 . . . . 0.0 112.604 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.44 -161.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.276 18.4 tptp 65.34 10.2 6.32 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 153.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 52.97 36.81 22.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 0.0 113.919 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.73 1.212 . . . . 0.0 113.551 177.15 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -123.2 22.53 9.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.28 1.432 . . . . 0.0 113.257 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.4 mt -68.42 133.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.513 1.125 . . . . 0.0 109.875 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.2 p -78.64 141.17 38.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 112.607 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 27.2 m -83.32 45.0 0.99 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.284 1.434 . . . . 0.0 114.171 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -44.17 136.49 3.88 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.601 2.36 . . . . 0.0 112.956 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.29 117.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.118 0.967 . . . . 0.0 109.315 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.424 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.3 -14.42 0.04 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 127.053 2.263 . . . . 0.0 113.89 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -67.64 -15.49 63.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.136 2.174 . . . . 0.0 114.689 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.81 -33.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.045 1.338 . . . . 0.0 113.579 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.02 30.02 63.89 Favored Glycine 0 N--CA 1.478 1.459 0 C-N-CA 124.278 0.942 . . . . 0.0 114.04 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -163.86 1.1 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.104 1.762 . . . . 0.0 113.928 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.58 -70.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -137.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.852 1.661 . . . . 0.0 111.693 -178.333 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.7 m -67.9 147.76 98.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.366 1.066 . . . . 0.0 113.005 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.42 159.6 51.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.505 2.803 . . . . 0.0 112.552 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -72.88 151.5 41.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.106 0.962 . . . . 0.0 112.337 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.5 t -154.2 155.9 36.13 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.863 1.265 . . . . 0.0 112.098 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm -77.5 -11.71 59.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.133 . . . . 0.0 112.968 170.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.7 59.53 1.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.72 1.608 . . . . 0.0 112.268 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -88.57 -4.49 58.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.317 1.447 . . . . 0.0 114.688 -170.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.02 164.28 26.92 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.98 84.86 3.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.352 1.061 . . . . 0.0 108.593 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -82.93 39.07 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.859 1.264 . . . . 0.0 114.059 -163.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -86.4 -179.78 6.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.002 1.321 . . . . 0.0 113.414 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -167.14 129.18 1.66 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.707 2.403 . . . . 0.0 108.24 162.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.91 162.6 20.86 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -116.22 -29.26 6.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.646 1.579 . . . . 0.0 114.683 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.29 103.43 0.96 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.675 0.75 . . . . 0.0 111.569 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -94.93 162.69 13.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.851 1.261 . . . . 0.0 110.812 161.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.44 -22.25 42.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.956 2.103 . . . . 0.0 114.848 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmt-85 -103.68 -7.86 20.37 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 0.0 114.247 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.95 -106.43 0.91 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.584 1.564 . . . . 0.0 111.592 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.36 146.95 29.1 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -97.22 3.12 51.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.03 7.07 86.6 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.789 1.185 . . . . 0.0 115.808 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.26 6.5 t -127.45 30.55 5.34 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.414 1.485 . . . . 0.0 112.909 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.43 57.14 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.349 1.452 . . . . 0.0 113.942 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -144.5 170.23 16.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 113.552 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -132.34 161.87 32.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.498 1.519 . . . . 0.0 113.551 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.06 -157.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt 58.24 20.63 7.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.641 1.576 . . . . 0.0 114.41 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 54.32 29.28 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.085 1.754 . . . . 0.0 113.828 -173.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 124.902 1.281 . . . . 0.0 113.738 178.459 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 50.71 -96.39 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.116 1.767 . . . . 0.0 113.187 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 9.3 tp -148.98 155.84 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.738 1.615 . . . . 0.0 110.422 171.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -97.93 132.44 43.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.129 1.372 . . . . 0.0 111.372 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.4 m -138.59 66.96 1.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.489 1.116 . . . . 0.0 111.456 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -43.3 138.87 2.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 112.709 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 p -62.23 119.02 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.724 0.773 . . . . 0.0 109.165 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.83 -36.85 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.009 0.814 . . . . 0.0 114.944 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -78.16 -15.18 59.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 40.3 mt -97.46 -60.25 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.217 1.007 . . . . 0.0 111.665 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.77 38.63 Favored Glycine 0 N--CA 1.476 1.31 0 C-N-CA 125.383 1.468 . . . . 0.0 115.218 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -151.06 0.42 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.736 1.614 . . . . 0.0 114.121 -168.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -144.96 -179.68 6.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.2 1.8 . . . . 0.0 111.841 -146.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.434 170.686 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.5 t -149.93 141.67 15.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.97 1.308 . . . . 0.0 111.496 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.55 -14.64 42.86 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.449 2.766 . . . . 0.0 114.307 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -81.43 154.38 26.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.925 1.29 . . . . 0.0 112.529 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.1 m -65.27 127.38 31.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.308 1.043 . . . . 0.0 112.522 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -91.6 -4.26 55.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.435 1.094 . . . . 0.0 113.838 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 -6.71 12.22 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.192 1.397 . . . . 0.0 114.613 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -72.94 -15.27 61.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.981 1.312 . . . . 0.0 113.626 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.73 146.13 51.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.376 1.07 . . . . 0.0 112.204 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.8 mt -90.05 35.53 0.85 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.85 1.66 . . . . 0.0 112.214 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.28 105.04 17.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.618 1.167 . . . . 0.0 110.644 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.77 -174.97 5.19 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.056 1.342 . . . . 0.0 112.304 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.17 134.68 5.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.188 1.795 . . . . 0.0 108.713 159.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.03 160.57 20.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -111.2 -25.63 9.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.762 1.625 . . . . 0.0 114.601 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.73 106.17 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.928 0.871 . . . . 0.0 110.913 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.3 t -102.7 164.45 11.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.451 168.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -23.16 8.16 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.744 2.418 . . . . 0.0 116.963 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.28 19.66 8.97 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.24 -99.33 0.73 Allowed Glycine 0 N--CA 1.469 0.864 0 C-N-CA 125.454 1.502 . . . . 0.0 112.842 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -79.8 126.4 30.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -88.85 9.21 25.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -162.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.3 4.54 86.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.258 1.408 . . . . 0.0 115.661 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -129.73 27.13 5.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.063 1.345 . . . . 0.0 113.526 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.602 1.096 . . . . 0.0 113.734 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -142.31 175.12 10.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.174 1.79 . . . . 0.0 112.511 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m -108.81 160.32 16.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.052 . . . . 0.0 112.342 166.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.96 175.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 67.42 3.98 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 50.88 29.36 4.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.899 2.48 . . . . 0.0 114.938 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.381 1.072 . . . . 0.0 113.631 174.003 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.442 0.163 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -146.01 -44.31 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.983 1.313 . . . . 0.0 112.434 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.59 135.43 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.762 1.625 . . . . 0.0 108.944 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 16.4 p -75.65 148.29 38.82 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.396 1.079 . . . . 0.0 112.744 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -82.21 48.62 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.001 1.32 . . . . 0.0 113.136 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -56.49 169.74 0.43 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.532 2.333 . . . . 0.0 113.811 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.08 124.31 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 162.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.414 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.15 -14.8 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 127.356 2.408 . . . . 0.0 113.411 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -69.52 -16.92 63.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.068 2.147 . . . . 0.0 114.976 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.7 tp -123.85 -37.54 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.405 1.082 . . . . 0.0 113.254 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.5 67.63 1.72 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.137 0.875 . . . . 0.0 112.307 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -147.14 175.26 10.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -151.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -160.12 -43.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.742 2.417 . . . . 0.0 110.822 162.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.923 2.089 . . . . 0.0 111.214 164.901 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.7 m -67.65 149.45 98.29 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.435 1.094 . . . . 0.0 112.993 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.6 -24.66 13.51 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.174 2.582 . . . . 0.0 113.275 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -92.62 153.44 19.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 111.404 174.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 86.1 p -81.6 171.72 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.88 1.272 . . . . 0.0 113.131 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ttt -76.83 4.06 10.58 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.82 1.248 . . . . 0.0 113.591 178.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.98 -13.76 18.37 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.1 p -77.99 -14.78 59.4 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.316 1.447 . . . . 0.0 113.996 174.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.01 152.1 20.15 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.674 1.589 . . . . 0.0 112.055 176.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 9.16 9.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.537 1.535 . . . . 0.0 113.642 175.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.96 132.97 45.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.954 1.302 . . . . 0.0 111.677 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 17.2 p90 -150.98 177.88 9.72 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.92 136.01 4.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.512 2.325 . . . . 0.0 108.326 162.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.2 168.16 20.69 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -120.02 -48.4 2.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.846 1.658 . . . . 0.0 113.598 173.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 104.78 3.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.037 0.922 . . . . 0.0 112.719 -169.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -98.11 -151.8 0.38 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.675 1.59 . . . . 0.0 110.503 162.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.26 -43.29 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.113 0.965 . . . . 0.0 111.139 -163.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -85.2 -23.25 28.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.815 1.246 . . . . 0.0 112.768 166.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.6 -101.25 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.477 1.513 . . . . 0.0 113.287 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 HG21 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.458 ' H ' HG21 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.489 ' H ' HG23 ' B' ' 155' ' ' VAL . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -98.83 147.8 24.56 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.81 -6.74 59.57 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 172.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.58 4.6 89.04 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.044 1.307 . . . . 0.0 115.28 175.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.2 p -107.29 8.47 29.82 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.654 1.582 . . . . 0.0 113.347 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.26 7.59 51.78 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.646 1.593 . . . . 0.0 114.013 -172.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -119.67 169.59 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.637 1.575 . . . . 0.0 114.033 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -113.91 161.02 18.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.1 1.76 . . . . 0.0 112.423 173.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.58 -157.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.5 tttm 62.83 19.99 11.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 164.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 54.41 31.11 13.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.3 1.84 . . . . 0.0 114.064 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.894 1.677 . . . . 0.0 113.263 177.286 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.04 144.18 44.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.892 1.277 . . . . 0.0 111.056 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.8 mt -135.45 140.07 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.071 1.348 . . . . 0.0 110.399 -170.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 3.2 m -139.0 153.73 48.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.903 1.281 . . . . 0.0 109.893 164.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.3 m -156.89 29.94 0.31 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.014 1.726 . . . . 0.0 113.547 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -159.28 162.62 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.409 1.884 . . . . 0.0 112.757 170.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 88' ' ' SER . 7.4 p -86.94 142.92 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 143.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.447 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.27 -21.67 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 114.422 -1.263 . . . . 0.0 114.378 -177.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.04 -20.8 60.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 175.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -149.67 -47.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.05 54.51 6.98 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.117 0.871 . . . . 0.0 113.788 -174.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -98.88 -139.35 0.31 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.711 2.404 . . . . 0.0 114.423 -172.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.9 mmt-85 -139.43 -171.59 3.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.727 1.611 . . . . 0.0 112.109 -147.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.885 1.274 . . . . 0.0 113.093 168.625 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 47.4 t -149.23 144.86 18.43 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.118 1.367 . . . . 0.0 111.506 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.73 -8.14 21.06 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.443 2.762 . . . . 0.0 113.786 173.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.74 148.05 49.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.336 1.454 . . . . 0.0 112.354 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.7 t -149.06 151.29 34.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.03 1.332 . . . . 0.0 111.554 172.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt -116.29 3.21 13.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.664 1.586 . . . . 0.0 112.674 172.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.97 6.25 29.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.237 1.415 . . . . 0.0 113.936 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -86.35 -10.2 54.89 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.498 1.519 . . . . 0.0 114.857 -166.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.45 179.02 7.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.692 1.197 . . . . 0.0 113.485 177.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.92 37.03 0.14 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.476 1.911 . . . . 0.0 113.405 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.47 132.42 43.85 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 110.666 175.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -151.33 179.03 8.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.65 136.15 5.18 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.967 2.107 . . . . 0.0 109.07 165.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.8 171.5 13.08 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -126.25 -45.96 1.66 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.701 1.601 . . . . 0.0 113.547 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.9 96.15 2.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.163 0.982 . . . . 0.0 112.449 -169.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.4 t -90.83 162.37 14.86 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.733 1.213 . . . . 0.0 110.938 161.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.13 -20.47 26.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.289 1.836 . . . . 0.0 114.981 177.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -103.71 -9.47 19.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.226 1.41 . . . . 0.0 114.205 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.22 -109.75 1.4 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.422 1.486 . . . . 0.0 111.514 -172.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.428 HG21 ' H ' ' A' ' 86' ' ' THR . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.428 ' H ' HG21 ' A' ' 85' ' ' VAL . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -112.24 147.69 35.7 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -81.74 -7.55 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.63 6.44 83.18 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.283 1.42 . . . . 0.0 115.191 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.6 p -114.71 14.54 17.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.629 1.571 . . . . 0.0 113.624 -175.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.83 54.48 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.171 1.367 . . . . 0.0 113.815 -173.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -128.3 165.86 19.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.428 1.891 . . . . 0.0 112.889 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m -133.16 156.02 48.23 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 -175.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.7 178.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.8 tptt 64.94 -8.77 0.21 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.593 2.357 . . . . 0.0 117.286 -174.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 52.71 32.91 12.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.851 2.46 . . . . 0.0 113.803 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.619 1.567 . . . . 0.0 113.009 174.443 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -74.83 156.3 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 0.0 112.197 176.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 tp -72.46 157.73 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.171 0.988 . . . . 0.0 111.79 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.0 p -73.38 150.86 41.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.593 1.157 . . . . 0.0 112.67 175.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -82.45 44.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.515 1.526 . . . . 0.0 114.442 -172.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -46.0 137.33 5.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.969 2.508 . . . . 0.0 113.578 -170.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.96 116.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.847 0.832 . . . . 0.0 108.866 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -161.11 -31.5 0.02 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.652 1.596 . . . . 0.0 114.455 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -65.43 -27.29 68.42 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.4 1.1 . . . . 0.0 113.379 172.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 49.2 mm -98.09 -50.55 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.379 1.472 . . . . 0.0 109.748 170.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.36 63.54 2.9 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.469 1.509 . . . . 0.0 112.738 171.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -138.63 -160.28 1.04 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -138.24 -156.55 0.69 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.516 1.926 . . . . 0.0 110.643 -138.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.396 1.078 . . . . 0.0 113.194 166.791 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 95.0 p -77.6 165.46 51.19 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.473 1.109 . . . . 0.0 112.736 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.66 -22.22 66.3 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.244 2.63 . . . . 0.0 113.938 169.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.53 -7.82 59.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.06 1.744 . . . . 0.0 113.242 174.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.1 m 56.67 18.27 3.59 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.434 1.894 . . . . 0.0 114.771 -169.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt -159.04 126.41 4.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.796 2.038 . . . . 0.0 108.941 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.23 88.49 7.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.852 0.861 . . . . 0.0 110.708 174.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.18 53.69 1.51 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.903 1.681 . . . . 0.0 112.396 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.99 150.12 37.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.232 1.413 . . . . 0.0 112.08 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.24 33.99 0.69 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.731 1.613 . . . . 0.0 112.376 174.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -95.51 100.95 12.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -155.11 -173.91 4.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.833 1.253 . . . . 0.0 112.568 -176.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -162.31 136.51 6.57 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.389 1.475 . . . . 0.0 109.12 160.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.58 167.72 16.77 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -120.05 -46.09 2.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.616 1.966 . . . . 0.0 113.301 175.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.55 97.84 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.272 1.035 . . . . 0.0 111.903 -170.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -94.17 164.24 13.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.057 162.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -23.11 52.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.036 2.134 . . . . 0.0 114.805 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmt-85 -103.87 -9.09 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.136 1.374 . . . . 0.0 114.261 174.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.21 -111.09 1.29 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.662 1.601 . . . . 0.0 111.848 -177.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 55' ' ' THR . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 53' ' ' GLY . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 HG21 ' H ' ' A' ' 86' ' ' THR . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.417 ' H ' HG21 ' A' ' 85' ' ' VAL . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -106.62 147.96 28.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.8 -5.77 59.28 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.15 5.17 87.72 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.145 1.355 . . . . 0.0 115.295 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -111.65 12.16 21.15 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.51 1.524 . . . . 0.0 113.321 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.33 13.19 52.77 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.368 1.461 . . . . 0.0 113.857 -172.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -129.59 167.92 17.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.948 1.699 . . . . 0.0 113.559 -177.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -131.0 157.57 42.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.609 1.563 . . . . 0.0 113.293 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.69 -177.35 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.3 tttm 65.16 11.46 7.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 168.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 54.61 32.02 16.26 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.959 1.704 . . . . 0.0 114.007 168.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.354 1.862 . . . . 0.0 112.663 -178.026 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.789 0.328 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -137.64 152.95 49.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.744 1.618 . . . . 0.0 111.009 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -77.58 154.63 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.272 1.029 . . . . 0.0 111.929 176.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.0 p -93.83 136.15 34.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.3 1.44 . . . . 0.0 112.412 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 41.7 m -82.98 45.43 1.01 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.323 1.449 . . . . 0.0 113.247 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -51.23 152.28 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.713 2.405 . . . . 0.0 115.09 -166.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.12 125.18 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.696 1.198 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.451 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.42 -19.06 0.02 OUTLIER Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.971 2.224 . . . . 0.0 113.478 175.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -63.22 -26.11 68.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.363 1.465 . . . . 0.0 114.896 177.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.4 tt -109.93 -38.12 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.747 1.219 . . . . 0.0 112.956 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.75 2.06 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.374 0.987 . . . . 0.0 112.131 177.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -167.4 1.93 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.826 1.651 . . . . 0.0 110.854 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.29 31.4 mmt180 59.67 38.3 21.97 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.31 2.644 . . . . 0.0 113.941 174.655 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 70.1 m -131.38 150.03 75.26 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.482 1.513 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.24 152.35 66.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.416 2.744 . . . . 0.0 112.555 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.39 143.09 24.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.209 1.404 . . . . 0.0 111.033 177.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.7 m -65.18 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.19 -5.42 23.19 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 113.129 178.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.74 -5.09 58.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.751 1.22 . . . . 0.0 114.178 -178.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.5 p -77.66 -13.95 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.948 1.299 . . . . 0.0 114.414 -172.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -147.42 156.13 42.59 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.553 1.941 . . . . 0.0 110.725 175.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.65 18.34 0.98 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.168 1.387 . . . . 0.0 112.932 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.74 101.63 13.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.501 1.521 . . . . 0.0 110.54 -178.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -151.31 -174.97 4.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.679 1.191 . . . . 0.0 112.653 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.18 133.35 4.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.438 1.495 . . . . 0.0 108.676 161.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 156.5 27.76 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -102.99 -25.93 13.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.581 1.552 . . . . 0.0 114.361 169.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.66 102.79 0.81 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.639 1.176 . . . . 0.0 110.113 -176.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -90.61 162.35 15.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 0.0 111.432 169.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -21.69 12.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.264 2.226 . . . . 0.0 115.975 -176.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -114.72 -1.47 13.27 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.463 1.505 . . . . 0.0 114.235 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.42 -95.33 0.34 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.811 1.672 . . . . 0.0 110.711 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 55' ' ' THR . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 53' ' ' GLY . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.441 ' H ' HG21 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -89.04 146.14 25.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -84.98 -2.48 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.9 89.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.119 1.342 . . . . 0.0 115.245 174.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.3 p -113.8 13.66 18.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.612 1.565 . . . . 0.0 113.329 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 14.38 53.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.325 1.441 . . . . 0.0 113.886 -173.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -133.21 172.85 12.11 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.911 1.684 . . . . 0.0 113.55 -176.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -117.87 157.76 26.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 112.992 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.44 -154.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptp 63.65 16.05 9.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.259 2.224 . . . . 0.0 116.455 168.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 59.81 23.23 12.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.063 2.145 . . . . 0.0 114.789 171.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 114.545 -175.255 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 111.265 0.098 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 62.86 -47.95 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.812 2.845 . . . . 0.0 116.96 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.08 157.89 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.095 1.358 . . . . 0.0 112.266 178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -72.68 129.29 37.89 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.536 1.135 . . . . 0.0 112.279 174.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 21.8 p -170.21 105.25 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.013 1.325 . . . . 0.0 111.841 171.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 59.1 171.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.4 2.68 . . . . 0.0 115.735 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.22 127.79 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.402 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -149.02 -18.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.804 1.193 . . . . 0.0 115.389 -169.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -72.72 -17.38 61.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.416 1.108 . . . . 0.0 113.55 174.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.33 -36.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.23 43.44 92.98 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 124.152 0.882 . . . . 0.0 113.808 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.08 -148.3 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.087 1.755 . . . . 0.0 113.891 -167.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -144.29 169.61 17.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.111 1.764 . . . . 0.0 111.697 -143.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.679 174.848 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 73.0 m -63.22 151.96 85.66 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.352 1.061 . . . . 0.0 112.797 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.31 -14.09 28.22 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 114.585 -174.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -142.68 164.6 29.66 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.508 1.523 . . . . 0.0 111.158 176.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 38.2 t -129.67 146.25 51.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.751 1.62 . . . . 0.0 111.483 176.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt -101.17 2.45 40.12 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.907 1.283 . . . . 0.0 113.749 -175.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.11 -19.77 64.75 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -175.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.1 p -97.74 -7.39 30.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.032 1.733 . . . . 0.0 113.836 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -97.66 160.04 14.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.105 1.762 . . . . 0.0 112.362 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.306 0.3 OUTLIER -75.07 16.58 0.3 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 170.758 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -55.73 135.05 51.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.117 1.367 . . . . 0.0 112.031 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -150.24 178.67 8.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -164.38 135.13 4.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.142 2.177 . . . . 0.0 108.639 166.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -82.35 166.97 15.8 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -120.1 -27.78 5.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.731 1.613 . . . . 0.0 115.123 170.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.23 108.01 1.25 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.802 0.81 . . . . 0.0 111.924 -177.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -98.28 162.19 13.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.454 1.502 . . . . 0.0 110.814 160.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -22.3 37.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.522 1.929 . . . . 0.0 114.833 178.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -103.56 -5.04 23.11 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.229 1.411 . . . . 0.0 113.981 175.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.65 -102.94 0.76 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.595 1.569 . . . . 0.0 111.668 -173.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.518 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -85.08 149.17 25.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -92.54 0.01 57.38 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.176 0.991 . . . . 0.0 113.279 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 17.7 79.92 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.63 1.11 . . . . 0.0 115.154 178.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.257 9.6 t -141.95 33.94 1.57 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 19.23 61.91 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.199 1.381 . . . . 0.0 113.88 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.45 178.81 7.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.883 1.673 . . . . 0.0 113.03 -171.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p -145.59 162.74 36.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.72 -163.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp 69.13 12.19 8.44 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 162.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 54.73 22.42 4.11 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.824 2.05 . . . . 0.0 115.182 174.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.718 1.607 . . . . 0.0 113.157 178.873 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -73.2 155.05 39.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 112.368 176.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 42.1 mm -120.5 147.75 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 0.0 110.124 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -79.04 148.43 32.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.029 1.332 . . . . 0.0 113.172 -177.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -122.0 62.19 0.95 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.42 . . . . 0.0 111.54 -177.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.32 157.01 6.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.386 1.875 . . . . 0.0 113.112 -176.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 1.4 t -67.85 147.92 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.767 0.794 . . . . 0.0 109.496 171.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.518 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.39 19.99 0.47 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.006 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -146.28 -38.19 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -169.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.96 -34.36 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.858 0.753 . . . . 0.0 112.962 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.0 44.26 94.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.506 1.051 . . . . 0.0 113.513 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -108.79 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.285 1.834 . . . . 0.0 113.893 -164.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.14 158.48 25.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.361 2.664 . . . . 0.0 112.417 -175.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.835 2.054 . . . . 0.0 112.931 -168.873 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 85.7 p -76.79 164.27 60.39 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.4 1.08 . . . . 0.0 112.969 178.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -59.55 -21.15 60.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.349 2.699 . . . . 0.0 114.608 173.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -91.33 -5.45 54.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.115 1.366 . . . . 0.0 113.356 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.0 t -65.92 145.63 55.68 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.232 -0.917 . . . . 0.0 112.364 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm 59.06 7.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.991 2.116 . . . . 0.0 116.033 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.68 -3.8 58.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.665 1.186 . . . . 0.0 113.751 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -84.08 53.43 2.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.3 1.84 . . . . 0.0 113.83 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.38 152.66 27.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.101 1.36 . . . . 0.0 110.523 166.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.52 -45.89 81.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 39.37 45.55 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.411 2.285 . . . . 0.0 113.305 -177.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -79.99 175.68 10.42 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -166.21 123.12 1.35 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.308 1.443 . . . . 0.0 109.159 169.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 163.76 22.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -115.56 -44.8 2.94 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.448 1.899 . . . . 0.0 113.279 174.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.86 93.88 1.6 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.374 1.083 . . . . 0.0 111.721 -169.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 t -88.15 162.36 16.77 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.077 162.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -21.86 32.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.438 1.895 . . . . 0.0 114.789 178.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.33 -7.53 19.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.215 1.406 . . . . 0.0 114.109 175.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.88 -107.92 1.17 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.568 1.556 . . . . 0.0 111.694 -173.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' H ' ' A' ' 86' ' ' THR . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 85' ' ' VAL . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -79.33 138.3 37.66 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -86.41 5.38 35.27 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.7 87.89 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.21 1.386 . . . . 0.0 115.217 175.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -124.69 14.87 8.72 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.147 1.379 . . . . 0.0 113.769 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 15.34 57.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.053 1.311 . . . . 0.0 113.962 -175.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -133.77 176.97 8.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.342 1.857 . . . . 0.0 112.729 -176.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p -124.12 156.5 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.359 1.064 . . . . 0.0 113.721 170.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -168.22 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 tptt 63.05 14.08 7.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 178.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 53.92 24.86 4.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.814 2.046 . . . . 0.0 114.938 -178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.332 1.053 . . . . 0.0 113.801 174.544 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.8 40.99 32.18 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.505 1.522 . . . . 0.0 114.157 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.1 mt -78.08 138.25 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.647 1.179 . . . . 0.0 109.803 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.6 p -70.03 146.33 51.09 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.381 1.072 . . . . 0.0 113.081 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -83.54 51.62 2.05 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -43.78 144.09 0.91 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.18 2.192 . . . . 0.0 113.581 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.49 119.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.687 0.676 . . . . 0.0 109.297 -176.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.94 -18.47 0.02 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.633 1.587 . . . . 0.0 115.187 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -65.7 -20.18 66.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.8 tp -123.67 -33.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.393 . . . . 0.0 113.299 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.85 59.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.326 0.965 . . . . 0.0 114.198 172.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.54 -143.54 0.21 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.514 1.526 . . . . 0.0 113.192 -168.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -134.78 -161.65 1.17 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.504 1.522 . . . . 0.0 111.748 -149.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.105 1.362 . . . . 0.0 113.156 168.327 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 42.0 m -66.55 148.81 98.53 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 124.485 1.114 . . . . 0.0 112.853 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.27 155.11 64.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.312 2.675 . . . . 0.0 112.641 178.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.71 -32.52 67.89 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.129 0.972 . . . . 0.0 112.826 176.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -132.42 170.31 15.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.423 1.489 . . . . 0.0 112.383 -164.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -74.95 74.64 2.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.51 1.524 . . . . 0.0 111.402 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.23 53.61 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.617 1.567 . . . . 0.0 114.851 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -81.09 58.05 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.082 1.753 . . . . 0.0 112.749 -177.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.94 175.82 9.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.815 1.646 . . . . 0.0 113.157 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.61 86.39 6.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.402 169.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.06 65.68 0.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.346 1.459 . . . . 0.0 112.071 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -143.01 -178.45 5.84 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.636 1.174 . . . . 0.0 112.496 176.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 134.67 3.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.497 2.319 . . . . 0.0 108.487 166.469 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.46 171.74 13.26 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -125.58 -33.91 2.72 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.79 103.42 1.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.088 0.947 . . . . 0.0 113.47 -173.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.6 t -89.56 165.76 14.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 109.703 153.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -19.43 63.33 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.892 -1.13 . . . . 0.0 112.208 172.004 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -86.93 -17.35 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.667 1.187 . . . . 0.0 113.04 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.37 -101.94 0.59 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.288 1.423 . . . . 0.0 112.103 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' H ' ' A' ' 86' ' ' THR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.441 ' H ' HG21 ' A' ' 85' ' ' VAL . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -84.02 146.77 27.79 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.79 0.49 56.98 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.29 11.35 85.08 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.905 1.241 . . . . 0.0 115.176 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.5 t -142.9 53.52 1.38 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 123.237 1.494 . . . . 0.0 111.542 -177.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.36 16.07 80.02 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.594 1.569 . . . . 0.0 114.8 172.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -149.66 176.57 10.55 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.877 1.271 . . . . 0.0 113.448 -164.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -141.43 160.47 40.07 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.17 -161.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 63.79 -6.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.216 2.606 . . . . 0.0 117.846 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 52.18 35.72 17.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.531 2.332 . . . . 0.0 113.072 177.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.413 1.885 . . . . 0.0 112.519 -177.873 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -137.21 156.34 48.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.952 1.701 . . . . 0.0 111.188 -173.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.4 mt -116.08 137.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.169 1.788 . . . . 0.0 109.733 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.3 p -102.69 125.27 49.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.794 0.838 . . . . 0.0 112.435 175.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -143.92 42.14 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.492 1.917 . . . . 0.0 111.248 -178.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -48.67 144.98 3.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.462 1.905 . . . . 0.0 115.282 -159.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.19 137.46 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 159.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.9 -25.56 0.99 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.619 2.056 . . . . 0.0 114.252 175.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 -27.74 3.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -166.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.48 -33.31 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 120.234 1.379 . . . . 0.0 112.614 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.59 49.39 56.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.185 0.897 . . . . 0.0 113.146 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -104.91 -166.46 1.24 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.045 2.138 . . . . 0.0 111.103 -172.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.275 34.9 mmt180 56.55 37.11 28.55 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 162.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 128.103 2.561 . . . . 0.0 113.686 179.442 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -146.43 153.71 48.15 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.372 1.469 . . . . 0.0 112.167 -178.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.64 154.17 59.68 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.456 2.77 . . . . 0.0 112.64 178.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -85.0 114.33 22.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.174 0.99 . . . . 0.0 111.315 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -64.86 -16.08 62.71 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm -89.61 -13.47 37.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.476 1.11 . . . . 0.0 113.109 175.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.19 -17.61 32.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -83.85 55.15 3.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.553 1.541 . . . . 0.0 112.934 -176.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.43 140.0 32.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.096 1.758 . . . . 0.0 111.124 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.23 1.02 7.81 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.072 1.749 . . . . 0.0 112.555 173.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 53.48 39.24 29.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.652 1.981 . . . . 0.0 113.824 -178.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -93.48 -177.47 4.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.23 1.412 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -169.07 128.31 1.05 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.668 2.387 . . . . 0.0 109.084 169.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.18 163.1 15.33 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.39 -28.76 8.41 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.429 1.491 . . . . 0.0 114.948 168.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.63 103.19 0.92 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.609 0.719 . . . . 0.0 111.513 -172.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -93.29 162.71 13.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.612 1.165 . . . . 0.0 110.961 160.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -21.9 31.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.767 2.027 . . . . 0.0 114.934 179.075 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.66 -6.11 20.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.167 1.387 . . . . 0.0 114.149 175.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.97 -105.02 0.81 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.406 1.479 . . . . 0.0 111.336 -171.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.473 ' H ' HG21 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.76 141.73 37.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.35 -1.18 57.74 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.78 81.16 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.073 1.32 . . . . 0.0 115.353 175.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -136.0 28.35 3.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.653 1.181 . . . . 0.0 113.466 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.75 18.41 56.52 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.216 1.388 . . . . 0.0 113.892 178.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -144.65 160.05 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -172.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m -126.99 156.79 41.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.41 1.084 . . . . 0.0 113.266 -176.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.58 -176.58 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 tttm 68.49 10.9 8.14 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 151.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 57.11 29.02 15.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.94 2.096 . . . . 0.0 114.702 172.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.58 1.552 . . . . 0.0 113.315 178.372 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.56 -37.44 71.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.026 0.93 . . . . 0.0 111.375 173.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.82 146.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.438 1.495 . . . . 0.0 108.862 164.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.1 173.43 6.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.318 1.447 . . . . 0.0 112.833 177.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 26.0 m -77.9 35.92 0.21 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.056 1.342 . . . . 0.0 114.363 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -48.12 136.23 12.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.621 1.968 . . . . 0.0 113.06 -174.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . 0.254 4.1 p -65.3 128.96 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.823 1.297 . . . . 0.0 110.286 -172.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.445 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.32 -2.24 0.1 OUTLIER Glycine 0 C--N 1.298 -1.578 1 C-N-CA 132.317 4.77 . . . . 0.0 115.713 176.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -57.11 -20.19 24.17 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 149.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -154.47 -42.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 51.79 22.93 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.186 0.898 . . . . 0.0 114.682 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -140.42 0.33 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.538 1.935 . . . . 0.0 114.084 -173.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -135.52 -176.2 4.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.373 1.469 . . . . 0.0 112.968 -149.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.15 0.98 . . . . 0.0 112.97 166.826 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 96.8 p -80.14 155.32 74.81 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.424 1.09 . . . . 0.0 112.901 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.69 -10.84 28.63 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.248 2.632 . . . . 0.0 113.609 175.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.4 -1.31 49.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.199 1.4 . . . . 0.0 113.469 178.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.4 t -135.97 160.99 36.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.666 1.587 . . . . 0.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -81.09 39.75 0.52 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.071 -177.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.3 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.241 1.416 . . . . 0.0 114.297 -176.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.4 p -82.01 -11.17 58.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.16 1.784 . . . . 0.0 114.028 177.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.6 136.22 52.69 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.557 1.143 . . . . 0.0 112.046 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.1 24.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.521 1.529 . . . . 0.0 113.468 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.06 133.22 47.8 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.978 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.7 p90 -150.32 176.22 11.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.32 135.41 5.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.35 2.26 . . . . 0.0 108.66 163.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.05 163.61 30.59 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -127.95 -26.32 2.92 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.316 1.846 . . . . 0.0 115.171 176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.4 110.1 1.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.703 0.763 . . . . 0.0 112.133 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.1 p -105.1 171.37 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.2 1.0 . . . . 0.0 111.035 154.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.84 -19.9 65.82 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -87.93 -37.88 16.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.06 1.344 . . . . 0.0 111.843 173.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.54 -103.76 0.31 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.801 1.667 . . . . 0.0 110.312 172.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG21 ' H ' ' A' ' 86' ' ' THR . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.409 ' H ' HG21 ' A' ' 85' ' ' VAL . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -76.32 129.31 36.44 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.4 0.65 48.64 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.05 86.95 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.21 1.386 . . . . 0.0 115.493 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.8 p -110.11 13.63 23.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.552 1.541 . . . . 0.0 113.207 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.37 54.22 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.33 1.443 . . . . 0.0 113.932 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.15 169.54 17.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.064 1.745 . . . . 0.0 113.094 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p -105.47 152.6 22.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.501 1.12 . . . . 0.0 111.742 167.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.464 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m -121.94 -156.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.0 tptp 58.65 19.09 6.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.314 1.846 . . . . 0.0 114.781 177.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 53.38 29.39 8.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.46 1.904 . . . . 0.0 114.168 -173.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 C--O 1.255 1.348 0 C-N-CA 124.988 1.315 . . . . 0.0 113.862 176.413 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.458 0.169 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -75.97 144.46 40.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.805 0.842 . . . . 0.0 111.859 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.97 143.94 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.115 1.766 . . . . 0.0 108.886 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -64.97 150.92 47.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.17 0.988 . . . . 0.0 112.653 173.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.9 m -79.69 49.36 1.03 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.215 1.406 . . . . 0.0 113.065 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -59.48 166.38 2.4 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.096 2.158 . . . . 0.0 114.149 -173.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 4.0 p -64.64 119.69 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 154.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.4 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.5 -14.82 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.994 2.235 . . . . 0.0 113.876 176.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -67.38 -13.91 62.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.869 2.067 . . . . 0.0 114.528 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 tp -142.16 -34.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.122 1.369 . . . . 0.0 113.249 174.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.0 44.5 67.09 Favored Glycine 0 N--CA 1.477 1.367 0 C-N-CA 124.304 0.954 . . . . 0.0 113.983 171.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.99 -140.6 0.32 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.376 1.87 . . . . 0.0 114.324 -167.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -134.16 -161.07 1.11 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 112.756 -149.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.839 2.056 . . . . 0.0 112.906 177.134 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.9 m -66.66 152.41 95.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.687 1.195 . . . . 0.0 112.958 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.33 160.59 44.59 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.099 2.532 . . . . 0.0 112.167 172.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -63.62 -35.07 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 111.943 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 48.0 t -153.89 145.27 23.07 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 110.396 164.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -65.75 -13.73 59.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.635 0.774 . . . . 0.0 112.368 171.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.61 57.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.402 1.081 . . . . 0.0 113.833 170.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.9 p -118.88 -24.02 6.75 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -175.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.13 148.7 28.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.705 1.602 . . . . 0.0 110.117 173.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.0 mt -135.26 76.77 1.64 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.041 1.736 . . . . 0.0 107.253 179.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.84 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.28 1.032 . . . . 0.0 113.289 -176.015 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -134.79 179.52 6.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 111.06 159.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.52 132.45 2.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.473 1.909 . . . . 0.0 109.012 164.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.18 167.05 22.12 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.36 -26.95 3.84 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.661 1.584 . . . . 0.0 115.078 170.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.07 103.73 1.14 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.983 -173.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.9 t -97.63 168.59 10.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 0.0 110.672 160.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -27.41 60.71 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.517 1.927 . . . . 0.0 114.825 -176.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mtt85 -108.39 -6.56 16.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.318 1.847 . . . . 0.0 114.809 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.48 -109.78 1.0 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.136 1.827 . . . . 0.0 111.799 -177.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.432 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -77.09 133.61 38.99 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -87.41 4.53 42.82 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.43 7.31 82.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.934 1.254 . . . . 0.0 115.948 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -132.73 25.51 4.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.781 1.29 . . . . 0.0 113.871 -176.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.25 17.01 54.64 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.792 1.187 . . . . 0.0 113.924 178.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -137.88 169.91 16.96 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.95 1.7 . . . . 0.0 112.627 -177.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p -107.74 158.67 17.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.597 0.759 . . . . 0.0 112.33 161.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.04 -164.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 62.22 15.37 7.48 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.071 2.148 . . . . 0.0 115.944 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 54.31 24.98 5.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.224 1.81 . . . . 0.0 114.62 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 124.357 1.063 . . . . 0.0 113.742 173.801 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.516 0.198 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -110.25 5.4 21.73 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.793 1.637 . . . . 0.0 113.179 175.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.53 161.62 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.764 1.626 . . . . 0.0 111.444 -178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -71.84 172.61 9.57 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.577 1.18 . . . . 0.0 113.111 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m -128.76 27.85 5.43 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.519 1.928 . . . . 0.0 114.199 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -160.55 163.99 32.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.237 1.815 . . . . 0.0 114.404 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.16 124.26 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 142.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 156' ' ' TPO . . . . . 0.432 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.48 -18.23 0.04 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 126.05 1.786 . . . . 0.0 114.523 176.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -66.6 -26.88 67.31 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.4 tp -100.24 -34.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.311 1.044 . . . . 0.0 112.266 171.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.17 63.7 3.32 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.938 1.256 . . . . 0.0 112.556 166.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -141.74 170.59 15.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -153.484 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -165.05 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.275 2.23 . . . . 0.0 110.935 164.215 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.956 2.103 . . . . 0.0 111.351 168.022 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.583 HD13 HG11 ' A' ' 82' ' ' VAL . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 . . . . . 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HA ' HG23 ' A' ' 130' ' ' VAL . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.764 ' CD2' HG13 ' A' ' 82' ' ' VAL . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.769 HG11 HD13 ' A' ' 123' ' ' LEU . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.769 HD13 HG11 ' A' ' 82' ' ' VAL . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 CA-C-O 121.125 0.291 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.403 ' HA ' HG23 ' A' ' 130' ' ' VAL . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.169 0.509 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.517 0.675 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 82' ' ' VAL . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 82' ' ' VAL . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HG13 ' A' ' 82' ' ' VAL . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 77' ' ' TYR . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HG11 ' A' ' 82' ' ' VAL . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' HA ' HG23 ' A' ' 130' ' ' VAL . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 121.56 0.533 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.731 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 HG11 ' A' ' 82' ' ' VAL . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.407 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.966 0.889 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 123' ' ' LEU . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.585 ' CD1' HG13 ' A' ' 82' ' ' VAL . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 82' ' ' VAL . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.843 0.83 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 N-CA-C 113.677 0.231 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.496 HG12 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.431 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.548 0.69 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.74 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HG11 ' A' ' 82' ' ' VAL . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' HD2' HG13 ' A' ' 82' ' ' VAL . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 . . . . . 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD1' HG13 ' A' ' 82' ' ' VAL . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD1' ' A' ' 77' ' ' TYR . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 130' ' ' VAL . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 120.283 -0.176 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 . . . . . 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.939 0.876 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.69 0.757 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 . . . . . 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD2' HG13 ' A' ' 82' ' ' VAL . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.463 ' H ' ' NH2' ' A' ' 113' ' ' ARG . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.463 ' NH2' ' H ' ' A' ' 89' ' ' SER . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 130' ' ' VAL . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 122.067 0.936 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 82' ' ' VAL . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 91' ' ' TYR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' HG21 ' A' ' 85' ' ' VAL . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.454 ' H ' HG23 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 82' ' ' VAL . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.867 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.9 p -74.23 153.17 88.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.69 1.196 . . . . 0.0 112.829 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 160.58 48.92 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.302 2.668 . . . . 0.0 112.714 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.17 -27.67 68.87 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.15 0.98 . . . . 0.0 113.455 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.9 m -124.35 127.19 47.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.889 1.676 . . . . 0.0 110.103 170.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.49 131.05 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.414 1.086 . . . . 0.0 110.834 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.34 32.69 3.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.121 2.169 . . . . 0.0 111.88 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m 57.71 41.56 25.08 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.026 1.73 . . . . 0.0 113.302 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.99 173.63 7.64 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.281 1.832 . . . . 0.0 112.382 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.11 58.56 2.04 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.022 1.329 . . . . 0.0 111.823 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.67 33.25 0.2 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.978 1.711 . . . . 0.0 113.973 -174.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -81.4 178.86 8.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.777 1.231 . . . . 0.0 113.495 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.07 127.18 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.384 2.274 . . . . 0.0 108.57 165.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.48 166.89 17.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -118.27 -46.18 2.61 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.99 1.716 . . . . 0.0 113.654 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.32 91.97 1.82 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.283 1.039 . . . . 0.0 111.805 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 t -88.37 164.11 15.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.067 164.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.34 -24.23 11.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.231 1.813 . . . . 0.0 115.46 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -110.55 -4.0 15.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.664 1.586 . . . . 0.0 114.502 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.14 -111.21 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.799 1.666 . . . . 0.0 111.628 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 HG21 ' B' ' 155' ' ' VAL . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -85.28 145.02 27.74 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.36 -1.74 58.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.68 8.14 85.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.11 1.338 . . . . 0.0 115.269 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.5 p -121.57 13.37 10.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.345 1.458 . . . . 0.0 113.673 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.76 15.07 54.0 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.193 1.378 . . . . 0.0 113.828 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.19 162.21 33.18 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.026 1.73 . . . . 0.0 113.039 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -119.94 162.66 18.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.976 1.31 . . . . 0.0 113.973 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.583 HD13 HG11 ' A' ' 82' ' ' VAL . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.77 -155.91 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt 58.25 25.06 12.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.222 1.409 . . . . 0.0 114.288 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 56.06 29.82 15.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.27 1.828 . . . . 0.0 114.363 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 124.603 1.161 . . . . 0.0 113.823 174.957 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -86.22 -43.03 13.3 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.31 1.044 . . . . 0.0 112.184 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 17.0 tt -159.82 168.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 109.14 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -125.33 125.76 43.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.17 -0.956 . . . . 0.0 111.167 164.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.1 m -140.05 50.48 1.73 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.755 1.622 . . . . 0.0 110.9 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -45.36 140.32 3.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.968 2.107 . . . . 0.0 113.526 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.4 p -61.31 120.51 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.241 1.02 . . . . 0.0 109.177 176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.628 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.53 -28.37 0.03 OUTLIER Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.943 1.259 . . . . 0.0 114.853 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -66.45 -23.03 66.22 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.05 -35.9 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.873 1.669 . . . . 0.0 112.182 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.5 65.21 2.74 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.969 1.271 . . . . 0.0 113.108 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.22 -160.25 1.04 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -164.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -137.73 -56.74 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -137.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.361 1.864 . . . . 0.0 111.487 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 6.9 m -65.49 150.43 95.95 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.319 1.048 . . . . 0.0 112.755 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.82 -8.62 18.03 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.579 2.853 . . . . 0.0 113.724 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -127.94 -173.22 2.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.8 2.04 . . . . 0.0 112.062 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.1 m -58.88 -14.06 7.99 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.31 -23.52 62.52 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.601 1.091 . . . . 0.0 112.69 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.98 -15.31 55.66 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.6 p -82.34 -10.69 58.98 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -107.94 144.31 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.484 1.914 . . . . 0.0 110.952 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -118.58 -5.73 10.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.332 1.453 . . . . 0.0 113.344 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.15 22.84 7.91 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -114.71 178.55 4.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -163.81 132.42 3.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.411 1.884 . . . . 0.0 109.006 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.29 170.96 18.57 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -130.06 -37.12 1.5 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.826 1.65 . . . . 0.0 113.451 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.05 18.34 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.985 0.914 . . . . 0.0 112.157 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -83.83 -2.2 55.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -130.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -135.58 -78.19 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.385 1.074 . . . . 0.0 109.799 162.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.71 -3.77 11.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.499 1.919 . . . . 0.0 113.676 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.07 2.35 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.35 1.928 . . . . 0.0 110.038 -169.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.59 146.94 24.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.98 -2.33 58.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.89 11.97 84.65 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.752 1.168 . . . . 0.0 115.305 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.253 6.4 t -129.6 29.42 5.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.284 1.434 . . . . 0.0 112.885 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.89 56.36 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.436 1.494 . . . . 0.0 113.972 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -142.42 171.12 14.49 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.362 1.465 . . . . 0.0 113.735 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m -124.99 159.55 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.852 1.661 . . . . 0.0 113.272 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -164.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 61.11 31.56 19.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 157.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . 0.25 8.8 mp0 54.56 31.27 14.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.664 1.985 . . . . 0.0 114.925 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.704 1.202 . . . . 0.0 113.361 172.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -115.73 13.06 16.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.104 1.361 . . . . 0.0 113.748 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.94 130.13 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.105 . . . . 0.0 110.072 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -83.27 148.89 27.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.116 1.366 . . . . 0.0 113.152 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -92.63 59.65 3.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.1 1.36 . . . . 0.0 113.457 -164.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -43.93 144.97 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.026 1.73 . . . . 0.0 113.868 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.32 131.36 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.334 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.509 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.87 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.435 -1.711 . . . . 0.0 113.561 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -67.47 -20.6 65.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.288 1.435 . . . . 0.0 114.721 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.3 tp -128.54 -42.44 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -171.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.13 30.72 56.8 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.223 0.916 . . . . 0.0 114.772 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -93.3 0.08 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.992 2.117 . . . . 0.0 115.082 -168.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -71.71 146.2 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.292 2.637 . . . . 0.0 111.854 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.1 2.16 . . . . 0.0 111.504 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 45.9 m -66.59 144.13 98.48 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.309 1.044 . . . . 0.0 112.663 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.43 -13.78 36.06 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.588 2.858 . . . . 0.0 114.59 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -82.84 -7.38 59.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 114.015 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 150.6 31.26 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.303 1.041 . . . . 0.0 112.462 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.87 -17.48 61.52 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 113.389 170.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.91 -7.05 56.22 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -81.83 -10.25 59.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.49 172.54 12.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.761 1.624 . . . . 0.0 113.349 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.55 87.92 5.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.599 1.16 . . . . 0.0 108.459 166.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 44.57 1.0 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.011 1.324 . . . . 0.0 112.78 -167.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -89.96 -178.34 5.44 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.105 1.362 . . . . 0.0 113.584 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.44 132.16 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.923 2.089 . . . . 0.0 108.947 161.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.35 172.55 14.44 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -132.84 -40.03 0.96 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.473 1.509 . . . . 0.0 113.78 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.86 22.91 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.642 0.777 . . . . 0.0 112.25 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -85.39 3.43 40.01 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -131.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.3 -40.8 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 0.0 113.117 164.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.22 -51.36 0.53 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.129 1.772 . . . . 0.0 111.621 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.88 -120.02 1.34 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.432 1.491 . . . . 0.0 110.478 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 HG21 ' B' ' 155' ' ' VAL . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.69 ' HB3' HG23 ' B' ' 155' ' ' VAL . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -102.5 148.15 25.87 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.85 -5.0 59.33 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 4.35 89.68 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.07 1.319 . . . . 0.0 115.37 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.5 p -109.18 12.61 24.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.597 1.559 . . . . 0.0 113.363 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.34 53.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.388 1.47 . . . . 0.0 113.884 -172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -130.02 167.69 17.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.822 1.649 . . . . 0.0 113.629 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -124.32 158.59 32.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.893 1.677 . . . . 0.0 113.026 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HA ' HG23 ' A' ' 130' ' ' VAL . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.08 -163.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.4 tptp 60.2 19.13 8.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.706 1.603 . . . . 0.0 115.193 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 52.97 29.13 7.42 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.383 1.873 . . . . 0.0 114.398 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.838 1.255 . . . . 0.0 113.931 176.017 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.704 0.287 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -76.16 -21.43 56.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.447 1.099 . . . . 0.0 112.289 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 54.7 mt -80.01 143.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 110.23 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.8 p -65.59 166.67 10.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.187 1.395 . . . . 0.0 113.22 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 23.4 m -77.24 40.82 0.28 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.52 1.528 . . . . 0.0 113.64 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.21 163.21 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.129 2.172 . . . . 0.0 114.119 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.3 p -52.04 117.93 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.07 1.348 . . . . 0.0 109.316 167.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.527 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.04 -13.42 0.05 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.405 2.431 . . . . 0.0 113.641 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -69.85 -15.95 63.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.301 2.24 . . . . 0.0 114.988 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -145.31 -35.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.72 43.53 75.01 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 123.969 0.795 . . . . 0.0 113.851 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.67 -142.86 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.441 2.296 . . . . 0.0 113.916 -170.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -137.21 -174.25 3.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.231 1.812 . . . . 0.0 112.936 -150.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.928 1.291 . . . . 0.0 113.339 168.317 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.9 p -74.22 153.2 88.3 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.33 147.61 66.0 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.348 2.699 . . . . 0.0 112.34 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -151.72 155.43 38.27 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.964 1.306 . . . . 0.0 111.616 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.1 m -59.3 -16.39 21.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.582 1.553 . . . . 0.0 114.967 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.58 -7.83 5.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 -12.23 2.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.818 1.647 . . . . 0.0 115.161 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.3 p -73.53 -17.44 61.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.832 1.253 . . . . 0.0 113.777 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -87.75 140.67 29.28 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.703 1.601 . . . . 0.0 109.866 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.55 -9.64 15.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.853 1.261 . . . . 0.0 113.389 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 51.77 43.73 29.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.266 1.826 . . . . 0.0 115.237 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -138.92 -179.57 5.91 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.996 -1.065 . . . . 0.0 112.678 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.53 135.45 5.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.757 2.023 . . . . 0.0 108.325 161.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.2 161.6 20.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -111.45 -28.23 8.27 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.326 1.45 . . . . 0.0 114.877 169.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.22 104.82 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.671 0.789 . . . . 0.0 111.577 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 161.6 17.92 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.007 0.923 . . . . 0.0 110.362 158.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -67.62 -17.99 64.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.145 -0.972 . . . . 0.0 112.98 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -88.16 -15.26 36.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.999 1.32 . . . . 0.0 113.302 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.26 -101.55 0.79 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.246 1.403 . . . . 0.0 111.003 -168.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.764 ' CD2' HG13 ' A' ' 82' ' ' VAL . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.769 HG11 HD13 ' A' ' 123' ' ' LEU . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.686 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.22 155.89 17.68 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -86.15 -13.64 46.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 168.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.87 5.71 85.98 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.041 1.305 . . . . 0.0 114.843 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.4 p -114.56 18.12 16.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.745 1.618 . . . . 0.0 113.544 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.12 16.29 59.52 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.999 1.285 . . . . 0.0 113.946 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -135.48 174.25 10.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.077 1.751 . . . . 0.0 112.871 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -144.09 160.19 41.33 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.769 HD13 HG11 ' A' ' 82' ' ' VAL . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -160.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 tptp 59.0 18.88 6.66 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.404 1.881 . . . . 0.0 115.564 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.78 28.62 6.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.512 1.925 . . . . 0.0 114.641 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 177.113 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.656 0.265 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -142.32 163.6 32.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.207 1.403 . . . . 0.0 112.457 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.9 mt -70.42 141.49 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.11 1.364 . . . . 0.0 109.973 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 p -121.7 138.68 54.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.232 1.413 . . . . 0.0 111.915 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 58.6 m -87.59 46.98 1.44 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.887 1.275 . . . . 0.0 113.376 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -47.67 142.24 4.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.289 2.235 . . . . 0.0 113.534 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.4 p -60.0 124.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.857 0.836 . . . . 0.0 109.993 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.686 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -168.83 -15.95 0.02 OUTLIER Glycine 0 CA--C 1.539 1.588 0 C-N-CA 127.39 2.424 . . . . 0.0 113.461 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -68.63 -14.21 62.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.041 2.137 . . . . 0.0 114.751 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 tp -146.07 -40.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.917 1.287 . . . . 0.0 113.251 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.0 70.73 1.3 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.411 1.005 . . . . 0.0 112.569 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.38 -159.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -137.17 -60.23 0.68 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.659 -1.276 . . . . 0.0 114.345 -136.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.872 1.669 . . . . 0.0 111.808 -171.415 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.74 147.34 99.06 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.81 -19.64 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.21 2.607 . . . . 0.0 113.614 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.53 158.7 43.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.142 1.777 . . . . 0.0 110.385 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.5 t -75.19 150.16 38.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 112.474 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm -127.52 16.14 7.05 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.933 1.693 . . . . 0.0 112.529 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 128.3 35.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.179 0.99 . . . . 0.0 111.98 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.3 p -80.07 -17.77 51.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.874 1.67 . . . . 0.0 114.048 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.4 141.85 35.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.643 1.977 . . . . 0.0 110.836 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.61 -4.72 10.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.669 1.588 . . . . 0.0 113.111 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 56.32 33.4 22.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.773 2.029 . . . . 0.0 115.897 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -134.34 -178.34 5.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.96 129.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.361 1.864 . . . . 0.0 108.895 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.26 158.05 19.96 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -103.01 -27.03 12.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.459 1.504 . . . . 0.0 114.689 167.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.29 106.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.753 1.221 . . . . 0.0 109.42 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 t -90.48 164.6 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.62 1.168 . . . . 0.0 111.283 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -34.93 11.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.132 2.173 . . . . 0.0 115.412 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -129.45 93.4 3.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.645 1.578 . . . . 0.0 107.374 165.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.94 -96.31 0.1 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.043 1.306 . . . . 0.0 113.78 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG23 HG21 ' B' ' 155' ' ' VAL . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -78.36 127.61 32.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.51 10.75 21.66 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -162.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.77 85.62 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.025 1.298 . . . . 0.0 115.806 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -131.87 25.67 4.65 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.728 1.264 . . . . 0.0 113.747 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.2 55.92 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 124.365 0.983 . . . . 0.0 113.547 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -142.06 174.83 10.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.623 1.969 . . . . 0.0 111.945 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -123.99 154.24 40.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.25 1.02 . . . . 0.0 112.158 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.42 HH22 ' P ' ' B' ' 156' ' ' TPO . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.403 ' HA ' HG23 ' A' ' 130' ' ' VAL . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.46 -156.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 60.33 17.18 6.86 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 52.91 29.96 8.53 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.379 1.872 . . . . 0.0 113.945 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.11 1.764 . . . . 0.0 114.465 -178.459 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.251 0.072 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.45 157.66 43.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 112.513 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 68.5 mt -129.39 138.96 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.194 1.798 . . . . 0.0 108.308 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 42.2 p -139.36 148.19 42.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.2 m -118.01 49.07 1.29 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.325 1.85 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -45.03 142.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.442 2.697 . . . . 0.0 114.666 -162.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.5 p -61.36 126.35 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.986 0.898 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.67 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.24 -24.05 0.02 OUTLIER Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.802 1.667 . . . . 0.0 113.568 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.62 -27.74 65.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.23 -37.33 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.24 61.49 3.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.313 0.959 . . . . 0.0 112.772 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.53 -164.92 1.53 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 113.093 -164.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.369 30.8 mmt180 65.75 28.07 11.06 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 127.422 2.289 . . . . 0.0 114.286 169.133 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.3 m -138.54 149.81 63.94 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.169 1.388 . . . . 0.0 111.817 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.44 159.82 35.82 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.695 2.93 . . . . 0.0 113.787 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.54 -19.79 65.83 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.173 0.989 . . . . 0.0 113.383 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -63.44 -8.4 9.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.235 1.414 . . . . 0.0 114.738 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtm -55.26 -24.7 29.39 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.536 -1.352 . . . . 0.0 112.914 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.98 -16.51 60.63 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.7 p -122.64 -9.17 8.44 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.417 1.487 . . . . 0.0 114.065 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.9 156.16 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.802 2.041 . . . . 0.0 112.88 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.64 53.44 0.71 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.607 1.963 . . . . 0.0 111.514 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.51 45.71 0.5 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.483 2.313 . . . . 0.0 112.279 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.3 175.75 10.37 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.054 -1.029 . . . . 0.0 113.149 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.26 129.4 1.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.896 2.078 . . . . 0.0 109.241 165.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.38 159.31 36.43 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -112.82 -28.62 7.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.248 1.419 . . . . 0.0 114.768 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.31 106.33 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.891 0.876 . . . . 0.0 111.454 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -82.45 156.98 23.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.005 0.922 . . . . 0.0 110.467 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -8.61 53.62 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.156 0.982 . . . . 0.0 113.229 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -41.37 7.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.031 1.733 . . . . 0.0 110.407 171.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.09 -77.97 0.17 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.295 1.426 . . . . 0.0 111.832 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.637 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -73.82 129.72 38.48 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -86.52 3.9 42.18 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.87 -0.43 78.1 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.577 1.56 . . . . 0.0 115.597 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.2 p -112.79 14.15 19.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.522 1.529 . . . . 0.0 113.295 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.31 15.7 54.94 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.27 1.414 . . . . 0.0 113.95 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -134.34 172.28 13.1 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.258 1.823 . . . . 0.0 112.792 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p -108.7 152.13 25.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 111.871 167.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.53 -157.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 56.86 24.87 9.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.708 1.603 . . . . 0.0 114.784 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 54.46 31.45 14.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 114.529 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.862 1.265 . . . . 0.0 113.782 173.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.68 158.62 28.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.006 0.922 . . . . 0.0 112.5 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.7 tp -144.35 158.92 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.769 1.628 . . . . 0.0 110.713 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -76.8 151.44 35.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.546 1.138 . . . . 0.0 112.749 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -83.7 49.91 1.7 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.498 1.519 . . . . 0.0 113.862 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.17 156.03 7.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.743 2.017 . . . . 0.0 113.135 -172.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 88' ' ' SER . 3.8 t -62.13 136.42 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.637 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.93 -20.09 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 CA-C-N 113.369 -1.742 . . . . 0.0 113.393 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -65.07 -16.99 64.07 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.595 1.558 . . . . 0.0 114.664 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.421 HG23 ' CD1' ' B' ' 161' ' ' TRP . 8.6 tp -132.41 -39.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -172.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.09 63.7 3.33 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.456 1.027 . . . . 0.0 113.05 167.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' TRP . . . . . 0.421 ' CD1' HG23 ' B' ' 159' ' ' ILE . 1.0 OUTLIER -146.54 170.5 16.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -155.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -169.25 -50.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.307 2.243 . . . . 0.0 110.184 156.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.147 2.179 . . . . 0.0 111.635 179.686 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.3 m -140.2 157.72 68.3 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 125.337 1.455 . . . . 0.0 111.848 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.88 141.95 98.6 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.392 2.728 . . . . 0.0 113.695 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -153.72 161.05 42.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.34 1.456 . . . . 0.0 110.935 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.0 m -73.69 132.35 42.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.92 0.888 . . . . 0.0 110.896 170.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -110.42 -6.39 14.96 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.43 60.39 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.3 m -77.36 -26.71 52.23 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.598 1.559 . . . . 0.0 113.916 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.06 157.76 43.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.927 1.691 . . . . 0.0 111.468 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.5 54.07 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.029 1.732 . . . . 0.0 110.686 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.46 115.42 22.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 0.0 110.331 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.0 -176.51 5.8 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.073 1.349 . . . . 0.0 112.058 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.22 136.27 6.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.021 1.728 . . . . 0.0 109.207 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.2 158.29 20.15 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -104.42 -25.06 12.97 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.501 1.52 . . . . 0.0 114.439 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.02 104.65 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.507 1.123 . . . . 0.0 110.288 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -91.41 162.82 14.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.606 1.162 . . . . 0.0 111.235 167.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -24.27 56.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.754 2.022 . . . . 0.0 115.143 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -108.75 -0.86 19.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.441 1.496 . . . . 0.0 114.045 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.43 -92.1 0.34 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.837 1.684 . . . . 0.0 110.751 -170.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.734 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.26 147.73 22.66 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -88.27 0.38 56.19 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.47 13.47 83.19 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.77 1.176 . . . . 0.0 115.435 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -134.6 28.32 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.681 1.193 . . . . 0.0 113.541 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.78 17.91 55.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.213 1.387 . . . . 0.0 113.939 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -142.05 172.87 12.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.722 1.609 . . . . 0.0 113.173 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -149.17 161.76 41.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -168.32 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 tptt 57.02 20.49 5.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.932 1.693 . . . . 0.0 115.273 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.27 30.04 7.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.226 1.81 . . . . 0.0 114.576 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.933 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.496 0.188 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -125.18 35.99 4.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.226 1.411 . . . . 0.0 112.07 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.0 mt -74.72 136.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.563 1.145 . . . . 0.0 109.92 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 41.6 p -135.39 164.87 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.522 1.529 . . . . 0.0 112.34 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.61 46.6 0.88 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.847 1.659 . . . . 0.0 115.039 -170.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -58.61 150.78 22.23 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.124 2.17 . . . . 0.0 112.766 -174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 88' ' ' SER . 3.1 t -62.48 132.32 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.863 0.865 . . . . 0.0 110.561 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.734 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -162.5 -13.26 0.03 OUTLIER Glycine 0 CA--C 1.54 1.622 0 C-N-CA 127.721 2.581 . . . . 0.0 113.385 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.02 -17.67 62.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.002 2.121 . . . . 0.0 115.245 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.432 HG23 ' CD1' ' B' ' 161' ' ' TRP . 20.0 tt -123.86 -39.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.429 1.092 . . . . 0.0 113.44 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.86 67.69 1.82 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.437 1.017 . . . . 0.0 112.574 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' TRP . . . . . 0.432 ' CD1' HG23 ' B' ' 159' ' ' ILE . 0.9 OUTLIER -147.51 163.22 37.24 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -159.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.463 ' HG3' HH21 ' B' ' 162' ' ' ARG . 0.0 OUTLIER -170.03 -48.99 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.976 2.11 . . . . 0.0 109.559 159.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.067 2.147 . . . . 0.0 111.482 168.291 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.4 m -136.59 150.96 71.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.246 1.419 . . . . 0.0 111.834 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.31 -19.19 22.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.32 2.68 . . . . 0.0 113.731 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -143.37 161.55 38.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.251 1.82 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.9 t -148.25 150.86 34.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.916 1.286 . . . . 0.0 112.216 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt -116.35 12.39 15.28 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.495 1.518 . . . . 0.0 112.721 171.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.18 -28.57 38.71 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 113.521 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.0 p -94.55 -24.36 17.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.107 1.363 . . . . 0.0 113.897 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 10.0 tp10 -154.3 142.31 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.978 2.111 . . . . 0.0 109.765 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.0 -10.91 56.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.282 1.033 . . . . 0.0 113.407 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 6.5 mm-40 50.11 44.87 25.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.91 2.084 . . . . 0.0 114.071 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -101.16 -171.05 1.93 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.684 1.994 . . . . 0.0 112.36 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.64 130.01 1.94 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.454 1.901 . . . . 0.0 108.823 157.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 161.99 19.71 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -111.6 -23.62 10.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.183 1.793 . . . . 0.0 114.433 166.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.34 95.15 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.085 1.354 . . . . 0.0 108.777 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.8 t -80.34 -48.96 12.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -167.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -165.6 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.431 1.492 . . . . 0.0 110.973 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -83.99 -31.16 25.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.52 -124.43 0.73 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.683 1.611 . . . . 0.0 111.608 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -77.25 141.96 39.75 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.41 -0.8 57.32 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.365 0.666 . . . . 0.0 112.743 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.69 81.69 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.074 1.321 . . . . 0.0 115.29 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -137.19 30.23 2.71 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.734 1.254 . . . . 0.0 113.307 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.72 19.31 58.32 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 125.111 1.339 . . . . 0.0 113.793 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.34 161.0 40.67 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.97 1.708 . . . . 0.0 112.658 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -132.92 159.38 40.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 82' ' ' VAL . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.04 -162.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 tptt 58.16 22.38 9.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.204 1.802 . . . . 0.0 115.019 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 53.04 29.19 7.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.088 1.755 . . . . 0.0 114.041 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.972 1.309 . . . . 0.0 113.976 174.846 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -83.14 -13.44 55.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.53 1.132 . . . . 0.0 112.963 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.8 mt -75.67 138.94 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.696 1.198 . . . . 0.0 110.119 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.99 154.29 41.93 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.485 1.114 . . . . 0.0 112.722 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 82.1 p -150.86 17.62 0.78 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -164.63 166.75 19.88 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.806 2.042 . . . . 0.0 115.159 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 88' ' ' SER . 2.1 t -66.12 124.62 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 149.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.501 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.81 -13.56 0.04 OUTLIER Glycine 0 CA--C 1.541 1.659 0 C-N-CA 127.239 2.352 . . . . 0.0 113.383 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.37 -16.79 61.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.35 2.26 . . . . 0.0 115.157 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.9 tt -140.44 -33.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.23 32.89 57.68 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.94 0.781 . . . . 0.0 114.605 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -158.45 0.67 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.707 1.603 . . . . 0.0 113.786 -168.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -138.03 -161.94 1.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.024 1.729 . . . . 0.0 111.397 -143.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.786 1.234 . . . . 0.0 113.541 168.589 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 36.9 m -67.48 150.51 97.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.517 1.127 . . . . 0.0 113.073 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.13 166.92 25.15 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.58 2.853 . . . . 0.0 112.686 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -69.56 -19.37 63.68 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.2 m -133.04 133.47 43.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.738 1.615 . . . . 0.0 110.817 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -108.25 1.84 22.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.55 120.83 22.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.954 1.302 . . . . 0.0 111.228 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -81.92 54.12 2.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.699 1.6 . . . . 0.0 111.916 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.72 147.7 48.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.884 1.274 . . . . 0.0 112.243 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.65 31.45 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.521 1.928 . . . . 0.0 113.144 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.21 130.63 40.67 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.732 -1.23 . . . . 0.0 110.769 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 16.4 p90 -152.18 178.49 9.43 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.0 135.74 4.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.122 2.169 . . . . 0.0 108.355 161.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.53 164.93 27.92 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -123.99 -26.39 4.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.75 1.62 . . . . 0.0 114.775 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.85 104.19 1.03 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.787 0.804 . . . . 0.0 112.408 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.7 t -84.47 160.09 20.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.134 0.974 . . . . 0.0 109.498 153.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -66.85 -18.5 65.41 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.938 -1.102 . . . . 0.0 112.009 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -82.38 -16.23 49.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.375 1.47 . . . . 0.0 112.84 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.55 -101.32 0.92 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.488 1.518 . . . . 0.0 111.114 -171.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.594 ' HB3' HG13 ' B' ' 155' ' ' VAL . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -97.28 146.05 25.51 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.66 -4.43 57.76 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.56 6.39 87.45 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.166 1.365 . . . . 0.0 115.098 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.7 p -114.24 4.49 15.5 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.591 1.556 . . . . 0.0 113.592 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.8 54.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.652 1.596 . . . . 0.0 113.952 -172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -109.69 175.73 5.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.581 1.553 . . . . 0.0 113.409 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p -141.86 165.64 26.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.91 -163.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt 63.59 30.89 14.93 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 157.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 56.93 25.19 10.26 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.681 1.993 . . . . 0.0 115.472 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.012 1.325 . . . . 0.0 113.577 169.597 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.725 0.297 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -135.94 165.83 24.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.036 1.734 . . . . 0.0 111.048 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.65 158.6 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.379 1.472 . . . . 0.0 111.393 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.9 p -62.34 142.39 57.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.696 1.199 . . . . 0.0 112.448 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 71.2 m -130.39 70.08 1.45 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.918 1.287 . . . . 0.0 111.568 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.21 145.4 2.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.338 1.855 . . . . 0.0 114.479 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 88' ' ' SER . 3.0 t -57.56 124.43 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.489 1.116 . . . . 0.0 109.256 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.514 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.68 -26.54 0.02 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.688 1.613 . . . . 0.0 114.433 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -72.88 -29.53 63.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.97 -34.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.65 1.18 . . . . 0.0 112.531 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.42 31.81 62.91 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.573 1.083 . . . . 0.0 114.673 166.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -105.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.82 2.048 . . . . 0.0 114.271 -163.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -69.79 126.92 31.14 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.772 2.029 . . . . 0.0 111.131 -173.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.888 2.075 . . . . 0.0 113.887 -160.025 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 22.2 m -67.58 148.78 98.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.34 1.056 . . . . 0.0 112.982 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.77 154.29 73.53 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.184 2.589 . . . . 0.0 112.129 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.8 t30 50.4 45.91 25.76 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.554 1.542 . . . . 0.0 113.36 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -66.28 155.41 37.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.413 1.085 . . . . 0.0 112.88 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mtp -80.6 62.14 4.56 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.553 1.541 . . . . 0.0 112.639 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.68 -13.2 29.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.707 1.203 . . . . 0.0 113.864 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.1 p -81.32 -7.02 59.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.981 2.112 . . . . 0.0 114.176 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -59.45 147.27 37.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.944 1.298 . . . . 0.0 112.562 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.96 34.88 0.15 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.918 2.087 . . . . 0.0 112.991 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.0 134.54 49.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 110.32 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.77 178.67 9.63 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.41 133.53 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.254 2.222 . . . . 0.0 108.312 168.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.6 165.75 13.91 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.1 -24.93 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.971 1.708 . . . . 0.0 114.698 165.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.58 109.8 1.28 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.012 0.925 . . . . 0.0 110.349 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.4 p -119.47 169.59 9.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.302 1.441 . . . . 0.0 111.253 168.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -25.45 23.63 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -166.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -111.45 1.36 16.92 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.26 1.424 . . . . 0.0 114.717 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.29 -107.97 1.29 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.952 1.739 . . . . 0.0 111.125 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.415 HG23 HG21 ' B' ' 155' ' ' VAL . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.658 ' HB3' HG23 ' B' ' 155' ' ' VAL . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -81.49 128.13 33.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.9 0.29 51.61 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -163.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.6 89.12 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.613 1.578 . . . . 0.0 115.211 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.3 p -118.6 8.23 11.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.487 1.515 . . . . 0.0 113.533 -173.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.91 12.85 54.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.148 1.356 . . . . 0.0 113.96 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -127.99 176.46 7.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.804 1.642 . . . . 0.0 112.815 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m -118.25 155.34 30.74 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.369 1.068 . . . . 0.0 111.673 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 82' ' ' VAL . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.63 -163.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 60.78 16.87 7.13 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.475 1.91 . . . . 0.0 115.49 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 52.66 26.79 4.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.552 1.941 . . . . 0.0 114.425 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.379 1.071 . . . . 0.0 113.751 176.192 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.315 0.102 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -138.8 158.08 44.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.862 1.665 . . . . 0.0 111.692 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.14 132.67 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.489 1.516 . . . . 0.0 109.458 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -72.73 130.42 40.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.421 1.088 . . . . 0.0 112.334 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -95.03 44.26 1.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.749 1.22 . . . . 0.0 113.407 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -43.2 139.34 1.91 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.16 2.184 . . . . 0.0 114.4 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' SER . 4.1 p -61.34 118.1 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 109.406 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.605 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.68 -16.95 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.993 1.758 . . . . 0.0 114.158 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -73.4 -14.55 61.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.555 1.942 . . . . 0.0 114.678 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -146.56 -35.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.13 38.99 63.32 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.283 0.944 . . . . 0.0 113.893 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 -146.96 0.2 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.655 1.582 . . . . 0.0 113.51 -169.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -139.41 178.08 7.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -143.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.379 1.872 . . . . 0.0 113.503 175.904 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 51.0 p -73.58 155.14 89.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.731 1.213 . . . . 0.0 112.797 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.36 -20.89 20.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.053 2.502 . . . . 0.0 113.322 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -148.27 140.06 23.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.61 1.564 . . . . 0.0 110.986 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -74.63 -9.05 58.19 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -111.66 24.37 12.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.124 1.77 . . . . 0.0 112.999 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.02 135.82 57.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.454 1.121 . . . . 0.0 111.377 168.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.2 p -101.76 -12.08 18.62 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.72 162.66 29.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.24 90.52 4.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.601 1.16 . . . . 0.0 108.096 166.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 89.72 7.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.242 1.017 . . . . 0.0 110.328 -169.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -142.76 -176.67 4.97 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.878 1.271 . . . . 0.0 112.689 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.42 136.29 5.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.295 1.838 . . . . 0.0 108.541 163.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.09 165.74 21.35 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -116.29 -45.62 2.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.838 1.655 . . . . 0.0 113.592 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.2 100.78 2.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 112.221 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -93.77 162.06 14.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.943 1.297 . . . . 0.0 110.888 162.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -21.99 33.07 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 114.788 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -103.54 -7.93 20.46 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.186 1.395 . . . . 0.0 114.14 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.07 -107.92 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.662 1.601 . . . . 0.0 111.605 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HG13 ' A' ' 82' ' ' VAL . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 77' ' ' TYR . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.691 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.2 140.35 29.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.35 -3.04 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 8.44 84.24 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.169 1.366 . . . . 0.0 115.094 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.0 p -119.95 18.69 12.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.552 1.541 . . . . 0.0 113.549 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 17.86 56.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.944 1.259 . . . . 0.0 113.838 -175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -134.21 171.23 14.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.258 1.823 . . . . 0.0 113.12 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m -128.45 157.77 40.18 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.266 1.426 . . . . 0.0 112.136 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HG11 ' A' ' 82' ' ' VAL . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' HA ' HG23 ' A' ' 130' ' ' VAL . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -127.23 -167.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 67.42 23.76 9.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 154.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 57.3 29.21 16.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.295 1.838 . . . . 0.0 115.446 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.182 1.393 . . . . 0.0 113.099 168.922 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -127.32 -39.93 1.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.173 1.789 . . . . 0.0 112.074 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 16.2 tt -67.75 169.98 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.273 1.429 . . . . 0.0 110.875 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.8 p -56.36 134.97 54.01 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.78 -1.2 . . . . 0.0 111.592 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.0 m -158.74 106.92 1.89 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.536 1.134 . . . . 0.0 110.354 -150.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -47.67 118.7 2.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 88' ' ' SER . 5.1 t -51.02 129.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.239 1.416 . . . . 0.0 111.726 -157.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.691 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -166.54 -12.43 0.03 OUTLIER Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.873 2.654 . . . . 0.0 113.299 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -71.3 -20.63 62.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.994 2.117 . . . . 0.0 115.141 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 18.6 tt -135.92 -40.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 41.27 73.95 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.925 0.774 . . . . 0.0 113.842 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -105.09 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.028 2.131 . . . . 0.0 113.327 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -61.91 113.31 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.249 2.62 . . . . 0.0 111.294 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.498 2.719 . . . . 0.0 113.807 178.364 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.6 t -68.55 140.62 92.38 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.762 0.825 . . . . 0.0 112.07 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.85 -16.38 54.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.236 2.624 . . . . 0.0 114.345 170.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.45 -51.1 7.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.365 1.066 . . . . 0.0 112.178 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 40.6 t -160.89 160.29 30.77 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 111.421 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm -67.98 -24.69 65.17 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.585 0.754 . . . . 0.0 112.016 166.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.19 -19.64 31.41 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.716 1.206 . . . . 0.0 113.901 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.1 p -84.06 85.4 7.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.242 1.017 . . . . 0.0 110.844 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -130.71 150.18 52.01 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 111.723 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.284 0.4 OUTLIER -90.84 25.64 2.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.336 1.854 . . . . 0.0 114.609 -174.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -46.03 126.62 7.66 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.2 1.8 . . . . 0.0 113.624 -175.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -150.17 -178.93 6.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.675 1.19 . . . . 0.0 113.445 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -164.17 132.5 3.56 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.233 2.213 . . . . 0.0 108.87 159.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.02 158.56 18.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -95.83 -40.56 9.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.853 2.061 . . . . 0.0 112.276 163.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.41 104.59 2.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.809 1.29 . . . . 0.0 109.954 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 t -100.53 177.6 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.841 -1.981 . . . . 0.0 111.266 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 122.98 19.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.16 0.984 . . . . 0.0 110.489 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.276 0.6 OUTLIER 61.16 24.75 14.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.998 2.119 . . . . 0.0 115.214 -173.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.6 -92.15 0.29 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.15 1.357 . . . . 0.0 113.956 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.731 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.19 129.9 35.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.09 1.14 29.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.121 1.369 . . . . 0.0 113.503 -167.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.68 13.0 65.77 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.382 1.467 . . . . 0.0 114.824 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.25 6.4 t -136.52 22.91 3.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.643 1.177 . . . . 0.0 113.551 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 22.86 50.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.9 1.238 . . . . 0.0 113.262 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -139.52 146.42 39.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.698 1.599 . . . . 0.0 112.029 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -92.63 154.41 18.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.104 0.865 . . . . 0.0 112.156 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 HG11 ' A' ' 82' ' ' VAL . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.407 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -128.79 -155.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.6 tptp 59.24 21.49 9.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.054 1.742 . . . . 0.0 114.911 174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 53.67 28.12 7.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.401 1.88 . . . . 0.0 114.477 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.414 1.086 . . . . 0.0 113.791 176.753 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.85 169.85 17.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.952 1.301 . . . . 0.0 112.523 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 77.9 mt -75.82 140.69 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 109.334 166.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -84.83 174.1 10.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.049 1.739 . . . . 0.0 113.042 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -75.93 44.19 0.3 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.456 1.902 . . . . 0.0 114.897 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.71 162.48 1.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 130.097 3.359 . . . . 0.0 114.435 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 88' ' ' SER . 1.8 t -56.91 118.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.539 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.33 -21.58 0.04 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.53 2.014 . . . . 0.0 112.998 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -72.2 -11.38 60.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.483 2.313 . . . . 0.0 114.605 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.25 -59.58 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.355 1.462 . . . . 0.0 110.805 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.76 35.2 19.93 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.961 1.267 . . . . 0.0 114.345 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.33 -156.7 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.35 1.86 . . . . 0.0 114.675 -169.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -135.88 -154.09 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.257 1.823 . . . . 0.0 111.76 -139.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.27 1.828 . . . . 0.0 113.164 171.504 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.9 m -67.37 148.89 98.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.371 1.068 . . . . 0.0 112.929 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.04 161.6 45.51 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.49 2.793 . . . . 0.0 112.775 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -73.09 163.88 27.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.212 1.005 . . . . 0.0 111.68 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 39.6 t -62.46 144.44 55.92 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.183 0.993 . . . . 0.0 112.282 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.46 0.53 45.88 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.733 1.213 . . . . 0.0 113.316 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.17 14.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.413 1.485 . . . . 0.0 114.873 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.1 p -76.2 -15.59 60.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.21 1.404 . . . . 0.0 113.676 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.63 150.64 20.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.098 1.759 . . . . 0.0 111.131 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.27 -46.71 89.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 40.82 45.27 2.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.276 2.23 . . . . 0.0 113.266 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -77.15 172.84 12.6 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -167.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -165.68 122.44 1.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.941 1.696 . . . . 0.0 108.735 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.01 171.44 10.44 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -123.83 -50.43 1.83 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.175 1.79 . . . . 0.0 113.556 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.64 107.81 4.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 122.318 1.056 . . . . 0.0 112.593 -167.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.6 p -106.66 169.26 8.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.405 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -16.44 59.07 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -103.13 -16.86 15.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.793 1.237 . . . . 0.0 113.439 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.09 -111.61 1.39 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.576 1.56 . . . . 0.0 111.591 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 123' ' ' LEU . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.585 ' CD1' HG13 ' A' ' 82' ' ' VAL . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -84.7 141.02 30.88 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.64 -5.04 59.29 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 165.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 0.03 88.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.402 1.477 . . . . 0.0 115.19 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -109.24 12.14 25.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.306 1.442 . . . . 0.0 113.14 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.11 52.3 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.341 1.448 . . . . 0.0 113.79 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -132.5 152.71 51.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.964 1.706 . . . . 0.0 112.941 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m -124.42 157.21 35.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.393 1.077 . . . . 0.0 113.345 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 82' ' ' VAL . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -129.01 -158.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp 64.83 4.33 2.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 165.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 53.9 29.52 10.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.021 2.129 . . . . 0.0 114.599 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.004 1.722 . . . . 0.0 112.806 -176.908 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -71.02 140.15 50.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.097 0.959 . . . . 0.0 111.762 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.3 mt -85.96 134.91 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.646 1.179 . . . . 0.0 109.819 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.7 p -82.01 153.29 26.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.324 1.45 . . . . 0.0 113.067 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -78.84 49.66 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.66 1.584 . . . . 0.0 113.024 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -45.77 144.28 1.77 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.467 2.707 . . . . 0.0 114.949 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.87 142.13 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 166.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.467 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -131.42 7.06 5.63 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 114.732 -1.122 . . . . 0.0 114.287 -171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -150.62 -40.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -168.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.467 HG22 HG21 ' B' ' 156' ' ' TPO . 18.4 tt -90.65 -33.98 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -163.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.13 39.37 92.68 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 123.884 0.754 . . . . 0.0 113.472 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.67 -161.43 0.86 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 114.628 -165.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -138.77 -176.31 4.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -135.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 128.85 2.86 . . . . 0.0 114.826 -178.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 p -74.14 152.74 88.42 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.727 1.211 . . . . 0.0 112.921 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 152.97 62.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 112.698 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -78.61 153.91 30.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.235 1.014 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.7 t -153.81 147.22 24.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.389 1.476 . . . . 0.0 111.346 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -62.35 -18.56 61.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.419 1.088 . . . . 0.0 112.796 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.83 -1.04 29.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.87 1.268 . . . . 0.0 114.282 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -73.53 -9.88 59.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -142.73 167.36 22.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.19 1.396 . . . . 0.0 112.437 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.0 mt -82.63 52.25 2.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 112.037 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 31.63 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.973 1.309 . . . . 0.0 114.278 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -100.23 179.56 4.44 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -164.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.77 132.65 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.036 2.134 . . . . 0.0 108.399 163.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.61 155.45 24.28 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -99.33 -25.96 14.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.557 1.543 . . . . 0.0 114.16 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.81 102.82 0.79 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.895 1.278 . . . . 0.0 109.885 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -89.84 162.57 15.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.338 1.055 . . . . 0.0 111.479 170.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -21.94 14.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.356 2.262 . . . . 0.0 116.038 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -115.99 -0.18 12.86 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.463 1.505 . . . . 0.0 114.172 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.47 -93.96 0.3 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.789 1.662 . . . . 0.0 110.685 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 HG21 ' B' ' 155' ' ' VAL . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.665 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -90.82 146.44 23.94 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.89 -2.88 58.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.89 89.8 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.122 1.344 . . . . 0.0 115.261 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -113.16 13.48 19.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.635 1.574 . . . . 0.0 113.355 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.7 14.01 53.84 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.356 1.455 . . . . 0.0 113.969 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -132.44 172.25 12.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.854 1.662 . . . . 0.0 113.537 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -120.27 158.67 26.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.97 1.708 . . . . 0.0 113.187 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -166.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 tptt 61.37 14.68 5.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.674 1.99 . . . . 0.0 115.325 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.46 25.37 6.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.235 2.214 . . . . 0.0 114.543 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 172.851 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 62.82 -43.17 0.19 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.065 2.946 . . . . 0.0 116.394 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 59.5 mt -129.19 134.7 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.073 1.749 . . . . 0.0 109.492 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.0 p -99.01 166.31 11.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.699 1.6 . . . . 0.0 112.586 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -80.54 45.62 0.79 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.2 1.4 . . . . 0.0 114.709 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -51.46 145.72 8.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.809 2.044 . . . . 0.0 112.554 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.7 p -60.24 124.94 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.627 0.727 . . . . 0.0 109.397 170.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.665 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.88 -31.59 0.02 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.311 1.434 . . . . 0.0 113.72 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -75.3 -19.11 59.85 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 mm -90.42 -52.33 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.391 1.077 . . . . 0.0 110.589 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.02 54.41 6.41 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.827 1.204 . . . . 0.0 112.65 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.64 -159.93 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.846 1.658 . . . . 0.0 111.392 -171.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.257 34.5 mmt180 52.92 60.6 3.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.095 1.758 . . . . 0.0 114.045 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 127.761 2.424 . . . . 0.0 114.618 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 41.6 m -66.79 149.09 98.57 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.459 1.103 . . . . 0.0 112.95 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.03 156.76 61.87 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.213 2.608 . . . . 0.0 112.562 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -79.72 -10.24 59.76 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 91.4 p -143.01 161.58 37.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.354 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp -83.92 41.84 0.83 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.464 1.506 . . . . 0.0 112.862 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.73 -16.38 60.96 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.0 p -88.02 -11.52 47.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.836 1.655 . . . . 0.0 114.07 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -95.52 158.08 15.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.9 1.68 . . . . 0.0 112.678 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.73 38.29 0.1 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.51 2.324 . . . . 0.0 112.534 172.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -69.44 135.34 50.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.683 1.593 . . . . 0.0 111.239 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.54 178.56 9.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.311 1.044 . . . . 0.0 113.158 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.57 133.18 4.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.176 2.19 . . . . 0.0 108.873 169.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.42 158.48 14.72 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -102.09 -23.25 14.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.07 105.35 0.9 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.26 1.024 . . . . 0.0 110.037 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 t -90.59 163.14 14.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 111.194 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -31.39 9.64 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.9 2.08 . . . . 0.0 115.23 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -128.41 84.9 2.28 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.788 1.635 . . . . 0.0 108.259 167.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.58 -93.69 0.1 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.943 1.735 . . . . 0.0 113.677 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.496 HG12 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 155' ' ' VAL . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.428 ' HB2' HG23 ' B' ' 155' ' ' VAL . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -77.06 141.85 40.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.13 -2.76 45.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.366 1.066 . . . . 0.0 112.26 167.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.77 1.69 87.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.409 1.957 . . . . 0.0 115.256 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.1 p -96.74 -15.26 21.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.449 1.099 . . . . 0.0 112.905 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.01 -20.22 13.1 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.169 1.842 . . . . 0.0 112.986 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -86.22 158.76 19.66 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.152 1.476 . . . . 0.0 112.539 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m -126.35 155.88 41.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -129.23 -163.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 70.49 8.57 6.65 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 163.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.7 25.94 6.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.223 2.209 . . . . 0.0 114.499 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.884 1.674 . . . . 0.0 113.026 177.862 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.24 -17.58 48.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.705 1.202 . . . . 0.0 113.227 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.32 133.58 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.624 1.569 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -85.67 139.17 31.61 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.603 1.161 . . . . 0.0 113.338 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 46.3 m -81.88 57.37 3.43 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.263 1.825 . . . . 0.0 112.161 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -50.34 141.32 11.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.137 2.175 . . . . 0.0 114.598 -168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.435 HG21 HG23 ' A' ' 85' ' ' VAL . 14.4 p -73.2 139.72 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.543 1.137 . . . . 0.0 109.665 174.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.669 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.3 -8.63 0.52 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 126.343 1.925 . . . . 0.0 115.237 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.83 -27.09 3.38 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -173.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.669 HG22 HG21 ' B' ' 156' ' ' TPO . 20.2 tt -77.65 -34.96 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.482 1.492 . . . . 0.0 112.54 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.26 48.7 80.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.131 0.872 . . . . 0.0 112.6 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -147.45 0.25 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 111.988 -166.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.558 0.0 OUTLIER 63.27 -67.19 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.812 2.845 . . . . 0.0 114.203 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.868 1.667 . . . . 0.0 114.884 -170.632 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -151.39 178.99 1.34 Allowed Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 126.279 1.832 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -57.35 -22.84 51.73 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.391 2.061 . . . . 0.0 114.04 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -70.87 -27.74 64.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.097 0.959 . . . . 0.0 112.305 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 m -71.63 -9.4 58.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.021 1.329 . . . . 0.0 113.609 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.12 -9.21 58.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.554 1.142 . . . . 0.0 113.658 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.3 -13.29 60.41 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -81.55 75.71 8.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.725 1.21 . . . . 0.0 112.018 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -126.79 154.12 44.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.243 1.817 . . . . 0.0 111.721 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.98 35.28 0.1 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.947 2.099 . . . . 0.0 112.76 174.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -71.01 129.5 39.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.524 1.129 . . . . 0.0 110.562 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.2 p90 -146.76 177.01 9.43 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -167.6 127.87 1.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.249 2.22 . . . . 0.0 109.059 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.67 163.12 24.09 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -115.16 -27.7 7.2 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.529 1.532 . . . . 0.0 115.057 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.37 104.79 1.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.73 0.776 . . . . 0.0 111.876 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 t -96.28 162.9 13.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.978 1.311 . . . . 0.0 110.851 160.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -22.0 32.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.638 1.975 . . . . 0.0 114.871 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -104.51 -5.84 21.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.209 1.404 . . . . 0.0 114.123 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.5 -105.69 0.98 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.539 1.542 . . . . 0.0 111.489 -172.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -74.21 134.62 42.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -90.45 7.15 40.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.57 86.51 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.366 1.46 . . . . 0.0 115.683 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -118.39 15.26 13.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.485 1.514 . . . . 0.0 113.638 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.18 16.85 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.1 1.333 . . . . 0.0 113.814 -174.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -136.77 174.34 10.72 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.249 1.82 . . . . 0.0 112.969 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -112.29 158.42 19.76 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.105 1.362 . . . . 0.0 112.998 168.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.431 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -132.51 -157.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mmmp? 63.27 7.03 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 52.67 26.14 4.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 114.681 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.654 1.582 . . . . 0.0 114.683 -176.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -76.41 157.02 32.68 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.162 0.892 . . . . 0.0 111.91 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.2 tt -72.33 154.6 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.138 0.975 . . . . 0.0 112.156 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 47.5 p -134.24 151.04 51.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.519 1.528 . . . . 0.0 111.844 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 47.1 m -131.37 52.43 2.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.05 1.34 . . . . 0.0 112.055 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -50.12 135.68 20.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.421 1.888 . . . . 0.0 112.014 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 88' ' ' SER . 3.5 t -52.7 140.06 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.16 0.984 . . . . 0.0 111.603 -164.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.651 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -158.46 23.66 0.36 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 111.624 -2.535 . . . . 0.0 112.967 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -144.03 -37.87 0.32 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.0 tp -79.96 -34.51 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.2 0.909 . . . . 0.0 112.873 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.04 49.36 58.67 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.872 1.225 . . . . 0.0 113.521 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.13 -137.57 0.37 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.527 1.531 . . . . 0.0 113.247 -165.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 62.19 169.43 0.12 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.466 3.507 . . . . 0.0 113.794 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.295 1.838 . . . . 0.0 110.885 176.211 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 77.8 p -146.09 155.08 51.09 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.393 1.477 . . . . 0.0 112.118 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.15 -23.93 13.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.004 2.469 . . . . 0.0 113.354 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -151.98 152.05 31.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.196 1.798 . . . . 0.0 109.759 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.8 m -61.93 -20.82 64.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -95.89 -8.68 33.36 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.434 1.494 . . . . 0.0 113.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 -14.41 62.55 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.1 p -83.1 -10.06 58.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.485 1.514 . . . . 0.0 113.533 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -107.83 159.52 16.45 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.553 1.941 . . . . 0.0 111.648 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.56 49.75 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.727 1.611 . . . . 0.0 111.53 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.47 43.55 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.502 1.921 . . . . 0.0 112.903 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -84.82 178.37 7.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.357 1.063 . . . . 0.0 113.1 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.72 130.88 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.214 2.205 . . . . 0.0 109.14 163.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -83.4 163.41 14.82 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -110.3 -24.24 10.76 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.792 1.637 . . . . 0.0 114.573 165.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.37 105.63 0.99 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.162 0.985 . . . . 0.0 110.538 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.4 t -100.3 164.96 11.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.689 1.596 . . . . 0.0 111.494 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.06 -28.83 4.42 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.086 2.554 . . . . 0.0 116.66 -173.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -126.8 24.74 6.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.322 1.449 . . . . 0.0 114.902 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.02 -97.59 0.67 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.748 1.642 . . . . 0.0 112.501 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.74 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 HG21 ' B' ' 155' ' ' VAL . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.546 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -74.15 135.47 42.86 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.81 1.82 52.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.383 0.992 . . . . 0.0 113.478 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.04 -0.45 87.34 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.373 1.463 . . . . 0.0 115.699 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.3 p -113.34 14.27 19.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.42 1.488 . . . . 0.0 113.439 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.72 15.57 54.33 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.379 1.466 . . . . 0.0 113.971 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -135.28 174.24 10.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.146 1.779 . . . . 0.0 112.902 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -115.99 153.99 30.65 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 112.779 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HG11 ' A' ' 82' ' ' VAL . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.41 179.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 tptp 67.68 5.86 4.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 165.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 51.82 31.46 8.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.576 2.35 . . . . 0.0 114.388 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.132 1.373 . . . . 0.0 113.683 175.849 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -132.56 152.84 51.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.441 1.497 . . . . 0.0 111.126 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 80.6 mt -76.71 129.11 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.862 0.865 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 50.1 m -115.19 -2.75 12.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.796 2.039 . . . . 0.0 114.619 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m 61.94 30.79 18.18 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.882 3.273 . . . . 0.0 114.394 -166.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -59.25 160.96 5.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 129.386 3.074 . . . . 0.0 113.891 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.444 HG21 HG23 ' A' ' 85' ' ' VAL . 8.4 p -78.3 139.78 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 122.029 0.919 . . . . 0.0 109.31 157.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.599 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.4 -11.18 0.15 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 127.687 2.565 . . . . 0.0 114.784 168.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.5 -29.83 8.58 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.737 2.268 . . . . 0.0 116.256 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 156' ' ' TPO . 10.3 tp -81.37 -35.5 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.007 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.16 48.64 78.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.33 0.967 . . . . 0.0 112.901 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -162.05 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.933 2.093 . . . . 0.0 110.983 -169.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 59.01 -164.99 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.409 167.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.598 1.959 . . . . 0.0 110.936 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -67.99 149.17 98.29 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 112.999 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.04 167.22 26.7 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.525 2.817 . . . . 0.0 112.184 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.15 -29.65 69.91 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.61 0.764 . . . . 0.0 112.689 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.9 m -76.35 74.55 3.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.398 1.479 . . . . 0.0 111.108 171.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -63.23 -20.95 65.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.385 1.074 . . . . 0.0 113.845 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.75 137.56 54.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 149.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.7 p -100.05 -30.1 12.16 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.28 137.83 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.404 2.282 . . . . 0.0 113.243 -160.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.2 mt -112.02 -6.8 14.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.441 1.496 . . . . 0.0 113.001 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 48.77 56.63 7.38 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.676 1.991 . . . . 0.0 113.472 172.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -123.65 -179.23 4.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.964 1.305 . . . . 0.0 113.319 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -166.94 134.84 2.58 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.822 2.049 . . . . 0.0 108.256 163.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.2 162.09 20.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -110.48 -28.09 8.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.529 1.532 . . . . 0.0 114.675 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.51 105.78 0.97 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.742 0.782 . . . . 0.0 111.66 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -88.86 155.99 19.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.458 1.103 . . . . 0.0 109.584 156.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -65.04 -20.2 66.37 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.819 -1.175 . . . . 0.0 113.147 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.67 -10.81 47.19 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.118 1.367 . . . . 0.0 113.345 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.47 -99.11 0.54 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 126.606 2.051 . . . . 0.0 111.385 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.456 ' HD2' HG13 ' A' ' 82' ' ' VAL . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 HG21 ' B' ' 155' ' ' VAL . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.649 ' HB3' HG23 ' B' ' 155' ' ' VAL . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -76.87 135.67 38.85 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.06 -18.2 47.46 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.219 -0.926 . . . . 0.0 113.329 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.56 86.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.974 1.273 . . . . 0.0 115.02 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.4 p -107.61 15.03 25.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.293 1.437 . . . . 0.0 113.271 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.6 16.58 54.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.083 1.325 . . . . 0.0 113.852 -173.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -136.35 175.08 9.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.171 1.789 . . . . 0.0 112.689 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -132.03 154.33 49.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.414 1.086 . . . . 0.0 112.604 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.44 -161.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.276 18.4 tptp 65.34 10.2 6.32 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 153.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 52.97 36.81 22.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 0.0 113.919 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.73 1.212 . . . . 0.0 113.551 177.15 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -123.2 22.53 9.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.28 1.432 . . . . 0.0 113.257 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.4 mt -68.42 133.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.513 1.125 . . . . 0.0 109.875 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.2 p -78.64 141.17 38.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 112.607 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 27.2 m -83.32 45.0 0.99 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.284 1.434 . . . . 0.0 114.171 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -44.17 136.49 3.88 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.601 2.36 . . . . 0.0 112.956 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.649 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.1 p -55.29 117.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.118 0.967 . . . . 0.0 109.315 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.502 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.3 -14.42 0.04 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 127.053 2.263 . . . . 0.0 113.89 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -67.64 -15.49 63.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.136 2.174 . . . . 0.0 114.689 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.81 -33.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.045 1.338 . . . . 0.0 113.579 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.02 30.02 63.89 Favored Glycine 0 N--CA 1.478 1.459 0 C-N-CA 124.278 0.942 . . . . 0.0 114.04 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -163.86 1.1 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.104 1.762 . . . . 0.0 113.928 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.58 -70.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -137.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.852 1.661 . . . . 0.0 111.693 -178.333 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.7 m -67.9 147.76 98.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.366 1.066 . . . . 0.0 113.005 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.42 159.6 51.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.505 2.803 . . . . 0.0 112.552 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -72.88 151.5 41.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.106 0.962 . . . . 0.0 112.337 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.5 t -154.2 155.9 36.13 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.863 1.265 . . . . 0.0 112.098 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm -77.5 -11.71 59.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.133 . . . . 0.0 112.968 170.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.7 59.53 1.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.72 1.608 . . . . 0.0 112.268 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -88.57 -4.49 58.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.317 1.447 . . . . 0.0 114.688 -170.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.02 164.28 26.92 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.98 84.86 3.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.352 1.061 . . . . 0.0 108.593 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -82.93 39.07 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.859 1.264 . . . . 0.0 114.059 -163.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -86.4 -179.78 6.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.002 1.321 . . . . 0.0 113.414 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -167.14 129.18 1.66 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.707 2.403 . . . . 0.0 108.24 162.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.91 162.6 20.86 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -116.22 -29.26 6.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.646 1.579 . . . . 0.0 114.683 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.29 103.43 0.96 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.675 0.75 . . . . 0.0 111.569 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -94.93 162.69 13.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.851 1.261 . . . . 0.0 110.812 161.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.44 -22.25 42.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.956 2.103 . . . . 0.0 114.848 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmt-85 -103.68 -7.86 20.37 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 0.0 114.247 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.95 -106.43 0.91 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.584 1.564 . . . . 0.0 111.592 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD1' HG13 ' A' ' 82' ' ' VAL . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD1' ' A' ' 77' ' ' TYR . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 HG21 ' B' ' 155' ' ' VAL . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.62 ' HB3' HG23 ' B' ' 155' ' ' VAL . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.36 146.95 29.1 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -97.22 3.12 51.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.03 7.07 86.6 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.789 1.185 . . . . 0.0 115.808 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.26 6.5 t -127.45 30.55 5.34 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.414 1.485 . . . . 0.0 112.909 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.43 57.14 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.349 1.452 . . . . 0.0 113.942 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -144.5 170.23 16.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 113.552 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -132.34 161.87 32.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.498 1.519 . . . . 0.0 113.551 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 130' ' ' VAL . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -127.06 -157.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt 58.24 20.63 7.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.641 1.576 . . . . 0.0 114.41 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 54.32 29.28 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.085 1.754 . . . . 0.0 113.828 -173.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 124.902 1.281 . . . . 0.0 113.738 178.459 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 50.71 -96.39 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.116 1.767 . . . . 0.0 113.187 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 9.3 tp -148.98 155.84 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.738 1.615 . . . . 0.0 110.422 171.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -97.93 132.44 43.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.129 1.372 . . . . 0.0 111.372 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.4 m -138.59 66.96 1.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.489 1.116 . . . . 0.0 111.456 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -43.3 138.87 2.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 112.709 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 88' ' ' SER . 4.5 p -62.23 119.02 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.724 0.773 . . . . 0.0 109.165 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.83 -36.85 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.009 0.814 . . . . 0.0 114.944 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -78.16 -15.18 59.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 40.3 mt -97.46 -60.25 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.217 1.007 . . . . 0.0 111.665 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.77 38.63 Favored Glycine 0 N--CA 1.476 1.31 0 C-N-CA 125.383 1.468 . . . . 0.0 115.218 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -151.06 0.42 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.736 1.614 . . . . 0.0 114.121 -168.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -144.96 -179.68 6.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.2 1.8 . . . . 0.0 111.841 -146.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.434 170.686 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.5 t -149.93 141.67 15.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.97 1.308 . . . . 0.0 111.496 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.55 -14.64 42.86 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.449 2.766 . . . . 0.0 114.307 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -81.43 154.38 26.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.925 1.29 . . . . 0.0 112.529 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.1 m -65.27 127.38 31.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.308 1.043 . . . . 0.0 112.522 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -91.6 -4.26 55.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.435 1.094 . . . . 0.0 113.838 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 -6.71 12.22 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.192 1.397 . . . . 0.0 114.613 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -72.94 -15.27 61.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.981 1.312 . . . . 0.0 113.626 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.73 146.13 51.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.376 1.07 . . . . 0.0 112.204 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.8 mt -90.05 35.53 0.85 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.85 1.66 . . . . 0.0 112.214 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.28 105.04 17.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.618 1.167 . . . . 0.0 110.644 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.77 -174.97 5.19 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.056 1.342 . . . . 0.0 112.304 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.17 134.68 5.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.188 1.795 . . . . 0.0 108.713 159.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.03 160.57 20.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -111.2 -25.63 9.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.762 1.625 . . . . 0.0 114.601 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.73 106.17 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.928 0.871 . . . . 0.0 110.913 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.3 t -102.7 164.45 11.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.451 168.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -23.16 8.16 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.744 2.418 . . . . 0.0 116.963 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.28 19.66 8.97 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.24 -99.33 0.73 Allowed Glycine 0 N--CA 1.469 0.864 0 C-N-CA 125.454 1.502 . . . . 0.0 112.842 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 155' ' ' VAL . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -79.8 126.4 30.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -88.85 9.21 25.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -162.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.3 4.54 86.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.258 1.408 . . . . 0.0 115.661 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -129.73 27.13 5.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.063 1.345 . . . . 0.0 113.526 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.602 1.096 . . . . 0.0 113.734 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -142.31 175.12 10.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.174 1.79 . . . . 0.0 112.511 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m -108.81 160.32 16.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.052 . . . . 0.0 112.342 166.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.96 175.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 67.42 3.98 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 50.88 29.36 4.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.899 2.48 . . . . 0.0 114.938 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.381 1.072 . . . . 0.0 113.631 174.003 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.442 0.163 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -146.01 -44.31 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.983 1.313 . . . . 0.0 112.434 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.59 135.43 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.762 1.625 . . . . 0.0 108.944 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 16.4 p -75.65 148.29 38.82 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.396 1.079 . . . . 0.0 112.744 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -82.21 48.62 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.001 1.32 . . . . 0.0 113.136 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -56.49 169.74 0.43 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.532 2.333 . . . . 0.0 113.811 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 88' ' ' SER . 2.0 t -64.08 124.31 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 162.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.472 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.15 -14.8 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 127.356 2.408 . . . . 0.0 113.411 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -69.52 -16.92 63.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.068 2.147 . . . . 0.0 114.976 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.7 tp -123.85 -37.54 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.405 1.082 . . . . 0.0 113.254 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.5 67.63 1.72 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.137 0.875 . . . . 0.0 112.307 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -147.14 175.26 10.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -151.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -160.12 -43.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.742 2.417 . . . . 0.0 110.822 162.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.923 2.089 . . . . 0.0 111.214 164.901 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.7 m -67.65 149.45 98.29 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.435 1.094 . . . . 0.0 112.993 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.6 -24.66 13.51 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.174 2.582 . . . . 0.0 113.275 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -92.62 153.44 19.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 111.404 174.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 86.1 p -81.6 171.72 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.88 1.272 . . . . 0.0 113.131 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ttt -76.83 4.06 10.58 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.82 1.248 . . . . 0.0 113.591 178.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.98 -13.76 18.37 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.1 p -77.99 -14.78 59.4 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.316 1.447 . . . . 0.0 113.996 174.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 9.2 tp10 -92.01 152.1 20.15 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.674 1.589 . . . . 0.0 112.055 176.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 9.16 9.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.537 1.535 . . . . 0.0 113.642 175.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 8.6 mm-40 -70.96 132.97 45.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.954 1.302 . . . . 0.0 111.677 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.417 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 17.2 p90 -150.98 177.88 9.72 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.92 136.01 4.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.512 2.325 . . . . 0.0 108.326 162.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.2 168.16 20.69 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -120.02 -48.4 2.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.846 1.658 . . . . 0.0 113.598 173.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 104.78 3.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.037 0.922 . . . . 0.0 112.719 -169.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -98.11 -151.8 0.38 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.675 1.59 . . . . 0.0 110.503 162.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.26 -43.29 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.113 0.965 . . . . 0.0 111.139 -163.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -85.2 -23.25 28.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.815 1.246 . . . . 0.0 112.768 166.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.6 -101.25 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.477 1.513 . . . . 0.0 113.287 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.52 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -98.83 147.8 24.56 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.81 -6.74 59.57 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 172.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.58 4.6 89.04 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.044 1.307 . . . . 0.0 115.28 175.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.2 p -107.29 8.47 29.82 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.654 1.582 . . . . 0.0 113.347 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.26 7.59 51.78 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.646 1.593 . . . . 0.0 114.013 -172.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -119.67 169.59 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.637 1.575 . . . . 0.0 114.033 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -113.91 161.02 18.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.1 1.76 . . . . 0.0 112.423 173.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -132.58 -157.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.5 tttm 62.83 19.99 11.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 164.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 54.41 31.11 13.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.3 1.84 . . . . 0.0 114.064 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.894 1.677 . . . . 0.0 113.263 177.286 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.04 144.18 44.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.892 1.277 . . . . 0.0 111.056 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.8 mt -135.45 140.07 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.071 1.348 . . . . 0.0 110.399 -170.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.409 HG22 ' H ' ' B' ' 154' ' ' GLN . 3.2 m -139.0 153.73 48.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.903 1.281 . . . . 0.0 109.893 164.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.3 m -156.89 29.94 0.31 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.014 1.726 . . . . 0.0 113.547 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 154' ' ' GLN . . . . . 0.409 ' H ' HG22 ' B' ' 152' ' ' THR . 13.5 pt20 -159.28 162.62 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.409 1.884 . . . . 0.0 112.757 170.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 88' ' ' SER . 7.4 p -86.94 142.92 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 143.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.52 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.27 -21.67 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 114.422 -1.263 . . . . 0.0 114.378 -177.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.04 -20.8 60.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 175.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -149.67 -47.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.05 54.51 6.98 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.117 0.871 . . . . 0.0 113.788 -174.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -98.88 -139.35 0.31 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.711 2.404 . . . . 0.0 114.423 -172.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.9 mmt-85 -139.43 -171.59 3.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.727 1.611 . . . . 0.0 112.109 -147.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.885 1.274 . . . . 0.0 113.093 168.625 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 47.4 t -149.23 144.86 18.43 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.118 1.367 . . . . 0.0 111.506 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.73 -8.14 21.06 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.443 2.762 . . . . 0.0 113.786 173.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.74 148.05 49.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.336 1.454 . . . . 0.0 112.354 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.7 t -149.06 151.29 34.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.03 1.332 . . . . 0.0 111.554 172.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt -116.29 3.21 13.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.664 1.586 . . . . 0.0 112.674 172.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.97 6.25 29.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.237 1.415 . . . . 0.0 113.936 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -86.35 -10.2 54.89 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.498 1.519 . . . . 0.0 114.857 -166.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.45 179.02 7.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.692 1.197 . . . . 0.0 113.485 177.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.92 37.03 0.14 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.476 1.911 . . . . 0.0 113.405 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.47 132.42 43.85 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 110.666 175.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -151.33 179.03 8.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.65 136.15 5.18 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.967 2.107 . . . . 0.0 109.07 165.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.8 171.5 13.08 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -126.25 -45.96 1.66 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.701 1.601 . . . . 0.0 113.547 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.9 96.15 2.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.163 0.982 . . . . 0.0 112.449 -169.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.4 t -90.83 162.37 14.86 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.733 1.213 . . . . 0.0 110.938 161.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.13 -20.47 26.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.289 1.836 . . . . 0.0 114.981 177.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -103.71 -9.47 19.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.226 1.41 . . . . 0.0 114.205 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.22 -109.75 1.4 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.422 1.486 . . . . 0.0 111.514 -172.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB3' HG23 ' B' ' 155' ' ' VAL . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -112.24 147.69 35.7 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -81.74 -7.55 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.63 6.44 83.18 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.283 1.42 . . . . 0.0 115.191 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.6 p -114.71 14.54 17.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.629 1.571 . . . . 0.0 113.624 -175.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.83 54.48 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.171 1.367 . . . . 0.0 113.815 -173.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -128.3 165.86 19.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.428 1.891 . . . . 0.0 112.889 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m -133.16 156.02 48.23 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 -175.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.7 178.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.8 tptt 64.94 -8.77 0.21 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.593 2.357 . . . . 0.0 117.286 -174.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 52.71 32.91 12.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.851 2.46 . . . . 0.0 113.803 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.619 1.567 . . . . 0.0 113.009 174.443 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -74.83 156.3 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 0.0 112.197 176.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 tp -72.46 157.73 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.171 0.988 . . . . 0.0 111.79 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.0 p -73.38 150.86 41.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.593 1.157 . . . . 0.0 112.67 175.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -82.45 44.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.515 1.526 . . . . 0.0 114.442 -172.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -46.0 137.33 5.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.969 2.508 . . . . 0.0 113.578 -170.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.2 p -58.96 116.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.847 0.832 . . . . 0.0 108.866 175.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.429 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -161.11 -31.5 0.02 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.652 1.596 . . . . 0.0 114.455 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -65.43 -27.29 68.42 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.4 1.1 . . . . 0.0 113.379 172.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 49.2 mm -98.09 -50.55 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.379 1.472 . . . . 0.0 109.748 170.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.36 63.54 2.9 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.469 1.509 . . . . 0.0 112.738 171.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -138.63 -160.28 1.04 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -138.24 -156.55 0.69 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.516 1.926 . . . . 0.0 110.643 -138.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.396 1.078 . . . . 0.0 113.194 166.791 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 95.0 p -77.6 165.46 51.19 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.473 1.109 . . . . 0.0 112.736 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.66 -22.22 66.3 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.244 2.63 . . . . 0.0 113.938 169.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.53 -7.82 59.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.06 1.744 . . . . 0.0 113.242 174.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.1 m 56.67 18.27 3.59 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.434 1.894 . . . . 0.0 114.771 -169.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt -159.04 126.41 4.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.796 2.038 . . . . 0.0 108.941 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.23 88.49 7.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.852 0.861 . . . . 0.0 110.708 174.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.18 53.69 1.51 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.903 1.681 . . . . 0.0 112.396 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.99 150.12 37.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.232 1.413 . . . . 0.0 112.08 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.24 33.99 0.69 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.731 1.613 . . . . 0.0 112.376 174.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -95.51 100.95 12.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -155.11 -173.91 4.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.833 1.253 . . . . 0.0 112.568 -176.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -162.31 136.51 6.57 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.389 1.475 . . . . 0.0 109.12 160.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.58 167.72 16.77 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -120.05 -46.09 2.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.616 1.966 . . . . 0.0 113.301 175.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.55 97.84 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.272 1.035 . . . . 0.0 111.903 -170.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -94.17 164.24 13.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.057 162.184 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -23.11 52.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.036 2.134 . . . . 0.0 114.805 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmt-85 -103.87 -9.09 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.136 1.374 . . . . 0.0 114.261 174.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.21 -111.09 1.29 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.662 1.601 . . . . 0.0 111.848 -177.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -106.62 147.96 28.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.8 -5.77 59.28 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.15 5.17 87.72 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.145 1.355 . . . . 0.0 115.295 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -111.65 12.16 21.15 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.51 1.524 . . . . 0.0 113.321 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.33 13.19 52.77 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.368 1.461 . . . . 0.0 113.857 -172.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -129.59 167.92 17.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.948 1.699 . . . . 0.0 113.559 -177.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -131.0 157.57 42.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.609 1.563 . . . . 0.0 113.293 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.69 -177.35 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.3 tttm 65.16 11.46 7.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 168.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 54.61 32.02 16.26 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.959 1.704 . . . . 0.0 114.007 168.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.354 1.862 . . . . 0.0 112.663 -178.026 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.789 0.328 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -137.64 152.95 49.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.744 1.618 . . . . 0.0 111.009 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -77.58 154.63 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.272 1.029 . . . . 0.0 111.929 176.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.0 p -93.83 136.15 34.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.3 1.44 . . . . 0.0 112.412 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 41.7 m -82.98 45.43 1.01 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.323 1.449 . . . . 0.0 113.247 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -51.23 152.28 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.713 2.405 . . . . 0.0 115.09 -166.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.12 125.18 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.696 1.198 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.531 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.42 -19.06 0.02 OUTLIER Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.971 2.224 . . . . 0.0 113.478 175.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -63.22 -26.11 68.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.363 1.465 . . . . 0.0 114.896 177.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.4 tt -109.93 -38.12 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.747 1.219 . . . . 0.0 112.956 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.75 2.06 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.374 0.987 . . . . 0.0 112.131 177.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -167.4 1.93 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.826 1.651 . . . . 0.0 110.854 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.29 31.4 mmt180 59.67 38.3 21.97 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.31 2.644 . . . . 0.0 113.941 174.655 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 70.1 m -131.38 150.03 75.26 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.482 1.513 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.24 152.35 66.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.416 2.744 . . . . 0.0 112.555 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.39 143.09 24.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.209 1.404 . . . . 0.0 111.033 177.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.7 m -65.18 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.19 -5.42 23.19 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 113.129 178.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.74 -5.09 58.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.751 1.22 . . . . 0.0 114.178 -178.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.5 p -77.66 -13.95 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.948 1.299 . . . . 0.0 114.414 -172.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -147.42 156.13 42.59 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.553 1.941 . . . . 0.0 110.725 175.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.65 18.34 0.98 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.168 1.387 . . . . 0.0 112.932 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.74 101.63 13.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.501 1.521 . . . . 0.0 110.54 -178.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -151.31 -174.97 4.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.679 1.191 . . . . 0.0 112.653 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.18 133.35 4.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.438 1.495 . . . . 0.0 108.676 161.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 156.5 27.76 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -102.99 -25.93 13.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.581 1.552 . . . . 0.0 114.361 169.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.66 102.79 0.81 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.639 1.176 . . . . 0.0 110.113 -176.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -90.61 162.35 15.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 0.0 111.432 169.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -21.69 12.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.264 2.226 . . . . 0.0 115.975 -176.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -114.72 -1.47 13.27 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.463 1.505 . . . . 0.0 114.235 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.42 -95.33 0.34 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.811 1.672 . . . . 0.0 110.711 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD21 ' H ' ' B' ' 154' ' ' GLN . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD2' HG13 ' A' ' 82' ' ' VAL . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -89.04 146.14 25.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -84.98 -2.48 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.9 89.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.119 1.342 . . . . 0.0 115.245 174.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.3 p -113.8 13.66 18.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.612 1.565 . . . . 0.0 113.329 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 14.38 53.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.325 1.441 . . . . 0.0 113.886 -173.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -133.21 172.85 12.11 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.911 1.684 . . . . 0.0 113.55 -176.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -117.87 157.76 26.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 112.992 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.44 -154.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptp 63.65 16.05 9.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.259 2.224 . . . . 0.0 116.455 168.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 59.81 23.23 12.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.063 2.145 . . . . 0.0 114.789 171.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 114.545 -175.255 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 111.265 0.098 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 62.86 -47.95 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.812 2.845 . . . . 0.0 116.96 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.08 157.89 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.095 1.358 . . . . 0.0 112.266 178.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -72.68 129.29 37.89 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.536 1.135 . . . . 0.0 112.279 174.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 21.8 p -170.21 105.25 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.013 1.325 . . . . 0.0 111.841 171.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 154' ' ' GLN . . . . . 0.521 ' H ' HD21 ' A' ' 38' ' ' LEU . 28.9 mt-30 59.1 171.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.4 2.68 . . . . 0.0 115.735 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.22 127.79 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -149.02 -18.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.804 1.193 . . . . 0.0 115.389 -169.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -72.72 -17.38 61.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.416 1.108 . . . . 0.0 113.55 174.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.33 -36.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.23 43.44 92.98 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 124.152 0.882 . . . . 0.0 113.808 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.08 -148.3 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.087 1.755 . . . . 0.0 113.891 -167.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -144.29 169.61 17.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.111 1.764 . . . . 0.0 111.697 -143.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.679 174.848 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 73.0 m -63.22 151.96 85.66 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.352 1.061 . . . . 0.0 112.797 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.31 -14.09 28.22 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 114.585 -174.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -142.68 164.6 29.66 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.508 1.523 . . . . 0.0 111.158 176.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 38.2 t -129.67 146.25 51.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.751 1.62 . . . . 0.0 111.483 176.047 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt -101.17 2.45 40.12 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.907 1.283 . . . . 0.0 113.749 -175.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.11 -19.77 64.75 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -175.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.1 p -97.74 -7.39 30.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.032 1.733 . . . . 0.0 113.836 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -97.66 160.04 14.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.105 1.762 . . . . 0.0 112.362 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.306 0.3 OUTLIER -75.07 16.58 0.3 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 170.758 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -55.73 135.05 51.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.117 1.367 . . . . 0.0 112.031 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -150.24 178.67 8.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -164.38 135.13 4.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.142 2.177 . . . . 0.0 108.639 166.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -82.35 166.97 15.8 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -120.1 -27.78 5.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.731 1.613 . . . . 0.0 115.123 170.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.23 108.01 1.25 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.802 0.81 . . . . 0.0 111.924 -177.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -98.28 162.19 13.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.454 1.502 . . . . 0.0 110.814 160.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -22.3 37.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.522 1.929 . . . . 0.0 114.833 178.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -103.56 -5.04 23.11 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.229 1.411 . . . . 0.0 113.981 175.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.65 -102.94 0.76 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.595 1.569 . . . . 0.0 111.668 -173.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.529 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.463 ' H ' ' NH2' ' A' ' 113' ' ' ARG . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -85.08 149.17 25.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -92.54 0.01 57.38 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.176 0.991 . . . . 0.0 113.279 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 17.7 79.92 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.63 1.11 . . . . 0.0 115.154 178.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.257 9.6 t -141.95 33.94 1.57 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 19.23 61.91 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.199 1.381 . . . . 0.0 113.88 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.45 178.81 7.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.883 1.673 . . . . 0.0 113.03 -171.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p -145.59 162.74 36.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.463 ' NH2' ' H ' ' A' ' 89' ' ' SER . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 130' ' ' VAL . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -133.72 -163.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp 69.13 12.19 8.44 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 162.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 54.73 22.42 4.11 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.824 2.05 . . . . 0.0 115.182 174.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.718 1.607 . . . . 0.0 113.157 178.873 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -73.2 155.05 39.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 112.368 176.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 42.1 mm -120.5 147.75 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 0.0 110.124 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -79.04 148.43 32.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.029 1.332 . . . . 0.0 113.172 -177.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -122.0 62.19 0.95 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.42 . . . . 0.0 111.54 -177.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.32 157.01 6.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.386 1.875 . . . . 0.0 113.112 -176.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 88' ' ' SER . 1.4 t -67.85 147.92 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.767 0.794 . . . . 0.0 109.496 171.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.529 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.39 19.99 0.47 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.006 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -146.28 -38.19 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -169.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.96 -34.36 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.858 0.753 . . . . 0.0 112.962 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.0 44.26 94.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.506 1.051 . . . . 0.0 113.513 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -108.79 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.285 1.834 . . . . 0.0 113.893 -164.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.14 158.48 25.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.361 2.664 . . . . 0.0 112.417 -175.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.835 2.054 . . . . 0.0 112.931 -168.873 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 85.7 p -76.79 164.27 60.39 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.4 1.08 . . . . 0.0 112.969 178.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -59.55 -21.15 60.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.349 2.699 . . . . 0.0 114.608 173.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -91.33 -5.45 54.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.115 1.366 . . . . 0.0 113.356 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.0 t -65.92 145.63 55.68 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.232 -0.917 . . . . 0.0 112.364 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm 59.06 7.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.991 2.116 . . . . 0.0 116.033 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.68 -3.8 58.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.665 1.186 . . . . 0.0 113.751 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -84.08 53.43 2.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.3 1.84 . . . . 0.0 113.83 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.38 152.66 27.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.101 1.36 . . . . 0.0 110.523 166.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.52 -45.89 81.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 39.37 45.55 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.411 2.285 . . . . 0.0 113.305 -177.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -79.99 175.68 10.42 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.283 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -166.21 123.12 1.35 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.308 1.443 . . . . 0.0 109.159 169.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 163.76 22.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -115.56 -44.8 2.94 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.448 1.899 . . . . 0.0 113.279 174.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.86 93.88 1.6 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.374 1.083 . . . . 0.0 111.721 -169.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 t -88.15 162.36 16.77 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.077 162.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -21.86 32.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.438 1.895 . . . . 0.0 114.789 178.089 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.33 -7.53 19.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.215 1.406 . . . . 0.0 114.109 175.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.88 -107.92 1.17 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.568 1.556 . . . . 0.0 111.694 -173.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -79.33 138.3 37.66 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -86.41 5.38 35.27 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.7 87.89 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.21 1.386 . . . . 0.0 115.217 175.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -124.69 14.87 8.72 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.147 1.379 . . . . 0.0 113.769 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 15.34 57.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.053 1.311 . . . . 0.0 113.962 -175.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -133.77 176.97 8.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.342 1.857 . . . . 0.0 112.729 -176.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p -124.12 156.5 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.359 1.064 . . . . 0.0 113.721 170.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -168.22 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 tptt 63.05 14.08 7.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 178.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 53.92 24.86 4.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.814 2.046 . . . . 0.0 114.938 -178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.332 1.053 . . . . 0.0 113.801 174.544 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.8 40.99 32.18 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.505 1.522 . . . . 0.0 114.157 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.1 mt -78.08 138.25 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.647 1.179 . . . . 0.0 109.803 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.6 p -70.03 146.33 51.09 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.381 1.072 . . . . 0.0 113.081 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -83.54 51.62 2.05 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -43.78 144.09 0.91 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.18 2.192 . . . . 0.0 113.581 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.49 119.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.687 0.676 . . . . 0.0 109.297 -176.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.94 -18.47 0.02 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.633 1.587 . . . . 0.0 115.187 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -65.7 -20.18 66.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.395 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.8 tp -123.67 -33.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.393 . . . . 0.0 113.299 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.85 59.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.326 0.965 . . . . 0.0 114.198 172.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.54 -143.54 0.21 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.514 1.526 . . . . 0.0 113.192 -168.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -134.78 -161.65 1.17 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.504 1.522 . . . . 0.0 111.748 -149.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.105 1.362 . . . . 0.0 113.156 168.327 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 42.0 m -66.55 148.81 98.53 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 124.485 1.114 . . . . 0.0 112.853 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.27 155.11 64.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.312 2.675 . . . . 0.0 112.641 178.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.71 -32.52 67.89 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.129 0.972 . . . . 0.0 112.826 176.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -132.42 170.31 15.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.423 1.489 . . . . 0.0 112.383 -164.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -74.95 74.64 2.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.51 1.524 . . . . 0.0 111.402 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.23 53.61 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.617 1.567 . . . . 0.0 114.851 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -81.09 58.05 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.082 1.753 . . . . 0.0 112.749 -177.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.94 175.82 9.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.815 1.646 . . . . 0.0 113.157 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.61 86.39 6.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.402 169.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.06 65.68 0.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.346 1.459 . . . . 0.0 112.071 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -143.01 -178.45 5.84 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.636 1.174 . . . . 0.0 112.496 176.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 134.67 3.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.497 2.319 . . . . 0.0 108.487 166.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.46 171.74 13.26 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -125.58 -33.91 2.72 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.79 103.42 1.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.088 0.947 . . . . 0.0 113.47 -173.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.6 t -89.56 165.76 14.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 109.703 153.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -70.0 -19.43 63.33 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.892 -1.13 . . . . 0.0 112.208 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -86.93 -17.35 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.667 1.187 . . . . 0.0 113.04 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.37 -101.94 0.59 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.288 1.423 . . . . 0.0 112.103 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 82' ' ' VAL . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 91' ' ' TYR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' HG21 ' A' ' 85' ' ' VAL . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -84.02 146.77 27.79 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.79 0.49 56.98 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.29 11.35 85.08 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.905 1.241 . . . . 0.0 115.176 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.5 t -142.9 53.52 1.38 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 123.237 1.494 . . . . 0.0 111.542 -177.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.36 16.07 80.02 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.594 1.569 . . . . 0.0 114.8 172.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -149.66 176.57 10.55 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.877 1.271 . . . . 0.0 113.448 -164.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -141.43 160.47 40.07 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.17 -161.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 63.79 -6.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.216 2.606 . . . . 0.0 117.846 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 52.18 35.72 17.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.531 2.332 . . . . 0.0 113.072 177.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.413 1.885 . . . . 0.0 112.519 -177.873 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -137.21 156.34 48.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.952 1.701 . . . . 0.0 111.188 -173.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.4 mt -116.08 137.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.169 1.788 . . . . 0.0 109.733 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.3 p -102.69 125.27 49.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.794 0.838 . . . . 0.0 112.435 175.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -143.92 42.14 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.492 1.917 . . . . 0.0 111.248 -178.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -48.67 144.98 3.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.462 1.905 . . . . 0.0 115.282 -159.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.19 137.46 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 159.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.554 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.9 -25.56 0.99 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.619 2.056 . . . . 0.0 114.252 175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 -27.74 3.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -166.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.554 HG22 HG21 ' B' ' 156' ' ' TPO . 20.8 tt -79.48 -33.31 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 120.234 1.379 . . . . 0.0 112.614 -177.219 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.59 49.39 56.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.185 0.897 . . . . 0.0 113.146 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -104.91 -166.46 1.24 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.045 2.138 . . . . 0.0 111.103 -172.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.275 34.9 mmt180 56.55 37.11 28.55 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 162.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 128.103 2.561 . . . . 0.0 113.686 179.442 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -146.43 153.71 48.15 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.372 1.469 . . . . 0.0 112.167 -178.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.64 154.17 59.68 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.456 2.77 . . . . 0.0 112.64 178.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -85.0 114.33 22.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.174 0.99 . . . . 0.0 111.315 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -64.86 -16.08 62.71 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm -89.61 -13.47 37.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.476 1.11 . . . . 0.0 113.109 175.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.19 -17.61 32.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -83.85 55.15 3.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.553 1.541 . . . . 0.0 112.934 -176.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.43 140.0 32.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.096 1.758 . . . . 0.0 111.124 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.23 1.02 7.81 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.072 1.749 . . . . 0.0 112.555 173.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 53.48 39.24 29.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.652 1.981 . . . . 0.0 113.824 -178.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -93.48 -177.47 4.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.23 1.412 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -169.07 128.31 1.05 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.668 2.387 . . . . 0.0 109.084 169.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.18 163.1 15.33 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.39 -28.76 8.41 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.429 1.491 . . . . 0.0 114.948 168.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.63 103.19 0.92 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.609 0.719 . . . . 0.0 111.513 -172.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -93.29 162.71 13.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.612 1.165 . . . . 0.0 110.961 160.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -21.9 31.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.767 2.027 . . . . 0.0 114.934 179.075 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.66 -6.11 20.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.167 1.387 . . . . 0.0 114.149 175.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.97 -105.02 0.81 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.406 1.479 . . . . 0.0 111.336 -171.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.454 ' H ' HG23 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.469 ' HB3' HG23 ' B' ' 155' ' ' VAL . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.76 141.73 37.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.35 -1.18 57.74 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.78 81.16 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.073 1.32 . . . . 0.0 115.353 175.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -136.0 28.35 3.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.653 1.181 . . . . 0.0 113.466 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.75 18.41 56.52 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.216 1.388 . . . . 0.0 113.892 178.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -144.65 160.05 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -172.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m -126.99 156.79 41.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.41 1.084 . . . . 0.0 113.266 -176.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 82' ' ' VAL . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 131' ' ' LYS . 38.9 t -110.58 -176.58 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' HG12 ' A' ' 130' ' ' VAL . 22.7 tttm 68.49 10.9 8.14 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 151.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 57.11 29.02 15.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.94 2.096 . . . . 0.0 114.702 172.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.58 1.552 . . . . 0.0 113.315 178.372 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.56 -37.44 71.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.026 0.93 . . . . 0.0 111.375 173.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.82 146.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.438 1.495 . . . . 0.0 108.862 164.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.1 173.43 6.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.318 1.447 . . . . 0.0 112.833 177.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 26.0 m -77.9 35.92 0.21 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.056 1.342 . . . . 0.0 114.363 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -48.12 136.23 12.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.621 1.968 . . . . 0.0 113.06 -174.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 88' ' ' SER 0.254 4.1 p -65.3 128.96 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.823 1.297 . . . . 0.0 110.286 -172.688 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.468 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.32 -2.24 0.1 OUTLIER Glycine 0 C--N 1.298 -1.578 1 C-N-CA 132.317 4.77 . . . . 0.0 115.713 176.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -57.11 -20.19 24.17 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 149.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -154.47 -42.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 51.79 22.93 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.186 0.898 . . . . 0.0 114.682 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -140.42 0.33 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.538 1.935 . . . . 0.0 114.084 -173.223 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -135.52 -176.2 4.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.373 1.469 . . . . 0.0 112.968 -149.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.15 0.98 . . . . 0.0 112.97 166.826 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 96.8 p -80.14 155.32 74.81 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.424 1.09 . . . . 0.0 112.901 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.69 -10.84 28.63 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.248 2.632 . . . . 0.0 113.609 175.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.4 -1.31 49.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.199 1.4 . . . . 0.0 113.469 178.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.4 t -135.97 160.99 36.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.666 1.587 . . . . 0.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -81.09 39.75 0.52 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.071 -177.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.3 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.241 1.416 . . . . 0.0 114.297 -176.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.4 p -82.01 -11.17 58.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.16 1.784 . . . . 0.0 114.028 177.119 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.6 136.22 52.69 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.557 1.143 . . . . 0.0 112.046 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.1 24.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.521 1.529 . . . . 0.0 113.468 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.06 133.22 47.8 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.978 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.7 p90 -150.32 176.22 11.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.32 135.41 5.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.35 2.26 . . . . 0.0 108.66 163.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.05 163.61 30.59 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -127.95 -26.32 2.92 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.316 1.846 . . . . 0.0 115.171 176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.4 110.1 1.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.703 0.763 . . . . 0.0 112.133 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.1 p -105.1 171.37 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.2 1.0 . . . . 0.0 111.035 154.467 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.84 -19.9 65.82 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -87.93 -37.88 16.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.06 1.344 . . . . 0.0 111.843 173.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.54 -103.76 0.31 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.801 1.667 . . . . 0.0 110.312 172.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' B' ' 154' ' ' GLN . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -76.32 129.31 36.44 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.4 0.65 48.64 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.05 86.95 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.21 1.386 . . . . 0.0 115.493 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.8 p -110.11 13.63 23.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.552 1.541 . . . . 0.0 113.207 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.37 54.22 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.33 1.443 . . . . 0.0 113.932 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.15 169.54 17.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.064 1.745 . . . . 0.0 113.094 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p -105.47 152.6 22.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.501 1.12 . . . . 0.0 111.742 167.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m -121.94 -156.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.0 tptp 58.65 19.09 6.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.314 1.846 . . . . 0.0 114.781 177.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 53.38 29.39 8.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.46 1.904 . . . . 0.0 114.168 -173.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 C--O 1.255 1.348 0 C-N-CA 124.988 1.315 . . . . 0.0 113.862 176.413 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.458 0.169 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -75.97 144.46 40.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.805 0.842 . . . . 0.0 111.859 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.97 143.94 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.115 1.766 . . . . 0.0 108.886 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -64.97 150.92 47.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.17 0.988 . . . . 0.0 112.653 173.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.9 m -79.69 49.36 1.03 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.215 1.406 . . . . 0.0 113.065 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 154' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 38' ' ' LEU . 13.4 pt20 -59.48 166.38 2.4 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.096 2.158 . . . . 0.0 114.149 -173.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 4.0 p -64.64 119.69 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 154.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.45 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.5 -14.82 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.994 2.235 . . . . 0.0 113.876 176.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -67.38 -13.91 62.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.869 2.067 . . . . 0.0 114.528 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 tp -142.16 -34.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.122 1.369 . . . . 0.0 113.249 174.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.0 44.5 67.09 Favored Glycine 0 N--CA 1.477 1.367 0 C-N-CA 124.304 0.954 . . . . 0.0 113.983 171.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.99 -140.6 0.32 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.376 1.87 . . . . 0.0 114.324 -167.568 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -134.16 -161.07 1.11 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 112.756 -149.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.839 2.056 . . . . 0.0 112.906 177.134 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.9 m -66.66 152.41 95.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.687 1.195 . . . . 0.0 112.958 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.33 160.59 44.59 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.099 2.532 . . . . 0.0 112.167 172.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -63.62 -35.07 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 111.943 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 48.0 t -153.89 145.27 23.07 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 110.396 164.465 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -65.75 -13.73 59.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.635 0.774 . . . . 0.0 112.368 171.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.61 57.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.402 1.081 . . . . 0.0 113.833 170.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.9 p -118.88 -24.02 6.75 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -175.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.13 148.7 28.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.705 1.602 . . . . 0.0 110.117 173.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.0 mt -135.26 76.77 1.64 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.041 1.736 . . . . 0.0 107.253 179.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.84 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.28 1.032 . . . . 0.0 113.289 -176.015 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -134.79 179.52 6.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 111.06 159.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.52 132.45 2.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.473 1.909 . . . . 0.0 109.012 164.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.18 167.05 22.12 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.36 -26.95 3.84 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.661 1.584 . . . . 0.0 115.078 170.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.07 103.73 1.14 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.983 -173.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.9 t -97.63 168.59 10.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 0.0 110.672 160.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -27.41 60.71 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.517 1.927 . . . . 0.0 114.825 -176.026 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mtt85 -108.39 -6.56 16.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.318 1.847 . . . . 0.0 114.809 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.48 -109.78 1.0 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.136 1.827 . . . . 0.0 111.799 -177.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.581 ' HB3' HG23 ' B' ' 155' ' ' VAL . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -77.09 133.61 38.99 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -87.41 4.53 42.82 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.43 7.31 82.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.934 1.254 . . . . 0.0 115.948 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -132.73 25.51 4.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.781 1.29 . . . . 0.0 113.871 -176.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.25 17.01 54.64 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.792 1.187 . . . . 0.0 113.924 178.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -137.88 169.91 16.96 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.95 1.7 . . . . 0.0 112.627 -177.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p -107.74 158.67 17.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.597 0.759 . . . . 0.0 112.33 161.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.04 -164.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 62.22 15.37 7.48 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.071 2.148 . . . . 0.0 115.944 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 54.31 24.98 5.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.224 1.81 . . . . 0.0 114.62 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 124.357 1.063 . . . . 0.0 113.742 173.801 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.516 0.198 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -110.25 5.4 21.73 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.793 1.637 . . . . 0.0 113.179 175.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.53 161.62 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.764 1.626 . . . . 0.0 111.444 -178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -71.84 172.61 9.57 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.577 1.18 . . . . 0.0 113.111 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m -128.76 27.85 5.43 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.519 1.928 . . . . 0.0 114.199 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -160.55 163.99 32.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.237 1.815 . . . . 0.0 114.404 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 155' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.0 p -78.16 124.26 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 142.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 156' ' ' TPO . . . . . 0.499 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.48 -18.23 0.04 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 126.05 1.786 . . . . 0.0 114.523 176.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -66.6 -26.88 67.31 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.4 tp -100.24 -34.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.311 1.044 . . . . 0.0 112.266 171.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.17 63.7 3.32 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.938 1.256 . . . . 0.0 112.556 166.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -141.74 170.59 15.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -153.484 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -165.05 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.275 2.23 . . . . 0.0 110.935 164.215 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.956 2.103 . . . . 0.0 111.351 168.022 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.583 HD13 HG11 ' A' ' 82' ' ' VAL . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 . . . . . 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HA ' HG23 ' A' ' 130' ' ' VAL . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.764 ' CD2' HG13 ' A' ' 82' ' ' VAL . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.769 HG11 HD13 ' A' ' 123' ' ' LEU . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.769 HD13 HG11 ' A' ' 82' ' ' VAL . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 CA-C-O 121.125 0.291 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.403 ' HA ' HG23 ' A' ' 130' ' ' VAL . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.169 0.509 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.517 0.675 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 82' ' ' VAL . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 82' ' ' VAL . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HG13 ' A' ' 82' ' ' VAL . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 77' ' ' TYR . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HG11 ' A' ' 82' ' ' VAL . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' HA ' HG23 ' A' ' 130' ' ' VAL . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-O 121.56 0.533 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.731 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 HG11 ' A' ' 82' ' ' VAL . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.407 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.966 0.889 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 123' ' ' LEU . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.585 ' CD1' HG13 ' A' ' 82' ' ' VAL . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 82' ' ' VAL . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.843 0.83 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 N-CA-C 113.677 0.231 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.496 HG12 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.431 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.548 0.69 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.74 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HG11 ' A' ' 82' ' ' VAL . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' HD2' HG13 ' A' ' 82' ' ' VAL . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 . . . . . 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD1' HG13 ' A' ' 82' ' ' VAL . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD1' ' A' ' 77' ' ' TYR . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 . . . . . 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 130' ' ' VAL . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 120.283 -0.176 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.287 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 . . . . . 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.939 0.876 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.69 0.757 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 . . . . . 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD2' HG13 ' A' ' 82' ' ' VAL . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.463 ' H ' ' NH2' ' A' ' 113' ' ' ARG . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.463 ' NH2' ' H ' ' A' ' 89' ' ' SER . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 130' ' ' VAL . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 122.067 0.936 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 82' ' ' VAL . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 91' ' ' TYR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' HG21 ' A' ' 85' ' ' VAL . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.454 ' H ' HG23 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 82' ' ' VAL . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.867 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.9 p -74.23 153.17 88.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.69 1.196 . . . . 0.0 112.829 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 160.58 48.92 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.302 2.668 . . . . 0.0 112.714 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.17 -27.67 68.87 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.15 0.98 . . . . 0.0 113.455 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.9 m -124.35 127.19 47.23 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.889 1.676 . . . . 0.0 110.103 170.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.49 131.05 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.414 1.086 . . . . 0.0 110.834 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.34 32.69 3.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.121 2.169 . . . . 0.0 111.88 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m 57.71 41.56 25.08 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.026 1.73 . . . . 0.0 113.302 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.99 173.63 7.64 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.281 1.832 . . . . 0.0 112.382 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.11 58.56 2.04 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.022 1.329 . . . . 0.0 111.823 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.67 33.25 0.2 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.978 1.711 . . . . 0.0 113.973 -174.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -81.4 178.86 8.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.777 1.231 . . . . 0.0 113.495 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.07 127.18 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.384 2.274 . . . . 0.0 108.57 165.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -98.49 128.41 44.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.89 1.276 . . . . 0.0 111.422 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.72 134.27 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.933 -1.104 . . . . 0.0 111.468 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.5 mt -112.71 -43.25 3.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.821 1.648 . . . . 0.0 112.75 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -146.62 154.79 41.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.063 0.935 . . . . 0.0 113.303 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.33 137.45 46.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 126.035 1.734 . . . . 0.0 108.409 166.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -129.24 138.98 34.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.07 -29.8 9.57 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.976 3.117 . . . . 0.0 114.871 -162.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.79 128.21 17.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.576 1.151 . . . . 0.0 110.683 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.8 144.61 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.085 1.354 . . . . 0.0 109.663 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 m -124.3 149.17 46.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.358 1.463 . . . . 0.0 111.528 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.37 156.01 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.07 108.75 12.14 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.498 1.519 . . . . 0.0 111.075 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -69.96 78.59 0.48 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.95 -1.719 . . . . 0.0 111.164 166.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -70.55 147.01 94.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.296 1.839 . . . . 0.0 114.142 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -71.74 -46.31 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 122.987 2.458 . . . . 0.0 116.935 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.48 166.89 17.61 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.02 2.48 . . . . 0.0 114.176 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -118.27 -46.18 2.61 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.99 1.716 . . . . 0.0 113.654 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.32 91.97 1.82 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.283 1.039 . . . . 0.0 111.805 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 t -88.37 164.11 15.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.067 164.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.34 -24.23 11.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.231 1.813 . . . . 0.0 115.46 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -110.55 -4.0 15.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.664 1.586 . . . . 0.0 114.502 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.14 -111.21 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.799 1.666 . . . . 0.0 111.628 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -120.48 -32.85 3.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.21 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.74 2.816 . . . . 0.0 115.037 -172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.38 -36.77 54.68 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.123 -0.985 . . . . 0.0 113.353 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -54.31 -19.56 5.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.01 2.524 . . . . 0.0 114.986 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.46 -22.69 28.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.041 1.337 . . . . 0.0 114.18 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -118.97 -89.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -143.97 28.71 1.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.28 1.032 . . . . 0.0 113.649 -155.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.4 -11.45 0.82 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -123.15 8.8 9.2 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.211 2.204 . . . . 0.0 114.413 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -135.83 70.62 64.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 126.04 1.736 . . . . 0.0 112.321 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.82 152.99 58.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.766 2.311 . . . . 0.0 113.02 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.85 -27.69 13.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 112.524 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -144.36 148.45 34.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.997 1.719 . . . . 0.0 110.1 174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -135.49 154.27 51.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 166.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.4 -136.91 2.33 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.417 1.008 . . . . 0.0 111.022 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -124.0 144.12 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.845 2.058 . . . . 0.0 110.27 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.58 137.59 32.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.966 0.907 . . . . 0.0 110.634 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -124.04 143.42 50.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.177 1.391 . . . . 0.0 110.202 157.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mt -125.23 130.04 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.3 p -130.35 169.18 15.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.468 1.507 . . . . 0.0 109.874 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 85.4 p -150.98 127.95 11.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -101.19 87.46 3.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.235 1.814 . . . . 0.0 109.65 165.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.58 -129.47 16.69 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.617 1.58 . . . . 0.0 112.242 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.38 -7.43 6.5 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.633 1.573 . . . . 0.0 114.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -109.08 118.04 35.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.644 0.778 . . . . 0.0 111.182 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.11 161.42 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.33 0.586 . . . . 0.0 110.853 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -136.82 112.52 9.45 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 mm -77.25 112.44 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 170.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -116.39 124.83 51.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.578 0.751 . . . . 0.0 111.204 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.7 134.11 46.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.917 0.887 . . . . 0.0 110.327 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -125.3 148.91 48.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.015 1.326 . . . . 0.0 111.995 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.08 137.0 53.16 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.891 -1.13 . . . . 0.0 110.613 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.71 -8.56 28.81 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.55 -39.24 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.37 1.868 . . . . 0.0 111.564 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -128.33 -2.58 5.61 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.04 9.61 71.77 Favored Glycine 0 CA--C 1.538 1.486 0 N-CA-C 115.31 0.884 . . . . 0.0 115.31 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.6 145.13 50.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.49 1.145 . . . . 0.0 112.094 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 tp -71.76 123.13 21.94 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.677 -0.639 . . . . 0.0 112.31 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -86.09 -53.67 4.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.641 1.576 . . . . 0.0 111.27 169.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.92 161.15 39.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.927 1.291 . . . . 0.0 111.568 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -140.07 136.79 33.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.113 0.965 . . . . 0.0 112.684 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.63 108.14 31.22 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.923 1.689 . . . . 0.0 112.299 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -75.01 133.52 16.66 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.428 2.752 . . . . 0.0 112.561 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.82 131.67 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.735 1.614 . . . . 0.0 112.388 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.2 2.93 12.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.878 0.871 . . . . 0.0 113.286 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.03 138.47 14.91 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.453 1.501 . . . . 0.0 111.791 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.2 t80 -131.85 129.95 22.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.548 1.139 . . . . 0.0 111.704 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.43 155.39 31.57 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.305 1.145 . . . . 0.0 113.851 -11.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.37 -167.07 28.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.695 0.664 . . . . 0.0 113.66 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -76.7 -24.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.08 0.952 . . . . 0.0 111.412 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.45 -12.38 49.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.4 p -160.41 116.18 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.204 1.401 . . . . 0.0 109.132 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.23 150.44 51.47 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.328 1.851 . . . . 0.0 110.961 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.91 88.32 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 HG21 ' B' ' 155' ' ' VAL . 2.3 m 23.52 -75.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 129.216 3.007 . . . . 0.0 116.297 159.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 p -136.13 -48.05 0.66 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.963 1.305 . . . . 0.0 111.257 154.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.83 -55.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.4 t -51.77 113.55 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.782 1.174 . . . . 0.0 112.493 171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 p -87.97 28.81 0.99 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.68 -1.146 . . . . 0.0 112.791 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -64.44 -30.89 71.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.815 2.046 . . . . 0.0 111.77 152.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -124.9 162.98 23.22 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.677 1.591 . . . . 0.0 112.158 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -142.42 176.05 9.31 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.735 1.214 . . . . 0.0 111.259 170.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.91 132.03 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.588 1.555 . . . . 0.0 108.883 163.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -125.19 151.38 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.709 1.204 . . . . 0.0 111.104 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.71 111.02 22.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.735 0.814 . . . . 0.0 110.175 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.87 159.96 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 111.429 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -85.28 145.02 27.74 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.53 0.732 . . . . 0.0 110.832 161.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.36 -1.74 58.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.68 8.14 85.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.11 1.338 . . . . 0.0 115.269 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.5 p -121.57 13.37 10.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.345 1.458 . . . . 0.0 113.673 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.76 15.07 54.0 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.193 1.378 . . . . 0.0 113.828 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.19 162.21 33.18 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.026 1.73 . . . . 0.0 113.039 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -119.94 162.66 18.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.976 1.31 . . . . 0.0 113.973 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.73 151.87 39.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.009 1.724 . . . . 0.0 111.451 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -98.0 129.22 44.89 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.578 -0.701 . . . . 0.0 110.737 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.6 pt -123.56 137.47 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.586 0.755 . . . . 0.0 110.611 166.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.12 159.69 51.22 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.15 141.21 46.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.619 1.168 . . . . 0.0 109.13 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.27 135.81 8.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.048 1.308 . . . . 0.0 111.548 166.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -96.75 164.61 12.5 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -70.77 -24.57 62.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.726 172.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.92 144.31 32.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.398 1.479 . . . . 0.0 112.54 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -35.94 76.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.025 1.33 . . . . 0.0 111.903 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.9 56.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.878 1.228 . . . . 0.0 113.522 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -66.56 -35.45 80.26 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.791 1.296 . . . . 0.0 111.359 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.18 -42.06 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -60.78 -30.4 70.02 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.497 -1.377 . . . . 0.0 112.03 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.51 -27.55 46.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 112.499 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.15 -41.42 92.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.066 0.848 . . . . 0.0 110.854 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -53.87 49.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.561 0.744 . . . . 0.0 111.638 169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.33 -32.91 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.477 1.035 . . . . 0.0 112.633 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.3 m -58.32 -24.64 60.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.473 1.109 . . . . 0.0 113.199 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.583 HD13 HG11 ' A' ' 82' ' ' VAL . 76.6 mt -100.09 -34.34 10.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.983 1.313 . . . . 0.0 111.983 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -56.71 -49.63 74.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.786 1.175 . . . . 0.0 110.895 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.79 -7.9 55.55 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -86.95 -35.01 19.13 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.023 0.929 . . . . 0.0 111.738 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.15 -8.11 40.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -28.15 68.53 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -103.18 -5.47 23.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.871 1.268 . . . . 0.0 114.194 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.77 -155.91 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 127.012 2.125 . . . . 0.0 109.133 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt 58.25 25.06 12.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.222 1.409 . . . . 0.0 114.288 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 56.06 29.82 15.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.27 1.828 . . . . 0.0 114.363 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 124.603 1.161 . . . . 0.0 113.823 174.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -86.22 -43.03 13.3 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.31 1.044 . . . . 0.0 112.184 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 17.0 tt -159.82 168.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 109.14 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -125.33 125.76 43.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.17 -0.956 . . . . 0.0 111.167 164.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.1 m -140.05 50.48 1.73 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.755 1.622 . . . . 0.0 110.9 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -45.36 140.32 3.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.968 2.107 . . . . 0.0 113.526 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.4 p -61.31 120.51 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.241 1.02 . . . . 0.0 109.177 176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.628 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.53 -28.37 0.03 OUTLIER Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.943 1.259 . . . . 0.0 114.853 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -66.45 -23.03 66.22 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.05 -35.9 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.873 1.669 . . . . 0.0 112.182 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.5 65.21 2.74 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.969 1.271 . . . . 0.0 113.108 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.22 -160.25 1.04 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -164.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -137.73 -56.74 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -137.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.361 1.864 . . . . 0.0 111.487 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 6.9 m -65.49 150.43 95.95 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.319 1.048 . . . . 0.0 112.755 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.82 -8.62 18.03 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.579 2.853 . . . . 0.0 113.724 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -127.94 -173.22 2.88 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.8 2.04 . . . . 0.0 112.062 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.1 m -58.88 -14.06 7.99 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -59.31 -23.52 62.52 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.601 1.091 . . . . 0.0 112.69 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.98 -15.31 55.66 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.6 p -82.34 -10.69 58.98 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -107.94 144.31 35.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.484 1.914 . . . . 0.0 110.952 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -118.58 -5.73 10.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.332 1.453 . . . . 0.0 113.344 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.15 22.84 7.91 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -114.71 178.55 4.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -163.81 132.42 3.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.411 1.884 . . . . 0.0 109.006 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -96.21 127.63 42.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.394 1.477 . . . . 0.0 111.539 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.71 136.41 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.048 -1.032 . . . . 0.0 112.491 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -117.87 -42.22 2.85 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.618 1.567 . . . . 0.0 112.695 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -149.68 151.91 34.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.25 129.62 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 126.066 1.746 . . . . 0.0 108.361 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -124.76 138.15 30.79 Favored Pre-proline 0 N--CA 1.479 1.015 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.14 -25.96 15.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.687 3.592 . . . . 0.0 114.516 -164.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -143.9 131.24 20.87 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.226 1.01 . . . . 0.0 111.33 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.94 142.9 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 109.426 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.3 p -117.88 152.03 36.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 112.592 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -126.08 142.42 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.926 1.291 . . . . 0.0 111.594 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.4 119.7 24.29 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.031 1.333 . . . . 0.0 110.012 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -59.8 139.63 57.17 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 119.755 -1.84 . . . . 0.0 110.798 162.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.19 143.39 46.9 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.45 -36.26 0.5 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 123.149 2.566 . . . . 0.0 118.127 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.29 170.96 18.57 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.745 2.297 . . . . 0.0 113.711 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -130.06 -37.12 1.5 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.826 1.65 . . . . 0.0 113.451 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.05 18.34 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.985 0.914 . . . . 0.0 112.157 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -83.83 -2.2 55.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -130.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -135.58 -78.19 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.385 1.074 . . . . 0.0 109.799 162.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.71 -3.77 11.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.499 1.919 . . . . 0.0 113.676 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.07 2.35 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.35 1.928 . . . . 0.0 110.038 -169.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -111.54 -35.72 5.71 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.79 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.284 3.034 . . . . 0.0 114.513 -171.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.57 49.28 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.046 -1.034 . . . . 0.0 112.084 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.5 m -59.64 -16.36 25.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.332 2.253 . . . . 0.0 115.263 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.14 -24.23 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.122 1.369 . . . . 0.0 113.431 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.06 -173.13 2.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.101 1.76 . . . . 0.0 111.035 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.98 105.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.846 -1.159 . . . . 0.0 110.22 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.61 1.28 48.58 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -123.43 -12.24 7.78 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.023 1.329 . . . . 0.0 113.641 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -130.84 88.16 46.97 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.785 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.01 154.62 72.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.887 3.058 . . . . 0.0 114.91 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -91.35 -33.74 15.17 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.168 1.387 . . . . 0.0 112.042 164.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -145.98 149.56 34.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.017 1.327 . . . . 0.0 111.092 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -140.92 148.55 40.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.271 1.428 . . . . 0.0 111.436 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.62 -133.82 2.6 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.105 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -121.96 140.24 52.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.435 2.294 . . . . 0.0 111.033 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.24 141.57 29.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.788 0.835 . . . . 0.0 110.216 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -140.92 101.93 4.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.792 0.837 . . . . 0.0 110.835 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.3 mt -94.4 129.96 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.458 -0.776 . . . . 0.0 109.059 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -133.21 172.5 12.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.067 1.747 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -155.1 122.42 5.58 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -94.22 82.52 4.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.016 1.327 . . . . 0.0 109.544 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.79 -128.94 10.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.222 1.392 . . . . 0.0 112.091 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -68.08 -3.78 11.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.285 1.434 . . . . 0.0 114.528 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -105.22 121.52 44.01 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.447 0.699 . . . . 0.0 111.474 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.6 156.55 18.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.83 0.852 . . . . 0.0 110.995 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -133.8 118.27 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 108.239 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mm -84.66 100.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.98 148.43 24.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.411 0.684 . . . . 0.0 110.048 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.5 mt -125.71 129.79 50.24 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.505 1.122 . . . . 0.0 109.173 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -126.62 146.32 50.21 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.723 1.209 . . . . 0.0 112.209 -165.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.84 135.75 46.75 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.142 -0.974 . . . . 0.0 110.574 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.48 -12.03 61.32 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.633 1.173 . . . . 0.0 113.747 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.57 -32.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.999 1.72 . . . . 0.0 111.439 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -129.73 -15.07 3.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -168.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.78 70.65 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.161 0.886 . . . . 0.0 114.356 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.01 143.83 55.4 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.073 1.437 . . . . 0.0 112.067 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.38 125.39 28.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.976 0.51 . . . . 0.0 111.954 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -86.33 -53.29 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.141 1.377 . . . . 0.0 111.393 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.15 164.57 38.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.975 1.31 . . . . 0.0 111.705 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -138.2 142.84 39.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.812 0.845 . . . . 0.0 112.544 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.19 28.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.455 1.502 . . . . 0.0 111.027 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.31 126.47 5.53 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.28 2.654 . . . . 0.0 111.388 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.75 124.07 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.202 1.801 . . . . 0.0 109.697 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.56 -3.4 13.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.534 1.134 . . . . 0.0 112.962 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.16 142.55 16.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.873 1.669 . . . . 0.0 110.722 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.0 t80 -130.84 125.91 21.54 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.429 1.092 . . . . 0.0 111.275 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -64.45 160.02 68.82 Favored 'Cis proline' 0 CA--C 1.545 1.031 0 CA-C-N 120.255 1.127 . . . . 0.0 113.102 -10.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.85 -157.8 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.107 0.861 . . . . 0.0 113.996 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -86.43 -27.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.016 0.926 . . . . 0.0 111.878 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.35 43.9 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.1 p -147.44 131.82 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.53 1.532 . . . . 0.0 110.507 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 154.21 41.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.65 1.58 . . . . 0.0 112.3 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 83.22 1.96 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.183 0.992 . . . . 0.0 108.826 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 m 34.41 -77.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 128.778 2.831 . . . . 0.0 116.467 157.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -135.71 -53.19 0.76 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.592 1.157 . . . . 0.0 112.411 158.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.25 -70.21 0.35 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.263 0.625 . . . . 0.0 112.051 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.4 OUTLIER -67.44 154.97 40.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.6 p -119.12 70.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.188 1.395 . . . . 0.0 112.12 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 -87.9 -20.16 26.35 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.901 133.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -122.64 160.74 25.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.26 174.95 10.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.671 1.589 . . . . 0.0 110.025 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.95 137.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.073 161.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -129.3 149.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.4 0.68 . . . . 0.0 111.159 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.39 100.17 11.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.802 1.241 . . . . 0.0 108.773 172.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 pt -85.13 164.24 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.493 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.59 146.94 24.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 156.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.98 -2.33 58.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.89 11.97 84.65 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.752 1.168 . . . . 0.0 115.305 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.253 6.4 t -129.6 29.42 5.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.284 1.434 . . . . 0.0 112.885 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.35 17.89 56.36 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.436 1.494 . . . . 0.0 113.972 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -142.42 171.12 14.49 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.362 1.465 . . . . 0.0 113.735 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.5 m -124.99 159.55 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.852 1.661 . . . . 0.0 113.272 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.17 149.41 32.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.934 1.294 . . . . 0.0 111.923 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.89 130.04 45.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.679 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.98 141.18 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.161 0.985 . . . . 0.0 110.084 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 153.47 44.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 157.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -125.19 145.01 33.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.307 . . . . 0.0 108.215 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.07 128.36 5.24 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.05 1.31 . . . . 0.0 112.108 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.9 m-85 -92.24 161.69 14.61 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.286 1.034 . . . . 0.0 112.992 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -77.09 -21.61 54.07 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 112.961 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.79 147.57 40.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.508 1.523 . . . . 0.0 112.55 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -59.65 -36.22 75.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.131 0.972 . . . . 0.0 112.654 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.92 -35.08 78.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.619 0.628 . . . . 0.0 112.842 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.96 -37.14 75.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.242 1.021 . . . . 0.0 112.013 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.18 -43.46 61.38 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 169.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -57.97 -27.81 63.78 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.159 -1.588 . . . . 0.0 113.337 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.29 -31.6 60.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 0.0 112.275 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.6 -33.23 73.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.041 0.837 . . . . 0.0 111.092 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.7 -57.15 4.98 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.602 -0.686 . . . . 0.0 112.041 168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.28 -34.67 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.714 -1.241 . . . . 0.0 113.17 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 p -62.85 -23.65 67.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.47 -38.56 12.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.514 1.126 . . . . 0.0 111.805 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -57.26 -51.31 69.88 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.498 1.045 . . . . 0.0 111.049 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.24 -8.57 56.98 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -84.19 -38.64 20.36 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.428 0.691 . . . . 0.0 111.399 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.03 -15.8 33.19 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -28.16 69.35 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.4 p-90 -100.44 6.68 44.44 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.954 1.301 . . . . 0.0 113.646 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -164.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.013 2.125 . . . . 0.0 110.544 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 61.11 31.56 19.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 157.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . 0.25 8.8 mp0 54.56 31.27 14.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.664 1.985 . . . . 0.0 114.925 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.704 1.202 . . . . 0.0 113.361 172.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -115.73 13.06 16.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.104 1.361 . . . . 0.0 113.748 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.94 130.13 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.105 . . . . 0.0 110.072 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -83.27 148.89 27.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.116 1.366 . . . . 0.0 113.152 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -92.63 59.65 3.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.1 1.36 . . . . 0.0 113.457 -164.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -43.93 144.97 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.026 1.73 . . . . 0.0 113.868 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.32 131.36 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.334 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.509 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -169.87 -20.7 0.02 OUTLIER Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.435 -1.711 . . . . 0.0 113.561 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -67.47 -20.6 65.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.288 1.435 . . . . 0.0 114.721 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.3 tp -128.54 -42.44 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -171.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.13 30.72 56.8 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.223 0.916 . . . . 0.0 114.772 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -93.3 0.08 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.992 2.117 . . . . 0.0 115.082 -168.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -71.71 146.2 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.292 2.637 . . . . 0.0 111.854 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.1 2.16 . . . . 0.0 111.504 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 45.9 m -66.59 144.13 98.48 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.309 1.044 . . . . 0.0 112.663 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.43 -13.78 36.06 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.588 2.858 . . . . 0.0 114.59 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -82.84 -7.38 59.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 114.015 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 150.6 31.26 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.303 1.041 . . . . 0.0 112.462 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.87 -17.48 61.52 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 113.389 170.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.91 -7.05 56.22 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -81.83 -10.25 59.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.49 172.54 12.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.761 1.624 . . . . 0.0 113.349 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.55 87.92 5.7 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.599 1.16 . . . . 0.0 108.459 166.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 44.57 1.0 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.011 1.324 . . . . 0.0 112.78 -167.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -89.96 -178.34 5.44 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.105 1.362 . . . . 0.0 113.584 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.44 132.16 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.923 2.089 . . . . 0.0 108.947 161.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -104.42 129.35 52.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.6 133.06 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.278 -0.889 . . . . 0.0 112.458 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.5 -43.32 3.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.925 1.69 . . . . 0.0 112.163 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.8 t -144.79 154.05 42.28 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.062 0.934 . . . . 0.0 113.153 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.11 132.49 33.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 126.72 2.008 . . . . 0.0 108.67 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -123.59 141.2 35.86 Favored Pre-proline 0 N--CA 1.481 1.107 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.71 -29.94 4.19 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.033 3.155 . . . . 0.0 114.746 -163.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -147.94 122.25 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.482 1.113 . . . . 0.0 110.813 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.16 142.08 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.622 1.569 . . . . 0.0 109.693 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.8 m -126.37 143.25 51.24 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.716 1.206 . . . . 0.0 111.522 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.93 133.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.455 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.67 1.81 13.59 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -162.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 40.22 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 129.337 3.055 . . . . 0.0 115.257 167.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -104.0 147.14 33.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -155.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -82.01 -36.88 0.27 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.249 2.632 . . . . 0.0 118.275 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.35 172.55 14.44 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.951 2.434 . . . . 0.0 113.781 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -132.84 -40.03 0.96 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.473 1.509 . . . . 0.0 113.78 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.86 22.91 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.642 0.777 . . . . 0.0 112.25 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -85.39 3.43 40.01 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -131.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.3 -40.8 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 0.0 113.117 164.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.22 -51.36 0.53 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.129 1.772 . . . . 0.0 111.621 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.88 -120.02 1.34 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.432 1.491 . . . . 0.0 110.478 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -117.23 -35.24 4.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 108.42 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 129.444 3.097 . . . . 0.0 114.884 -171.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.03 48.17 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.909 -1.12 . . . . 0.0 113.625 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -70.77 -17.28 62.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.553 1.541 . . . . 0.0 113.893 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.39 -35.21 47.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.517 1.127 . . . . 0.0 112.8 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -165.87 1.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.922 2.089 . . . . 0.0 111.15 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -60.79 118.6 6.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.629 1.204 . . . . 0.0 111.169 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.4 tp -103.0 -27.1 12.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.737 2.015 . . . . 0.0 111.515 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.82 -4.64 3.19 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.369 1.467 . . . . 0.0 114.21 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.43 88.4 53.21 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.928 1.291 . . . . 0.0 111.819 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.15 162.97 37.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.291 2.661 . . . . 0.0 112.763 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -99.86 -24.05 14.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.652 1.181 . . . . 0.0 112.37 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -142.1 146.05 34.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.706 1.602 . . . . 0.0 110.715 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -136.6 155.29 50.12 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.683 0.793 . . . . 0.0 111.768 164.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.42 -137.31 2.43 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 123.895 0.76 . . . . 0.0 112.418 -174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -132.13 148.54 52.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.857 2.463 . . . . 0.0 110.056 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.88 137.66 41.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.213 1.005 . . . . 0.0 111.141 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -119.93 140.98 50.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.104 1.361 . . . . 0.0 110.294 153.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -119.4 122.13 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 164.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.9 p -122.29 163.33 19.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.717 2.007 . . . . 0.0 110.271 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.5 p -150.88 124.77 9.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -101.19 85.67 2.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.058 1.743 . . . . 0.0 109.672 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.67 -126.78 24.92 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.201 1.381 . . . . 0.0 112.105 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -61.31 -13.21 17.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.071 1.348 . . . . 0.0 113.962 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -98.12 126.85 43.75 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.674 -0.642 . . . . 0.0 111.938 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.91 158.38 15.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.035 1.334 . . . . 0.0 111.171 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -136.02 116.9 14.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.167 1.387 . . . . 0.0 107.266 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.56 112.7 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -110.23 124.31 51.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.067 1.347 . . . . 0.0 110.717 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -105.56 131.11 53.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.991 0.917 . . . . 0.0 109.882 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -125.93 150.4 48.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.58 1.552 . . . . 0.0 111.562 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.42 152.15 36.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.332 -1.48 . . . . 0.0 112.171 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -70.11 -11.45 60.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.088 1.355 . . . . 0.0 114.369 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.19 -43.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.029 1.732 . . . . 0.0 111.588 -168.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 m -125.97 -8.5 6.6 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.55 79.06 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 118.803 0.729 . . . . 0.0 114.347 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.13 149.99 37.28 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.817 1.308 . . . . 0.0 111.541 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.07 121.55 20.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.129 0.49 . . . . 0.0 112.071 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.02 -52.26 6.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.641 1.576 . . . . 0.0 111.238 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 162.56 40.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.923 1.289 . . . . 0.0 111.566 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -141.15 142.4 34.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.49 120.81 23.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.646 1.578 . . . . 0.0 111.538 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.67 128.7 5.38 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.369 2.712 . . . . 0.0 111.655 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.43 127.84 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.4 1.88 . . . . 0.0 109.653 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.06 7.27 8.57 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.034 -1.041 . . . . 0.0 113.607 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.88 145.15 19.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.564 1.945 . . . . 0.0 110.212 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -131.49 127.65 21.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.056 0.943 . . . . 0.0 113.402 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -66.0 166.61 55.39 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 CA-C-N 119.195 0.748 . . . . 0.0 111.814 -15.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.03 -155.46 7.97 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.825 0.726 . . . . 0.0 113.73 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.66 -29.07 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 121.764 -0.844 . . . . 0.0 111.424 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.26 -23.34 38.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.79 128.55 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 109.535 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.58 153.13 48.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.108 1.763 . . . . 0.0 111.435 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -109.5 82.87 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.05 0.929 . . . . 0.0 109.277 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 HG21 ' B' ' 155' ' ' VAL . 2.2 m 32.06 -74.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 129.378 3.071 . . . . 0.0 117.327 159.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 p -133.85 -52.58 0.86 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.697 1.199 . . . . 0.0 111.546 158.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.86 -70.31 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.69 ' HB3' HG23 ' B' ' 155' ' ' VAL . 3.3 t -51.71 123.77 10.87 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . 0.25 60.4 p -85.69 64.48 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 124.135 1.922 . . . . 0.0 110.642 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -126.86 -33.84 2.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 131.508 3.923 . . . . 0.0 110.533 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -126.6 164.32 21.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.577 2.351 . . . . 0.0 109.028 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.59 172.63 12.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.62 1.168 . . . . 0.0 110.565 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -127.4 136.77 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.328 1.051 . . . . 0.0 108.657 161.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -127.04 148.18 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.241 0.616 . . . . 0.0 111.939 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 99.28 12.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.839 1.256 . . . . 0.0 108.946 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.21 165.87 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.493 1.117 . . . . 0.0 111.552 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -102.5 148.15 25.87 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.784 0.434 . . . . 0.0 112.049 157.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.85 -5.0 59.33 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 4.35 89.68 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.07 1.319 . . . . 0.0 115.37 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.5 p -109.18 12.61 24.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.597 1.559 . . . . 0.0 113.363 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.34 53.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.388 1.47 . . . . 0.0 113.884 -172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -130.02 167.69 17.88 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.822 1.649 . . . . 0.0 113.629 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -124.32 158.59 32.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.893 1.677 . . . . 0.0 113.026 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.98 151.7 36.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.04 1.336 . . . . 0.0 111.902 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -98.04 128.62 44.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.435 0.694 . . . . 0.0 110.495 169.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 pt -119.98 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.948 0.899 . . . . 0.0 112.074 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.09 139.0 18.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 167.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.92 142.87 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 125.116 1.366 . . . . 0.0 109.578 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.52 138.06 9.89 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.279 1.419 . . . . 0.0 111.232 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.79 164.48 14.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.922 0.868 . . . . 0.0 113.211 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -69.83 -22.19 63.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.944 0.898 . . . . 0.0 112.436 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.19 146.1 38.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.611 1.564 . . . . 0.0 111.844 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -37.66 71.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.816 1.246 . . . . 0.0 111.285 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.23 -33.67 64.68 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.407 1.003 . . . . 0.0 113.85 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -68.28 -34.47 76.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.791 1.295 . . . . 0.0 111.713 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.01 69.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 168.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -59.86 -32.24 70.52 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.42 -1.425 . . . . 0.0 111.513 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -75.11 -29.03 60.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.481 1.112 . . . . 0.0 111.882 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.32 -42.62 98.98 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.489 1.04 . . . . 0.0 110.642 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.68 72.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.706 0.802 . . . . 0.0 112.026 169.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.95 -34.15 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 120.128 1.331 . . . . 0.0 112.251 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.3 m -59.75 -22.71 62.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.509 1.124 . . . . 0.0 113.173 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -99.01 -38.9 8.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.402 1.481 . . . . 0.0 111.957 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -53.11 -55.12 26.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.168 0.895 . . . . 0.0 111.112 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.32 -8.8 57.87 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -86.1 -34.08 20.75 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 111.816 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HA ' HG23 ' A' ' 130' ' ' VAL . 69.8 m-85 -94.15 -13.41 26.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -28.35 68.43 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -99.99 3.2 44.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.219 1.408 . . . . 0.0 114.289 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.08 -163.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.21 2.204 . . . . 0.0 109.578 176.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.4 tptp 60.2 19.13 8.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.706 1.603 . . . . 0.0 115.193 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 52.97 29.13 7.42 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.383 1.873 . . . . 0.0 114.398 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.838 1.255 . . . . 0.0 113.931 176.017 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.704 0.287 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -76.16 -21.43 56.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.447 1.099 . . . . 0.0 112.289 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 54.7 mt -80.01 143.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 110.23 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.8 p -65.59 166.67 10.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.187 1.395 . . . . 0.0 113.22 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 23.4 m -77.24 40.82 0.28 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.52 1.528 . . . . 0.0 113.64 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.21 163.21 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.129 2.172 . . . . 0.0 114.119 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.3 p -52.04 117.93 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.07 1.348 . . . . 0.0 109.316 167.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.527 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.04 -13.42 0.05 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.405 2.431 . . . . 0.0 113.641 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -69.85 -15.95 63.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.301 2.24 . . . . 0.0 114.988 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.8 tt -145.31 -35.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.72 43.53 75.01 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 123.969 0.795 . . . . 0.0 113.851 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.67 -142.86 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.441 2.296 . . . . 0.0 113.916 -170.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -137.21 -174.25 3.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.231 1.812 . . . . 0.0 112.936 -150.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.928 1.291 . . . . 0.0 113.339 168.317 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.9 p -74.22 153.2 88.3 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.33 147.61 66.0 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.348 2.699 . . . . 0.0 112.34 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -151.72 155.43 38.27 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.964 1.306 . . . . 0.0 111.616 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.1 m -59.3 -16.39 21.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.582 1.553 . . . . 0.0 114.967 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.58 -7.83 5.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 -12.23 2.2 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.818 1.647 . . . . 0.0 115.161 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.3 p -73.53 -17.44 61.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.832 1.253 . . . . 0.0 113.777 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -87.75 140.67 29.28 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.703 1.601 . . . . 0.0 109.866 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.55 -9.64 15.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.853 1.261 . . . . 0.0 113.389 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 51.77 43.73 29.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.266 1.826 . . . . 0.0 115.237 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -138.92 -179.57 5.91 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.996 -1.065 . . . . 0.0 112.678 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.53 135.45 5.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.757 2.023 . . . . 0.0 108.325 161.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -97.0 126.36 42.08 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.548 1.139 . . . . 0.0 110.878 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.59 138.69 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.01 -1.056 . . . . 0.0 111.369 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.34 -42.06 2.69 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.715 1.606 . . . . 0.0 112.393 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.2 t -145.3 150.82 37.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.427 1.091 . . . . 0.0 111.742 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.83 135.05 51.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.841 1.656 . . . . 0.0 108.5 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -128.33 140.2 37.67 Favored Pre-proline 0 N--CA 1.483 1.186 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.22 -22.28 9.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.101 3.201 . . . . 0.0 114.634 -168.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -146.32 123.91 11.79 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.502 1.121 . . . . 0.0 111.168 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.61 144.79 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.629 1.571 . . . . 0.0 108.936 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.56 144.06 51.01 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.432 1.093 . . . . 0.0 111.502 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.67 140.42 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.704 1.202 . . . . 0.0 112.104 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.04 107.98 11.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.957 1.703 . . . . 0.0 110.674 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -58.1 131.43 50.51 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.517 -1.99 . . . . 0.0 110.549 162.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.81 144.33 40.6 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.666 1.186 . . . . 0.0 113.179 -175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -73.28 -42.9 0.81 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.885 2.39 . . . . 0.0 117.123 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.2 161.6 20.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.813 2.342 . . . . 0.0 113.806 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -111.45 -28.23 8.27 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.326 1.45 . . . . 0.0 114.877 169.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.22 104.82 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.671 0.789 . . . . 0.0 111.577 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 161.6 17.92 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.007 0.923 . . . . 0.0 110.362 158.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.62 -17.99 64.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.145 -0.972 . . . . 0.0 112.98 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -88.16 -15.26 36.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.999 1.32 . . . . 0.0 113.302 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.26 -101.55 0.79 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.246 1.403 . . . . 0.0 111.003 -168.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -131.74 -32.91 1.44 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.78 106.42 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.22 3.008 . . . . 0.0 115.15 -170.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -35.48 29.76 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.299 -0.875 . . . . 0.0 113.342 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.3 m -56.78 -18.96 14.61 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.778 2.431 . . . . 0.0 115.132 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -84.69 -24.62 28.88 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.923 1.289 . . . . 0.0 113.728 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -125.83 -150.18 0.44 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.106 1.762 . . . . 0.0 111.27 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -77.09 89.13 3.59 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 123.096 1.427 . . . . 0.0 111.487 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.02 -27.12 64.42 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.133 2.573 . . . . 0.0 113.504 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.02 7.5 1.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -112.62 88.96 12.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.907 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.01 145.14 44.24 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.556 2.171 . . . . 0.0 113.837 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.6 -31.23 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.217 1.407 . . . . 0.0 111.617 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -149.35 148.85 29.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.979 1.711 . . . . 0.0 110.021 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -139.09 152.33 47.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.06 0.944 . . . . 0.0 110.992 168.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.73 1.59 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.1 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -126.01 146.03 50.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.783 2.433 . . . . 0.0 110.609 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.7 136.58 38.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.737 1.215 . . . . 0.0 110.875 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -121.0 142.49 49.75 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 109.764 151.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.26 129.64 75.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.4 p -135.55 170.33 16.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 109.692 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 p -149.91 122.61 8.63 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.919 -1.113 . . . . 0.0 113.932 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -101.16 94.68 6.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.672 1.589 . . . . 0.0 109.537 165.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.23 -135.53 19.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.659 1.599 . . . . 0.0 112.805 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.8 -5.63 12.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.612 1.565 . . . . 0.0 114.256 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -104.82 127.87 52.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.184 0.994 . . . . 0.0 111.677 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.08 157.04 16.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 110.791 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -138.28 117.82 12.98 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.556 1.142 . . . . 0.0 108.438 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.05 107.36 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -112.93 113.16 25.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.262 1.025 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.44 131.09 40.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 110.55 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -120.17 147.99 44.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.024 1.329 . . . . 0.0 112.66 -171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.14 132.56 43.41 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.91 -1.119 . . . . 0.0 110.319 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.65 -15.12 60.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.087 1.355 . . . . 0.0 113.701 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.38 -38.18 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.894 1.678 . . . . 0.0 110.797 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -129.65 -11.63 4.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.67 10.89 72.32 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.945 0.783 . . . . 0.0 113.939 -170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.75 141.63 51.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.057 1.428 . . . . 0.0 111.74 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -71.54 123.73 23.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.633 -0.667 . . . . 0.0 111.839 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -84.05 -54.43 4.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.574 1.55 . . . . 0.0 111.285 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.25 160.26 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.209 . . . . 0.0 111.679 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 135.41 49.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.882 1.273 . . . . 0.0 111.711 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.62 114.17 38.03 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.569 1.148 . . . . 0.0 110.664 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.11 124.33 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.222 2.614 . . . . 0.0 111.113 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.68 124.26 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.119 1.768 . . . . 0.0 109.905 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -119.63 1.93 11.14 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.164 0.986 . . . . 0.0 113.267 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.16 145.94 16.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.601 1.961 . . . . 0.0 110.721 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.764 ' CD2' HG13 ' A' ' 82' ' ' VAL . 7.7 t80 -140.62 128.98 12.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.907 0.883 . . . . 0.0 112.596 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.83 154.33 28.61 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 120.117 1.078 . . . . 0.0 113.863 -10.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.71 -163.06 16.99 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.341 0.496 . . . . 0.0 113.765 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 tp -82.98 -27.61 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.494 0.718 . . . . 0.0 111.357 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.72 -20.37 27.79 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.769 HG11 HD13 ' A' ' 123' ' ' LEU . 5.8 p -149.08 129.39 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.429 1.092 . . . . 0.0 111.449 163.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.26 155.37 42.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.0 1.72 . . . . 0.0 112.268 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -101.96 96.68 7.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.233 1.013 . . . . 0.0 108.697 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 86' ' ' THR . 2.4 m 16.27 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 129.288 3.035 . . . . 0.0 116.351 159.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 85' ' ' VAL . 7.8 p -142.52 -50.67 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.907 1.683 . . . . 0.0 110.92 159.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.91 -62.48 0.21 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.686 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 20.6 t -50.34 105.36 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 122.898 1.332 . . . . 0.0 112.908 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 76.3 p -82.06 6.63 15.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.209 -174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -45.17 -30.34 1.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.611 2.364 . . . . 0.0 112.288 152.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -124.6 162.68 23.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.75 1.62 . . . . 0.0 113.137 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -141.05 176.47 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.974 1.71 . . . . 0.0 110.325 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.29 136.37 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.822 1.649 . . . . 0.0 108.81 164.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.504 1.122 . . . . 0.0 111.408 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -96.7 102.85 14.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 109.246 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -89.17 160.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 111.801 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.22 155.89 17.68 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.292 0.637 . . . . 0.0 112.609 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -86.15 -13.64 46.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 168.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.87 5.71 85.98 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.041 1.305 . . . . 0.0 114.843 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.4 p -114.56 18.12 16.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.745 1.618 . . . . 0.0 113.544 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.12 16.29 59.52 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.999 1.285 . . . . 0.0 113.946 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -135.48 174.25 10.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.077 1.751 . . . . 0.0 112.871 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -144.09 160.19 41.33 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.36 150.27 46.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.551 1.941 . . . . 0.0 112.065 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -93.55 132.47 37.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.286 0.634 . . . . 0.0 110.935 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.4 pt -128.44 139.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.162 0.985 . . . . 0.0 110.29 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.92 159.02 53.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.087 0.851 . . . . 0.0 111.09 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.0 mt -128.08 141.64 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.975 1.31 . . . . 0.0 108.516 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.8 134.17 10.4 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.381 1.467 . . . . 0.0 111.377 164.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 11.3 m-85 -98.37 159.9 14.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -77.87 -24.88 48.36 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.449 1.099 . . . . 0.0 112.855 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -144.53 143.07 30.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.709 1.604 . . . . 0.0 111.129 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -63.22 -32.85 74.35 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.578 -0.702 . . . . 0.0 112.564 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -35.67 60.27 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.927 0.775 . . . . 0.0 113.111 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -64.97 -37.37 87.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.432 1.116 . . . . 0.0 111.227 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.0 -41.82 61.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.653 0.781 . . . . 0.0 112.979 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -63.35 -25.27 68.22 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.29 -1.506 . . . . 0.0 111.65 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 -28.14 36.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.208 1.003 . . . . 0.0 112.71 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.0 -40.99 86.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.11 0.868 . . . . 0.0 110.632 164.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.09 -55.68 17.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.908 0.883 . . . . 0.0 112.364 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -63.76 -32.17 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.556 1.071 . . . . 0.0 112.792 -173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -55.09 -34.25 63.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.642 0.777 . . . . 0.0 112.54 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.769 HD13 HG11 ' A' ' 82' ' ' VAL . 66.8 mt -90.95 -35.12 14.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.635 1.174 . . . . 0.0 112.241 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -56.57 -51.0 70.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.187 0.903 . . . . 0.0 110.548 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.05 -8.8 57.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.16 0.984 . . . . 0.0 113.476 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -82.57 -36.79 25.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.354 -0.841 . . . . 0.0 111.852 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -93.19 -21.42 19.66 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.051 0.841 . . . . 0.0 113.105 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -42.68 0.51 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.167 2.987 . . . . 0.0 115.624 168.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -102.94 5.43 38.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.171 1.389 . . . . 0.0 114.6 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -160.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 127.445 2.298 . . . . 0.0 109.563 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 tptp 59.0 18.88 6.66 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.404 1.881 . . . . 0.0 115.564 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.78 28.62 6.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.512 1.925 . . . . 0.0 114.641 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 177.113 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.656 0.265 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -142.32 163.6 32.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.207 1.403 . . . . 0.0 112.457 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.9 mt -70.42 141.49 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.11 1.364 . . . . 0.0 109.973 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 p -121.7 138.68 54.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.232 1.413 . . . . 0.0 111.915 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 58.6 m -87.59 46.98 1.44 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.887 1.275 . . . . 0.0 113.376 -174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -47.67 142.24 4.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.289 2.235 . . . . 0.0 113.534 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.4 p -60.0 124.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.857 0.836 . . . . 0.0 109.993 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.686 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -168.83 -15.95 0.02 OUTLIER Glycine 0 CA--C 1.539 1.588 0 C-N-CA 127.39 2.424 . . . . 0.0 113.461 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -68.63 -14.21 62.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.041 2.137 . . . . 0.0 114.751 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 tp -146.07 -40.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.917 1.287 . . . . 0.0 113.251 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.0 70.73 1.3 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.411 1.005 . . . . 0.0 112.569 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.38 -159.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -137.17 -60.23 0.68 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.659 -1.276 . . . . 0.0 114.345 -136.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.872 1.669 . . . . 0.0 111.808 -171.415 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.74 147.34 99.06 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.81 -19.64 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.21 2.607 . . . . 0.0 113.614 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.53 158.7 43.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.142 1.777 . . . . 0.0 110.385 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.5 t -75.19 150.16 38.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 112.474 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtm -127.52 16.14 7.05 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.933 1.693 . . . . 0.0 112.529 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 128.3 35.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.179 0.99 . . . . 0.0 111.98 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.3 p -80.07 -17.77 51.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.874 1.67 . . . . 0.0 114.048 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.4 141.85 35.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.643 1.977 . . . . 0.0 110.836 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.61 -4.72 10.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.669 1.588 . . . . 0.0 113.111 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 56.32 33.4 22.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.773 2.029 . . . . 0.0 115.897 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -134.34 -178.34 5.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.96 129.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.361 1.864 . . . . 0.0 108.895 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -97.97 139.25 34.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.432 1.493 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.92 138.08 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.063 -1.023 . . . . 0.0 112.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.2 mt -116.11 -44.78 2.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.026 1.731 . . . . 0.0 111.52 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -144.81 151.65 39.12 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.456 1.102 . . . . 0.0 111.897 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.53 127.46 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.288 1.835 . . . . 0.0 108.312 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -124.69 136.87 28.47 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.186 0.994 . . . . 0.0 111.227 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.78 -4.97 15.56 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.041 3.161 . . . . 0.0 113.827 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -136.23 144.14 44.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.227 1.411 . . . . 0.0 111.511 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 p -164.06 138.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 108.861 163.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.2 p -123.13 146.83 47.41 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.01 135.41 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.359 1.064 . . . . 0.0 112.508 -171.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -105.76 -7.03 18.6 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.984 2.586 . . . . 0.0 117.984 -167.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 40.7 78.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.736 2.014 . . . . 0.0 113.706 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -82.62 148.37 58.06 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.38 1.472 . . . . 0.0 113.697 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.77 -45.46 1.04 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 122.838 2.358 . . . . 0.0 116.79 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.26 158.05 19.96 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.84 2.36 . . . . 0.0 114.136 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -103.01 -27.03 12.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.459 1.504 . . . . 0.0 114.689 167.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.29 106.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.753 1.221 . . . . 0.0 109.42 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 t -90.48 164.6 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.62 1.168 . . . . 0.0 111.283 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -34.93 11.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.132 2.173 . . . . 0.0 115.412 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -129.45 93.4 3.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.645 1.578 . . . . 0.0 107.374 165.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.94 -96.31 0.1 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.043 1.306 . . . . 0.0 113.78 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -139.54 -31.98 0.66 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.89 107.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 129.646 3.178 . . . . 0.0 114.531 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.32 -31.6 33.99 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -66.85 -14.38 62.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.664 1.186 . . . . 0.0 113.783 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.07 -23.02 59.3 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.299 -0.875 . . . . 0.0 113.067 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -133.63 -161.01 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.202 1.401 . . . . 0.0 111.893 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -78.12 45.55 0.55 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -161.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -4.63 0.97 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -172.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -113.81 -8.42 13.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.943 1.697 . . . . 0.0 113.741 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -133.79 87.09 36.83 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.677 1.191 . . . . 0.0 113.082 -165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.76 148.96 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.651 2.234 . . . . 0.0 112.717 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -97.34 -22.92 16.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.042 1.337 . . . . 0.0 112.148 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -143.51 147.15 34.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.231 1.413 . . . . 0.0 111.214 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -140.74 152.6 45.4 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.248 1.419 . . . . 0.0 111.694 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 -129.14 1.39 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -132.13 144.89 51.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.966 2.507 . . . . 0.0 110.827 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.89 141.75 31.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.475 1.11 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -130.25 127.4 39.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.389 1.076 . . . . 0.0 109.773 157.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -110.32 124.03 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.1 p -125.49 167.84 14.46 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.971 1.709 . . . . 0.0 110.062 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 t -154.74 137.88 15.62 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.984 -1.072 . . . . 0.0 113.164 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -94.41 24.8 4.25 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.085 2.154 . . . . 0.0 112.677 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.67 120.0 0.43 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.296 1.903 . . . . 0.0 112.687 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? 58.12 -16.89 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 128.258 2.623 . . . . 0.0 116.696 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.4 m -108.89 112.55 24.84 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.452 -0.78 . . . . 0.0 109.319 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.93 149.74 24.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.099 0.56 . . . . 0.0 109.532 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.03 119.64 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mm -85.26 106.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.17 140.82 38.54 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.049 1.339 . . . . 0.0 111.322 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.2 mt -120.07 127.67 52.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.37 1.068 . . . . 0.0 110.035 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -119.16 145.97 45.55 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.929 1.292 . . . . 0.0 112.353 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.08 131.66 41.55 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.148 -0.97 . . . . 0.0 109.913 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -66.23 -16.2 63.82 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.98 -37.5 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.598 1.559 . . . . 0.0 111.003 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -130.0 -3.35 4.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 13.55 67.44 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.264 0.935 . . . . 0.0 114.472 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.82 139.8 49.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.362 1.081 . . . . 0.0 111.6 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -74.48 115.11 13.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.025 0.93 . . . . 0.0 111.024 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -80.97 -50.37 9.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.868 1.267 . . . . 0.0 111.726 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 163.43 38.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.912 0.885 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -142.6 123.18 14.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.47 1.508 . . . . 0.0 111.079 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.32 117.45 34.77 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.121 0.969 . . . . 0.0 111.742 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.66 125.03 6.58 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.009 2.473 . . . . 0.0 111.205 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.0 120.19 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.027 2.131 . . . . 0.0 108.938 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -112.89 -3.46 14.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.037 1.335 . . . . 0.0 112.837 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.49 143.38 17.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.367 1.867 . . . . 0.0 110.401 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.83 134.14 25.98 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.686 1.195 . . . . 0.0 111.92 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.23 161.11 45.26 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.14 0.729 . . . . 0.0 112.272 -16.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.06 -159.31 10.78 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 121.695 -0.628 . . . . 0.0 114.24 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 -27.83 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.83 0.852 . . . . 0.0 111.703 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -29.33 62.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.975 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 p -147.47 130.62 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.612 1.165 . . . . 0.0 109.882 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.57 151.77 39.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.424 1.49 . . . . 0.0 111.973 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -107.51 80.03 1.36 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.058 0.943 . . . . 0.0 109.478 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG23 HG21 ' B' ' 155' ' ' VAL . 2.7 m 35.96 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 128.96 2.904 . . . . 0.0 117.243 156.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -138.76 -46.68 0.49 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.465 1.506 . . . . 0.0 111.498 156.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -154.99 -55.22 0.1 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.9 t -54.79 123.99 15.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.757 1.265 . . . . 0.0 112.17 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 88.8 p -91.67 13.43 18.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.81 -1.541 . . . . 0.0 112.974 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -53.27 -29.77 34.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.762 1.225 . . . . 0.0 111.441 157.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -128.48 163.32 25.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 113.096 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -143.17 174.91 10.28 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.662 1.585 . . . . 0.0 110.237 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.28 139.24 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.443 161.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.12 150.68 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.418 0.687 . . . . 0.0 111.523 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -96.53 103.87 15.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.963 1.305 . . . . 0.0 108.656 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -91.75 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.023 1.329 . . . . 0.0 111.93 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -78.36 127.61 32.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 150.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.51 10.75 21.66 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -162.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.77 85.62 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.025 1.298 . . . . 0.0 115.806 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -131.87 25.67 4.65 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.728 1.264 . . . . 0.0 113.747 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.2 55.92 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 124.365 0.983 . . . . 0.0 113.547 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -142.06 174.83 10.24 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.623 1.969 . . . . 0.0 111.945 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -123.99 154.24 40.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.25 1.02 . . . . 0.0 112.158 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.18 157.49 43.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.654 1.582 . . . . 0.0 112.315 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.73 130.48 44.7 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.397 0.679 . . . . 0.0 110.6 169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 pt -122.2 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.908 0.883 . . . . 0.0 112.23 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.11 145.99 27.48 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 166.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.05 143.89 37.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.973 1.309 . . . . 0.0 109.43 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.07 141.74 13.1 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.927 1.251 . . . . 0.0 112.47 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 33.7 m-85 -101.22 151.87 21.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.15 0.98 . . . . 0.0 111.885 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -17.62 49.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.109 0.963 . . . . 0.0 112.751 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -134.97 136.77 42.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 111.038 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.42 HH22 ' P ' ' B' ' 156' ' ' TPO . 15.2 tpt180 -64.71 -31.6 72.9 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.61 -0.681 . . . . 0.0 112.376 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.84 -35.39 79.54 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.955 0.788 . . . . 0.0 112.93 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -72.49 -35.89 68.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.095 0.947 . . . . 0.0 111.814 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -66.94 -34.26 77.38 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.014 -1.054 . . . . 0.0 113.073 170.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.32 -25.76 68.18 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.089 -1.007 . . . . 0.0 112.405 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -76.3 -29.48 57.39 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.859 -1.15 . . . . 0.0 111.66 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -63.98 -41.58 97.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.942 0.792 . . . . 0.0 110.852 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.29 -39.73 24.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.87 -31.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.206 0.912 . . . . 0.0 113.061 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.1 p -60.79 -29.39 69.41 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.594 1.088 . . . . 0.0 112.465 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 mt -84.98 -40.83 16.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.723 0.809 . . . . 0.0 112.055 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -53.68 -50.91 64.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.167 0.894 . . . . 0.0 111.195 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.01 -11.12 60.24 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -85.57 -31.36 22.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.865 0.866 . . . . 0.0 112.74 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.403 ' HA ' HG23 ' A' ' 130' ' ' VAL . 54.3 m-85 -99.0 -17.83 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 113.278 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.92 -30.98 6.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.475 3.11 . . . . 0.0 115.914 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -109.15 4.77 23.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.46 -156.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.859 2.064 . . . . 0.0 109.553 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 60.33 17.18 6.86 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 52.91 29.96 8.53 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.379 1.872 . . . . 0.0 113.945 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.11 1.764 . . . . 0.0 114.465 -178.459 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.251 0.072 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.45 157.66 43.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 112.513 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 68.5 mt -129.39 138.96 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.194 1.798 . . . . 0.0 108.308 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 42.2 p -139.36 148.19 42.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.2 m -118.01 49.07 1.29 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.325 1.85 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -45.03 142.68 1.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.442 2.697 . . . . 0.0 114.666 -162.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.5 p -61.36 126.35 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.986 0.898 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.67 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.24 -24.05 0.02 OUTLIER Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.802 1.667 . . . . 0.0 113.568 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.62 -27.74 65.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.23 -37.33 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.24 61.49 3.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.313 0.959 . . . . 0.0 112.772 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.53 -164.92 1.53 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 113.093 -164.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.369 30.8 mmt180 65.75 28.07 11.06 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 127.422 2.289 . . . . 0.0 114.286 169.133 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.3 m -138.54 149.81 63.94 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.169 1.388 . . . . 0.0 111.817 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.44 159.82 35.82 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.695 2.93 . . . . 0.0 113.787 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.54 -19.79 65.83 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.173 0.989 . . . . 0.0 113.383 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -63.44 -8.4 9.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.235 1.414 . . . . 0.0 114.738 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtm -55.26 -24.7 29.39 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.536 -1.352 . . . . 0.0 112.914 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.98 -16.51 60.63 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.7 p -122.64 -9.17 8.44 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.417 1.487 . . . . 0.0 114.065 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.9 156.16 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.802 2.041 . . . . 0.0 112.88 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.64 53.44 0.71 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.607 1.963 . . . . 0.0 111.514 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.51 45.71 0.5 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.483 2.313 . . . . 0.0 112.279 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.3 175.75 10.37 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.054 -1.029 . . . . 0.0 113.149 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.26 129.4 1.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.896 2.078 . . . . 0.0 109.241 165.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -89.95 134.35 34.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.592 1.557 . . . . 0.0 111.505 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.88 138.15 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.738 -1.227 . . . . 0.0 112.38 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.94 -45.36 2.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.431 1.492 . . . . 0.0 113.077 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 t -145.82 152.28 39.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.46 129.41 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.015 1.326 . . . . 0.0 108.568 168.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.33 139.11 30.12 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 -27.22 13.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.533 3.489 . . . . 0.0 114.501 -166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -144.36 129.92 19.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.739 1.215 . . . . 0.0 110.773 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.0 142.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.943 1.297 . . . . 0.0 109.658 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -116.7 143.83 45.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 111.511 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -122.09 139.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 111.369 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.85 81.33 1.91 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.014 2.125 . . . . 0.0 108.495 -169.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -49.12 135.11 16.85 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.735 1.214 . . . . 0.0 112.001 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 pt -120.32 140.35 30.01 Favored Pre-proline 0 N--CA 1.485 1.299 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.78 -41.38 1.09 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.912 2.408 . . . . 0.0 116.975 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.38 159.31 36.43 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.781 2.321 . . . . 0.0 113.52 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -112.82 -28.62 7.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.248 1.419 . . . . 0.0 114.768 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.31 106.33 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.891 0.876 . . . . 0.0 111.454 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -82.45 156.98 23.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.005 0.922 . . . . 0.0 110.467 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -8.61 53.62 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.156 0.982 . . . . 0.0 113.229 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -41.37 7.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.031 1.733 . . . . 0.0 110.407 171.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.09 -77.97 0.17 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.295 1.426 . . . . 0.0 111.832 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -141.32 -31.15 0.59 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.6 111.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.515 3.126 . . . . 0.0 114.971 -170.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.55 36.01 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.628 -1.295 . . . . 0.0 113.647 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -78.17 -12.0 59.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.641 1.577 . . . . 0.0 114.252 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.17 -38.9 42.41 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.065 -1.022 . . . . 0.0 112.237 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.05 -166.84 1.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.531 2.332 . . . . 0.0 110.495 173.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -65.2 119.08 10.22 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.816 -1.178 . . . . 0.0 111.338 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.96 -30.86 12.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.699 2.399 . . . . 0.0 112.278 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -140.47 10.44 2.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.679 1.192 . . . . 0.0 113.856 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -117.66 88.83 31.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.988 1.715 . . . . 0.0 110.78 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.86 159.57 41.67 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.887 2.391 . . . . 0.0 113.207 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.03 -25.04 14.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 112.256 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -146.87 147.76 31.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.945 1.698 . . . . 0.0 110.273 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -135.58 153.2 51.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.25 -135.37 2.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 123.975 0.798 . . . . 0.0 111.297 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.42 143.91 51.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.985 2.114 . . . . 0.0 109.924 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -90.79 141.77 28.46 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.716 0.806 . . . . 0.0 110.567 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -139.38 106.41 5.45 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.241 1.017 . . . . 0.0 110.432 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.44 130.99 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.44 -0.787 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.3 p -130.64 174.76 9.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.8 p -153.09 127.69 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.221 1.01 . . . . 0.0 113.454 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -90.67 76.12 6.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 109.261 166.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.76 -124.51 7.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.551 1.548 . . . . 0.0 111.897 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.31 -10.32 41.61 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.088 1.355 . . . . 0.0 114.394 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -103.93 116.59 32.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.3 0.64 . . . . 0.0 111.846 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.94 158.35 20.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.839 0.856 . . . . 0.0 111.564 169.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -134.49 121.03 20.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.784 1.234 . . . . 0.0 108.215 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.9 mm -85.99 102.45 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -103.31 147.27 27.28 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.102 0.961 . . . . 0.0 109.372 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.61 127.21 47.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.114 0.966 . . . . 0.0 109.451 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -114.53 151.52 33.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.868 1.667 . . . . 0.0 112.233 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.69 135.28 56.59 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 109.159 166.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -60.03 -17.35 38.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.884 1.273 . . . . 0.0 113.823 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.04 -46.41 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.644 1.978 . . . . 0.0 111.125 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 t -107.95 -13.84 14.88 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -163.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.33 13.88 81.18 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.305 -0.872 . . . . 0.0 114.195 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.56 140.53 46.35 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.151 0.975 . . . . 0.0 111.993 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.78 118.63 18.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.239 0.616 . . . . 0.0 111.518 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -88.5 -52.78 4.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.496 1.518 . . . . 0.0 111.458 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.72 160.83 42.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.806 1.243 . . . . 0.0 111.413 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -141.83 142.02 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 167.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 118.77 29.44 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.708 1.603 . . . . 0.0 111.303 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.12 131.64 11.01 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.021 2.48 . . . . 0.0 111.46 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.25 126.6 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.435 2.294 . . . . 0.0 109.733 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.65 4.64 10.07 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.208 -0.933 . . . . 0.0 113.364 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.16 145.83 18.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.799 2.04 . . . . 0.0 109.904 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -130.95 126.86 21.91 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.48 167.06 56.39 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.281 0.779 . . . . 0.0 111.875 -15.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.46 -155.14 7.88 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.149 0.88 . . . . 0.0 113.587 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.12 -29.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.583 -0.951 . . . . 0.0 111.286 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.1 -29.52 57.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.292 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -147.31 127.92 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.003 1.321 . . . . 0.0 109.558 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 154.21 43.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.529 1.532 . . . . 0.0 111.693 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 84.04 2.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.292 1.037 . . . . 0.0 109.864 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 3.7 m 31.65 -75.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.899 2.88 . . . . 0.0 117.358 157.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.82 -47.15 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 111.28 154.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -156.69 -50.93 0.08 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.637 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 29.5 t -55.73 131.41 46.61 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.353 1.073 . . . . 0.0 111.416 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t -109.92 36.85 2.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.516 -1.674 . . . . 0.0 111.121 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -78.01 -31.16 50.42 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.302 1.041 . . . . 0.0 111.027 149.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -116.1 158.3 23.41 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.171 1.388 . . . . 0.0 112.574 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -141.22 172.89 12.06 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.247 1.419 . . . . 0.0 110.684 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.98 137.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 124.953 1.301 . . . . 0.0 108.118 159.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.3 151.68 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.362 0.665 . . . . 0.0 111.572 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -100.34 101.61 12.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 109.157 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.5 pt -94.39 162.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.505 1.522 . . . . 0.0 112.739 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -73.82 129.72 38.48 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 148.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -86.52 3.9 42.18 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.87 -0.43 78.1 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.577 1.56 . . . . 0.0 115.597 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.2 p -112.79 14.15 19.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.522 1.529 . . . . 0.0 113.295 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.31 15.7 54.94 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.27 1.414 . . . . 0.0 113.95 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -134.34 172.28 13.1 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.258 1.823 . . . . 0.0 112.792 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.0 p -108.7 152.13 25.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 111.871 167.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.15 153.36 44.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.711 1.204 . . . . 0.0 112.655 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -91.43 136.06 33.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.677 -0.639 . . . . 0.0 110.919 164.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.4 pt -126.48 141.37 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.2 1.0 . . . . 0.0 111.165 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.45 150.98 37.46 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 161.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -125.91 145.07 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.161 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.39 129.77 4.33 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.936 1.255 . . . . 0.0 111.098 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -90.02 165.05 14.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.237 1.018 . . . . 0.0 113.389 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -72.14 -24.58 61.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.213 1.005 . . . . 0.0 112.63 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.61 144.28 41.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.492 1.517 . . . . 0.0 112.548 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -55.83 -38.58 70.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.864 1.266 . . . . 0.0 111.584 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.4 -34.32 68.44 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.704 1.145 . . . . 0.0 113.819 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -69.01 -35.96 77.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.605 1.202 . . . . 0.0 111.641 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -34.53 63.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 170.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.17 -30.31 70.97 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.347 -1.471 . . . . 0.0 111.691 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -73.43 -34.47 65.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.064 -1.023 . . . . 0.0 111.862 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -58.46 -45.59 88.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 110.583 171.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -51.23 60.21 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 112.781 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.02 -30.26 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.065 -1.022 . . . . 0.0 112.549 -174.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.7 t -57.27 -35.13 69.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 111.739 169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.9 -37.42 24.26 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.392 1.077 . . . . 0.0 112.144 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -54.52 -53.26 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.554 1.07 . . . . 0.0 110.775 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.79 -8.96 58.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -84.48 -40.61 17.48 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.527 -0.733 . . . . 0.0 111.581 170.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 71.4 m-85 -87.72 -12.34 45.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -27.44 68.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -103.55 2.09 33.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.819 1.247 . . . . 0.0 113.862 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -125.53 -157.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 128.271 2.628 . . . . 0.0 108.478 174.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 56.86 24.87 9.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.708 1.603 . . . . 0.0 114.784 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 54.46 31.45 14.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 114.529 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.862 1.265 . . . . 0.0 113.782 173.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.68 158.62 28.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.006 0.922 . . . . 0.0 112.5 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.7 tp -144.35 158.92 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.769 1.628 . . . . 0.0 110.713 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -76.8 151.44 35.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.546 1.138 . . . . 0.0 112.749 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -83.7 49.91 1.7 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.498 1.519 . . . . 0.0 113.862 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.17 156.03 7.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.743 2.017 . . . . 0.0 113.135 -172.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 88' ' ' SER . 3.8 t -62.13 136.42 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.637 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -173.93 -20.09 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 CA-C-N 113.369 -1.742 . . . . 0.0 113.393 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -65.07 -16.99 64.07 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.595 1.558 . . . . 0.0 114.664 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.421 HG23 ' CD1' ' B' ' 161' ' ' TRP . 8.6 tp -132.41 -39.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -172.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.09 63.7 3.33 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.456 1.027 . . . . 0.0 113.05 167.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . 0.421 ' CD1' HG23 ' B' ' 159' ' ' ILE . 1.0 OUTLIER -146.54 170.5 16.76 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -155.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -169.25 -50.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.307 2.243 . . . . 0.0 110.184 156.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.147 2.179 . . . . 0.0 111.635 179.686 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.3 m -140.2 157.72 68.3 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 125.337 1.455 . . . . 0.0 111.848 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.88 141.95 98.6 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.392 2.728 . . . . 0.0 113.695 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -153.72 161.05 42.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.34 1.456 . . . . 0.0 110.935 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.0 m -73.69 132.35 42.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.92 0.888 . . . . 0.0 110.896 170.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -110.42 -6.39 14.96 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.43 60.39 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.834 1.254 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.3 m -77.36 -26.71 52.23 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.598 1.559 . . . . 0.0 113.916 -171.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.06 157.76 43.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.927 1.691 . . . . 0.0 111.468 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.5 54.07 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.029 1.732 . . . . 0.0 110.686 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.46 115.42 22.55 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 0.0 110.331 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.0 -176.51 5.8 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.073 1.349 . . . . 0.0 112.058 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.22 136.27 6.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.021 1.728 . . . . 0.0 109.207 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 m -97.4 127.05 43.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.694 1.197 . . . . 0.0 110.976 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.59 138.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.877 -1.139 . . . . 0.0 111.51 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.3 mt -118.31 -44.26 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.85 1.66 . . . . 0.0 112.225 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.5 t -143.59 154.69 43.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 112.271 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.44 127.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 108.653 172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.82 139.12 29.59 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.19 -28.07 19.15 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 124.968 3.779 . . . . 0.0 114.768 -167.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.84 128.03 13.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 110.823 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.03 142.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.14 1.376 . . . . 0.0 109.08 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -126.05 141.96 51.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.137 0.975 . . . . 0.0 111.579 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.99 139.06 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.792 1.237 . . . . 0.0 111.957 -169.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -120.87 105.15 10.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.702 1.601 . . . . 0.0 110.431 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 -56.86 132.51 52.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.777 -1.827 . . . . 0.0 110.778 163.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 pt -124.28 144.97 47.17 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 124.813 1.245 . . . . 0.0 112.888 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -73.09 -41.89 1.17 Allowed 'Trans proline' 0 CA--C 1.553 1.451 0 C-N-CA 122.816 2.344 . . . . 0.0 117.065 173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.2 158.29 20.15 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.766 2.31 . . . . 0.0 113.988 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -104.42 -25.06 12.97 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.501 1.52 . . . . 0.0 114.439 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.02 104.65 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.507 1.123 . . . . 0.0 110.288 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -91.41 162.82 14.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.606 1.162 . . . . 0.0 111.235 167.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -24.27 56.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.754 2.022 . . . . 0.0 115.143 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -108.75 -0.86 19.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.441 1.496 . . . . 0.0 114.045 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.43 -92.1 0.34 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.837 1.684 . . . . 0.0 110.751 -170.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -137.78 -36.24 0.63 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.25 109.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.869 3.268 . . . . 0.0 114.752 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.4 32.47 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.95 -1.094 . . . . 0.0 113.848 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -66.13 -23.31 66.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.145 1.778 . . . . 0.0 114.093 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.36 -34.04 61.12 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.943 -1.098 . . . . 0.0 113.012 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -115.92 -152.29 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.784 2.034 . . . . 0.0 110.811 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -76.81 108.53 9.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.849 1.309 . . . . 0.0 111.429 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.47 -23.62 24.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.301 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -153.65 22.93 0.53 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -115.62 93.36 36.73 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.395 1.078 . . . . 0.0 111.661 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.6 146.06 33.95 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.445 2.096 . . . . 0.0 114.264 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.86 -32.15 17.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.302 1.441 . . . . 0.0 111.406 167.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -150.42 148.43 28.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.768 1.627 . . . . 0.0 110.356 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.4 p -139.04 152.78 47.87 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.475 1.11 . . . . 0.0 111.202 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.11 -131.99 1.86 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.382 -0.372 . . . . 0.0 112.951 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -125.42 142.87 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.273 2.229 . . . . 0.0 110.952 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -94.49 137.87 33.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.148 0.979 . . . . 0.0 110.657 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -120.89 142.67 49.47 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.161 0.984 . . . . 0.0 109.912 150.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.3 mt -119.64 129.02 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 161.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -132.46 173.89 10.83 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.109 1.364 . . . . 0.0 109.231 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -153.77 124.75 7.32 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 120.916 -1.115 . . . . 0.0 113.076 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -87.76 67.24 9.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 109.761 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.91 -124.14 6.66 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.547 1.546 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -73.28 18.41 0.11 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.914 2.086 . . . . 0.0 114.471 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -132.87 115.78 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.251 1.42 . . . . 0.0 109.647 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.99 159.66 20.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.629 0.772 . . . . 0.0 111.066 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -138.57 126.29 22.21 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.252 1.021 . . . . 0.0 108.784 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.11 103.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -112.38 119.57 38.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.091 0.956 . . . . 0.0 110.925 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.02 129.95 46.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.128 0.971 . . . . 0.0 110.695 -172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -120.86 153.56 37.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.319 1.447 . . . . 0.0 112.621 -170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.76 142.14 58.08 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.085 -1.009 . . . . 0.0 109.665 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.81 -18.06 64.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.459 1.104 . . . . 0.0 112.907 -170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.82 -29.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.053 1.341 . . . . 0.0 114.234 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -105.04 -8.91 18.2 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.708 0.685 . . . . 0.0 112.785 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.89 57.66 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.673 1.13 . . . . 0.0 115.179 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.73 138.17 44.47 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.407 1.103 . . . . 0.0 111.573 -173.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -70.84 119.73 15.4 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.863 -0.523 . . . . 0.0 111.456 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -82.17 -52.7 6.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.15 1.38 . . . . 0.0 111.22 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.56 162.11 38.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.846 1.258 . . . . 0.0 111.595 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -140.06 131.22 26.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.864 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.14 43.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.69 1.196 . . . . 0.0 111.132 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.69 124.73 5.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.31 2.673 . . . . 0.0 111.405 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.61 123.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.198 1.799 . . . . 0.0 110.099 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -123.1 5.57 9.24 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.931 1.292 . . . . 0.0 112.053 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.2 146.49 18.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.485 1.914 . . . . 0.0 110.019 171.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -131.92 132.12 23.01 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 113.15 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -65.65 163.19 66.75 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.18 0.743 . . . . 0.0 111.047 -16.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.19 -158.28 10.04 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.393 -0.817 . . . . 0.0 114.488 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 tp -77.66 -29.78 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.965 -0.726 . . . . 0.0 111.21 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.57 -22.48 32.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.42 127.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 119.46 1.027 . . . . 0.0 109.981 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.03 40.43 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.314 1.446 . . . . 0.0 112.253 -175.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.84 97.01 9.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 169.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 13.74 -71.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 129.776 3.231 . . . . 0.0 117.347 162.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.482 ' H ' HG23 ' A' ' 85' ' ' VAL . 41.3 p -136.48 -47.7 0.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.206 154.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -159.02 -51.54 0.06 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.734 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 23.2 t -55.07 121.48 8.85 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.28 1.038 . . . . 0.0 111.771 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 77.9 p -103.43 12.48 35.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.849 -162.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -60.51 -25.27 65.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.871 0.868 . . . . 0.0 111.173 157.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -114.17 156.74 23.7 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.337 1.455 . . . . 0.0 113.293 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.57 176.03 9.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.471 1.508 . . . . 0.0 110.338 167.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.76 135.77 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.464 1.506 . . . . 0.0 108.531 163.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.8 150.47 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.171 0.989 . . . . 0.0 111.715 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 94.08 5.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.06 1.344 . . . . 0.0 109.998 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.3 pt -81.75 154.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.971 1.308 . . . . 0.0 112.293 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.26 147.73 22.66 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 111.729 161.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -88.27 0.38 56.19 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.47 13.47 83.19 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.77 1.176 . . . . 0.0 115.435 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -134.6 28.32 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.681 1.193 . . . . 0.0 113.541 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.78 17.91 55.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.213 1.387 . . . . 0.0 113.939 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -142.05 172.87 12.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.722 1.609 . . . . 0.0 113.173 -173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -149.17 161.76 41.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.57 153.69 42.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.364 1.866 . . . . 0.0 112.342 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.68 133.06 38.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.484 0.714 . . . . 0.0 111.159 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.2 pt -128.08 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.192 0.997 . . . . 0.0 110.215 165.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.76 158.33 53.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.17 0.89 . . . . 0.0 110.944 156.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.11 144.8 34.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.051 1.341 . . . . 0.0 108.255 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.39 132.57 7.58 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.277 1.417 . . . . 0.0 111.402 162.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 20.9 m-85 -92.48 164.29 13.51 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -80.66 -25.09 38.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.41 1.084 . . . . 0.0 113.084 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.68 138.45 37.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 111.438 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -61.92 -34.92 76.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.642 0.777 . . . . 0.0 112.344 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.86 -36.84 65.71 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.106 0.86 . . . . 0.0 112.962 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -68.24 -33.77 75.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.548 1.174 . . . . 0.0 111.964 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.38 -41.42 63.38 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.932 0.893 . . . . 0.0 112.911 173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -61.06 -30.1 70.13 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.362 -1.461 . . . . 0.0 111.623 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -77.82 -30.14 51.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.482 1.113 . . . . 0.0 111.857 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.09 -47.22 81.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.735 166.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -51.12 51.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.841 0.857 . . . . 0.0 113.031 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.04 -26.99 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.209 0.913 . . . . 0.0 112.503 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -57.34 -34.54 68.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.164 0.893 . . . . 0.0 112.097 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.88 -37.9 23.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 112.059 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -55.26 -49.54 71.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.592 1.087 . . . . 0.0 110.86 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.78 -8.66 57.1 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.502 1.121 . . . . 0.0 113.546 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -83.68 -39.3 20.36 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.789 . . . . 0.0 111.418 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -89.38 -14.17 36.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -26.49 66.48 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -104.84 4.69 32.4 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.02 1.328 . . . . 0.0 114.057 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -168.32 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.953 2.101 . . . . 0.0 110.52 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 tptt 57.02 20.49 5.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.932 1.693 . . . . 0.0 115.273 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.27 30.04 7.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.226 1.81 . . . . 0.0 114.576 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.933 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.496 0.188 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -125.18 35.99 4.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.226 1.411 . . . . 0.0 112.07 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.0 mt -74.72 136.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.563 1.145 . . . . 0.0 109.92 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 41.6 p -135.39 164.87 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.522 1.529 . . . . 0.0 112.34 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.61 46.6 0.88 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.847 1.659 . . . . 0.0 115.039 -170.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -58.61 150.78 22.23 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.124 2.17 . . . . 0.0 112.766 -174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 88' ' ' SER . 3.1 t -62.48 132.32 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.863 0.865 . . . . 0.0 110.561 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.734 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -162.5 -13.26 0.03 OUTLIER Glycine 0 CA--C 1.54 1.622 0 C-N-CA 127.721 2.581 . . . . 0.0 113.385 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.02 -17.67 62.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.002 2.121 . . . . 0.0 115.245 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.432 HG23 ' CD1' ' B' ' 161' ' ' TRP . 20.0 tt -123.86 -39.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.429 1.092 . . . . 0.0 113.44 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.86 67.69 1.82 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.437 1.017 . . . . 0.0 112.574 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . 0.432 ' CD1' HG23 ' B' ' 159' ' ' ILE . 0.9 OUTLIER -147.51 163.22 37.24 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -159.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.463 ' HG3' HH21 ' B' ' 162' ' ' ARG . 0.0 OUTLIER -170.03 -48.99 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.976 2.11 . . . . 0.0 109.559 159.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.067 2.147 . . . . 0.0 111.482 168.291 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.4 m -136.59 150.96 71.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.246 1.419 . . . . 0.0 111.834 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.31 -19.19 22.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.32 2.68 . . . . 0.0 113.731 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -143.37 161.55 38.06 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.251 1.82 . . . . 0.0 110.249 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.9 t -148.25 150.86 34.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.916 1.286 . . . . 0.0 112.216 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt -116.35 12.39 15.28 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.495 1.518 . . . . 0.0 112.721 171.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.18 -28.57 38.71 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 113.521 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.0 p -94.55 -24.36 17.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.107 1.363 . . . . 0.0 113.897 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 10.0 tp10 -154.3 142.31 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.978 2.111 . . . . 0.0 109.765 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.0 -10.91 56.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.282 1.033 . . . . 0.0 113.407 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 6.5 mm-40 50.11 44.87 25.92 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.91 2.084 . . . . 0.0 114.071 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -101.16 -171.05 1.93 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.684 1.994 . . . . 0.0 112.36 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.64 130.01 1.94 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.454 1.901 . . . . 0.0 108.823 157.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -92.75 136.59 33.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.846 1.259 . . . . 0.0 111.078 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.63 136.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 120.874 -1.141 . . . . 0.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -116.96 -45.78 2.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.335 1.454 . . . . 0.0 112.484 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 t -148.28 155.22 41.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.969 0.89 . . . . 0.0 113.366 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.0 131.58 20.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.798 1.639 . . . . 0.0 108.633 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -126.0 141.56 39.87 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.38 -27.57 13.17 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.33 3.354 . . . . 0.0 114.611 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -144.08 135.55 25.82 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.644 1.178 . . . . 0.0 111.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.5 140.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.113 1.365 . . . . 0.0 109.367 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.227 1.011 . . . . 0.0 112.002 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.2 t -122.3 136.95 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.385 1.474 . . . . 0.0 110.649 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -126.99 40.86 3.64 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.196 1.798 . . . . 0.0 111.885 -165.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -24.95 121.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 128.873 2.869 . . . . 0.0 115.041 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 pt -111.6 147.38 36.63 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.565 1.146 . . . . 0.0 113.369 -157.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -72.26 -43.44 1.08 Allowed 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 122.672 2.248 . . . . 0.0 117.042 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 161.99 19.71 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.973 2.448 . . . . 0.0 114.35 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -111.6 -23.62 10.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.183 1.793 . . . . 0.0 114.433 166.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.34 95.15 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.085 1.354 . . . . 0.0 108.777 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.8 t -80.34 -48.96 12.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -167.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -165.6 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.431 1.492 . . . . 0.0 110.973 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -83.99 -31.16 25.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.2 1.0 . . . . 0.0 112.77 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.52 -124.43 0.73 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.683 1.611 . . . . 0.0 111.608 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.17 -37.33 3.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.33 114.28 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.467 3.107 . . . . 0.0 115.684 -167.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.79 43.3 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.731 -1.23 . . . . 0.0 112.181 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.6 m -59.63 -22.78 62.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.979 2.512 . . . . 0.0 115.847 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.25 -26.94 23.23 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.55 1.068 . . . . 0.0 113.273 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -160.82 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.301 1.84 . . . . 0.0 109.995 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.18 113.91 8.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.901 -1.124 . . . . 0.0 111.61 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.95 -30.23 14.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.728 1.611 . . . . 0.0 113.242 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.93 1.71 4.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.582 1.553 . . . . 0.0 113.213 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -116.31 79.82 9.25 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.128 1.771 . . . . 0.0 110.849 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.22 148.14 61.46 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.619 2.213 . . . . 0.0 112.828 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -100.24 -24.93 14.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.863 1.265 . . . . 0.0 112.093 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.3 t90 -147.68 147.84 30.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.372 1.869 . . . . 0.0 109.989 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -137.24 155.57 49.34 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.75 0.786 . . . . 0.0 111.849 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.7 -136.17 2.15 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.886 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -128.83 145.57 51.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.992 2.517 . . . . 0.0 109.648 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.9 tp -97.56 136.87 37.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.375 0.67 . . . . 0.0 110.7 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -124.41 140.13 53.25 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.026 1.33 . . . . 0.0 109.706 157.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.1 mt -125.9 128.65 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 p -129.98 171.3 12.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.187 1.795 . . . . 0.0 110.417 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.5 p -153.38 124.82 7.6 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 113.853 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -96.13 83.43 3.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.52 1.528 . . . . 0.0 109.715 165.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.49 -138.04 21.87 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.35 1.452 . . . . 0.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.74 42.21 0.23 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.189 1.396 . . . . 0.0 113.11 174.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 m -151.02 112.49 4.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.943 1.697 . . . . 0.0 108.161 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.66 160.15 16.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.393 0.616 . . . . 0.0 110.638 170.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -133.9 110.87 10.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.94 117.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -113.79 109.86 19.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.757 1.623 . . . . 0.0 109.611 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.07 127.93 36.19 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.651 -0.655 . . . . 0.0 109.998 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.29 152.36 35.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.943 1.697 . . . . 0.0 111.627 -169.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.99 152.27 35.29 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.25 -1.531 . . . . 0.0 111.388 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.7 -3.08 32.68 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.26 -43.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.951 1.7 . . . . 0.0 111.787 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 m -124.26 -9.77 7.55 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.42 80.71 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 123.827 0.727 . . . . 0.0 114.51 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -76.67 152.43 35.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.726 1.263 . . . . 0.0 112.151 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -77.2 124.3 27.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -168.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -84.94 -53.43 5.31 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.928 1.691 . . . . 0.0 111.289 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.19 162.13 40.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.411 1.484 . . . . 0.0 110.879 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.48 144.75 36.21 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.1 110.86 26.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.842 1.657 . . . . 0.0 111.903 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -76.43 134.59 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.296 2.664 . . . . 0.0 112.208 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.51 133.14 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.533 1.533 . . . . 0.0 112.718 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.93 -3.28 12.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.822 1.249 . . . . 0.0 112.905 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -159.89 142.81 13.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.299 1.84 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.2 t80 -135.29 126.47 17.41 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.994 0.918 . . . . 0.0 112.349 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.34 156.83 41.97 Favored 'Cis proline' 0 C--N 1.355 0.903 0 CA-C-N 120.077 1.063 . . . . 0.0 114.364 -8.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.29 -165.38 25.6 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.923 0.773 . . . . 0.0 113.7 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -77.62 -24.34 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.098 0.959 . . . . 0.0 111.446 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.58 -12.73 50.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.3 p -159.6 117.23 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.679 1.191 . . . . 0.0 109.584 168.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.62 151.6 50.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.265 1.826 . . . . 0.0 110.932 -176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -103.5 88.02 2.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.11 0.964 . . . . 0.0 109.065 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 86' ' ' THR . 2.8 m 23.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.469 3.108 . . . . 0.0 116.823 160.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.4 p -134.91 -47.47 0.73 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 112.015 154.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.83 -63.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 8.9 t -49.17 137.77 13.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p -113.95 33.32 5.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.573 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -72.86 -26.81 61.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.057 1.343 . . . . 0.0 112.059 153.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.99 157.7 35.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.045 1.738 . . . . 0.0 111.95 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -145.31 171.13 15.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.171 1.388 . . . . 0.0 111.12 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.59 133.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.422 1.089 . . . . 0.0 109.17 162.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.6 pt -126.49 150.68 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.956 0.902 . . . . 0.0 111.909 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.63 111.0 22.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.108 0.963 . . . . 0.0 110.439 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 pt -98.22 148.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 124.848 1.259 . . . . 0.0 111.431 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -77.25 141.96 39.75 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.752 -0.593 . . . . 0.0 110.814 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.41 -0.8 57.32 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.365 0.666 . . . . 0.0 112.743 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.69 81.69 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.074 1.321 . . . . 0.0 115.29 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -137.19 30.23 2.71 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.734 1.254 . . . . 0.0 113.307 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.72 19.31 58.32 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 125.111 1.339 . . . . 0.0 113.793 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.34 161.0 40.67 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.97 1.708 . . . . 0.0 112.658 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -132.92 159.38 40.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.35 152.34 51.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.143 2.177 . . . . 0.0 111.366 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -98.31 129.99 45.0 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.631 -0.668 . . . . 0.0 111.024 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.56 136.67 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 112.128 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.34 138.47 17.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 166.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.82 145.85 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 109.269 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.06 134.21 6.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.828 1.204 . . . . 0.0 111.617 165.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -93.21 160.83 14.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.84 0.829 . . . . 0.0 112.546 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -73.07 -23.0 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 0.0 112.785 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -127.74 138.29 52.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.557 1.543 . . . . 0.0 112.375 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.88 -35.25 72.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.787 1.235 . . . . 0.0 112.332 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.31 -31.45 57.1 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.971 1.272 . . . . 0.0 113.912 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.75 -36.9 78.95 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.007 1.403 . . . . 0.0 111.497 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.9 66.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -63.47 -32.34 73.75 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 111.959 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.25 -34.02 72.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.051 0.94 . . . . 0.0 111.716 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.45 -39.97 89.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.472 1.033 . . . . 0.0 111.526 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.05 -55.7 20.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.87 0.868 . . . . 0.0 111.924 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.94 -32.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.222 -0.924 . . . . 0.0 112.559 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.0 m -59.62 -26.89 65.84 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.343 1.057 . . . . 0.0 113.222 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 82' ' ' VAL . 83.2 mt -96.37 -35.53 11.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.376 1.07 . . . . 0.0 112.105 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -56.26 -51.63 67.43 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.34 0.973 . . . . 0.0 110.731 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.66 -7.01 53.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.536 1.134 . . . . 0.0 113.451 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -84.7 -39.8 18.12 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.523 -0.736 . . . . 0.0 111.54 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -89.45 -15.38 33.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -29.77 68.85 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -97.09 5.97 49.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.033 1.333 . . . . 0.0 113.901 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.04 -162.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.592 2.357 . . . . 0.0 109.704 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.7 tptt 58.16 22.38 9.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.204 1.802 . . . . 0.0 115.019 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 53.04 29.19 7.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.088 1.755 . . . . 0.0 114.041 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.972 1.309 . . . . 0.0 113.976 174.846 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -83.14 -13.44 55.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.53 1.132 . . . . 0.0 112.963 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.8 mt -75.67 138.94 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.696 1.198 . . . . 0.0 110.119 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.99 154.29 41.93 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.485 1.114 . . . . 0.0 112.722 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 82.1 p -150.86 17.62 0.78 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -164.63 166.75 19.88 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.806 2.042 . . . . 0.0 115.159 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 88' ' ' SER . 2.1 t -66.12 124.62 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 149.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.501 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.81 -13.56 0.04 OUTLIER Glycine 0 CA--C 1.541 1.659 0 C-N-CA 127.239 2.352 . . . . 0.0 113.383 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -72.37 -16.79 61.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.35 2.26 . . . . 0.0 115.157 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.9 tt -140.44 -33.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.23 32.89 57.68 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.94 0.781 . . . . 0.0 114.605 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -158.45 0.67 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.707 1.603 . . . . 0.0 113.786 -168.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -138.03 -161.94 1.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.024 1.729 . . . . 0.0 111.397 -143.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.786 1.234 . . . . 0.0 113.541 168.589 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 36.9 m -67.48 150.51 97.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.517 1.127 . . . . 0.0 113.073 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.13 166.92 25.15 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.58 2.853 . . . . 0.0 112.686 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -69.56 -19.37 63.68 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.2 m -133.04 133.47 43.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.738 1.615 . . . . 0.0 110.817 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -108.25 1.84 22.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.55 120.83 22.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.954 1.302 . . . . 0.0 111.228 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -81.92 54.12 2.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.699 1.6 . . . . 0.0 111.916 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.72 147.7 48.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.884 1.274 . . . . 0.0 112.243 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.65 31.45 0.19 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.521 1.928 . . . . 0.0 113.144 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.21 130.63 40.67 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.732 -1.23 . . . . 0.0 110.769 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 16.4 p90 -152.18 178.49 9.43 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.0 135.74 4.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.122 2.169 . . . . 0.0 108.355 161.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -105.2 129.0 53.68 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.216 1.406 . . . . 0.0 112.227 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.48 134.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.973 0.806 . . . . 0.0 112.737 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -113.95 -45.28 3.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 112.081 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.6 t -145.43 136.69 24.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.664 1.185 . . . . 0.0 111.274 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.45 137.0 57.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.008 1.323 . . . . 0.0 108.765 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -128.85 136.1 28.64 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.26 -23.92 11.35 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.238 3.292 . . . . 0.0 114.67 -164.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -144.49 122.47 12.06 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 111.096 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.26 150.89 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.707 1.603 . . . . 0.0 109.423 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.2 p -126.27 152.05 46.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.174 1.39 . . . . 0.0 112.06 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.1 t -129.38 140.6 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.211 1.004 . . . . 0.0 111.984 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -124.32 107.75 11.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.672 1.589 . . . . 0.0 109.575 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -58.36 134.93 57.04 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.912 -1.742 . . . . 0.0 110.922 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.0 pt -124.29 142.89 41.31 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 124.096 0.958 . . . . 0.0 113.361 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.2 -38.68 1.41 Allowed 'Trans proline' 0 CA--C 1.553 1.47 0 C-N-CA 122.817 2.345 . . . . 0.0 117.408 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.53 164.93 27.92 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.766 2.311 . . . . 0.0 113.731 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -123.99 -26.39 4.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.75 1.62 . . . . 0.0 114.775 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.85 104.19 1.03 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.787 0.804 . . . . 0.0 112.408 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.7 t -84.47 160.09 20.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.134 0.974 . . . . 0.0 109.498 153.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -18.5 65.41 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.938 -1.102 . . . . 0.0 112.009 169.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -82.38 -16.23 49.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.375 1.47 . . . . 0.0 112.84 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.55 -101.32 0.92 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.488 1.518 . . . . 0.0 111.114 -171.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -131.68 -28.82 1.78 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.71 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 114.518 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.7 -35.14 41.75 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.278 -0.889 . . . . 0.0 113.013 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -16.32 46.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.791 1.636 . . . . 0.0 114.245 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.83 -14.05 49.18 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.909 1.284 . . . . 0.0 113.76 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -131.77 -169.34 2.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.234 1.813 . . . . 0.0 110.364 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -66.44 112.35 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.481 -1.387 . . . . 0.0 110.544 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.7 pt? -111.9 9.12 20.58 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.881 1.272 . . . . 0.0 114.302 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -146.17 9.38 1.11 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.095 1.358 . . . . 0.0 113.758 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.15 78.0 69.89 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.368 1.467 . . . . 0.0 110.879 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.69 146.93 68.47 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.432 2.755 . . . . 0.0 113.135 -174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.07 -23.1 17.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 111.658 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -145.24 149.11 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.661 1.584 . . . . 0.0 111.333 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.6 p -139.72 150.41 44.79 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.566 1.546 . . . . 0.0 111.425 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.36 -132.04 2.23 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.169 0.414 . . . . 0.0 112.946 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.47 144.21 49.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.4 2.28 . . . . 0.0 111.3 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.69 136.39 35.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -139.92 100.67 3.99 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.917 0.865 . . . . 0.0 111.627 160.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.79 127.46 37.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.383 1.473 . . . . 0.0 108.861 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -128.09 171.11 12.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.433 1.493 . . . . 0.0 110.67 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.8 p -155.43 129.28 8.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 23.6 ttmt -104.11 88.27 2.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.257 1.823 . . . . 0.0 109.48 170.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.72 -128.25 23.55 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.124 1.345 . . . . 0.0 112.111 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.85 -14.63 35.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.042 1.337 . . . . 0.0 114.052 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 115.78 29.1 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.833 -0.542 . . . . 0.0 111.688 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.47 155.85 21.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.682 . . . . 0.0 110.782 167.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -134.5 112.05 10.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 108.183 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.1 mm -79.47 100.2 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -102.87 143.3 32.65 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 111.149 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -122.62 130.7 53.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.436 1.494 . . . . 0.0 108.702 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.95 156.29 48.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.196 0.998 . . . . 0.0 112.053 -163.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.66 141.47 56.68 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.937 -1.102 . . . . 0.0 110.156 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -66.52 -19.47 65.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.492 1.117 . . . . 0.0 112.93 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.37 -28.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.901 1.281 . . . . 0.0 114.22 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -106.09 -8.53 17.43 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.42 14.66 57.73 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.678 1.132 . . . . 0.0 114.913 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.57 134.94 43.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.485 1.143 . . . . 0.0 111.756 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.86 119.4 13.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.224 1.009 . . . . 0.0 111.177 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -88.32 -53.9 4.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 110.994 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.13 42.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.448 1.099 . . . . 0.0 111.864 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -140.26 133.43 29.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.386 1.075 . . . . 0.0 111.599 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.4 118.92 39.04 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.497 1.119 . . . . 0.0 111.372 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.69 124.52 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.967 2.445 . . . . 0.0 111.144 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.83 123.79 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.538 1.935 . . . . 0.0 109.028 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -113.42 -3.67 13.71 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.697 1.199 . . . . 0.0 112.916 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 141.82 17.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.536 1.934 . . . . 0.0 110.391 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -128.64 130.28 23.5 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.441 1.096 . . . . 0.0 112.159 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -64.64 163.71 58.98 Favored 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.383 0.815 . . . . 0.0 111.76 -15.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.46 -156.8 8.85 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 121.485 -0.759 . . . . 0.0 113.817 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.5 -29.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.842 -0.799 . . . . 0.0 111.691 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.33 47.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.04 127.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.044 1.338 . . . . 0.0 109.739 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 154.05 42.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.493 1.517 . . . . 0.0 112.329 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -108.15 71.81 0.82 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.553 1.141 . . . . 0.0 110.111 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 42.15 -72.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 128.759 2.824 . . . . 0.0 117.539 160.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.8 p -137.13 -45.71 0.57 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.748 1.219 . . . . 0.0 111.853 157.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -154.16 -62.05 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.594 ' HB3' HG13 ' B' ' 155' ' ' VAL . 9.5 t -52.18 129.6 28.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.2 p -93.51 22.05 5.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -54.78 -25.79 30.29 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.998 -1.064 . . . . 0.0 111.062 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -136.99 165.69 25.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.654 1.982 . . . . 0.0 113.335 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -138.25 175.94 9.13 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.982 1.713 . . . . 0.0 110.202 167.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.54 140.17 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.805 1.642 . . . . 0.0 108.605 162.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.4 pt -130.76 153.77 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.853 0.861 . . . . 0.0 111.808 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.0 90.99 3.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.266 1.426 . . . . 0.0 109.977 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.1 pt -78.63 157.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.931 1.293 . . . . 0.0 112.513 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -97.28 146.05 25.51 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.415 0.686 . . . . 0.0 111.745 161.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.66 -4.43 57.76 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.56 6.39 87.45 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.166 1.365 . . . . 0.0 115.098 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.7 p -114.24 4.49 15.5 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.591 1.556 . . . . 0.0 113.592 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.8 54.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.652 1.596 . . . . 0.0 113.952 -172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -109.69 175.73 5.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.581 1.553 . . . . 0.0 113.409 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.9 p -141.86 165.64 26.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.45 155.62 42.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.271 1.828 . . . . 0.0 112.267 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -96.34 132.83 41.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.63 0.772 . . . . 0.0 111.298 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 pt -126.84 139.45 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.084 0.953 . . . . 0.0 110.984 167.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.54 153.79 41.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.456 1.027 . . . . 0.0 111.153 158.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.0 140.08 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.908 1.283 . . . . 0.0 109.103 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.58 132.38 8.72 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.304 1.43 . . . . 0.0 112.015 168.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -98.29 159.43 14.95 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -76.37 -25.63 54.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.621 1.168 . . . . 0.0 112.85 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.06 143.73 29.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.512 1.525 . . . . 0.0 111.426 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -64.79 -31.85 73.26 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.628 -0.67 . . . . 0.0 112.682 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.15 66.32 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.976 0.798 . . . . 0.0 112.839 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -66.16 -36.64 83.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.066 0.933 . . . . 0.0 111.38 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.84 64.42 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.14 -29.17 69.61 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.231 -1.543 . . . . 0.0 111.568 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -80.71 -26.82 37.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.612 1.165 . . . . 0.0 112.873 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -57.64 -43.09 84.64 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.152 0.887 . . . . 0.0 110.123 164.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -50.18 61.05 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.949 0.9 . . . . 0.0 112.908 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.27 -31.4 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.102 1.319 . . . . 0.0 112.324 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 t -55.69 -30.07 60.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.961 0.904 . . . . 0.0 112.54 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.57 -35.87 13.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.883 1.273 . . . . 0.0 111.717 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -55.57 -57.54 11.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.11 0.868 . . . . 0.0 110.783 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.7 -16.96 64.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 113.126 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -86.66 -29.55 22.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.939 0.896 . . . . 0.0 113.155 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -100.78 -15.04 17.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -48.27 -35.6 12.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.217 3.007 . . . . 0.0 114.9 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -104.66 8.77 35.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.228 1.411 . . . . 0.0 114.361 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.91 -163.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.349 1.86 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt 63.59 30.89 14.93 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 157.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 56.93 25.19 10.26 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.681 1.993 . . . . 0.0 115.472 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 125.012 1.325 . . . . 0.0 113.577 169.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.725 0.297 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -135.94 165.83 24.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.036 1.734 . . . . 0.0 111.048 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.65 158.6 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.379 1.472 . . . . 0.0 111.393 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.9 p -62.34 142.39 57.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.696 1.199 . . . . 0.0 112.448 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 71.2 m -130.39 70.08 1.45 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.918 1.287 . . . . 0.0 111.568 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.21 145.4 2.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.338 1.855 . . . . 0.0 114.479 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 88' ' ' SER . 3.0 t -57.56 124.43 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.489 1.116 . . . . 0.0 109.256 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.514 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.68 -26.54 0.02 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.688 1.613 . . . . 0.0 114.433 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -72.88 -29.53 63.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.97 -34.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.65 1.18 . . . . 0.0 112.531 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.42 31.81 62.91 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.573 1.083 . . . . 0.0 114.673 166.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -105.48 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.82 2.048 . . . . 0.0 114.271 -163.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -69.79 126.92 31.14 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.772 2.029 . . . . 0.0 111.131 -173.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.888 2.075 . . . . 0.0 113.887 -160.025 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 22.2 m -67.58 148.78 98.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.34 1.056 . . . . 0.0 112.982 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.77 154.29 73.53 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.184 2.589 . . . . 0.0 112.129 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.8 t30 50.4 45.91 25.76 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.554 1.542 . . . . 0.0 113.36 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -66.28 155.41 37.27 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.413 1.085 . . . . 0.0 112.88 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mtp -80.6 62.14 4.56 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.553 1.541 . . . . 0.0 112.639 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.68 -13.2 29.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.707 1.203 . . . . 0.0 113.864 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.1 p -81.32 -7.02 59.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.981 2.112 . . . . 0.0 114.176 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -59.45 147.27 37.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.944 1.298 . . . . 0.0 112.562 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.96 34.88 0.15 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.918 2.087 . . . . 0.0 112.991 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.0 134.54 49.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 110.32 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -153.77 178.67 9.63 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.41 133.53 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.254 2.222 . . . . 0.0 108.312 168.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -99.71 134.16 43.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.089 1.356 . . . . 0.0 111.13 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.12 134.26 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 119.485 1.038 . . . . 0.0 112.542 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 mt -111.92 -45.93 3.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.356 1.463 . . . . 0.0 111.891 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.1 t -146.49 139.39 25.43 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.492 1.117 . . . . 0.0 111.233 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.43 129.49 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.929 1.292 . . . . 0.0 109.184 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -122.89 140.85 34.12 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.792 0.837 . . . . 0.0 113.202 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -26.18 13.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.399 3.399 . . . . 0.0 114.445 -167.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -145.98 130.28 17.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 111.104 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.45 143.68 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.295 1.438 . . . . 0.0 109.613 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.1 m -123.03 142.58 50.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.392 1.077 . . . . 0.0 111.983 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.63 135.81 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.37 1.468 . . . . 0.0 110.825 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -119.08 4.61 11.34 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -160.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 34.38 96.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 129.467 3.107 . . . . 0.0 115.436 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -98.96 145.92 30.79 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.62 1.168 . . . . 0.0 113.459 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.27 -40.52 1.18 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.759 2.306 . . . . 0.0 117.354 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.6 165.75 13.91 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.891 2.394 . . . . 0.0 114.063 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.1 -24.93 6.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.971 1.708 . . . . 0.0 114.698 165.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.58 109.8 1.28 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.012 0.925 . . . . 0.0 110.349 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.4 p -119.47 169.59 9.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.302 1.441 . . . . 0.0 111.253 168.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -25.45 23.63 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -166.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -111.45 1.36 16.92 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.26 1.424 . . . . 0.0 114.717 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.29 -107.97 1.29 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.952 1.739 . . . . 0.0 111.125 -171.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.21 -35.09 3.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.39 105.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.4 3.08 . . . . 0.0 114.301 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.95 -31.67 18.54 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -63.04 -21.26 66.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.275 1.43 . . . . 0.0 113.862 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.15 -21.81 59.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.802 -1.186 . . . . 0.0 113.975 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -130.8 -166.45 1.69 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.986 1.314 . . . . 0.0 111.089 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 22.6 mtmm -69.47 105.47 2.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.028 -1.045 . . . . 0.0 109.702 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.08 -5.15 23.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.925 1.084 . . . . 0.0 113.925 170.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -118.27 -22.13 7.83 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.333 1.453 . . . . 0.0 113.268 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 41.5 mt-30 -116.64 100.52 53.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.072 1.349 . . . . 0.0 111.531 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.72 156.88 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.33 2.02 . . . . 0.0 112.618 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.72 -30.19 13.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 111.577 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -145.18 145.87 31.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.861 1.664 . . . . 0.0 110.182 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -136.41 152.92 51.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.384 165.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.14 -138.64 2.82 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.067 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -117.7 141.47 48.35 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.818 2.447 . . . . 0.0 109.764 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.67 133.98 39.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.536 0.734 . . . . 0.0 109.257 169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttp85 -138.0 97.81 3.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.043 0.925 . . . . 0.0 111.178 162.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.98 132.3 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.995 1.318 . . . . 0.0 108.798 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 p -133.16 172.56 12.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.129 1.372 . . . . 0.0 111.018 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 t -154.55 132.03 11.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.088 1.355 . . . . 0.0 112.1 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -91.79 25.23 2.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.124 1.77 . . . . 0.0 112.013 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.91 121.5 0.61 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.219 1.866 . . . . 0.0 112.166 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 57.9 -21.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.119 2.568 . . . . 0.0 116.836 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 m -110.63 111.7 23.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.827 0.851 . . . . 0.0 109.473 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 155.11 27.3 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.489 0.493 . . . . 0.0 109.76 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -134.19 115.74 14.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 mm -74.01 113.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -115.25 132.7 56.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.813 0.733 . . . . 0.0 110.251 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -113.85 130.75 56.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.107 1.363 . . . . 0.0 108.99 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -132.22 154.04 50.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.002 0.921 . . . . 0.0 112.32 -163.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.66 137.12 51.91 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.72 -1.238 . . . . 0.0 110.806 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -66.53 -8.54 27.34 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.923 1.289 . . . . 0.0 114.396 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.25 -39.22 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 126.322 1.849 . . . . 0.0 111.611 -171.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -128.7 -3.1 5.34 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.05 13.7 70.09 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 114.982 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.46 141.14 52.06 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.559 1.18 . . . . 0.0 111.353 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.07 124.78 25.7 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.647 -0.658 . . . . 0.0 112.208 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -85.87 -52.3 5.83 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 111.202 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.43 161.4 38.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.758 1.223 . . . . 0.0 112.1 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -140.93 137.76 33.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.805 0.842 . . . . 0.0 112.855 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.65 111.82 27.59 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.537 1.535 . . . . 0.0 111.494 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -70.98 126.91 12.97 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.526 2.817 . . . . 0.0 112.203 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 125.04 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.865 1.666 . . . . 0.0 109.927 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.61 -7.89 13.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.477 1.511 . . . . 0.0 113.024 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 146.62 18.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' CD1' HG13 ' A' ' 82' ' ' VAL . 4.6 t80 -135.21 122.13 14.8 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.804 1.242 . . . . 0.0 111.638 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.2 160.79 71.51 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.438 1.192 . . . . 0.0 113.28 -7.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -155.54 8.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.347 0.975 . . . . 0.0 113.206 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.65 -24.28 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.7 0.8 . . . . 0.0 112.232 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.37 -21.18 30.96 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.3 p -144.68 133.55 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.019 1.328 . . . . 0.0 110.305 164.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.31 150.19 38.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.391 1.477 . . . . 0.0 111.902 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 88.67 3.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.298 1.039 . . . . 0.0 108.556 173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.415 HG23 HG21 ' B' ' 155' ' ' VAL . 1.5 m 23.57 -73.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 129.727 3.211 . . . . 0.0 116.877 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 p -137.04 -52.1 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.14 1.376 . . . . 0.0 111.258 156.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.97 -61.18 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.658 ' HB3' HG23 ' B' ' 155' ' ' VAL . 11.4 t -52.36 136.49 31.14 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.47 1.129 . . . . 0.0 112.65 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.8 p -102.49 16.27 26.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.175 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttm105 -67.66 -26.75 66.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.257 2.223 . . . . 0.0 112.742 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -123.92 163.2 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.711 1.605 . . . . 0.0 112.767 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -141.19 171.35 14.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.159 1.383 . . . . 0.0 110.909 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.1 t -126.51 137.24 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 108.622 162.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.08 146.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.002 0.921 . . . . 0.0 110.158 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 116.85 29.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 166.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.05 160.72 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.122 1.769 . . . . 0.0 111.377 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -81.49 128.13 33.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 154.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.9 0.29 51.61 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -163.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.6 89.12 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.613 1.578 . . . . 0.0 115.211 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.3 p -118.6 8.23 11.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.487 1.515 . . . . 0.0 113.533 -173.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.91 12.85 54.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.148 1.356 . . . . 0.0 113.96 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -127.99 176.46 7.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.804 1.642 . . . . 0.0 112.815 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.1 m -118.25 155.34 30.74 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.369 1.068 . . . . 0.0 111.673 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.52 152.54 39.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.493 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -94.08 129.72 40.51 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.31 136.17 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 112.392 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.63 17.4 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.19 142.0 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.255 1.422 . . . . 0.0 109.387 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.19 136.39 8.49 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.104 1.335 . . . . 0.0 111.48 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -95.94 160.32 14.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 112.94 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -72.12 -23.76 61.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 112.678 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.55 138.11 47.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.719 1.608 . . . . 0.0 111.169 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -26.31 67.86 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.376 -0.827 . . . . 0.0 112.2 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.24 -34.45 69.41 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.502 1.049 . . . . 0.0 113.504 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.74 -35.06 79.21 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.051 1.426 . . . . 0.0 111.14 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.82 70.96 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.609 0.763 . . . . 0.0 112.962 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.48 -35.88 72.88 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.029 -1.669 . . . . 0.0 111.561 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.12 -28.88 60.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.0 0.92 . . . . 0.0 112.23 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.31 -43.82 95.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.643 0.656 . . . . 0.0 110.781 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.34 -52.12 63.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.88 0.872 . . . . 0.0 112.063 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.61 -33.81 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 121.32 -0.863 . . . . 0.0 112.43 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -56.4 -29.47 61.56 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 82' ' ' VAL . 70.7 mt -94.96 -34.64 12.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.508 1.123 . . . . 0.0 111.805 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -57.69 -55.8 30.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.76 0.709 . . . . 0.0 110.622 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.51 -14.1 61.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.716 1.607 . . . . 0.0 113.065 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -86.2 -32.79 21.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.438 1.095 . . . . 0.0 112.706 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -96.19 -20.26 18.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.279 0.945 . . . . 0.0 112.594 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -43.45 -35.66 1.69 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 129.054 2.941 . . . . 0.0 115.479 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -108.65 7.08 26.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.495 1.518 . . . . 0.0 114.716 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.63 -163.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 126.629 1.972 . . . . 0.0 110.258 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 60.78 16.87 7.13 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.475 1.91 . . . . 0.0 115.49 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 52.66 26.79 4.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.552 1.941 . . . . 0.0 114.425 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 124.379 1.071 . . . . 0.0 113.751 176.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.315 0.102 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -138.8 158.08 44.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.862 1.665 . . . . 0.0 111.692 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.14 132.67 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.489 1.516 . . . . 0.0 109.458 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -72.73 130.42 40.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.421 1.088 . . . . 0.0 112.334 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -95.03 44.26 1.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.749 1.22 . . . . 0.0 113.407 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -43.2 139.34 1.91 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.16 2.184 . . . . 0.0 114.4 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' SER . 4.1 p -61.34 118.1 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 109.406 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.605 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.68 -16.95 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.993 1.758 . . . . 0.0 114.158 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -73.4 -14.55 61.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.555 1.942 . . . . 0.0 114.678 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -146.56 -35.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.13 38.99 63.32 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.283 0.944 . . . . 0.0 113.893 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 -146.96 0.2 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.655 1.582 . . . . 0.0 113.51 -169.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -139.41 178.08 7.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -143.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.379 1.872 . . . . 0.0 113.503 175.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 51.0 p -73.58 155.14 89.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.731 1.213 . . . . 0.0 112.797 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.36 -20.89 20.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.053 2.502 . . . . 0.0 113.322 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -148.27 140.06 23.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.61 1.564 . . . . 0.0 110.986 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -74.63 -9.05 58.19 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -111.66 24.37 12.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.124 1.77 . . . . 0.0 112.999 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.02 135.82 57.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.454 1.121 . . . . 0.0 111.377 168.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.2 p -101.76 -12.08 18.62 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.72 162.66 29.12 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.24 90.52 4.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.601 1.16 . . . . 0.0 108.096 166.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 89.72 7.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.242 1.017 . . . . 0.0 110.328 -169.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -142.76 -176.67 4.97 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.878 1.271 . . . . 0.0 112.689 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.42 136.29 5.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.295 1.838 . . . . 0.0 108.541 163.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.5 m -102.99 131.56 49.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.591 1.556 . . . . 0.0 111.837 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.68 134.86 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.146 0.885 . . . . 0.0 111.833 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.3 mt -113.22 -42.7 3.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.595 1.958 . . . . 0.0 112.152 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.3 t -145.52 155.33 43.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.445 1.098 . . . . 0.0 112.608 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.69 130.57 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.23 1.812 . . . . 0.0 109.126 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -123.69 133.07 24.35 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.411 1.085 . . . . 0.0 110.411 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.79 -19.88 10.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.175 2.583 . . . . 0.0 114.512 -168.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.88 126.93 17.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.639 1.176 . . . . 0.0 111.4 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.7 148.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.438 1.495 . . . . 0.0 109.765 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.8 p -126.92 144.93 50.86 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.194 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.95 140.9 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.928 1.291 . . . . 0.0 111.228 -172.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -133.66 89.83 2.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.607 1.963 . . . . 0.0 108.382 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -58.62 140.03 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.454 -1.404 . . . . 0.0 111.876 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.73 143.28 44.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -165.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.38 -40.19 0.65 Allowed 'Trans proline' 0 CA--C 1.553 1.465 0 C-N-CA 122.925 2.417 . . . . 0.0 117.518 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.09 165.74 21.35 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.923 2.415 . . . . 0.0 113.884 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -116.29 -45.62 2.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.838 1.655 . . . . 0.0 113.592 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.2 100.78 2.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 112.221 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -93.77 162.06 14.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.943 1.297 . . . . 0.0 110.888 162.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -21.99 33.07 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 114.788 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -103.54 -7.93 20.46 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.186 1.395 . . . . 0.0 114.14 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.07 -107.92 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.662 1.601 . . . . 0.0 111.605 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.69 -31.9 3.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.15 110.96 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.245 3.018 . . . . 0.0 115.057 -171.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.96 -29.98 45.01 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.538 -1.351 . . . . 0.0 113.072 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -63.91 -18.18 63.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 114.102 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.54 -16.29 46.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.033 1.333 . . . . 0.0 113.298 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.1 -163.68 1.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.124 1.77 . . . . 0.0 110.03 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mtmm -73.77 110.32 7.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.761 -1.212 . . . . 0.0 109.963 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -101.1 -3.24 29.58 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -123.08 -21.04 5.56 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.719 1.608 . . . . 0.0 113.74 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -114.74 96.91 45.69 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.145 1.378 . . . . 0.0 111.285 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.9 147.63 50.05 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.374 2.049 . . . . 0.0 112.216 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -93.19 -25.62 17.75 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.5 1.52 . . . . 0.0 111.776 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -149.79 150.83 32.59 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 110.859 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.1 p -139.51 149.2 43.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.174 1.39 . . . . 0.0 111.473 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.46 -132.79 2.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.183 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -132.01 153.19 50.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.44 2.296 . . . . 0.0 110.926 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -110.01 139.36 45.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.879 1.271 . . . . 0.0 111.388 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.04 143.87 48.83 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.17 0.988 . . . . 0.0 109.76 153.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 mt -119.36 131.1 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 162.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -135.13 166.44 23.06 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.714 1.606 . . . . 0.0 109.243 -174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.3 p -156.49 146.19 20.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.648 1.567 . . . . 0.0 114.933 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -102.77 23.73 11.66 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.548 1.939 . . . . 0.0 112.346 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.23 120.91 0.51 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 126.19 1.853 . . . . 0.0 113.013 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm 55.81 -32.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 128.785 2.834 . . . . 0.0 116.49 -166.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -95.9 108.64 21.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 119.424 1.011 . . . . 0.0 110.236 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.4 157.06 20.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.114 162.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.43 110.56 10.61 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mm -69.28 121.46 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -106.6 135.64 47.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.213 1.405 . . . . 0.0 110.138 169.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.5 mt -114.28 126.66 55.28 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.475 0.71 . . . . 0.0 109.591 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.15 147.19 46.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.771 1.628 . . . . 0.0 112.124 -163.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.72 131.8 45.12 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.538 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -66.86 -12.43 59.16 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.409 1.084 . . . . 0.0 113.724 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.64 -38.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.957 1.703 . . . . 0.0 111.135 -173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.5 m -128.53 -2.96 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.28 70.81 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.314 0.959 . . . . 0.0 114.797 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.27 140.55 48.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.418 1.109 . . . . 0.0 111.768 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -74.59 120.03 19.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.072 0.549 . . . . 0.0 112.139 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -81.97 -49.76 9.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.915 1.686 . . . . 0.0 111.404 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.69 164.2 38.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.983 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -142.46 149.07 38.74 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 166.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.53 20.55 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.51 1.124 . . . . 0.0 111.081 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.19 134.66 13.06 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.207 2.605 . . . . 0.0 111.624 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.12 128.18 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.783 1.233 . . . . 0.0 112.042 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -109.99 -8.87 14.78 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.517 1.127 . . . . 0.0 113.195 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.32 143.31 16.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.931 1.692 . . . . 0.0 111.857 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HG13 ' A' ' 82' ' ' VAL . 9.4 t80 -132.13 132.42 23.03 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.203 1.801 . . . . 0.0 111.044 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -61.96 154.3 62.22 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 120.587 1.245 . . . . 0.0 112.468 -11.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.47 -167.59 27.36 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.76 0.695 . . . . 0.0 113.757 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.55 -22.59 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.717 -0.872 . . . . 0.0 111.406 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.43 -17.31 42.56 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 77' ' ' TYR . 2.6 p -162.6 121.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.921 1.289 . . . . 0.0 110.778 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.69 45.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.328 1.851 . . . . 0.0 111.503 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -103.22 90.03 3.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.148 0.979 . . . . 0.0 109.472 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 86' ' ' THR . 3.1 m 24.75 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 129.563 3.145 . . . . 0.0 116.805 160.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 85' ' ' VAL . 40.5 p -137.47 -46.63 0.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.935 1.294 . . . . 0.0 111.502 154.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -155.3 -55.61 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.691 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 21.0 t -51.25 120.6 5.16 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.982 0.81 . . . . 0.0 112.118 174.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.5 p -103.11 12.34 35.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -17.54 62.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.301 0.5 . . . . 0.0 112.087 161.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -119.18 158.04 26.76 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.11 1.764 . . . . 0.0 112.398 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.0 173.58 11.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.258 1.423 . . . . 0.0 109.996 167.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -128.56 131.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.09 1.356 . . . . 0.0 108.648 165.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.3 pt -125.99 140.94 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.267 1.027 . . . . 0.0 109.756 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.31 114.4 23.08 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.88 164.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.626 1.57 . . . . 0.0 111.633 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -89.2 140.35 29.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.457 144.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.35 -3.04 57.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 8.44 84.24 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.169 1.366 . . . . 0.0 115.094 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.0 p -119.95 18.69 12.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.552 1.541 . . . . 0.0 113.549 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.07 17.86 56.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.944 1.259 . . . . 0.0 113.838 -175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -134.21 171.23 14.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.258 1.823 . . . . 0.0 113.12 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.7 m -128.45 157.77 40.18 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.266 1.426 . . . . 0.0 112.136 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -151.19 151.95 32.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.127 1.371 . . . . 0.0 112.036 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.633 -0.667 . . . . 0.0 110.624 167.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.5 pt -125.72 140.57 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.859 0.864 . . . . 0.0 110.867 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.1 150.42 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 158.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -122.28 143.78 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.957 1.303 . . . . 0.0 107.89 171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.15 133.81 7.91 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.047 1.308 . . . . 0.0 111.133 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -92.76 163.21 13.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.181 0.991 . . . . 0.0 113.456 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.9 t -78.29 -24.19 46.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.492 1.117 . . . . 0.0 112.753 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -143.05 145.38 32.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.026 1.73 . . . . 0.0 111.334 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -61.11 -33.18 72.96 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.511 -0.743 . . . . 0.0 112.001 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.06 -35.66 64.46 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.539 1.066 . . . . 0.0 113.568 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -67.76 -34.37 76.67 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.435 1.118 . . . . 0.0 111.422 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.92 -36.71 72.78 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.509 -0.744 . . . . 0.0 112.925 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.77 -30.4 71.43 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.877 -1.139 . . . . 0.0 111.783 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -72.18 -37.18 69.35 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.278 -0.889 . . . . 0.0 111.771 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.59 -43.35 93.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.618 0.645 . . . . 0.0 111.135 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.66 -54.96 15.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.958 0.903 . . . . 0.0 112.946 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 t -66.96 -30.74 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.95 -1.094 . . . . 0.0 112.473 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.9 t -55.38 -36.55 66.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.68 0.673 . . . . 0.0 111.971 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HG11 ' A' ' 82' ' ' VAL . 74.0 mt -84.91 -37.92 20.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.943 0.897 . . . . 0.0 112.075 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -56.48 -49.64 74.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.021 1.282 . . . . 0.0 111.508 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.52 -8.99 58.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -85.88 -34.38 21.0 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.576 0.751 . . . . 0.0 111.763 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' HA ' HG23 ' A' ' 130' ' ' VAL . 63.4 m-85 -93.2 -12.23 30.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -26.84 68.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -101.63 4.06 40.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.157 1.383 . . . . 0.0 114.466 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -127.23 -167.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 127.163 2.185 . . . . 0.0 110.293 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 67.42 23.76 9.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 154.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 57.3 29.21 16.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.295 1.838 . . . . 0.0 115.446 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.182 1.393 . . . . 0.0 113.099 168.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -127.32 -39.93 1.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.173 1.789 . . . . 0.0 112.074 -175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 16.2 tt -67.75 169.98 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.273 1.429 . . . . 0.0 110.875 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 13.8 p -56.36 134.97 54.01 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.78 -1.2 . . . . 0.0 111.592 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.0 m -158.74 106.92 1.89 Allowed 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.536 1.134 . . . . 0.0 110.354 -150.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -47.67 118.7 2.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 88' ' ' SER . 5.1 t -51.02 129.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.239 1.416 . . . . 0.0 111.726 -157.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.691 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -166.54 -12.43 0.03 OUTLIER Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.873 2.654 . . . . 0.0 113.299 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -71.3 -20.63 62.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.994 2.117 . . . . 0.0 115.141 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 18.6 tt -135.92 -40.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 41.27 73.95 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.925 0.774 . . . . 0.0 113.842 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -105.09 0.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.028 2.131 . . . . 0.0 113.327 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -61.91 113.31 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.249 2.62 . . . . 0.0 111.294 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.498 2.719 . . . . 0.0 113.807 178.364 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.6 t -68.55 140.62 92.38 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.762 0.825 . . . . 0.0 112.07 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.85 -16.38 54.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.236 2.624 . . . . 0.0 114.345 170.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.45 -51.1 7.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.365 1.066 . . . . 0.0 112.178 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 40.6 t -160.89 160.29 30.77 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 111.421 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm -67.98 -24.69 65.17 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.585 0.754 . . . . 0.0 112.016 166.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.19 -19.64 31.41 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.716 1.206 . . . . 0.0 113.901 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.1 p -84.06 85.4 7.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.242 1.017 . . . . 0.0 110.844 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -130.71 150.18 52.01 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 111.723 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.284 0.4 OUTLIER -90.84 25.64 2.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.336 1.854 . . . . 0.0 114.609 -174.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -46.03 126.62 7.66 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.2 1.8 . . . . 0.0 113.624 -175.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -150.17 -178.93 6.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.675 1.19 . . . . 0.0 113.445 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -164.17 132.5 3.56 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.233 2.213 . . . . 0.0 108.87 159.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -78.65 167.74 20.79 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 0.0 111.402 170.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -112.01 139.36 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.026 1.285 . . . . 0.0 112.13 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.5 mt -126.82 -38.47 2.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.467 1.507 . . . . 0.0 113.466 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -144.46 148.82 35.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.876 0.87 . . . . 0.0 112.313 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.23 59.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.207 1.403 . . . . 0.0 111.236 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -65.33 126.49 91.54 Favored Pre-proline 0 CA--C 1.549 0.935 0 O-C-N 120.905 -1.122 . . . . 0.0 110.151 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.1 -14.28 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.311 2.674 . . . . 0.0 114.401 -166.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.24 131.56 36.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.682 1.193 . . . . 0.0 111.569 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.08 146.89 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.418 1.487 . . . . 0.0 109.942 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 p -119.78 151.61 38.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.305 1.042 . . . . 0.0 112.803 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.58 157.65 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -126.17 111.61 14.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.71 1.604 . . . . 0.0 109.902 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -65.25 115.77 5.9 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 119.987 -1.696 . . . . 0.0 109.069 163.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -104.4 145.52 30.83 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 113.135 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.04 -45.63 1.38 Allowed 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.778 2.319 . . . . 0.0 116.631 173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.02 158.56 18.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.737 2.291 . . . . 0.0 114.57 -172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -95.83 -40.56 9.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.853 2.061 . . . . 0.0 112.276 163.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.41 104.59 2.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.809 1.29 . . . . 0.0 109.954 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 t -100.53 177.6 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 112.841 -1.981 . . . . 0.0 111.266 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 122.98 19.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.16 0.984 . . . . 0.0 110.489 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.276 0.6 OUTLIER 61.16 24.75 14.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.998 2.119 . . . . 0.0 115.214 -173.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.6 -92.15 0.29 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.15 1.357 . . . . 0.0 113.956 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -142.93 -37.83 0.36 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.447 1.499 . . . . 0.0 113.507 -173.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.84 108.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.836 3.254 . . . . 0.0 114.685 -172.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.06 44.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.67 0.748 . . . . 0.0 112.475 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -49.88 -21.73 1.26 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 129.403 3.081 . . . . 0.0 116.385 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -87.79 -27.84 22.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.017 1.327 . . . . 0.0 113.702 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 2.4 p-90 -120.13 -148.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.674 1.589 . . . . 0.0 111.229 -174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 22.5 mtmm -77.63 68.72 3.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.039 1.736 . . . . 0.0 112.444 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -49.59 -31.12 9.92 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.423 2.689 . . . . 0.0 113.771 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.2 7.62 3.67 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.538 1.535 . . . . 0.0 114.927 -168.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -131.6 88.48 42.88 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.567 1.147 . . . . 0.0 112.021 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.77 147.51 44.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.072 2.514 . . . . 0.0 113.431 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.14 -31.35 13.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.668 1.187 . . . . 0.0 112.168 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.99 150.75 34.58 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.629 1.571 . . . . 0.0 110.309 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 p -137.46 152.04 49.14 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.295 1.438 . . . . 0.0 112.053 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.38 -135.29 2.85 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.459 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -118.21 140.47 49.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.355 2.262 . . . . 0.0 110.926 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.41 143.53 28.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -128.67 136.23 50.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.563 1.145 . . . . 0.0 109.549 154.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -119.58 123.99 72.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 164.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.8 p -127.43 168.42 14.9 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.647 1.579 . . . . 0.0 110.741 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 p -152.92 112.45 3.87 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -96.92 98.23 9.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.033 1.333 . . . . 0.0 110.049 164.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.78 -135.23 22.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.717 1.627 . . . . 0.0 112.521 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -65.82 -8.73 23.3 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.024 1.329 . . . . 0.0 114.254 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.2 m -100.91 127.54 47.34 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.698 0.799 . . . . 0.0 111.337 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.74 158.62 15.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.119 0.968 . . . . 0.0 110.394 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -137.95 118.65 14.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.572 1.149 . . . . 0.0 108.098 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.13 106.5 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -105.51 142.33 35.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.791 0.836 . . . . 0.0 110.038 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.88 130.01 53.03 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -123.08 149.25 44.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.636 1.174 . . . . 0.0 112.534 -169.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.39 131.71 44.51 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.753 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.59 -14.87 59.78 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.785 1.234 . . . . 0.0 113.633 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.98 -38.32 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.049 1.739 . . . . 0.0 111.18 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -128.16 -3.74 5.64 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 13.32 68.95 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.183 0.897 . . . . 0.0 114.772 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.48 139.08 49.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.394 1.097 . . . . 0.0 111.265 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -72.38 123.88 23.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.815 -0.553 . . . . 0.0 111.582 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -83.82 -52.68 6.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.405 1.482 . . . . 0.0 111.408 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.65 163.68 39.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.031 1.333 . . . . 0.0 111.522 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -138.32 138.98 38.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.946 0.899 . . . . 0.0 112.25 168.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.48 115.94 30.92 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 111.06 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.07 129.41 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.65 2.233 . . . . 0.0 110.631 170.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.89 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.552 1.941 . . . . 0.0 110.112 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.5 -8.19 11.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.33 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.58 149.28 11.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.183 2.193 . . . . 0.0 110.628 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.731 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.1 t80 -136.95 127.96 16.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.489 1.115 . . . . 0.0 111.693 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.97 154.34 69.48 Favored 'Cis proline' 0 C--N 1.354 0.86 0 CA-C-N 120.313 1.147 . . . . 0.0 112.876 -8.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.76 -166.12 27.3 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.892 0.758 . . . . 0.0 113.322 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -79.97 -25.4 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.574 -0.956 . . . . 0.0 111.436 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.9 -18.54 27.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 ' CD1' ' A' ' 77' ' ' TYR . 4.2 p -148.63 119.04 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.779 0.832 . . . . 0.0 109.79 159.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.43 150.67 50.68 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.754 1.622 . . . . 0.0 110.986 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -105.04 81.0 1.68 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.987 0.915 . . . . 0.0 109.267 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 86' ' ' THR . 2.5 m 31.71 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 129.332 3.053 . . . . 0.0 117.223 159.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.1 p -135.23 -49.59 0.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.38 1.072 . . . . 0.0 112.136 155.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.1 -71.61 0.17 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -168.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 10.7 t -46.76 136.28 8.15 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 76.5 p -105.89 35.21 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.823 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttm105 -70.74 -31.74 68.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.697 1.199 . . . . 0.0 111.736 156.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -124.54 162.21 24.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.974 1.71 . . . . 0.0 112.264 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -143.14 176.14 9.34 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.189 1.396 . . . . 0.0 111.159 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.87 136.44 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.89 1.676 . . . . 0.0 109.197 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.78 151.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.214 . . . . 0.0 111.575 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.88 110.37 22.89 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.645 1.178 . . . . 0.0 110.919 173.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.3 pt -103.29 165.03 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 124.933 1.293 . . . . 0.0 111.924 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.19 129.9 35.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 149.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.09 1.14 29.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.121 1.369 . . . . 0.0 113.503 -167.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.68 13.0 65.77 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.382 1.467 . . . . 0.0 114.824 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.25 6.4 t -136.52 22.91 3.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.643 1.177 . . . . 0.0 113.551 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 22.86 50.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.9 1.238 . . . . 0.0 113.262 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -139.52 146.42 39.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.698 1.599 . . . . 0.0 112.029 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -92.63 154.41 18.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.104 0.865 . . . . 0.0 112.156 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.24 153.91 40.37 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.238 1.415 . . . . 0.0 112.224 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -100.16 130.78 46.33 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.18 0.592 . . . . 0.0 110.624 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 pt -125.1 139.32 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.074 0.949 . . . . 0.0 110.232 168.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.22 161.05 50.5 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 158.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.22 144.37 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.682 1.193 . . . . 0.0 108.759 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.06 135.5 8.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.361 0.981 . . . . 0.0 112.258 166.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 162.21 13.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 111.882 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -76.44 -16.38 59.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 0.0 113.039 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -137.74 145.57 42.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 112.84 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -56.25 -37.85 70.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.344 1.458 . . . . 0.0 112.287 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -29.08 62.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.941 1.258 . . . . 0.0 113.813 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -72.61 -38.02 67.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.494 1.147 . . . . 0.0 111.701 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.84 -40.19 79.53 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -60.72 -27.75 68.15 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.306 -1.496 . . . . 0.0 113.033 174.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.11 -32.24 61.35 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.591 -1.318 . . . . 0.0 111.688 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.07 -32.96 73.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.678 0.791 . . . . 0.0 111.561 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -68.23 -56.95 6.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.581 -0.699 . . . . 0.0 111.476 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.14 -35.28 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.793 -1.192 . . . . 0.0 113.018 -171.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 p -64.49 -15.86 61.5 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 HG11 ' A' ' 82' ' ' VAL . 82.6 mt -100.72 -34.9 9.66 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.113 1.365 . . . . 0.0 112.395 171.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -57.63 -49.91 74.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.43 1.014 . . . . 0.0 110.426 172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.55 -9.62 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.095 0.958 . . . . 0.0 113.26 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -83.36 -38.41 22.05 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.524 -0.735 . . . . 0.0 112.121 170.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.407 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -92.65 -19.75 21.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.28 0.945 . . . . 0.0 112.786 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -45.78 -32.02 2.33 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.64 3.176 . . . . 0.0 116.116 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.8 5.87 26.97 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -128.79 -155.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.571 2.348 . . . . 0.0 109.061 178.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.6 tptp 59.24 21.49 9.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.054 1.742 . . . . 0.0 114.911 174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 53.67 28.12 7.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.401 1.88 . . . . 0.0 114.477 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.414 1.086 . . . . 0.0 113.791 176.753 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.85 169.85 17.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.952 1.301 . . . . 0.0 112.523 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 77.9 mt -75.82 140.69 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 109.334 166.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.5 p -84.83 174.1 10.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.049 1.739 . . . . 0.0 113.042 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 16.4 m -75.93 44.19 0.3 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.456 1.902 . . . . 0.0 114.897 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.71 162.48 1.19 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 130.097 3.359 . . . . 0.0 114.435 -174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 88' ' ' SER . 1.8 t -56.91 118.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.539 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.33 -21.58 0.04 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.53 2.014 . . . . 0.0 112.998 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -72.2 -11.38 60.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.483 2.313 . . . . 0.0 114.605 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.25 -59.58 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.355 1.462 . . . . 0.0 110.805 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.76 35.2 19.93 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.961 1.267 . . . . 0.0 114.345 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.33 -156.7 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.35 1.86 . . . . 0.0 114.675 -169.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -135.88 -154.09 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.257 1.823 . . . . 0.0 111.76 -139.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 7.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.27 1.828 . . . . 0.0 113.164 171.504 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.9 m -67.37 148.89 98.64 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.371 1.068 . . . . 0.0 112.929 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.04 161.6 45.51 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.49 2.793 . . . . 0.0 112.775 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -73.09 163.88 27.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.212 1.005 . . . . 0.0 111.68 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 39.6 t -62.46 144.44 55.92 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.183 0.993 . . . . 0.0 112.282 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.46 0.53 45.88 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.733 1.213 . . . . 0.0 113.316 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.17 14.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.413 1.485 . . . . 0.0 114.873 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.1 p -76.2 -15.59 60.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.21 1.404 . . . . 0.0 113.676 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.63 150.64 20.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.098 1.759 . . . . 0.0 111.131 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.27 -46.71 89.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 40.82 45.27 2.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.276 2.23 . . . . 0.0 113.266 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -77.15 172.84 12.6 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -167.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -165.68 122.44 1.42 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.941 1.696 . . . . 0.0 108.735 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.4 m -87.81 125.13 34.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.216 1.406 . . . . 0.0 111.224 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.14 133.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.992 0.814 . . . . 0.0 112.464 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.59 -43.37 3.32 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.661 1.584 . . . . 0.0 111.935 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.0 152.23 35.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.983 0.897 . . . . 0.0 113.313 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.31 130.3 24.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.781 2.032 . . . . 0.0 108.159 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -126.01 138.77 32.79 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.509 0.724 . . . . 0.0 112.744 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.83 -26.68 18.76 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.566 3.51 . . . . 0.0 114.282 -166.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.25 133.01 23.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.245 . . . . 0.0 110.997 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 139.6 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.444 1.497 . . . . 0.0 109.213 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.3 m -122.68 141.42 51.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.316 1.046 . . . . 0.0 111.917 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.27 131.79 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.273 1.429 . . . . 0.0 111.029 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -114.4 -0.71 13.71 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -161.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 43.34 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 129.461 3.105 . . . . 0.0 115.281 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -103.88 144.34 28.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -78.82 -39.82 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.501 0 C-N-CA 122.931 2.421 . . . . 0.0 117.877 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.01 171.44 10.44 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.97 2.446 . . . . 0.0 113.839 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -123.83 -50.43 1.83 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.175 1.79 . . . . 0.0 113.556 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.64 107.81 4.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 122.318 1.056 . . . . 0.0 112.593 -167.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.6 p -106.66 169.26 8.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.405 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -16.44 59.07 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -103.13 -16.86 15.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.793 1.237 . . . . 0.0 113.439 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.09 -111.61 1.39 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.576 1.56 . . . . 0.0 111.591 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -117.73 -31.64 5.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.77 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 129.37 3.068 . . . . 0.0 114.893 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.66 46.12 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.96 -1.087 . . . . 0.0 112.677 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 m -59.86 -17.21 34.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.566 2.346 . . . . 0.0 114.846 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.79 -19.74 32.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.391 1.476 . . . . 0.0 113.217 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -129.83 -161.88 1.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.747 1.619 . . . . 0.0 110.699 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' GLN . 24.5 mtmm -72.82 106.3 4.72 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.905 -1.122 . . . . 0.0 109.877 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.56 -4.92 27.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -118.59 -22.54 7.46 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.558 1.543 . . . . 0.0 113.466 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 42.1 mt-30 -119.75 100.59 48.82 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 111.72 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.9 157.55 27.35 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.285 1.99 . . . . 0.0 112.14 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.22 -19.46 14.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.423 . . . . 0.0 112.449 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -145.68 144.64 30.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.816 1.646 . . . . 0.0 110.247 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -137.07 154.3 50.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.796 0.839 . . . . 0.0 111.727 165.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 -137.92 2.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.804 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -125.06 143.08 51.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.396 2.278 . . . . 0.0 110.099 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.42 142.31 27.81 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.643 0.777 . . . . 0.0 110.683 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -139.58 110.34 6.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.326 1.051 . . . . 0.0 110.153 166.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -101.22 125.8 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -131.7 170.17 15.16 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.093 1.357 . . . . 0.0 110.605 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.4 p -152.51 121.46 6.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -95.81 63.57 2.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.217 1.407 . . . . 0.0 109.983 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.33 -134.58 12.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.083 1.802 . . . . 0.0 112.348 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -68.59 -4.23 14.61 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.572 1.549 . . . . 0.0 114.417 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.6 m -101.79 117.15 34.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.614 1.166 . . . . 0.0 110.602 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.14 163.85 15.27 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.542 0.687 . . . . 0.0 110.69 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.46 109.39 8.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.884 1.674 . . . . 0.0 106.976 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 123' ' ' LEU . 23.3 mm -78.09 107.65 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -112.34 148.71 33.66 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.708 0.766 . . . . 0.0 111.563 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.76 130.61 50.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.965 1.306 . . . . 0.0 108.858 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -127.35 151.85 48.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 111.649 -166.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.18 134.96 49.93 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 120.839 -1.163 . . . . 0.0 110.366 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -63.94 -14.54 54.52 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.88 -39.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.103 1.761 . . . . 0.0 111.314 -171.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -127.7 -3.27 5.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.09 71.92 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.031 0.824 . . . . 0.0 114.825 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.35 141.11 50.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.494 1.147 . . . . 0.0 111.558 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -70.59 123.37 21.68 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.702 -0.624 . . . . 0.0 112.153 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -85.88 -52.37 5.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.183 1.393 . . . . 0.0 111.127 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.22 161.99 39.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.09 136.73 28.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.532 1.133 . . . . 0.0 112.671 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.71 113.25 27.14 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.755 1.622 . . . . 0.0 111.502 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.93 136.36 14.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.277 2.652 . . . . 0.0 112.177 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.56 130.83 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.141 1.377 . . . . 0.0 113.057 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -112.57 -3.12 14.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.554 1.142 . . . . 0.0 113.061 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.38 140.72 14.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.819 1.648 . . . . 0.0 111.717 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.585 ' CD1' HG13 ' A' ' 82' ' ' VAL . 14.8 t80 -131.65 127.67 21.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.217 1.007 . . . . 0.0 112.798 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.85 157.42 44.45 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.846 0.981 . . . . 0.0 113.824 -10.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.44 -169.99 31.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.035 0.826 . . . . 0.0 113.215 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -76.95 -23.55 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 121.512 -0.993 . . . . 0.0 111.404 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.8 47.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.4 p -162.23 117.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.965 1.306 . . . . 0.0 110.31 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.29 149.96 50.95 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.407 1.883 . . . . 0.0 111.113 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -95.32 97.17 9.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' THR . 1.7 m 13.64 -73.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.108 2.963 . . . . 0.0 116.039 158.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 85' ' ' VAL . 4.6 p -138.06 -54.94 0.65 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.523 . . . . 0.0 109.931 156.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -152.1 -61.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -59.87 101.7 0.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.255 1.843 . . . . 0.0 114.16 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 p -80.77 50.34 1.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.511 1.524 . . . . 0.0 114.051 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -78.39 -23.77 46.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.828 -0.545 . . . . 0.0 110.789 146.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -119.38 159.89 23.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.321 1.449 . . . . 0.0 113.181 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -145.6 173.41 12.08 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.549 1.54 . . . . 0.0 110.917 170.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.1 t -128.97 132.64 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.82 1.248 . . . . 0.0 109.044 164.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.06 144.82 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.159 0.984 . . . . 0.0 110.032 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.77 112.75 24.47 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.851 -0.53 . . . . 0.0 109.872 169.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 pt -96.38 156.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 111.508 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -84.7 141.02 30.88 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.016 0.926 . . . . 0.0 110.721 164.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.64 -5.04 59.29 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 165.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 0.03 88.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.402 1.477 . . . . 0.0 115.19 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -109.24 12.14 25.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.306 1.442 . . . . 0.0 113.14 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.11 52.3 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.341 1.448 . . . . 0.0 113.79 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -132.5 152.71 51.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.964 1.706 . . . . 0.0 112.941 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.9 m -124.42 157.21 35.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.393 1.077 . . . . 0.0 113.345 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.76 152.82 49.57 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.144 1.778 . . . . 0.0 111.628 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -102.29 126.63 49.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.751 0.82 . . . . 0.0 110.307 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.07 136.08 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.849 0.859 . . . . 0.0 112.309 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.66 137.03 15.22 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -114.79 146.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.446 1.498 . . . . 0.0 109.136 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.49 138.77 9.73 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.042 1.306 . . . . 0.0 111.35 163.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.39 151.8 19.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.925 -0.75 . . . . 0.0 112.445 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -70.76 -26.42 63.35 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.914 0.886 . . . . 0.0 112.308 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -116.56 133.95 55.41 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.373 1.469 . . . . 0.0 111.366 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -34.82 74.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.417 1.087 . . . . 0.0 111.559 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.47 71.54 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.557 1.075 . . . . 0.0 113.671 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.79 -37.02 73.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.817 1.308 . . . . 0.0 111.735 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.52 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -61.6 -31.82 71.9 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.546 -1.347 . . . . 0.0 111.97 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -73.15 -34.57 66.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 0.0 111.953 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.16 -40.53 81.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.449 1.022 . . . . 0.0 110.953 170.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.05 -54.39 30.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.191 0.996 . . . . 0.0 112.631 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.03 -31.88 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 120.996 -1.065 . . . . 0.0 112.21 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -60.25 -23.07 63.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.051 0.941 . . . . 0.0 113.225 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 82' ' ' VAL . 71.0 mt -98.94 -35.52 10.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.95 1.3 . . . . 0.0 111.857 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -55.53 -50.56 69.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.647 1.112 . . . . 0.0 110.721 171.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.21 -4.33 44.18 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -87.55 -37.64 16.69 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 111.731 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 74.5 m-85 -91.59 -16.12 27.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -23.78 67.53 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -103.91 4.44 34.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.364 1.466 . . . . 0.0 113.74 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -129.01 -158.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 128.206 2.603 . . . . 0.0 108.538 176.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp 64.83 4.33 2.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 165.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 53.9 29.52 10.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.021 2.129 . . . . 0.0 114.599 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.004 1.722 . . . . 0.0 112.806 -176.908 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -71.02 140.15 50.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.097 0.959 . . . . 0.0 111.762 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 76.3 mt -85.96 134.91 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.646 1.179 . . . . 0.0 109.819 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 19.7 p -82.01 153.29 26.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.324 1.45 . . . . 0.0 113.067 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -78.84 49.66 0.93 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.66 1.584 . . . . 0.0 113.024 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -45.77 144.28 1.77 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.467 2.707 . . . . 0.0 114.949 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.87 142.13 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 166.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.467 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -131.42 7.06 5.63 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 114.732 -1.122 . . . . 0.0 114.287 -171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -150.62 -40.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -168.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.467 HG22 HG21 ' B' ' 156' ' ' TPO . 18.4 tt -90.65 -33.98 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -163.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.13 39.37 92.68 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 123.884 0.754 . . . . 0.0 113.472 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.67 -161.43 0.86 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 114.628 -165.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -138.77 -176.31 4.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -135.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 128.85 2.86 . . . . 0.0 114.826 -178.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 p -74.14 152.74 88.42 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.727 1.211 . . . . 0.0 112.921 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 152.97 62.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 112.698 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -78.61 153.91 30.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.235 1.014 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.7 t -153.81 147.22 24.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.389 1.476 . . . . 0.0 111.346 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -62.35 -18.56 61.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.419 1.088 . . . . 0.0 112.796 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.83 -1.04 29.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.87 1.268 . . . . 0.0 114.282 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -73.53 -9.88 59.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -142.73 167.36 22.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.19 1.396 . . . . 0.0 112.437 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.0 mt -82.63 52.25 2.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 112.037 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.53 31.63 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.973 1.309 . . . . 0.0 114.278 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -100.23 179.56 4.44 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -164.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.77 132.65 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.036 2.134 . . . . 0.0 108.399 163.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.1 m -103.44 129.74 50.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.16 1.384 . . . . 0.0 111.563 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.58 135.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.074 -1.016 . . . . 0.0 111.458 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.93 -43.59 3.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.305 1.842 . . . . 0.0 111.562 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.1 t -143.14 150.96 40.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.005 1.322 . . . . 0.0 111.269 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 p -148.11 125.54 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.674 1.59 . . . . 0.0 108.228 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.88 139.74 33.06 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.81 -28.86 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.658 3.572 . . . . 0.0 114.561 -166.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.14 122.94 10.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.621 1.168 . . . . 0.0 110.571 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.05 145.68 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.93 1.692 . . . . 0.0 108.834 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.5 m -126.8 140.75 52.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.939 0.896 . . . . 0.0 111.689 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.03 132.18 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.243 1.417 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.43 -18.7 13.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 56.06 146.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.227 3.011 . . . . 0.0 114.382 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 138.85 31.6 Favored Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.74 -39.08 1.46 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.754 2.303 . . . . 0.0 116.835 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.61 155.45 24.28 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.555 2.17 . . . . 0.0 113.557 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -99.33 -25.96 14.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.557 1.543 . . . . 0.0 114.16 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.81 102.82 0.79 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.895 1.278 . . . . 0.0 109.885 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -89.84 162.57 15.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.338 1.055 . . . . 0.0 111.479 170.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.05 -21.94 14.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.356 2.262 . . . . 0.0 116.038 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -115.99 -0.18 12.86 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.463 1.505 . . . . 0.0 114.172 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.47 -93.96 0.3 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.789 1.662 . . . . 0.0 110.685 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -135.3 -34.34 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.44 107.04 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.674 3.19 . . . . 0.0 114.422 -173.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.38 33.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 t -72.3 -14.03 61.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.098 1.359 . . . . 0.0 114.291 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.78 -38.77 53.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.555 1.071 . . . . 0.0 112.75 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -106.41 -160.89 0.76 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.837 2.055 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.41 102.2 1.38 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.824 1.297 . . . . 0.0 111.251 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -78.33 -34.72 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.755 2.422 . . . . 0.0 112.127 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.43 8.07 3.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.744 1.218 . . . . 0.0 113.92 -167.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.27 88.27 54.39 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.108 1.363 . . . . 0.0 111.638 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.21 153.48 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.713 2.275 . . . . 0.0 112.231 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.95 -29.3 11.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.833 1.253 . . . . 0.0 112.475 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -137.31 146.57 44.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.539 1.536 . . . . 0.0 110.515 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -137.13 154.16 50.33 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 111.826 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.06 -138.77 2.95 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.937 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -125.17 142.5 51.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.223 2.209 . . . . 0.0 110.222 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.06 139.42 30.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.119 0.968 . . . . 0.0 111.001 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -125.0 137.51 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.846 1.258 . . . . 0.0 109.71 154.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.84 120.48 62.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.0 p -125.22 170.04 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.88 1.272 . . . . 0.0 109.733 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -152.11 126.4 9.29 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.607 1.163 . . . . 0.0 112.199 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -91.63 26.74 2.23 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.386 1.474 . . . . 0.0 112.077 168.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.53 118.71 0.3 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.192 1.853 . . . . 0.0 112.198 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? 58.1 -3.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.057 2.143 . . . . 0.0 116.459 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 m -125.26 114.67 19.26 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.747 1.619 . . . . 0.0 108.875 166.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.89 155.89 19.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.062 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -132.49 117.4 17.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.25 107.64 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -114.99 137.45 51.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.782 0.833 . . . . 0.0 111.344 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.3 mt -116.02 131.72 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.003 0.921 . . . . 0.0 109.921 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -123.99 151.39 43.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.922 1.289 . . . . 0.0 112.283 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.06 135.35 50.67 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.959 -1.088 . . . . 0.0 110.194 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -63.39 -15.65 58.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 113.944 -173.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.61 -38.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 111.399 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -126.85 -3.2 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.3 12.19 72.29 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.953 0.787 . . . . 0.0 114.919 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -71.54 139.82 49.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.458 1.129 . . . . 0.0 111.694 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.2 121.29 17.27 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.714 -0.616 . . . . 0.0 111.855 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -83.83 -52.8 6.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.407 1.483 . . . . 0.0 111.21 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.46 39.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 112.168 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -142.88 136.6 28.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.356 1.062 . . . . 0.0 112.508 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.61 118.23 28.64 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.045 1.738 . . . . 0.0 111.143 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.89 125.14 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.377 2.718 . . . . 0.0 111.619 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.6 122.48 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.217 1.807 . . . . 0.0 110.119 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -122.47 3.28 9.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.212 1.405 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.49 145.38 21.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.206 1.802 . . . . 0.0 109.762 171.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -132.87 130.79 21.68 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.752 0.821 . . . . 0.0 113.168 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -65.2 164.14 60.78 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.16 0.736 . . . . 0.0 111.34 -15.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.88 -156.17 8.42 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.445 -0.785 . . . . 0.0 113.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.44 -27.19 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.875 -0.779 . . . . 0.0 111.471 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.89 42.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.533 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.02 130.03 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.363 1.065 . . . . 0.0 109.902 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.78 154.62 42.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.344 1.458 . . . . 0.0 112.113 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -109.21 80.23 1.3 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 109.432 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 HG21 ' B' ' 155' ' ' VAL . 2.5 m 34.11 -74.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.039 2.936 . . . . 0.0 117.334 157.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 p -138.83 -47.85 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.834 1.253 . . . . 0.0 111.954 157.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.02 -57.24 0.14 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.665 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 7.9 t -56.68 134.56 54.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.762 1.267 . . . . 0.0 112.915 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.3 p -98.06 8.64 44.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.997 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.2 ttm105 -59.34 -24.82 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 164.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -128.67 162.97 26.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.144 1.778 . . . . 0.0 112.215 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -143.0 171.65 13.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.578 1.551 . . . . 0.0 110.506 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.3 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 108.664 163.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.4 pt -127.82 149.5 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.741 . . . . 0.0 111.211 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 102.98 14.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.764 1.226 . . . . 0.0 108.897 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 pt -88.68 165.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.949 1.299 . . . . 0.0 111.474 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -90.82 146.44 23.94 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.169 -0.332 . . . . 0.0 111.517 152.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.89 -2.88 58.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.89 89.8 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.122 1.344 . . . . 0.0 115.261 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -113.16 13.48 19.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.635 1.574 . . . . 0.0 113.355 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.7 14.01 53.84 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.356 1.455 . . . . 0.0 113.969 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -132.44 172.25 12.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.854 1.662 . . . . 0.0 113.537 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -120.27 158.67 26.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.97 1.708 . . . . 0.0 113.187 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.97 149.56 32.4 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.037 1.335 . . . . 0.0 112.064 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -95.34 133.29 39.43 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.555 0.742 . . . . 0.0 110.475 169.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.7 pt -128.86 140.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 112.464 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 135.53 13.02 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.929 1.252 . . . . 0.0 110.765 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -112.55 143.44 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.462 1.505 . . . . 0.0 109.272 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.03 139.11 10.66 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.31 1.433 . . . . 0.0 111.482 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -96.34 163.27 13.14 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.2 t -69.76 -29.46 66.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.628 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.67 141.02 26.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.002 1.721 . . . . 0.0 110.374 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -27.18 68.04 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.37 -0.831 . . . . 0.0 112.244 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.26 -30.69 64.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.587 1.089 . . . . 0.0 113.776 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.5 -33.44 66.94 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.722 1.261 . . . . 0.0 111.403 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.16 -37.0 72.22 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.14 0.976 . . . . 0.0 113.144 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.94 -30.18 67.68 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.612 -1.305 . . . . 0.0 111.66 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.26 -21.03 36.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.435 1.094 . . . . 0.0 112.509 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.53 -39.99 92.41 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.945 . . . . 0.0 110.897 165.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -37.47 20.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.25 -30.3 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.531 1.06 . . . . 0.0 112.116 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.6 p -61.75 -25.67 67.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.767 0.712 . . . . 0.0 112.912 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -86.89 -41.56 13.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.309 1.044 . . . . 0.0 112.331 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.13 -51.27 64.8 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.047 0.84 . . . . 0.0 110.897 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.5 -7.06 54.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.322 1.049 . . . . 0.0 113.691 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -84.68 -39.23 18.81 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.396 -0.815 . . . . 0.0 111.533 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -88.76 -16.23 32.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -27.14 65.16 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -104.67 5.11 33.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.143 1.377 . . . . 0.0 114.055 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -166.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.816 2.046 . . . . 0.0 110.964 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 tptt 61.37 14.68 5.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.674 1.99 . . . . 0.0 115.325 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.46 25.37 6.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.235 2.214 . . . . 0.0 114.543 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 172.851 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 62.82 -43.17 0.19 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.065 2.946 . . . . 0.0 116.394 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 59.5 mt -129.19 134.7 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.073 1.749 . . . . 0.0 109.492 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.0 p -99.01 166.31 11.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.699 1.6 . . . . 0.0 112.586 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -80.54 45.62 0.79 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.2 1.4 . . . . 0.0 114.709 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -51.46 145.72 8.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.809 2.044 . . . . 0.0 112.554 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.7 p -60.24 124.94 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.627 0.727 . . . . 0.0 109.397 170.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.665 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.88 -31.59 0.02 OUTLIER Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.311 1.434 . . . . 0.0 113.72 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -75.3 -19.11 59.85 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 mm -90.42 -52.33 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.391 1.077 . . . . 0.0 110.589 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.02 54.41 6.41 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.827 1.204 . . . . 0.0 112.65 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.64 -159.93 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.846 1.658 . . . . 0.0 111.392 -171.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.257 34.5 mmt180 52.92 60.6 3.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.095 1.758 . . . . 0.0 114.045 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 127.761 2.424 . . . . 0.0 114.618 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 41.6 m -66.79 149.09 98.57 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.459 1.103 . . . . 0.0 112.95 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.03 156.76 61.87 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.213 2.608 . . . . 0.0 112.562 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -79.72 -10.24 59.76 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 91.4 p -143.01 161.58 37.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.354 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp -83.92 41.84 0.83 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.464 1.506 . . . . 0.0 112.862 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.73 -16.38 60.96 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.0 p -88.02 -11.52 47.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.836 1.655 . . . . 0.0 114.07 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -95.52 158.08 15.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.9 1.68 . . . . 0.0 112.678 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.73 38.29 0.1 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.51 2.324 . . . . 0.0 112.534 172.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -69.44 135.34 50.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.683 1.593 . . . . 0.0 111.239 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -151.54 178.56 9.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.311 1.044 . . . . 0.0 113.158 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.57 133.18 4.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.176 2.19 . . . . 0.0 108.873 169.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -95.46 131.9 41.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.809 1.644 . . . . 0.0 111.133 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.38 134.59 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.036 -1.04 . . . . 0.0 111.879 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.13 -43.73 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.201 1.8 . . . . 0.0 111.745 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 t -146.02 154.84 42.33 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.578 1.151 . . . . 0.0 112.698 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.59 131.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.475 1.91 . . . . 0.0 109.005 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -124.58 139.0 32.18 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.537 0.735 . . . . 0.0 112.976 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.36 -28.28 8.72 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.123 3.215 . . . . 0.0 114.671 -163.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -143.28 132.11 22.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.865 1.266 . . . . 0.0 111.016 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.52 140.22 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.049 1.34 . . . . 0.0 109.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -117.12 144.46 44.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.794 1.237 . . . . 0.0 112.262 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.05 135.93 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.088 1.355 . . . . 0.0 111.377 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -106.51 -8.35 17.1 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -167.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 41.81 79.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 127.278 2.231 . . . . 0.0 113.944 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 pt -81.78 149.19 63.27 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.875 1.67 . . . . 0.0 113.813 -164.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.43 -47.24 0.76 Allowed 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.744 2.296 . . . . 0.0 116.621 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.42 158.48 14.72 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.948 2.432 . . . . 0.0 114.067 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -102.09 -23.25 14.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.07 105.35 0.9 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.26 1.024 . . . . 0.0 110.037 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 t -90.59 163.14 14.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 111.194 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -31.39 9.64 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.9 2.08 . . . . 0.0 115.23 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -128.41 84.9 2.28 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.788 1.635 . . . . 0.0 108.259 167.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.58 -93.69 0.1 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.943 1.735 . . . . 0.0 113.677 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.69 -33.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.79 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 129.292 3.037 . . . . 0.0 114.742 -164.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.0 -33.91 53.84 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.825 -1.172 . . . . 0.0 112.406 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 m -58.97 -18.65 35.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.659 2.384 . . . . 0.0 115.002 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -84.6 -20.15 31.89 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.204 1.402 . . . . 0.0 113.152 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -131.74 -159.92 1.0 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.96 1.704 . . . . 0.0 110.696 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -71.43 102.92 2.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 111.181 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 pp -99.14 -2.6 36.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.68 -4.21 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.455 1.502 . . . . 0.0 113.603 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -130.09 83.75 62.39 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.804 1.242 . . . . 0.0 112.394 -163.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.23 145.79 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.114 2.543 . . . . 0.0 114.045 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.81 -24.93 14.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.144 0.977 . . . . 0.0 112.107 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 t90 -144.78 148.06 33.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.257 1.823 . . . . 0.0 110.358 173.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.2 p -137.06 153.68 50.54 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.758 0.79 . . . . 0.0 111.58 163.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.48 -136.47 2.16 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.236 0.922 . . . . 0.0 111.581 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -129.15 149.12 51.1 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.049 2.139 . . . . 0.0 110.62 -171.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.52 135.23 45.5 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 111.288 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.68 139.53 51.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.103 153.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -119.63 134.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.7 p -141.6 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 109.315 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t -154.22 138.1 16.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.055 1.342 . . . . 0.0 112.626 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -97.37 -5.17 37.01 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.251 1.82 . . . . 0.0 112.95 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.43 -119.1 0.86 Allowed Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.66 -1.275 . . . . 0.0 112.621 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.22 -1.92 14.24 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.178 0.991 . . . . 0.0 112.962 164.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.79 114.81 24.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -176.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.56 154.85 18.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.418 0.687 . . . . 0.0 110.317 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -129.37 117.91 21.37 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.4 mm -79.81 108.59 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 172.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -103.76 118.81 37.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.018 1.327 . . . . 0.0 108.938 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.0 132.12 46.56 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.097 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.61 150.21 51.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.225 -164.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.34 137.37 48.4 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.819 -1.176 . . . . 0.0 110.816 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -65.81 -13.71 60.01 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.79 -39.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.107 1.763 . . . . 0.0 111.348 -171.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.4 m -129.52 -2.91 4.86 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 11.98 69.29 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.953 0.787 . . . . 0.0 114.832 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.43 143.2 51.89 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.48 1.14 . . . . 0.0 111.434 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -71.8 120.68 17.74 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.625 -0.672 . . . . 0.0 112.017 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.09 -50.92 9.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.77 163.85 37.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.169 1.387 . . . . 0.0 111.207 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.04 137.66 34.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.542 0.737 . . . . 0.0 111.856 169.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.35 118.47 32.44 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.169 0.988 . . . . 0.0 111.521 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.04 129.89 9.12 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.333 2.689 . . . . 0.0 111.197 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.496 HG12 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.272 1.429 . . . . 0.0 111.159 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.08 7.49 9.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.46 148.73 23.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.567 1.947 . . . . 0.0 109.679 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -137.21 130.7 17.39 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.167 0.987 . . . . 0.0 113.22 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.56 165.62 28.39 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-N 119.021 0.686 . . . . 0.0 112.421 -18.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.17 -156.72 8.56 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.512 -0.742 . . . . 0.0 114.217 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -80.76 -29.6 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 122.063 -0.669 . . . . 0.0 110.743 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -80.78 -22.42 40.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.459 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.93 127.1 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.769 1.228 . . . . 0.0 109.174 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.88 149.3 40.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.61 1.564 . . . . 0.0 111.578 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -98.96 82.83 2.81 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.825 0.85 . . . . 0.0 109.303 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 155' ' ' VAL . 3.1 m 33.89 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.378 2.671 . . . . 0.0 116.723 154.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 p -134.93 -47.75 0.73 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.032 1.333 . . . . 0.0 111.375 151.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -155.73 -60.01 0.1 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.428 ' HB2' HG23 ' B' ' 155' ' ' VAL . 14.5 m -60.47 107.09 0.62 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.061 0.934 . . . . 0.0 113.276 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.4 p -88.04 46.24 1.36 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -83.68 -23.94 31.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.377 0.671 . . . . 0.0 111.273 152.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -116.2 158.75 22.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.791 1.236 . . . . 0.0 112.762 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -143.22 173.72 11.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.128 1.371 . . . . 0.0 110.555 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.21 136.44 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.664 1.186 . . . . 0.0 108.43 161.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.8 pt -125.35 150.53 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 111.657 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -98.24 104.71 16.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.019 1.328 . . . . 0.0 108.772 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -94.18 157.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.491 1.516 . . . . 0.0 112.697 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -77.06 141.85 40.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.02 0.928 . . . . 0.0 109.732 151.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.13 -2.76 45.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.366 1.066 . . . . 0.0 112.26 167.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.77 1.69 87.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.409 1.957 . . . . 0.0 115.256 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.1 p -96.74 -15.26 21.48 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.449 1.099 . . . . 0.0 112.905 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.01 -20.22 13.1 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.169 1.842 . . . . 0.0 112.986 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -86.22 158.76 19.66 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.152 1.476 . . . . 0.0 112.539 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.0 m -126.35 155.88 41.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.13 157.92 43.77 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.192 1.797 . . . . 0.0 112.23 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -99.67 130.84 45.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.601 0.76 . . . . 0.0 111.23 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -123.69 133.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.31 1.044 . . . . 0.0 112.508 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.75 143.4 22.37 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.7 mt -121.52 145.58 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.206 1.402 . . . . 0.0 109.65 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.59 139.32 10.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.692 1.139 . . . . 0.0 112.398 161.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -94.44 162.59 13.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.238 1.018 . . . . 0.0 113.246 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -71.54 -23.07 61.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.338 1.055 . . . . 0.0 112.625 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -136.0 143.71 44.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.735 1.614 . . . . 0.0 112.038 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -54.76 -40.93 69.87 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.024 0.93 . . . . 0.0 111.447 168.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.88 75.05 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.13 0.871 . . . . 0.0 113.651 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -73.29 -38.3 65.93 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.41 1.105 . . . . 0.0 111.496 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.72 -40.05 69.73 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.76 -32.07 68.94 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.698 -1.252 . . . . 0.0 111.257 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -81.51 -28.42 34.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.98 1.312 . . . . 0.0 112.898 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -57.66 -43.61 85.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.191 0.905 . . . . 0.0 110.219 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.84 -51.98 54.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.875 0.87 . . . . 0.0 112.79 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.92 -31.55 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 120.235 1.38 . . . . 0.0 112.615 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 t -56.64 -34.87 67.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.824 0.738 . . . . 0.0 111.977 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.0 -37.29 22.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 0.0 112.259 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -58.31 -48.28 81.0 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.696 1.135 . . . . 0.0 111.213 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.75 -8.45 57.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -84.86 -34.4 22.64 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.745 0.818 . . . . 0.0 111.213 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 130' ' ' VAL . 59.1 m-85 -95.61 -13.25 24.51 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -21.59 66.51 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -105.74 5.61 31.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.078 1.351 . . . . 0.0 114.294 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -129.23 -163.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.28 2.232 . . . . 0.0 109.707 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp 70.49 8.57 6.65 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 163.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 54.7 25.94 6.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.223 2.209 . . . . 0.0 114.499 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.884 1.674 . . . . 0.0 113.026 177.862 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.716 0.293 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.24 -17.58 48.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.705 1.202 . . . . 0.0 113.227 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.32 133.58 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.624 1.569 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 p -85.67 139.17 31.61 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.603 1.161 . . . . 0.0 113.338 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 46.3 m -81.88 57.37 3.43 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.263 1.825 . . . . 0.0 112.161 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -50.34 141.32 11.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.137 2.175 . . . . 0.0 114.598 -168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.435 HG21 HG23 ' A' ' 85' ' ' VAL . 14.4 p -73.2 139.72 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.543 1.137 . . . . 0.0 109.665 174.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.669 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.3 -8.63 0.52 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 126.343 1.925 . . . . 0.0 115.237 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.83 -27.09 3.38 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -173.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.669 HG22 HG21 ' B' ' 156' ' ' TPO . 20.2 tt -77.65 -34.96 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 120.482 1.492 . . . . 0.0 112.54 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.26 48.7 80.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.131 0.872 . . . . 0.0 112.6 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -147.45 0.25 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 111.988 -166.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.558 0.0 OUTLIER 63.27 -67.19 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.812 2.845 . . . . 0.0 114.203 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.868 1.667 . . . . 0.0 114.884 -170.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -151.39 178.99 1.34 Allowed Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 126.279 1.832 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -57.35 -22.84 51.73 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.391 2.061 . . . . 0.0 114.04 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -70.87 -27.74 64.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.097 0.959 . . . . 0.0 112.305 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 m -71.63 -9.4 58.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.021 1.329 . . . . 0.0 113.609 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.12 -9.21 58.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.554 1.142 . . . . 0.0 113.658 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.3 -13.29 60.41 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -81.55 75.71 8.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.725 1.21 . . . . 0.0 112.018 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -126.79 154.12 44.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.243 1.817 . . . . 0.0 111.721 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.98 35.28 0.1 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.947 2.099 . . . . 0.0 112.76 174.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -71.01 129.5 39.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.524 1.129 . . . . 0.0 110.562 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.2 p90 -146.76 177.01 9.43 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -167.6 127.87 1.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.249 2.22 . . . . 0.0 109.059 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 m -87.8 133.3 33.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.672 1.189 . . . . 0.0 111.244 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.78 135.78 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.241 1.382 . . . . 0.0 112.432 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -116.98 -41.22 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.792 1.637 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 t -148.28 151.66 35.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.812 0.845 . . . . 0.0 112.732 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.17 137.1 46.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.807 1.643 . . . . 0.0 108.437 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -130.01 140.43 38.62 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -84.72 -15.83 5.79 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.346 3.364 . . . . 0.0 115.139 -164.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -154.09 123.26 6.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.914 1.286 . . . . 0.0 110.611 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.72 150.04 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.157 1.383 . . . . 0.0 110.176 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.0 p -125.55 145.8 49.96 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.961 1.305 . . . . 0.0 112.116 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.2 141.0 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.106 1.362 . . . . 0.0 111.081 -173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -135.59 84.28 2.08 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.742 2.017 . . . . 0.0 108.378 -172.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 140.64 57.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.333 -1.479 . . . . 0.0 112.912 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.67 143.28 41.37 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -161.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -75.83 -40.69 0.66 Allowed 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 122.916 2.411 . . . . 0.0 117.392 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.67 163.12 24.09 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.884 2.39 . . . . 0.0 113.837 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -115.16 -27.7 7.2 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.529 1.532 . . . . 0.0 115.057 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.37 104.79 1.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.73 0.776 . . . . 0.0 111.876 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 t -96.28 162.9 13.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.978 1.311 . . . . 0.0 110.851 160.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -22.0 32.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.638 1.975 . . . . 0.0 114.871 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -104.51 -5.84 21.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.209 1.404 . . . . 0.0 114.123 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.5 -105.69 0.98 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.539 1.542 . . . . 0.0 111.489 -172.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -125.21 -32.47 2.97 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.17 104.69 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.66 2.784 . . . . 0.0 114.067 -172.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.69 76.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.636 1.208 . . . . 0.0 109.062 158.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.9 t -174.7 -37.78 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.683 2.793 . . . . 0.0 108.66 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.35 -28.44 56.83 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 112.863 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -119.71 170.04 9.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.288 2.235 . . . . 0.0 109.868 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -48.81 110.59 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.109 1.364 . . . . 0.0 110.925 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -104.59 0.36 28.51 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.486 1.514 . . . . 0.0 112.709 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -135.34 -19.72 1.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.988 2.515 . . . . 0.0 113.51 -161.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -125.66 96.02 39.09 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.552 1.941 . . . . 0.0 110.49 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.34 155.2 69.92 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.317 2.678 . . . . 0.0 114.198 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.41 -27.7 13.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.364 1.466 . . . . 0.0 112.298 166.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -146.92 151.69 37.44 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.619 1.567 . . . . 0.0 111.027 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 p -140.01 149.49 43.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.293 1.437 . . . . 0.0 111.763 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.13 -131.76 2.1 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.757 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.91 160.92 35.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.856 2.062 . . . . 0.0 112.961 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 tp -110.39 138.24 47.04 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.813 1.645 . . . . 0.0 110.869 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -129.16 123.84 33.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 110.06 156.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.18 126.38 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.4 p -128.95 168.81 15.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.034 1.333 . . . . 0.0 110.404 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.5 p -150.23 119.29 6.72 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.036 -1.04 . . . . 0.0 113.321 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 28.3 ttmt -90.48 76.73 6.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.874 168.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 -132.06 10.99 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.4 1.476 . . . . 0.0 112.34 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.38 22.73 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.488 1.915 . . . . 0.0 114.307 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 m -136.61 121.25 18.42 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.978 1.311 . . . . 0.0 109.743 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.77 155.1 17.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.393 1.077 . . . . 0.0 110.981 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -134.03 111.34 10.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.448 1.499 . . . . 0.0 108.046 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 mm -83.22 103.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -100.59 140.09 35.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.376 1.071 . . . . 0.0 110.862 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.1 mt -121.07 129.97 53.56 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.618 1.167 . . . . 0.0 109.016 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -134.76 153.5 51.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.52 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.19 135.69 47.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.238 1.015 . . . . 0.0 110.855 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.6 -16.0 59.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.08 1.352 . . . . 0.0 114.033 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.64 -38.65 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.284 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.1 m -129.32 -3.03 4.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.49 13.72 68.5 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 123.916 0.77 . . . . 0.0 114.679 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.27 138.98 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.382 1.091 . . . . 0.0 111.264 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.63 127.46 32.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.12 0.568 . . . . 0.0 112.235 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -89.74 -51.08 5.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.963 1.705 . . . . 0.0 111.359 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.85 158.34 40.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.269 . . . . 0.0 111.667 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -135.8 139.17 43.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.861 0.864 . . . . 0.0 111.917 167.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.79 119.74 32.17 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.172 1.389 . . . . 0.0 111.623 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.08 125.11 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.052 2.502 . . . . 0.0 111.339 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.09 128.44 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 127.274 2.23 . . . . 0.0 109.561 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -122.74 6.61 9.4 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.251 -0.906 . . . . 0.0 113.392 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.12 144.27 17.29 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.102 1.761 . . . . 0.0 110.486 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -130.24 128.81 22.78 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.59 166.35 36.92 Favored 'Cis proline' 0 CA--C 1.542 0.898 0 CA-C-N 118.968 0.667 . . . . 0.0 112.413 -17.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.48 -159.07 10.03 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.917 0.77 . . . . 0.0 113.773 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -74.66 -28.96 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 121.756 -0.849 . . . . 0.0 111.136 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.37 31.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.1 125.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 119.255 0.934 . . . . 0.0 109.755 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 151.03 46.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.439 1.495 . . . . 0.0 111.475 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 m -103.17 80.49 1.85 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.871 0.843 . . . . 0.0 109.574 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 86' ' ' THR . 2.9 m 37.08 -73.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 129.205 3.002 . . . . 0.0 117.551 158.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 85' ' ' VAL . 36.7 p -134.75 -47.11 0.74 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.561 1.144 . . . . 0.0 111.694 156.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -152.21 -58.42 0.15 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -70.89 140.95 51.2 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.1 p -114.7 76.55 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.067 0.947 . . . . 0.0 113.254 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -76.46 -29.11 56.78 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.794 123.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -117.47 160.65 20.85 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.918 1.287 . . . . 0.0 114.379 -166.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.15 174.31 10.99 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.044 1.738 . . . . 0.0 110.755 169.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.91 135.94 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.638 1.575 . . . . 0.0 108.686 163.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.1 pt -131.08 151.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.941 0.897 . . . . 0.0 111.826 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.85 110.09 22.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.171 0.988 . . . . 0.0 111.03 173.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 pt -105.22 162.23 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.072 1.349 . . . . 0.0 112.725 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -74.21 134.62 42.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.043 -0.411 . . . . 0.0 110.114 145.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -90.45 7.15 40.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.57 86.51 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.366 1.46 . . . . 0.0 115.683 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -118.39 15.26 13.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.485 1.514 . . . . 0.0 113.638 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.18 16.85 55.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.1 1.333 . . . . 0.0 113.814 -174.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -136.77 174.34 10.72 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.249 1.82 . . . . 0.0 112.969 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -112.29 158.42 19.76 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.105 1.362 . . . . 0.0 112.998 168.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.37 39.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.602 1.561 . . . . 0.0 111.712 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -91.57 134.75 34.41 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.7 pt -124.98 141.57 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.687 0.795 . . . . 0.0 111.729 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.0 149.25 34.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 160.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.04 146.69 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.108 1.363 . . . . 0.0 108.19 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.62 133.84 6.77 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.36 1.457 . . . . 0.0 111.023 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -90.52 166.3 13.3 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.8 -22.51 56.29 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.525 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.64 146.55 34.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.66 1.584 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -63.61 -34.26 77.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.836 1.254 . . . . 0.0 113.177 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.95 -33.54 62.63 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.671 0.653 . . . . 0.0 112.863 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -67.04 -39.72 87.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.356 1.078 . . . . 0.0 111.349 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.05 -44.09 61.14 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.13 -27.73 65.89 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.415 -1.428 . . . . 0.0 112.761 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.76 -27.86 36.63 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.889 -1.132 . . . . 0.0 112.93 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.273 -0.892 . . . . 0.0 110.755 165.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.76 -54.12 15.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.697 0.799 . . . . 0.0 112.3 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.59 -33.75 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.738 -1.226 . . . . 0.0 113.053 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -62.12 -21.03 64.68 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 mt -94.46 -37.33 11.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.769 1.228 . . . . 0.0 111.973 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -54.87 -53.66 52.55 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.611 1.096 . . . . 0.0 111.041 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.11 -8.11 52.8 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -86.64 -32.64 20.46 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 112.843 172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.431 ' HA ' HG23 ' A' ' 130' ' ' VAL . 67.5 m-85 -97.96 -18.68 18.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.65 -42.05 1.63 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.314 3.046 . . . . 0.0 115.524 170.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -101.42 5.93 42.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.247 1.419 . . . . 0.0 114.313 -174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -132.51 -157.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.827 2.451 . . . . 0.0 108.992 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mmmp? 63.27 7.03 2.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 52.67 26.14 4.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 114.681 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.654 1.582 . . . . 0.0 114.683 -176.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -76.41 157.02 32.68 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.162 0.892 . . . . 0.0 111.91 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.2 tt -72.33 154.6 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.138 0.975 . . . . 0.0 112.156 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 47.5 p -134.24 151.04 51.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.519 1.528 . . . . 0.0 111.844 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 47.1 m -131.37 52.43 2.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.05 1.34 . . . . 0.0 112.055 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -50.12 135.68 20.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.421 1.888 . . . . 0.0 112.014 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 88' ' ' SER . 3.5 t -52.7 140.06 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.16 0.984 . . . . 0.0 111.603 -164.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.651 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -158.46 23.66 0.36 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 111.624 -2.535 . . . . 0.0 112.967 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -144.03 -37.87 0.32 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.0 tp -79.96 -34.51 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.2 0.909 . . . . 0.0 112.873 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.04 49.36 58.67 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.872 1.225 . . . . 0.0 113.521 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.13 -137.57 0.37 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.527 1.531 . . . . 0.0 113.247 -165.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 62.19 169.43 0.12 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.466 3.507 . . . . 0.0 113.794 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.295 1.838 . . . . 0.0 110.885 176.211 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 77.8 p -146.09 155.08 51.09 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.393 1.477 . . . . 0.0 112.118 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.15 -23.93 13.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.004 2.469 . . . . 0.0 113.354 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -151.98 152.05 31.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.196 1.798 . . . . 0.0 109.759 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.8 m -61.93 -20.82 64.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -95.89 -8.68 33.36 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.434 1.494 . . . . 0.0 113.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 -14.41 62.55 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.1 p -83.1 -10.06 58.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.485 1.514 . . . . 0.0 113.533 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -107.83 159.52 16.45 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.553 1.941 . . . . 0.0 111.648 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.56 49.75 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.727 1.611 . . . . 0.0 111.53 171.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.47 43.55 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.502 1.921 . . . . 0.0 112.903 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -84.82 178.37 7.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.357 1.063 . . . . 0.0 113.1 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.72 130.88 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.214 2.205 . . . . 0.0 109.14 163.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -90.55 139.16 30.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.251 1.42 . . . . 0.0 111.618 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -72.58 136.97 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 120.431 -1.418 . . . . 0.0 112.453 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.35 -46.55 2.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.113 1.365 . . . . 0.0 113.289 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.9 t -146.59 150.49 35.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.581 0.705 . . . . 0.0 112.878 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 p -143.45 128.41 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.132 1.773 . . . . 0.0 108.245 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -125.07 135.76 27.24 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.486 1.114 . . . . 0.0 110.409 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.74 -21.22 19.17 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.457 2.772 . . . . 0.0 114.834 -163.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.92 132.44 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.53 1.132 . . . . 0.0 111.063 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.49 143.87 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.448 . . . . 0.0 109.616 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 m -126.24 144.59 50.73 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.198 0.999 . . . . 0.0 111.473 -175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.2 t -123.62 136.3 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.144 1.377 . . . . 0.0 110.952 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.03 0.87 12.5 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -161.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 39.61 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 128.944 2.898 . . . . 0.0 115.42 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -101.11 145.92 31.25 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.614 1.166 . . . . 0.0 113.699 -161.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -73.74 -41.44 1.09 Allowed 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 122.77 2.313 . . . . 0.0 117.231 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -83.4 163.41 14.82 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.885 2.39 . . . . 0.0 114.007 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -110.3 -24.24 10.76 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.792 1.637 . . . . 0.0 114.573 165.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.37 105.63 0.99 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.162 0.985 . . . . 0.0 110.538 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.4 t -100.3 164.96 11.71 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.689 1.596 . . . . 0.0 111.494 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.06 -28.83 4.42 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.086 2.554 . . . . 0.0 116.66 -173.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -126.8 24.74 6.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.322 1.449 . . . . 0.0 114.902 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.02 -97.59 0.67 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.748 1.642 . . . . 0.0 112.501 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.85 -34.77 0.88 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 107.49 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 129.34 3.056 . . . . 0.0 115.197 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.24 45.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.156 -0.965 . . . . 0.0 112.941 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.4 m -62.14 -18.25 60.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.414 2.285 . . . . 0.0 114.933 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.61 -33.27 31.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.968 1.307 . . . . 0.0 112.847 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -111.6 -153.17 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.935 2.094 . . . . 0.0 110.45 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -72.24 92.09 1.36 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.916 1.286 . . . . 0.0 111.115 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.56 -41.61 98.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.966 2.106 . . . . 0.0 112.53 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -141.75 25.42 1.98 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -120.77 90.17 46.08 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.087 1.355 . . . . 0.0 111.493 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.38 155.51 41.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.755 2.303 . . . . 0.0 113.023 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -107.79 -24.92 11.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.26 1.424 . . . . 0.0 112.798 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -142.32 148.24 37.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.84 1.656 . . . . 0.0 110.643 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.6 p -137.3 153.35 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.813 0.845 . . . . 0.0 112.081 165.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.76 -135.68 1.96 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.348 0.975 . . . . 0.0 111.838 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 ttp-105 -133.99 141.99 47.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.791 2.037 . . . . 0.0 110.295 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.8 143.29 27.56 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.227 0.611 . . . . 0.0 111.042 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -140.91 102.83 4.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 0.0 110.601 166.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.31 129.89 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -129.81 173.72 10.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.322 1.449 . . . . 0.0 110.696 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -154.08 123.66 6.64 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.731 -1.23 . . . . 0.0 113.202 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -89.23 77.37 7.49 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.705 1.202 . . . . 0.0 109.825 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.83 -115.61 6.32 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.206 1.384 . . . . 0.0 112.066 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -72.93 12.25 0.55 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.48 1.912 . . . . 0.0 114.872 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -137.07 121.44 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.94 158.04 17.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.234 1.014 . . . . 0.0 111.451 171.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -136.17 115.3 12.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.282 1.433 . . . . 0.0 108.027 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -84.3 107.02 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -109.62 148.99 30.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.506 0.669 . . . . 0.0 111.143 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.82 126.79 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.552 1.141 . . . . 0.0 109.534 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -113.1 148.41 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 111.691 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.95 132.54 44.46 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.008 -1.057 . . . . 0.0 110.22 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -71.96 -0.91 12.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.49 -38.2 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.079 1.751 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.7 m -122.92 -10.79 8.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.13 13.79 70.4 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 119.016 0.825 . . . . 0.0 114.196 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.45 147.21 38.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.341 1.056 . . . . 0.0 111.912 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.68 119.65 18.19 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.937 0.495 . . . . 0.0 111.536 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -84.95 -51.72 6.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.955 1.302 . . . . 0.0 111.429 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.45 162.1 38.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.701 1.2 . . . . 0.0 112.081 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -142.51 135.91 28.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.691 1.196 . . . . 0.0 112.208 172.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.3 120.03 28.3 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.073 1.749 . . . . 0.0 112.037 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.89 125.73 4.89 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.124 2.549 . . . . 0.0 111.627 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.97 128.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.119 2.167 . . . . 0.0 109.701 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.39 5.16 9.65 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.259 -0.901 . . . . 0.0 113.236 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.35 144.07 15.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.104 1.762 . . . . 0.0 110.761 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.74 ' CD1' HG13 ' A' ' 82' ' ' VAL . 9.7 t80 -138.09 126.19 14.08 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.065 0.946 . . . . 0.0 112.304 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.71 155.3 33.3 Favored 'Cis proline' 0 C--N 1.354 0.842 0 CA-C-N 120.375 1.17 . . . . 0.0 114.348 -8.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.68 27.09 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.785 0.707 . . . . 0.0 113.497 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -79.5 -25.36 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.917 -0.755 . . . . 0.0 111.27 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.49 -17.97 26.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.6 p -147.68 120.6 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.222 160.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.05 151.78 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.898 1.679 . . . . 0.0 111.479 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -105.82 80.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.237 1.015 . . . . 0.0 109.219 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 HG21 ' B' ' 155' ' ' VAL . 2.2 m 35.8 -74.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.767 2.827 . . . . 0.0 117.187 156.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -136.91 -47.53 0.6 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.908 1.283 . . . . 0.0 111.587 154.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -155.41 -59.52 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.546 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -67.74 122.91 19.1 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.745 0.783 . . . . 0.0 112.988 -176.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 86.1 p -95.99 16.64 17.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -161.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -56.59 -33.12 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.478 1.035 . . . . 0.0 110.894 160.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -112.07 156.87 21.5 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.61 1.164 . . . . 0.0 112.779 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -144.67 171.72 14.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.265 1.426 . . . . 0.0 110.244 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.62 135.89 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.557 1.143 . . . . 0.0 109.005 166.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.7 pt -129.76 149.92 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.072 0.949 . . . . 0.0 111.391 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.36 110.9 23.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.119 0.968 . . . . 0.0 111.07 174.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 pt -101.84 161.36 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 125.451 1.5 . . . . 0.0 112.238 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -74.15 135.47 42.86 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 155.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.81 1.82 52.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.383 0.992 . . . . 0.0 113.478 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.04 -0.45 87.34 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.373 1.463 . . . . 0.0 115.699 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.3 p -113.34 14.27 19.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.42 1.488 . . . . 0.0 113.439 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.72 15.57 54.33 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.379 1.466 . . . . 0.0 113.971 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -135.28 174.24 10.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.146 1.779 . . . . 0.0 112.902 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 p -115.99 153.99 30.65 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 112.779 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.48 153.04 47.45 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.357 1.463 . . . . 0.0 112.457 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -96.6 130.67 43.75 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.496 -0.752 . . . . 0.0 110.613 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.1 pt -121.76 135.13 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.957 0.903 . . . . 0.0 112.294 171.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.43 137.63 16.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 166.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.86 148.59 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.729 1.611 . . . . 0.0 109.043 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.11 136.61 8.06 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.188 1.375 . . . . 0.0 111.614 165.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 38.4 m-85 -96.42 159.34 14.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.308 1.043 . . . . 0.0 113.629 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -80.81 -25.93 37.47 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.362 1.065 . . . . 0.0 113.088 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -133.57 142.49 48.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.605 1.562 . . . . 0.0 111.692 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -61.78 -36.61 81.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.829 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.98 -35.39 78.77 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 118.914 0.779 . . . . 0.0 112.625 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.37 -35.99 78.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.398 1.099 . . . . 0.0 112.005 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -74.25 -41.11 61.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.501 -0.749 . . . . 0.0 112.91 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -63.53 -27.75 69.48 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.899 -1.125 . . . . 0.0 112.055 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.06 -37.66 64.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.314 1.046 . . . . 0.0 111.729 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -57.9 -39.06 76.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.032 0.833 . . . . 0.0 111.326 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -69.33 -59.25 3.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.544 0.737 . . . . 0.0 112.449 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.93 -29.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 120.8 -1.188 . . . . 0.0 113.178 -168.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 62.4 p -61.73 -26.92 68.36 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.041 0.837 . . . . 0.0 113.141 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HG11 ' A' ' 82' ' ' VAL . 61.5 mt -89.07 -36.4 15.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 112.155 171.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -56.02 -50.68 70.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.478 1.036 . . . . 0.0 110.735 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.18 -9.22 58.35 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -83.43 -37.44 23.2 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.566 -0.709 . . . . 0.0 111.521 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -92.46 -12.01 33.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -27.45 68.76 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 120.125 1.33 . . . . 0.0 114.256 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -103.05 1.75 33.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.583 1.553 . . . . 0.0 113.272 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.41 179.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.735 2.414 . . . . 0.0 109.133 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 tptp 67.68 5.86 4.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 165.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 51.82 31.46 8.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.576 2.35 . . . . 0.0 114.388 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.132 1.373 . . . . 0.0 113.683 175.849 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -132.56 152.84 51.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.441 1.497 . . . . 0.0 111.126 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 80.6 mt -76.71 129.11 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.862 0.865 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 50.1 m -115.19 -2.75 12.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.796 2.039 . . . . 0.0 114.619 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m 61.94 30.79 18.18 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.882 3.273 . . . . 0.0 114.394 -166.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -59.25 160.96 5.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 129.386 3.074 . . . . 0.0 113.891 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.444 HG21 HG23 ' A' ' 85' ' ' VAL . 8.4 p -78.3 139.78 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 122.029 0.919 . . . . 0.0 109.31 157.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.599 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.4 -11.18 0.15 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 127.687 2.565 . . . . 0.0 114.784 168.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.5 -29.83 8.58 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.737 2.268 . . . . 0.0 116.256 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 156' ' ' TPO . 10.3 tp -81.37 -35.5 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.007 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.16 48.64 78.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.33 0.967 . . . . 0.0 112.901 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -162.05 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.933 2.093 . . . . 0.0 110.983 -169.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 59.01 -164.99 0.2 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.409 167.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.598 1.959 . . . . 0.0 110.936 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -67.99 149.17 98.29 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 112.999 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.04 167.22 26.7 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.525 2.817 . . . . 0.0 112.184 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.15 -29.65 69.91 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.61 0.764 . . . . 0.0 112.689 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.9 m -76.35 74.55 3.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.398 1.479 . . . . 0.0 111.108 171.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -63.23 -20.95 65.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.385 1.074 . . . . 0.0 113.845 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.75 137.56 54.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 149.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.7 p -100.05 -30.1 12.16 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.28 137.83 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.404 2.282 . . . . 0.0 113.243 -160.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.2 mt -112.02 -6.8 14.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.441 1.496 . . . . 0.0 113.001 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 48.77 56.63 7.38 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.676 1.991 . . . . 0.0 113.472 172.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -123.65 -179.23 4.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.964 1.305 . . . . 0.0 113.319 -171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -166.94 134.84 2.58 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.822 2.049 . . . . 0.0 108.256 163.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -101.26 127.44 47.85 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.354 1.462 . . . . 0.0 112.083 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.21 132.35 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.996 0.816 . . . . 0.0 111.887 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.56 -39.64 4.57 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.069 1.748 . . . . 0.0 112.714 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.5 148.8 30.65 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.008 0.923 . . . . 0.0 112.103 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.22 129.74 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.856 1.662 . . . . 0.0 108.794 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -125.91 139.91 35.45 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.775 0.83 . . . . 0.0 112.896 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.02 -27.25 12.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.426 3.417 . . . . 0.0 114.552 -164.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -145.01 131.04 19.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.798 1.239 . . . . 0.0 110.633 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.25 140.31 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 109.485 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -119.86 142.11 48.95 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.299 1.04 . . . . 0.0 111.046 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.03 139.8 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.284 1.434 . . . . 0.0 110.826 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -134.49 90.03 2.62 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.369 1.868 . . . . 0.0 108.709 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -52.22 135.6 31.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.089 1.355 . . . . 0.0 111.451 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -121.3 144.74 40.58 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.415 1.086 . . . . 0.0 113.646 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -74.44 -43.14 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 122.832 2.355 . . . . 0.0 117.088 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.2 162.09 20.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.93 2.42 . . . . 0.0 114.047 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -110.48 -28.09 8.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.529 1.532 . . . . 0.0 114.675 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.51 105.78 0.97 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.742 0.782 . . . . 0.0 111.66 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -88.86 155.99 19.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.458 1.103 . . . . 0.0 109.584 156.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -20.2 66.37 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.819 -1.175 . . . . 0.0 113.147 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.67 -10.81 47.19 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.118 1.367 . . . . 0.0 113.345 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.47 -99.11 0.54 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 126.606 2.051 . . . . 0.0 111.385 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.71 -33.57 1.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.31 107.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.204 3.002 . . . . 0.0 114.433 -169.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.88 -36.48 38.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.207 -0.933 . . . . 0.0 112.201 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.4 m -61.51 -10.92 8.91 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.94 2.496 . . . . 0.0 115.278 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.15 -24.75 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 -163.06 1.01 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.435 1.494 . . . . 0.0 110.543 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -71.02 103.95 2.85 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.046 -1.034 . . . . 0.0 109.623 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.7 -5.35 28.98 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.39 -23.18 7.88 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.328 1.451 . . . . 0.0 113.306 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -113.3 97.74 44.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.099 1.359 . . . . 0.0 111.436 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.98 151.87 40.16 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.211 1.941 . . . . 0.0 112.469 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.9 -24.27 15.94 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.589 1.556 . . . . 0.0 112.018 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -152.14 149.18 28.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.44 1.896 . . . . 0.0 110.036 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.8 p -137.01 152.84 50.59 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.64 0.733 . . . . 0.0 111.616 165.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.74 -134.49 1.79 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.734 0.683 . . . . 0.0 112.167 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -132.75 142.33 48.97 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.904 2.482 . . . . 0.0 109.529 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.79 140.7 29.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.645 0.778 . . . . 0.0 110.712 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -142.74 92.79 2.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.962 0.905 . . . . 0.0 110.841 169.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.18 135.83 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.978 -1.076 . . . . 0.0 108.965 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -136.62 171.27 14.75 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.863 1.665 . . . . 0.0 110.576 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.2 p -154.97 135.4 13.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -102.59 51.88 0.8 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.581 1.952 . . . . 0.0 110.678 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.75 -132.1 10.84 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.595 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.12 -9.96 45.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.496 1.518 . . . . 0.0 114.458 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -99.84 116.99 33.19 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.512 1.125 . . . . 0.0 110.483 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.49 161.34 17.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.741 0.781 . . . . 0.0 110.517 163.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -137.3 115.5 11.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.05 1.34 . . . . 0.0 107.544 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 mm -73.88 109.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -95.6 144.84 25.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.403 1.001 . . . . 0.0 108.9 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.49 126.65 50.92 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.144 0.978 . . . . 0.0 109.326 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -115.21 145.97 41.89 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.662 1.585 . . . . 0.0 111.601 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.63 132.93 44.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.618 -1.301 . . . . 0.0 110.464 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.62 0.67 9.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.71 -38.89 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.15 1.78 . . . . 0.0 111.317 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -128.38 -5.64 5.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.28 11.13 70.88 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.354 0.978 . . . . 0.0 114.613 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.56 148.47 40.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.468 1.107 . . . . 0.0 112.342 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -72.84 119.39 17.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.996 0.518 . . . . 0.0 111.681 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -83.32 -53.17 5.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.154 1.382 . . . . 0.0 111.231 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.24 163.5 38.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.69 1.196 . . . . 0.0 111.625 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.87 137.69 31.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.763 0.825 . . . . 0.0 113.172 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.5 109.66 30.68 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.407 1.483 . . . . 0.0 111.888 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -73.33 136.68 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.766 2.977 . . . . 0.0 112.869 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.43 132.37 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.559 1.543 . . . . 0.0 112.824 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -118.75 1.76 11.6 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.55 139.55 14.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.917 1.687 . . . . 0.0 111.152 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.456 ' HD2' HG13 ' A' ' 82' ' ' VAL . 19.5 t80 -129.8 126.04 22.41 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.313 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -65.77 161.61 71.52 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.762 0.951 . . . . 0.0 112.891 -9.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.36 -161.97 16.72 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.244 0.926 . . . . 0.0 113.458 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.17 -25.84 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.776 -0.838 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.61 -16.9 52.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -162.89 118.02 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.091 1.356 . . . . 0.0 109.498 176.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.37 151.65 51.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.08 1.752 . . . . 0.0 110.987 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -103.59 79.39 1.68 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.939 0.896 . . . . 0.0 108.796 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 HG21 ' B' ' 155' ' ' VAL . 1.7 m 32.85 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 129.14 2.976 . . . . 0.0 116.914 160.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.6 p -132.89 -52.75 0.92 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.89 0.876 . . . . 0.0 112.236 157.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.06 -71.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.475 -167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.649 ' HB3' HG23 ' B' ' 155' ' ' VAL . 1.5 t -53.49 133.52 40.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -81.36 56.8 3.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.383 165.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -104.84 -36.63 7.31 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.44 2.696 . . . . 0.0 110.494 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.72 167.65 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.398 2.279 . . . . 0.0 110.883 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -139.91 172.95 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.806 1.242 . . . . 0.0 110.274 167.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.37 129.35 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.082 1.353 . . . . 0.0 108.499 165.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.6 150.2 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.816 0.847 . . . . 0.0 111.366 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -92.77 107.71 19.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.546 0.739 . . . . 0.0 109.639 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.5 pt -92.04 144.37 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.948 0.899 . . . . 0.0 110.369 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -76.87 135.67 38.85 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.237 -0.914 . . . . 0.0 110.132 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.06 -18.2 47.46 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.219 -0.926 . . . . 0.0 113.329 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.56 86.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.974 1.273 . . . . 0.0 115.02 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.4 p -107.61 15.03 25.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.293 1.437 . . . . 0.0 113.271 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.6 16.58 54.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.083 1.325 . . . . 0.0 113.852 -173.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -136.35 175.08 9.93 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.171 1.789 . . . . 0.0 112.689 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -132.03 154.33 49.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.414 1.086 . . . . 0.0 112.604 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.57 147.87 42.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.298 1.839 . . . . 0.0 111.703 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -98.13 128.88 44.87 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.399 0.679 . . . . 0.0 110.706 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.18 143.55 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.166 0.986 . . . . 0.0 110.552 170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.65 154.17 43.39 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 160.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.75 142.63 43.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 125.069 1.347 . . . . 0.0 108.207 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.06 134.05 7.55 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.035 1.303 . . . . 0.0 111.5 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -94.19 160.17 14.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.956 0.884 . . . . 0.0 113.152 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -75.74 -21.78 57.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.305 1.042 . . . . 0.0 112.875 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -137.24 145.68 43.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.659 1.583 . . . . 0.0 112.201 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -62.46 -34.24 76.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.764 0.825 . . . . 0.0 113.008 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.82 -34.01 76.63 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.841 0.734 . . . . 0.0 112.857 172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.41 -39.08 78.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.684 1.242 . . . . 0.0 111.664 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.78 78.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 168.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -60.33 -27.08 67.06 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.659 -1.275 . . . . 0.0 113.572 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -75.98 -33.45 59.75 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.878 -1.139 . . . . 0.0 112.142 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -60.78 -34.31 74.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.938 0.79 . . . . 0.0 111.354 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -70.85 -56.11 7.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.662 0.785 . . . . 0.0 112.41 170.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.4 -34.14 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.543 1.065 . . . . 0.0 112.856 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.0 p -63.86 -19.92 65.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.46 -36.56 11.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -55.23 -51.43 66.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.681 1.128 . . . . 0.0 110.808 173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.94 -7.45 54.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.342 1.057 . . . . 0.0 113.557 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.17 -38.53 18.9 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.402 -0.811 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.85 -14.25 34.75 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -29.03 69.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -100.94 4.41 42.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.103 1.361 . . . . 0.0 113.933 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.44 -161.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.142 2.577 . . . . 0.0 108.869 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.276 18.4 tptp 65.34 10.2 6.32 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 153.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 52.97 36.81 22.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 0.0 113.919 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.73 1.212 . . . . 0.0 113.551 177.15 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -123.2 22.53 9.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.28 1.432 . . . . 0.0 113.257 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 78.4 mt -68.42 133.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.513 1.125 . . . . 0.0 109.875 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.2 p -78.64 141.17 38.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 112.607 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 27.2 m -83.32 45.0 0.99 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.284 1.434 . . . . 0.0 114.171 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -44.17 136.49 3.88 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.601 2.36 . . . . 0.0 112.956 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.649 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.1 p -55.29 117.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.118 0.967 . . . . 0.0 109.315 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.502 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.3 -14.42 0.04 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 127.053 2.263 . . . . 0.0 113.89 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -67.64 -15.49 63.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.136 2.174 . . . . 0.0 114.689 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.81 -33.59 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.045 1.338 . . . . 0.0 113.579 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.02 30.02 63.89 Favored Glycine 0 N--CA 1.478 1.459 0 C-N-CA 124.278 0.942 . . . . 0.0 114.04 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -163.86 1.1 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.104 1.762 . . . . 0.0 113.928 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.58 -70.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -137.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.852 1.661 . . . . 0.0 111.693 -178.333 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.7 m -67.9 147.76 98.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.366 1.066 . . . . 0.0 113.005 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.42 159.6 51.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.505 2.803 . . . . 0.0 112.552 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -72.88 151.5 41.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.106 0.962 . . . . 0.0 112.337 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 34.5 t -154.2 155.9 36.13 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.863 1.265 . . . . 0.0 112.098 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm -77.5 -11.71 59.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.531 1.133 . . . . 0.0 112.968 170.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.7 59.53 1.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.72 1.608 . . . . 0.0 112.268 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -88.57 -4.49 58.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.317 1.447 . . . . 0.0 114.688 -170.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.02 164.28 26.92 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.98 84.86 3.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.352 1.061 . . . . 0.0 108.593 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -82.93 39.07 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.859 1.264 . . . . 0.0 114.059 -163.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -86.4 -179.78 6.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.002 1.321 . . . . 0.0 113.414 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -167.14 129.18 1.66 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.707 2.403 . . . . 0.0 108.24 162.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -100.34 132.21 45.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 111.702 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.47 135.57 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.67 1.123 . . . . 0.0 112.505 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.44 -44.52 3.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.027 1.731 . . . . 0.0 112.375 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 t -147.09 152.13 38.0 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.178 0.991 . . . . 0.0 112.378 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.33 132.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.786 1.635 . . . . 0.0 109.019 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.72 140.95 37.83 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.084 0.953 . . . . 0.0 113.313 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.23 -29.94 3.71 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.001 3.134 . . . . 0.0 115.054 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -147.43 122.57 10.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.647 1.179 . . . . 0.0 110.463 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -149.62 145.58 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.417 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -122.77 145.38 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.899 1.28 . . . . 0.0 111.141 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.85 142.17 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.117 1.367 . . . . 0.0 110.974 -173.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.19 109.43 13.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.423 1.489 . . . . 0.0 109.426 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -57.63 121.21 9.82 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 119.495 -2.003 . . . . 0.0 109.89 156.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.03 145.87 32.64 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.515 1.126 . . . . 0.0 113.448 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.18 -45.76 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 122.83 2.354 . . . . 0.0 116.85 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.91 162.6 20.86 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.902 2.402 . . . . 0.0 113.986 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -116.22 -29.26 6.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.646 1.579 . . . . 0.0 114.683 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.29 103.43 0.96 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.675 0.75 . . . . 0.0 111.569 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -94.93 162.69 13.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.851 1.261 . . . . 0.0 110.812 161.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.44 -22.25 42.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.956 2.103 . . . . 0.0 114.848 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmt-85 -103.68 -7.86 20.37 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 0.0 114.247 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.95 -106.43 0.91 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.584 1.564 . . . . 0.0 111.592 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.39 -33.53 2.81 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.87 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.052 2.941 . . . . 0.0 114.865 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -33.79 55.31 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.854 -1.154 . . . . 0.0 113.203 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -62.46 -14.4 40.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.946 2.098 . . . . 0.0 114.707 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.7 -32.78 21.75 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.393 1.477 . . . . 0.0 113.408 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -112.62 -152.16 0.5 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.426 1.89 . . . . 0.0 110.871 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.67 97.17 0.78 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.021 1.391 . . . . 0.0 110.998 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.0 tp -74.44 -30.96 62.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.552 1.941 . . . . 0.0 112.082 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -138.66 8.14 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.345 1.458 . . . . 0.0 114.701 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -130.97 83.19 61.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.861 1.264 . . . . 0.0 112.192 -167.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.35 153.26 79.06 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.562 2.841 . . . . 0.0 114.887 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.81 -23.91 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.93 1.692 . . . . 0.0 112.119 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.1 t90 -150.42 149.95 30.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.511 1.924 . . . . 0.0 109.947 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.28 154.7 50.05 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.483 -0.761 . . . . 0.0 111.609 164.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.18 -136.67 2.49 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.78 0.705 . . . . 0.0 112.065 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -123.74 146.1 48.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.937 2.495 . . . . 0.0 109.785 -172.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 tp -101.78 137.87 39.51 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.272 1.029 . . . . 0.0 109.863 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -132.96 142.97 49.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.088 0.555 . . . . 0.0 110.556 155.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -120.48 126.14 74.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.024 1.329 . . . . 0.0 107.861 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.0 p -123.37 169.11 11.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.933 1.693 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p -152.23 128.64 10.63 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 113.823 175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -104.74 90.94 3.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.102 1.761 . . . . 0.0 109.493 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 -132.86 25.21 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.12 1.343 . . . . 0.0 112.656 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.2 22.23 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.515 1.926 . . . . 0.0 114.1 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -135.36 115.68 13.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.254 1.421 . . . . 0.0 109.143 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.28 158.1 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.384 0.674 . . . . 0.0 110.184 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.86 117.58 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -80.85 114.95 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -103.31 129.27 50.28 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.952 1.701 . . . . 0.0 109.225 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.7 127.82 55.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.276 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -132.02 153.41 50.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.739 1.216 . . . . 0.0 111.982 -160.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.95 137.57 51.61 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.497 -1.377 . . . . 0.0 110.998 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -67.1 -7.98 27.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.92 -39.27 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.319 1.848 . . . . 0.0 111.558 -172.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -128.79 -2.91 5.29 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.08 69.56 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 140.47 52.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.599 1.199 . . . . 0.0 111.45 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -74.44 122.88 23.69 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.511 -0.743 . . . . 0.0 112.292 -170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -84.45 -51.46 6.91 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.248 1.819 . . . . 0.0 111.129 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.1 162.45 41.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.154 1.381 . . . . 0.0 111.01 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -141.54 144.8 34.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 166.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.96 111.77 30.69 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.508 1.523 . . . . 0.0 111.399 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.2 127.84 13.17 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.902 2.401 . . . . 0.0 111.197 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.18 130.88 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.553 1.541 . . . . 0.0 111.065 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -120.44 4.98 10.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.413 1.085 . . . . 0.0 112.782 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.26 147.96 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.662 1.985 . . . . 0.0 109.491 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD1' HG13 ' A' ' 82' ' ' VAL . 15.2 t80 -134.67 127.7 18.65 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.004 0.922 . . . . 0.0 112.053 173.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -65.64 164.35 62.49 Favored 'Cis proline' 0 CA--C 1.545 1.037 0 CA-C-N 119.631 0.904 . . . . 0.0 112.483 -13.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.61 -157.56 9.37 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 123.884 0.754 . . . . 0.0 114.483 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.39 -31.84 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.952 -0.734 . . . . 0.0 110.699 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.63 -12.18 54.48 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD1' ' A' ' 77' ' ' TYR . 2.5 p -156.83 119.62 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.196 1.398 . . . . 0.0 108.931 168.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.71 151.01 50.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.926 1.69 . . . . 0.0 110.804 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.19 78.07 1.47 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.775 0.83 . . . . 0.0 109.5 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 HG21 ' B' ' 155' ' ' VAL . 2.3 m 37.63 -74.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 129.057 2.943 . . . . 0.0 117.179 158.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -134.61 -46.77 0.75 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.652 1.181 . . . . 0.0 111.761 156.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -156.18 -61.65 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.62 ' HB3' HG23 ' B' ' 155' ' ' VAL . 1.9 t -53.83 121.99 9.07 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.932 1.349 . . . . 0.0 113.956 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.7 t -85.9 47.96 1.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.194 1.397 . . . . 0.0 111.64 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -97.33 -25.93 15.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.226 2.611 . . . . 0.0 111.227 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.48 164.18 27.73 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.909 2.084 . . . . 0.0 111.297 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -140.77 174.02 10.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.53 1.132 . . . . 0.0 110.952 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -129.64 132.72 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.296 1.438 . . . . 0.0 108.543 162.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.07 151.49 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.166 0.986 . . . . 0.0 111.372 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 109.53 21.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 0.0 109.978 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 pt -96.76 157.81 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.279 1.032 . . . . 0.0 111.762 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.36 146.95 29.1 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.033 -0.417 . . . . 0.0 111.193 158.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -97.22 3.12 51.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.03 7.07 86.6 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.789 1.185 . . . . 0.0 115.808 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.26 6.5 t -127.45 30.55 5.34 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.414 1.485 . . . . 0.0 112.909 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.43 57.14 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.349 1.452 . . . . 0.0 113.942 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -144.5 170.23 16.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 113.552 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -132.34 161.87 32.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.498 1.519 . . . . 0.0 113.551 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.12 38.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.141 1.776 . . . . 0.0 111.807 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -97.27 130.02 44.51 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.653 -0.655 . . . . 0.0 111.055 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.25 140.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.38 1.072 . . . . 0.0 110.569 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.62 155.74 47.2 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 159.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.99 142.8 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.754 1.222 . . . . 0.0 109.08 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.15 132.59 6.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.417 1.484 . . . . 0.0 111.433 167.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -89.64 163.0 15.33 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 t -70.16 -23.1 62.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.107 0.963 . . . . 0.0 112.48 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.65 144.14 35.54 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.582 1.553 . . . . 0.0 111.849 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.75 72.88 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.741 1.216 . . . . 0.0 111.607 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.59 -24.53 76.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.933 1.254 . . . . 0.0 114.566 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -79.41 -37.36 37.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.779 1.29 . . . . 0.0 111.584 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.11 92.31 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.786 -0.571 . . . . 0.0 111.935 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.44 -31.21 70.2 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.642 -1.286 . . . . 0.0 112.456 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -72.78 -35.54 67.44 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.585 -1.322 . . . . 0.0 111.888 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -58.15 -42.99 87.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.677 1.126 . . . . 0.0 110.92 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -63.61 -54.03 42.23 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.868 0.867 . . . . 0.0 112.667 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.56 -29.07 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.055 -1.028 . . . . 0.0 112.606 -174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.9 m -62.09 -26.63 68.4 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.604 0.762 . . . . 0.0 112.802 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.46 -34.14 14.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.722 1.209 . . . . 0.0 111.715 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -55.06 -57.11 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.659 1.118 . . . . 0.0 110.15 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.84 -6.11 25.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -91.5 -29.54 16.94 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 130' ' ' VAL . 48.9 m-85 -104.85 -16.03 15.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.348 1.059 . . . . 0.0 113.504 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -36.3 33.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.452 3.101 . . . . 0.0 115.327 175.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -105.94 6.25 31.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.605 1.562 . . . . 0.0 113.975 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -127.06 -157.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.396 2.278 . . . . 0.0 109.304 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt 58.24 20.63 7.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.641 1.576 . . . . 0.0 114.41 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 54.32 29.28 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.085 1.754 . . . . 0.0 113.828 -173.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 124.902 1.281 . . . . 0.0 113.738 178.459 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 50.71 -96.39 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.116 1.767 . . . . 0.0 113.187 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 9.3 tp -148.98 155.84 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.738 1.615 . . . . 0.0 110.422 171.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -97.93 132.44 43.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.129 1.372 . . . . 0.0 111.372 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 55.4 m -138.59 66.96 1.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.489 1.116 . . . . 0.0 111.456 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -43.3 138.87 2.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.475 1.91 . . . . 0.0 112.709 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 88' ' ' SER . 4.5 p -62.23 119.02 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.724 0.773 . . . . 0.0 109.165 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -159.83 -36.85 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.009 0.814 . . . . 0.0 114.944 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -78.16 -15.18 59.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 40.3 mt -97.46 -60.25 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.217 1.007 . . . . 0.0 111.665 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.77 38.63 Favored Glycine 0 N--CA 1.476 1.31 0 C-N-CA 125.383 1.468 . . . . 0.0 115.218 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -151.06 0.42 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.736 1.614 . . . . 0.0 114.121 -168.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -144.96 -179.68 6.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.2 1.8 . . . . 0.0 111.841 -146.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.434 170.686 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.5 t -149.93 141.67 15.1 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.97 1.308 . . . . 0.0 111.496 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.55 -14.64 42.86 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.449 2.766 . . . . 0.0 114.307 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -81.43 154.38 26.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.925 1.29 . . . . 0.0 112.529 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.1 m -65.27 127.38 31.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.308 1.043 . . . . 0.0 112.522 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -91.6 -4.26 55.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.435 1.094 . . . . 0.0 113.838 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 -6.71 12.22 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.192 1.397 . . . . 0.0 114.613 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -72.94 -15.27 61.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.981 1.312 . . . . 0.0 113.626 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -69.73 146.13 51.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.376 1.07 . . . . 0.0 112.204 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.8 mt -90.05 35.53 0.85 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.85 1.66 . . . . 0.0 112.214 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.28 105.04 17.16 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.618 1.167 . . . . 0.0 110.644 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.77 -174.97 5.19 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.056 1.342 . . . . 0.0 112.304 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.17 134.68 5.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.188 1.795 . . . . 0.0 108.713 159.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.6 m -92.89 133.21 36.32 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.162 0.985 . . . . 0.0 110.716 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -69.59 138.62 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.67 1.123 . . . . 0.0 112.115 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.35 -46.49 2.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 111.985 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -145.15 153.25 41.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.907 0.883 . . . . 0.0 112.455 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.11 127.39 20.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.834 1.653 . . . . 0.0 108.958 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -120.22 132.06 24.23 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.007 0.923 . . . . 0.0 110.473 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.85 -19.54 16.05 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.439 2.759 . . . . 0.0 114.345 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -138.87 132.62 30.76 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.344 1.058 . . . . 0.0 111.455 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.9 144.93 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.654 1.581 . . . . 0.0 109.305 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 t -122.22 142.18 50.71 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.787 1.235 . . . . 0.0 111.927 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.24 138.36 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.696 1.598 . . . . 0.0 110.832 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -129.69 50.17 2.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.507 1.923 . . . . 0.0 111.495 -167.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -25.78 123.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 127.955 2.502 . . . . 0.0 114.947 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 pt -112.2 144.1 30.12 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -160.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -72.62 -43.69 0.87 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.803 2.335 . . . . 0.0 116.998 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.03 160.57 20.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.884 2.389 . . . . 0.0 113.998 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -111.2 -25.63 9.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.762 1.625 . . . . 0.0 114.601 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.73 106.17 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.928 0.871 . . . . 0.0 110.913 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.3 t -102.7 164.45 11.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.451 168.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -23.16 8.16 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.744 2.418 . . . . 0.0 116.963 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.28 19.66 8.97 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.24 -99.33 0.73 Allowed Glycine 0 N--CA 1.469 0.864 0 C-N-CA 125.454 1.502 . . . . 0.0 112.842 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -133.09 -33.72 1.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.28 109.08 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.531 3.132 . . . . 0.0 115.092 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.87 -27.62 44.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.908 -1.12 . . . . 0.0 113.742 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -75.62 -11.66 60.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.547 1.539 . . . . 0.0 113.971 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.39 -37.16 32.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.522 1.129 . . . . 0.0 112.707 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -103.42 -163.95 1.03 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.211 2.204 . . . . 0.0 111.107 176.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -63.81 100.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.116 1.436 . . . . 0.0 111.148 173.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -78.38 -34.33 48.3 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.273 -2.24 . . . . 0.0 111.893 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.43 18.37 2.74 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.874 1.27 . . . . 0.0 113.608 -169.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -126.02 92.78 45.21 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.153 1.381 . . . . 0.0 111.219 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.12 149.07 82.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.895 3.063 . . . . 0.0 114.276 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -106.68 -32.53 7.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.819 1.248 . . . . 0.0 112.298 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -148.06 147.6 29.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.126 1.37 . . . . 0.0 110.419 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -136.85 147.17 46.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.695 1.198 . . . . 0.0 111.565 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -137.11 2.82 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.942 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -124.62 142.48 51.34 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.247 2.219 . . . . 0.0 110.755 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.39 136.94 33.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.045 0.938 . . . . 0.0 110.664 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -119.94 139.9 51.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.229 1.012 . . . . 0.0 109.516 152.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.4 mt -118.43 128.92 75.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.5 p -135.72 172.2 13.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.801 1.24 . . . . 0.0 110.53 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.2 p -151.67 121.89 7.23 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.015 0.926 . . . . 0.0 112.87 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.95 65.69 8.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.725 1.21 . . . . 0.0 110.086 167.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -125.62 6.96 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.468 1.508 . . . . 0.0 112.474 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.45 35.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.651 1.98 . . . . 0.0 113.92 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -154.89 122.28 5.65 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.637 1.575 . . . . 0.0 108.957 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.91 158.84 18.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.418 0.687 . . . . 0.0 110.692 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -138.71 119.08 13.7 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.8 mm -79.77 112.19 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -117.55 117.95 30.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.95 0.9 . . . . 0.0 110.889 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.35 129.76 45.58 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 110.531 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -118.51 141.95 48.06 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.729 1.212 . . . . 0.0 112.235 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -68.48 130.63 43.42 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.25 -0.906 . . . . 0.0 109.014 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -64.78 -18.56 65.18 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.215 1.006 . . . . 0.0 112.988 -168.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.96 -31.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 126.903 2.081 . . . . 0.0 113.333 -169.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.3 m -122.71 -9.98 8.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.88 16.9 64.56 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.243 0.925 . . . . 0.0 113.963 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.05 146.21 30.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.253 1.027 . . . . 0.0 111.473 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.14 120.48 18.82 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.818 -0.551 . . . . 0.0 111.558 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -79.58 -51.76 8.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.961 1.304 . . . . 0.0 111.034 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.42 162.03 37.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.96 1.304 . . . . 0.0 111.706 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -138.66 138.23 37.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 112.971 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.68 109.48 34.3 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.74 1.616 . . . . 0.0 111.025 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.51 130.92 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.29 126.93 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.613 1.965 . . . . 0.0 109.538 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -119.47 0.44 11.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 112.823 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -158.05 144.62 17.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 109.847 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.79 126.75 22.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.985 0.914 . . . . 0.0 113.393 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.54 166.99 57.05 Favored 'Cis proline' 0 CA--C 1.545 1.033 0 CA-C-N 119.259 0.771 . . . . 0.0 111.841 -15.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.43 -154.48 7.59 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.055 0.836 . . . . 0.0 113.664 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.41 -28.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.606 -0.937 . . . . 0.0 111.448 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.65 45.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.388 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.93 129.21 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.442 1.097 . . . . 0.0 110.069 170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.2 151.67 40.89 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 112.026 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -104.45 77.62 1.4 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.939 0.876 . . . . 0.0 109.588 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 36.7 -72.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 129.112 2.965 . . . . 0.0 117.944 158.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -136.71 -47.25 0.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.458 1.103 . . . . 0.0 111.963 156.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -153.44 -64.73 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 155' ' ' VAL . 4.9 t -52.92 138.69 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 8.9 t -90.18 -0.61 57.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.854 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -56.9 -28.0 61.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.452 1.101 . . . . 0.0 112.079 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.5 164.81 21.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.639 1.976 . . . . 0.0 112.451 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -142.59 172.1 13.16 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.299 1.839 . . . . 0.0 110.61 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -128.64 139.25 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.888 1.275 . . . . 0.0 108.801 161.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.55 151.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.681 0.792 . . . . 0.0 111.686 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 107.61 19.81 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.429 1.091 . . . . 0.0 108.968 170.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 pt -95.36 159.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.184 1.393 . . . . 0.0 111.844 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -79.8 126.4 30.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 150.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -88.85 9.21 25.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -162.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.3 4.54 86.92 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.258 1.408 . . . . 0.0 115.661 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -129.73 27.13 5.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.063 1.345 . . . . 0.0 113.526 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.602 1.096 . . . . 0.0 113.734 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -142.31 175.12 10.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.174 1.79 . . . . 0.0 112.511 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 m -108.81 160.32 16.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.052 . . . . 0.0 112.342 166.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.5 152.92 38.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.915 1.286 . . . . 0.0 111.749 171.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.68 133.42 35.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 110.015 164.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 pt -125.69 135.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.063 171.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.37 142.49 25.01 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 166.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 mt -121.44 142.41 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.866 1.266 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.47 137.86 9.85 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.986 1.279 . . . . 0.0 111.801 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 32.2 m-85 -100.66 157.95 16.3 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.677 1.191 . . . . 0.0 113.621 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -77.72 -24.68 49.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.555 1.142 . . . . 0.0 113.06 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -139.99 147.8 40.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.457 1.503 . . . . 0.0 112.095 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -55.02 -44.52 74.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.074 0.95 . . . . 0.0 111.617 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.46 84.56 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.212 0.911 . . . . 0.0 112.941 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.193 0.996 . . . . 0.0 112.112 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -79.82 -37.03 36.02 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.382 -0.823 . . . . 0.0 113.196 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.37 -29.32 70.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.562 -1.336 . . . . 0.0 111.441 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -70.19 -36.65 74.78 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.409 1.084 . . . . 0.0 111.603 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.18 -44.73 92.18 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.763 0.711 . . . . 0.0 111.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -52.74 56.21 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.203 1.001 . . . . 0.0 112.82 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.01 -30.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.087 -1.008 . . . . 0.0 112.903 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -57.51 -29.89 64.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 112.439 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.4 -37.15 13.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.566 1.146 . . . . 0.0 111.648 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -54.31 -53.51 52.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.743 0.701 . . . . 0.0 111.0 171.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -82.16 -40.03 22.37 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.609 -0.682 . . . . 0.0 111.363 169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.91 -9.77 41.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -26.23 67.59 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.24 1.382 . . . . 0.0 114.04 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -104.31 6.54 35.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.765 1.626 . . . . 0.0 113.326 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.96 175.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 128.059 2.544 . . . . 0.0 109.277 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 67.42 3.98 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 50.88 29.36 4.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.899 2.48 . . . . 0.0 114.938 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.381 1.072 . . . . 0.0 113.631 174.003 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.442 0.163 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -146.01 -44.31 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.983 1.313 . . . . 0.0 112.434 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.59 135.43 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.762 1.625 . . . . 0.0 108.944 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 16.4 p -75.65 148.29 38.82 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.396 1.079 . . . . 0.0 112.744 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 25.3 m -82.21 48.62 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.001 1.32 . . . . 0.0 113.136 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -56.49 169.74 0.43 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.532 2.333 . . . . 0.0 113.811 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 88' ' ' SER . 2.0 t -64.08 124.31 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 162.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.472 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.15 -14.8 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 127.356 2.408 . . . . 0.0 113.411 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -69.52 -16.92 63.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.068 2.147 . . . . 0.0 114.976 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.7 tp -123.85 -37.54 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.405 1.082 . . . . 0.0 113.254 176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.5 67.63 1.72 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.137 0.875 . . . . 0.0 112.307 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -147.14 175.26 10.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -151.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -160.12 -43.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.742 2.417 . . . . 0.0 110.822 162.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.923 2.089 . . . . 0.0 111.214 164.901 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.7 m -67.65 149.45 98.29 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.435 1.094 . . . . 0.0 112.993 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.6 -24.66 13.51 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.174 2.582 . . . . 0.0 113.275 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -92.62 153.44 19.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 111.404 174.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 86.1 p -81.6 171.72 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.88 1.272 . . . . 0.0 113.131 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ttt -76.83 4.06 10.58 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.82 1.248 . . . . 0.0 113.591 178.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.98 -13.76 18.37 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.1 p -77.99 -14.78 59.4 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.316 1.447 . . . . 0.0 113.996 174.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 9.2 tp10 -92.01 152.1 20.15 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.674 1.589 . . . . 0.0 112.055 176.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 9.16 9.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.537 1.535 . . . . 0.0 113.642 175.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 8.6 mm-40 -70.96 132.97 45.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.954 1.302 . . . . 0.0 111.677 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.417 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 17.2 p90 -150.98 177.88 9.72 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.92 136.01 4.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.512 2.325 . . . . 0.0 108.326 162.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -97.22 132.29 43.12 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.832 1.253 . . . . 0.0 111.211 -176.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.82 134.58 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.856 1.207 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.7 mt -113.12 -44.53 3.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.755 1.622 . . . . 0.0 112.2 177.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 t -147.56 149.7 33.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 0.0 112.442 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.82 129.1 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.226 1.411 . . . . 0.0 108.87 171.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -118.03 142.93 31.78 Favored Pre-proline 0 N--CA 1.483 1.219 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.65 -19.17 11.53 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.64 3.56 . . . . 0.0 115.348 -164.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.04 136.57 16.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.288 1.435 . . . . 0.0 110.429 175.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.37 142.76 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.498 1.119 . . . . 0.0 109.915 176.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 m -116.5 145.73 43.11 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.291 1.036 . . . . 0.0 111.96 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -121.82 140.37 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.342 1.457 . . . . 0.0 111.714 -174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -136.01 84.47 2.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 109.169 -170.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -53.54 139.11 32.35 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.603 -1.311 . . . . 0.0 112.126 177.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -123.02 140.54 33.7 Favored Pre-proline 0 N--CA 1.484 1.266 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.03 -37.03 0.61 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 123.002 2.468 . . . . 0.0 117.795 171.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.2 168.16 20.69 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.997 2.464 . . . . 0.0 113.762 -176.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -120.02 -48.4 2.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.846 1.658 . . . . 0.0 113.598 173.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 104.78 3.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.037 0.922 . . . . 0.0 112.719 -169.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -98.11 -151.8 0.38 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.675 1.59 . . . . 0.0 110.503 162.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -101.26 -43.29 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.113 0.965 . . . . 0.0 111.139 -163.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -85.2 -23.25 28.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.815 1.246 . . . . 0.0 112.768 166.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.6 -101.25 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.477 1.513 . . . . 0.0 113.287 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -112.35 -30.26 7.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.25 110.09 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.659 3.184 . . . . 0.0 116.21 -170.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.95 -38.9 24.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.082 0.953 . . . . 0.0 112.767 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -57.35 -20.99 32.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.788 2.035 . . . . 0.0 115.089 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.52 -15.65 42.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.45 1.1 . . . . 0.0 113.675 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -125.72 -169.56 2.03 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.871 1.668 . . . . 0.0 110.406 176.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -69.63 111.21 5.28 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.613 -1.305 . . . . 0.0 110.384 173.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.1 pt? -105.48 -4.25 21.54 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 174.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -130.54 -5.07 4.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.432 1.493 . . . . 0.0 113.338 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -120.24 78.33 26.26 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 126.719 2.007 . . . . 0.0 110.855 -172.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.56 157.63 52.29 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.042 2.494 . . . . 0.0 113.712 -172.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.02 -30.73 12.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.959 1.304 . . . . 0.0 112.266 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -144.0 146.85 33.18 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.521 1.528 . . . . 0.0 110.328 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -136.42 154.09 50.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.745 0.783 . . . . 0.0 111.382 164.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.55 -133.68 1.84 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -174.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -130.34 154.83 47.26 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.887 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.83 140.07 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.856 1.262 . . . . 0.0 110.365 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -136.12 104.63 5.74 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.848 1.259 . . . . 0.0 109.954 164.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.2 mt -89.57 129.12 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.9 p -132.2 172.49 12.34 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.058 1.343 . . . . 0.0 110.54 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.0 p -154.1 128.38 9.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 25.5 ttmt -94.69 75.46 3.7 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.912 1.685 . . . . 0.0 109.49 167.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.16 -128.29 9.36 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.337 1.446 . . . . 0.0 112.303 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.54 -9.94 30.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.452 1.501 . . . . 0.0 114.313 175.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -100.5 116.03 31.49 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.306 0.642 . . . . 0.0 111.347 177.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.66 159.46 22.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.823 . . . . 0.0 111.063 167.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -137.36 117.75 13.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.863 1.265 . . . . 0.0 107.628 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.34 110.43 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -110.95 148.46 32.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.499 0.719 . . . . 0.0 110.533 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.06 133.93 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.398 1.079 . . . . 0.0 109.807 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.51 150.92 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.394 . . . . 0.0 112.769 -167.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.53 137.95 56.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -65.35 -10.74 35.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.093 1.357 . . . . 0.0 114.357 -173.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.24 -39.57 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.416 1.886 . . . . 0.0 111.598 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -126.63 -2.5 6.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -168.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 11.41 73.47 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.021 0.768 . . . . 0.0 115.021 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.05 141.91 47.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.443 1.121 . . . . 0.0 111.912 -175.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 tp -70.36 124.32 23.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.283 0.633 . . . . 0.0 112.267 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -88.4 -53.69 4.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.48 1.512 . . . . 0.0 111.366 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.45 162.62 40.71 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.913 1.285 . . . . 0.0 111.714 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -140.92 139.31 34.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.066 0.946 . . . . 0.0 112.638 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.18 110.47 30.92 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.298 1.839 . . . . 0.0 110.872 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -69.75 128.1 15.55 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.285 2.657 . . . . 0.0 111.782 172.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.94 120.83 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.701 2.001 . . . . 0.0 109.047 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.39 2.87 14.83 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.189 -0.944 . . . . 0.0 112.914 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.36 138.83 14.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.603 1.561 . . . . 0.0 110.759 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -123.73 130.84 24.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.253 1.021 . . . . 0.0 112.633 174.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -65.09 164.86 57.18 Favored 'Cis proline' 0 CA--C 1.544 0.995 0 CA-C-N 119.287 0.781 . . . . 0.0 111.399 -17.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.01 -157.3 8.84 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 114.064 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -78.72 -28.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.869 -0.783 . . . . 0.0 111.396 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.92 -23.44 38.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.003 -0.999 . . . . 0.0 113.565 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -147.23 128.27 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.412 1.005 . . . . 0.0 110.309 168.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.29 151.74 40.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.626 1.571 . . . . 0.0 112.174 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -95.03 98.54 10.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 170.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 86' ' ' THR . 1.8 m 14.59 -74.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.992 2.917 . . . . 0.0 115.91 158.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 85' ' ' VAL . 25.3 p -144.98 -59.62 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.869 1.668 . . . . 0.0 110.722 158.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.16 -44.12 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -163.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.52 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 43.0 t -66.01 129.05 38.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 120.964 1.711 . . . . 0.0 110.171 164.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -104.11 24.24 11.74 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.052 0.941 . . . . 0.0 113.215 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.2 ttt180 -70.04 -23.19 63.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.579 1.152 . . . . 0.0 111.94 160.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -121.77 161.24 23.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.33 1.452 . . . . 0.0 112.485 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.87 174.06 10.89 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.86 1.264 . . . . 0.0 110.845 168.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -126.12 135.47 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 125.579 1.552 . . . . 0.0 108.01 162.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.6 pt -128.59 149.62 33.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.607 174.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 97.67 9.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.052 1.341 . . . . 0.0 109.119 174.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 pt -84.56 167.85 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.569 1.148 . . . . 0.0 111.556 175.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -98.83 147.8 24.56 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 154.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.81 -6.74 59.57 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 172.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.58 4.6 89.04 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.044 1.307 . . . . 0.0 115.28 175.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.2 p -107.29 8.47 29.82 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.654 1.582 . . . . 0.0 113.347 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.26 7.59 51.78 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.646 1.593 . . . . 0.0 114.013 -172.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -119.67 169.59 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.637 1.575 . . . . 0.0 114.033 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -113.91 161.02 18.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.1 1.76 . . . . 0.0 112.423 173.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.04 148.49 29.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.021 1.328 . . . . 0.0 111.669 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -96.6 132.63 42.02 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.236 0.614 . . . . 0.0 110.884 170.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.136 0.974 . . . . 0.0 111.203 169.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.74 150.85 34.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 161.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.0 143.23 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.019 1.328 . . . . 0.0 108.354 173.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.21 128.38 4.17 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.485 1.04 . . . . 0.0 111.521 169.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.35 165.32 14.45 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.297 1.046 . . . . 0.0 112.991 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 t -72.74 -19.49 61.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.159 0.983 . . . . 0.0 112.829 174.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -141.79 144.85 34.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.497 1.519 . . . . 0.0 112.58 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -52.31 -41.08 62.64 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.794 1.238 . . . . 0.0 111.865 168.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.53 -38.39 86.41 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.681 1.134 . . . . 0.0 113.779 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.07 -34.98 78.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.37 1.085 . . . . 0.0 111.83 178.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -38.59 63.58 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 171.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -57.23 -35.54 69.82 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.293 -1.504 . . . . 0.0 111.533 172.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.99 -30.71 58.66 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.192 -0.943 . . . . 0.0 112.535 176.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.51 -42.84 83.57 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.977 0.808 . . . . 0.0 110.508 169.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -46.37 69.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.208 1.003 . . . . 0.0 111.947 175.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -30.48 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.967 0.803 . . . . 0.0 112.782 -174.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -65.49 -19.78 66.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.672 1.189 . . . . 0.0 112.788 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.29 -39.83 9.04 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.433 1.493 . . . . 0.0 111.24 174.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -55.48 -57.35 12.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.893 0.769 . . . . 0.0 110.774 172.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.45 -15.15 60.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.588 1.155 . . . . 0.0 113.365 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -86.46 -30.23 22.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.652 0.781 . . . . 0.0 112.989 174.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 130' ' ' VAL . 50.9 m-85 -100.32 -17.03 17.47 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.824 0.85 . . . . 0.0 113.168 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -47.56 -35.94 9.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 129.48 3.112 . . . . 0.0 114.956 174.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -105.69 10.5 32.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.531 1.532 . . . . 0.0 113.87 -177.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -132.58 -157.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.417 2.287 . . . . 0.0 109.848 -177.077 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.5 tttm 62.83 19.99 11.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 164.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 54.41 31.11 13.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.3 1.84 . . . . 0.0 114.064 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.894 1.677 . . . . 0.0 113.263 177.286 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.04 144.18 44.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.892 1.277 . . . . 0.0 111.056 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 64.8 mt -135.45 140.07 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.071 1.348 . . . . 0.0 110.399 -170.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.409 HG22 ' H ' ' B' ' 154' ' ' GLN . 3.2 m -139.0 153.73 48.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.903 1.281 . . . . 0.0 109.893 164.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 61.3 m -156.89 29.94 0.31 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.014 1.726 . . . . 0.0 113.547 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . 0.409 ' H ' HG22 ' B' ' 152' ' ' THR . 13.5 pt20 -159.28 162.62 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.409 1.884 . . . . 0.0 112.757 170.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 88' ' ' SER . 7.4 p -86.94 142.92 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 143.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.52 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -160.27 -21.67 0.03 OUTLIER Glycine 0 CA--C 1.529 0.968 0 CA-C-N 114.422 -1.263 . . . . 0.0 114.378 -177.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.04 -20.8 60.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 175.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 tp -149.67 -47.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.05 54.51 6.98 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.117 0.871 . . . . 0.0 113.788 -174.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -98.88 -139.35 0.31 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.711 2.404 . . . . 0.0 114.423 -172.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.9 mmt-85 -139.43 -171.59 3.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.727 1.611 . . . . 0.0 112.109 -147.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.885 1.274 . . . . 0.0 113.093 168.625 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 47.4 t -149.23 144.86 18.43 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.118 1.367 . . . . 0.0 111.506 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.73 -8.14 21.06 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.443 2.762 . . . . 0.0 113.786 173.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.74 148.05 49.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.336 1.454 . . . . 0.0 112.354 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.7 t -149.06 151.29 34.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.03 1.332 . . . . 0.0 111.554 172.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt -116.29 3.21 13.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.664 1.586 . . . . 0.0 112.674 172.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.97 6.25 29.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.237 1.415 . . . . 0.0 113.936 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.2 p -86.35 -10.2 54.89 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.498 1.519 . . . . 0.0 114.857 -166.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -78.45 179.02 7.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.692 1.197 . . . . 0.0 113.485 177.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.92 37.03 0.14 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.476 1.911 . . . . 0.0 113.405 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.47 132.42 43.85 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 110.666 175.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -151.33 179.03 8.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.65 136.15 5.18 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.967 2.107 . . . . 0.0 109.07 165.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -91.21 139.81 30.4 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.545 1.538 . . . . 0.0 111.007 174.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.62 136.79 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 120.802 -1.186 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 mt -113.46 -46.69 3.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.445 1.498 . . . . 0.0 112.37 176.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.7 t -146.31 155.45 42.65 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.21 134.41 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.206 1.803 . . . . 0.0 108.791 171.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -123.33 137.96 29.26 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 168.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.19 -25.11 19.29 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.72 3.614 . . . . 0.0 114.454 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.53 135.65 30.36 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.678 1.191 . . . . 0.0 111.11 176.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.88 144.69 16.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.739 1.215 . . . . 0.0 109.826 172.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.8 p -118.43 151.19 38.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.455 1.102 . . . . 0.0 112.284 173.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -118.57 157.88 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 172.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -126.54 112.99 16.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.677 1.591 . . . . 0.0 109.242 169.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -61.08 129.6 42.18 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 119.646 -1.909 . . . . 0.0 110.382 162.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 pt -124.25 144.85 46.78 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 124.53 1.132 . . . . 0.0 113.076 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.64 -32.74 1.08 Allowed 'Trans proline' 0 CA--C 1.556 1.582 0 N-CA-C 118.218 2.353 . . . . 0.0 118.218 176.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.8 171.5 13.08 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.906 2.404 . . . . 0.0 113.55 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -126.25 -45.96 1.66 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.701 1.601 . . . . 0.0 113.547 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.9 96.15 2.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.163 0.982 . . . . 0.0 112.449 -169.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.4 t -90.83 162.37 14.86 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.733 1.213 . . . . 0.0 110.938 161.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.13 -20.47 26.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.289 1.836 . . . . 0.0 114.981 177.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -103.71 -9.47 19.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.226 1.41 . . . . 0.0 114.205 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.22 -109.75 1.4 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.422 1.486 . . . . 0.0 111.514 -172.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.97 -32.03 3.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.96 107.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 129.333 3.053 . . . . 0.0 114.583 -169.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.71 -40.45 54.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.36 -0.837 . . . . 0.0 111.908 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -54.71 -15.12 1.64 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.459 2.704 . . . . 0.0 115.756 173.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.06 -24.05 24.73 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.319 1.448 . . . . 0.0 113.601 175.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -123.07 -167.31 1.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.008 2.123 . . . . 0.0 111.234 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -69.8 107.36 3.48 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.449 -1.407 . . . . 0.0 110.824 174.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 38' ' ' LEU . 2.5 pt? -104.42 2.53 31.25 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.48 16.89 0.91 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -124.94 81.29 62.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 126.215 1.806 . . . . 0.0 109.984 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.28 152.51 50.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.555 2.837 . . . . 0.0 113.983 -168.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.07 -31.04 12.7 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.444 1.498 . . . . 0.0 112.181 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -147.47 152.28 37.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.955 1.702 . . . . 0.0 110.246 171.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 p -138.16 151.49 47.78 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.081 1.352 . . . . 0.0 112.101 173.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.31 -131.88 1.9 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.602 0.62 . . . . 0.0 112.557 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.97 142.93 50.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.137 2.175 . . . . 0.0 110.95 -172.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.55 138.98 31.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.862 0.865 . . . . 0.0 110.322 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.98 132.56 46.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.325 1.05 . . . . 0.0 109.902 161.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -116.62 129.21 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.5 p -135.41 165.94 24.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.917 1.287 . . . . 0.0 110.845 -173.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t -152.42 127.77 9.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.007 1.323 . . . . 0.0 111.991 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -88.98 19.15 4.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.15 1.78 . . . . 0.0 112.34 169.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.69 121.31 0.82 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.265 1.888 . . . . 0.0 111.618 -174.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 58.38 -13.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 127.652 2.381 . . . . 0.0 116.608 -173.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -118.82 112.57 19.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.12 0.968 . . . . 0.0 109.281 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.1 153.23 22.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.07 0.548 . . . . 0.0 110.053 171.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -129.78 114.01 15.41 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.9 mm -74.84 108.92 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -104.38 140.7 37.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.652 1.581 . . . . 0.0 110.025 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.0 128.73 52.97 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.627 0.771 . . . . 0.0 109.491 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -126.6 150.55 48.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.658 1.183 . . . . 0.0 112.18 -164.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.27 132.3 45.5 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.094 -1.004 . . . . 0.0 109.607 172.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -64.73 -13.59 55.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.736 1.214 . . . . 0.0 113.709 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.98 -38.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.104 1.762 . . . . 0.0 111.358 -172.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -127.95 -2.97 5.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.95 11.69 70.23 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.303 0.954 . . . . 0.0 115.168 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.85 138.59 50.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.397 1.099 . . . . 0.0 111.46 -176.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 tp -75.07 123.24 24.84 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.792 -0.567 . . . . 0.0 112.028 -172.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -81.06 -52.53 7.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.962 1.705 . . . . 0.0 111.333 170.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.99 166.23 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.425 1.49 . . . . 0.0 111.001 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -143.05 152.39 41.84 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 159.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.16 120.22 27.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.968 1.707 . . . . 0.0 111.195 177.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.74 123.56 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.458 2.772 . . . . 0.0 111.52 176.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.38 125.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.121 1.768 . . . . 0.0 110.232 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.12 -2.06 12.3 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.819 1.647 . . . . 0.0 112.758 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.4 146.35 13.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.791 2.036 . . . . 0.0 109.921 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -130.23 127.03 22.48 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.93 166.94 59.7 Favored 'Cis proline' 0 CA--C 1.545 1.052 0 CA-C-N 119.219 0.757 . . . . 0.0 111.769 -15.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -154.53 7.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.14 0.876 . . . . 0.0 113.689 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 tp -78.82 -28.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.55 -0.971 . . . . 0.0 111.31 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.76 -25.36 44.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.9 129.38 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.473 1.109 . . . . 0.0 110.074 170.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.08 153.26 41.25 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.577 1.551 . . . . 0.0 112.134 -174.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -101.79 87.65 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.445 1.098 . . . . 0.0 108.893 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 m 26.87 -77.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 129.019 2.927 . . . . 0.0 116.309 158.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.6 p -132.1 -50.71 0.95 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 155.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -154.36 -66.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -172.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.439 ' HB3' HG23 ' B' ' 155' ' ' VAL . 0.5 OUTLIER -51.41 152.26 2.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.678 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.3 t -122.07 39.9 3.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.975 -163.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -79.49 -31.57 42.33 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.753 -0.592 . . . . 0.0 111.156 152.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -116.85 160.4 20.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.534 1.134 . . . . 0.0 113.429 -169.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.34 177.18 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.949 1.3 . . . . 0.0 110.217 165.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.57 137.55 57.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.436 1.494 . . . . 0.0 108.04 161.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -127.5 148.61 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.83 0.852 . . . . 0.0 111.502 172.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.64 97.74 10.32 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.878 1.271 . . . . 0.0 108.44 172.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.71 162.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.689 0.795 . . . . 0.0 111.193 173.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -112.24 147.69 35.7 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.199 0.6 . . . . 0.0 111.89 163.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -81.74 -7.55 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.63 6.44 83.18 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.283 1.42 . . . . 0.0 115.191 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.6 p -114.71 14.54 17.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.629 1.571 . . . . 0.0 113.624 -175.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.83 54.48 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.171 1.367 . . . . 0.0 113.815 -173.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -128.3 165.86 19.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.428 1.891 . . . . 0.0 112.889 -177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.8 m -133.16 156.02 48.23 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 -175.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.56 149.61 42.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.519 1.128 . . . . 0.0 112.492 166.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -97.31 130.31 44.5 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.667 0.787 . . . . 0.0 110.74 171.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 pt -127.61 137.36 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.073 0.949 . . . . 0.0 110.553 169.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.26 155.29 53.23 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 158.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.2 mt -123.71 141.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 108.179 172.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.42 133.85 8.31 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.449 1.023 . . . . 0.0 112.354 167.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -99.44 158.33 15.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.365 1.079 . . . . 0.0 112.093 174.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 t -79.42 -18.98 51.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.666 1.186 . . . . 0.0 112.808 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.56 141.82 45.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.615 1.566 . . . . 0.0 112.476 175.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 -58.09 -37.69 74.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.338 1.455 . . . . 0.0 112.297 174.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.5 -33.96 60.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.301 0.953 . . . . 0.0 113.499 176.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.93 -37.76 82.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.731 1.266 . . . . 0.0 111.766 177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.85 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 169.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -63.53 -29.25 70.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.263 -1.523 . . . . 0.0 112.339 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -73.04 -30.7 63.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.125 0.97 . . . . 0.0 112.027 172.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.66 -42.97 98.11 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.252 0.933 . . . . 0.0 110.591 170.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -62.23 -51.57 67.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.926 0.89 . . . . 0.0 112.126 170.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.37 -32.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.624 1.102 . . . . 0.0 112.427 -175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.2 m -60.11 -19.91 55.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.199 1.0 . . . . 0.0 113.407 172.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.0 mt -105.67 -34.46 7.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.788 1.635 . . . . 0.0 112.028 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -54.6 -50.24 68.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.783 0.833 . . . . 0.0 110.752 169.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.88 -8.18 56.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.122 0.969 . . . . 0.0 113.308 178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -84.26 -40.53 17.93 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.352 -0.842 . . . . 0.0 111.751 172.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.77 16.42 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 176.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.41 42.49 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.181 -0.949 . . . . 0.0 113.284 169.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -107.86 0.46 22.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 113.705 -177.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.7 178.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.608 2.363 . . . . 0.0 109.915 174.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.8 tptt 64.94 -8.77 0.21 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.593 2.357 . . . . 0.0 117.286 -174.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 52.71 32.91 12.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.851 2.46 . . . . 0.0 113.803 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.619 1.567 . . . . 0.0 113.009 174.443 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -74.83 156.3 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 0.0 112.197 176.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.6 tp -72.46 157.73 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.171 0.988 . . . . 0.0 111.79 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.0 p -73.38 150.86 41.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.593 1.157 . . . . 0.0 112.67 175.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -82.45 44.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.515 1.526 . . . . 0.0 114.442 -172.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -46.0 137.33 5.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.969 2.508 . . . . 0.0 113.578 -170.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 88' ' ' SER . 2.2 p -58.96 116.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.847 0.832 . . . . 0.0 108.866 175.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.429 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -161.11 -31.5 0.02 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.652 1.596 . . . . 0.0 114.455 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -65.43 -27.29 68.42 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.4 1.1 . . . . 0.0 113.379 172.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 49.2 mm -98.09 -50.55 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.379 1.472 . . . . 0.0 109.748 170.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.36 63.54 2.9 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.469 1.509 . . . . 0.0 112.738 171.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -138.63 -160.28 1.04 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -138.24 -156.55 0.69 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.516 1.926 . . . . 0.0 110.643 -138.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.396 1.078 . . . . 0.0 113.194 166.791 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 95.0 p -77.6 165.46 51.19 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.473 1.109 . . . . 0.0 112.736 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.66 -22.22 66.3 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.244 2.63 . . . . 0.0 113.938 169.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.53 -7.82 59.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.06 1.744 . . . . 0.0 113.242 174.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.1 m 56.67 18.27 3.59 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.434 1.894 . . . . 0.0 114.771 -169.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt -159.04 126.41 4.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.796 2.038 . . . . 0.0 108.941 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.23 88.49 7.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.852 0.861 . . . . 0.0 110.708 174.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.18 53.69 1.51 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.903 1.681 . . . . 0.0 112.396 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.99 150.12 37.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.232 1.413 . . . . 0.0 112.08 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.24 33.99 0.69 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.731 1.613 . . . . 0.0 112.376 174.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -95.51 100.95 12.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -155.11 -173.91 4.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.833 1.253 . . . . 0.0 112.568 -176.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -162.31 136.51 6.57 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.389 1.475 . . . . 0.0 109.12 160.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 m -102.44 137.56 40.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.274 1.43 . . . . 0.0 111.764 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.0 135.07 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.951 -1.093 . . . . 0.0 112.676 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 mt -111.18 -45.18 3.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.421 1.489 . . . . 0.0 112.099 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 t -148.03 144.32 27.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 112.587 -176.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 p -132.73 131.34 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 126.788 2.035 . . . . 0.0 108.655 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -124.23 134.42 25.46 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.577 1.151 . . . . 0.0 109.249 174.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -35.38 19.11 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.006 2.471 . . . . 0.0 114.325 -156.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -146.94 152.66 39.02 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 165.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -153.99 147.46 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.367 1.467 . . . . 0.0 109.929 -172.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -119.78 141.29 49.61 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.336 1.054 . . . . 0.0 111.849 -178.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.07 142.41 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.605 1.562 . . . . 0.0 111.251 -175.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -135.03 92.63 2.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.392 1.877 . . . . 0.0 109.498 -171.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -51.28 133.0 29.14 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.79 1.236 . . . . 0.0 111.331 170.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -118.77 142.78 32.35 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.655 1.182 . . . . 0.0 113.83 -171.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.32 -42.88 0.42 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 122.938 2.425 . . . . 0.0 117.184 171.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.58 167.72 16.77 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.011 2.474 . . . . 0.0 114.217 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -120.05 -46.09 2.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.616 1.966 . . . . 0.0 113.301 175.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.55 97.84 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.272 1.035 . . . . 0.0 111.903 -170.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -94.17 164.24 13.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.057 162.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -23.11 52.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.036 2.134 . . . . 0.0 114.805 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmt-85 -103.87 -9.09 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.136 1.374 . . . . 0.0 114.261 174.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.21 -111.09 1.29 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.662 1.601 . . . . 0.0 111.848 -177.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -117.01 -31.28 5.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.23 105.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.042 2.937 . . . . 0.0 114.76 -171.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.44 49.76 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.267 -0.896 . . . . 0.0 112.382 175.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.9 p -55.66 -22.12 21.45 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.528 2.331 . . . . 0.0 114.947 174.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.59 -20.44 33.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.017 1.327 . . . . 0.0 113.121 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 6.4 p-90 -129.4 -155.1 0.68 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.668 1.587 . . . . 0.0 111.894 -176.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 21.3 mtmm -82.85 42.38 0.79 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -159.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.97 -1.87 0.34 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 -170.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.18 7.77 5.49 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.32 1.848 . . . . 0.0 114.276 173.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.76 87.75 51.38 Favored Pre-proline 0 N--CA 1.479 1.018 0 O-C-N 120.524 -1.36 . . . . 0.0 111.93 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.96 147.87 50.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.483 2.122 . . . . 0.0 112.913 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.84 -31.26 14.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.189 1.396 . . . . 0.0 111.921 174.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -149.62 146.9 27.54 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 109.846 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 p -136.65 152.79 50.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.936 0.874 . . . . 0.0 111.188 164.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.8 -134.41 1.81 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -128.96 144.16 51.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 128.006 2.523 . . . . 0.0 110.064 -175.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -87.13 139.54 30.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.668 . . . . 0.0 110.749 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -141.94 91.18 2.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.257 1.023 . . . . 0.0 110.621 170.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.31 129.69 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.196 -0.94 . . . . 0.0 108.524 174.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.9 171.73 12.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 110.836 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 t -157.29 136.86 12.18 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.665 -1.272 . . . . 0.0 113.117 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -92.72 20.36 6.54 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.122 2.169 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.64 126.05 0.67 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.082 1.801 . . . . 0.0 112.547 -174.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 56.38 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 127.756 2.423 . . . . 0.0 117.102 -174.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -128.59 110.79 12.56 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 107.842 170.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.69 157.52 20.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.806 0.813 . . . . 0.0 109.557 167.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -130.91 110.92 11.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.601 1.56 . . . . 0.0 107.366 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 mm -74.6 104.48 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 171.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -106.93 146.89 30.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.806 0.73 . . . . 0.0 110.419 176.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.9 mt -124.48 124.79 43.06 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.511 1.125 . . . . 0.0 109.092 -175.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -119.31 149.02 42.49 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.955 1.302 . . . . 0.0 111.58 -168.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.94 131.04 44.44 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.659 -1.275 . . . . 0.0 109.314 171.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -69.47 -3.9 16.46 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.6 -42.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 127.063 2.145 . . . . 0.0 111.051 -177.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -114.24 -13.24 12.37 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.15 9.87 72.77 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.112 0.863 . . . . 0.0 114.269 -170.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.97 141.93 56.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.891 1.345 . . . . 0.0 112.257 -176.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.7 tp -74.42 121.55 21.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.033 0.533 . . . . 0.0 111.784 -174.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -87.47 -53.67 4.69 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.322 1.449 . . . . 0.0 111.513 171.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.86 162.85 39.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.533 1.133 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -141.61 136.89 31.45 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.348 1.059 . . . . 0.0 112.552 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.77 113.12 31.87 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.818 1.647 . . . . 0.0 111.175 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.92 139.51 13.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.418 2.745 . . . . 0.0 111.954 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.87 131.42 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.209 1.403 . . . . 0.0 112.75 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -112.77 -5.66 13.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.274 1.03 . . . . 0.0 113.13 178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 136.09 11.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.065 1.746 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 12.6 t80 -125.2 124.5 25.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.367 1.067 . . . . 0.0 111.895 172.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.63 158.75 46.94 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 120.058 1.056 . . . . 0.0 114.502 -7.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.77 -163.53 20.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.6 1.095 . . . . 0.0 113.256 176.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -80.8 -24.38 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.752 -0.852 . . . . 0.0 111.788 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.5 -19.55 60.32 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.2 p -160.98 122.31 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.59 1.556 . . . . 0.0 109.741 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.88 153.93 47.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.818 1.647 . . . . 0.0 111.522 -174.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.3 m -106.95 84.88 2.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.113 0.959 . . . . 0.0 109.184 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m 29.34 -75.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.054 2.942 . . . . 0.0 116.766 158.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 p -136.77 -50.88 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 112.642 158.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -149.61 -73.02 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 4.7 t -48.42 139.26 9.18 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 168.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.4 p -105.67 18.56 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -175.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.1 ttm105 -58.6 -31.94 68.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.129 0.972 . . . . 0.0 111.935 165.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.49 162.33 19.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.284 1.834 . . . . 0.0 112.285 176.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.18 174.46 10.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.757 1.623 . . . . 0.0 110.373 170.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.67 134.49 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.506 1.522 . . . . 0.0 108.715 165.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.72 150.69 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.045 0.938 . . . . 0.0 111.507 175.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 98.27 10.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.197 1.399 . . . . 0.0 108.973 173.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 pt -83.72 162.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.16 0.984 . . . . 0.0 111.238 173.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -106.62 147.96 28.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.032 0.533 . . . . 0.0 112.227 162.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.8 -5.77 59.28 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.15 5.17 87.72 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.145 1.355 . . . . 0.0 115.295 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 p -111.65 12.16 21.15 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.51 1.524 . . . . 0.0 113.321 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.33 13.19 52.77 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.368 1.461 . . . . 0.0 113.857 -172.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -129.59 167.92 17.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.948 1.699 . . . . 0.0 113.559 -177.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -131.0 157.57 42.63 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.609 1.563 . . . . 0.0 113.293 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.59 148.95 36.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 112.141 169.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.01 131.51 45.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.583 0.753 . . . . 0.0 110.784 170.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.9 pt -127.42 143.46 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.469 1.108 . . . . 0.0 110.641 170.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.08 155.73 44.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 161.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.15 144.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 124.944 1.297 . . . . 0.0 108.575 173.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.88 133.5 6.26 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.843 1.211 . . . . 0.0 111.334 167.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.18 161.44 14.42 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -70.85 -27.08 63.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.312 1.045 . . . . 0.0 112.666 174.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.05 139.04 45.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.956 1.702 . . . . 0.0 110.561 173.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -69.01 -22.02 64.09 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.079 -1.013 . . . . 0.0 112.726 176.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.28 -33.59 68.79 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.286 0.946 . . . . 0.0 113.127 168.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -69.16 -34.26 74.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 111.395 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.87 -37.46 76.08 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.531 -0.731 . . . . 0.0 112.796 169.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.66 -31.98 73.44 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.348 -1.47 . . . . 0.0 112.064 175.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.19 -33.68 70.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.4 1.08 . . . . 0.0 111.75 172.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -61.39 -36.5 80.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.997 0.817 . . . . 0.0 111.74 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.17 -56.16 7.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.338 0.655 . . . . 0.0 111.763 170.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.74 -33.02 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.897 -1.127 . . . . 0.0 113.013 -171.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.7 p -64.47 -20.18 66.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 172.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.09 -34.7 12.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.298 1.039 . . . . 0.0 112.284 171.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -57.38 -50.02 74.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.263 0.938 . . . . 0.0 110.407 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.19 -7.23 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 113.252 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -84.89 -38.96 18.8 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.326 -0.859 . . . . 0.0 112.791 173.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.35 -19.32 23.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.89 -43.4 0.69 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.992 2.917 . . . . 0.0 115.702 169.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -102.95 6.04 38.72 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -173.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.69 -177.35 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.932 1.693 . . . . 0.0 112.098 -175.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.3 tttm 65.16 11.46 7.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 168.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 54.61 32.02 16.26 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.959 1.704 . . . . 0.0 114.007 168.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.354 1.862 . . . . 0.0 112.663 -178.026 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.789 0.328 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -137.64 152.95 49.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.744 1.618 . . . . 0.0 111.009 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -77.58 154.63 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.272 1.029 . . . . 0.0 111.929 176.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.0 p -93.83 136.15 34.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.3 1.44 . . . . 0.0 112.412 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 41.7 m -82.98 45.43 1.01 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.323 1.449 . . . . 0.0 113.247 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -51.23 152.28 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.713 2.405 . . . . 0.0 115.09 -166.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.12 125.18 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.696 1.198 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.531 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.42 -19.06 0.02 OUTLIER Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.971 2.224 . . . . 0.0 113.478 175.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -63.22 -26.11 68.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.363 1.465 . . . . 0.0 114.896 177.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.4 tt -109.93 -38.12 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.747 1.219 . . . . 0.0 112.956 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.75 2.06 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.374 0.987 . . . . 0.0 112.131 177.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 -167.4 1.93 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.826 1.651 . . . . 0.0 110.854 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.29 31.4 mmt180 59.67 38.3 21.97 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.31 2.644 . . . . 0.0 113.941 174.655 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 70.1 m -131.38 150.03 75.26 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.482 1.513 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.24 152.35 66.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.416 2.744 . . . . 0.0 112.555 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.39 143.09 24.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.209 1.404 . . . . 0.0 111.033 177.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.7 m -65.18 -18.57 65.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.19 -5.42 23.19 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 113.129 178.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.74 -5.09 58.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.751 1.22 . . . . 0.0 114.178 -178.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.5 p -77.66 -13.95 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.948 1.299 . . . . 0.0 114.414 -172.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -147.42 156.13 42.59 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.553 1.941 . . . . 0.0 110.725 175.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.65 18.34 0.98 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.168 1.387 . . . . 0.0 112.932 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.74 101.63 13.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.501 1.521 . . . . 0.0 110.54 -178.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -151.31 -174.97 4.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.679 1.191 . . . . 0.0 112.653 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.18 133.35 4.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.438 1.495 . . . . 0.0 108.676 161.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -93.95 145.58 24.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.558 1.143 . . . . 0.0 111.652 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.21 131.06 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.754 1.161 . . . . 0.0 112.099 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.4 mt -106.29 -47.72 3.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.189 1.396 . . . . 0.0 111.714 174.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.03 151.9 41.32 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.496 1.118 . . . . 0.0 112.377 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.54 132.99 45.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.241 1.816 . . . . 0.0 108.573 171.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -124.94 139.02 32.57 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 169.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 -26.55 14.07 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.538 3.492 . . . . 0.0 114.341 -167.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -143.73 132.98 23.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.086 1.354 . . . . 0.0 110.735 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.13 138.73 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.001 1.321 . . . . 0.0 109.525 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -116.91 140.66 49.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.264 1.025 . . . . 0.0 111.632 -179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -118.88 138.53 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.259 1.423 . . . . 0.0 111.325 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.83 79.67 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.127 2.171 . . . . 0.0 108.298 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -55.49 138.45 46.34 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.742 -1.224 . . . . 0.0 112.459 177.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 pt -119.3 142.41 32.34 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -163.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -71.29 -43.15 1.6 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.806 2.338 . . . . 0.0 116.681 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 156.5 27.76 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.814 2.343 . . . . 0.0 113.812 -176.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -102.99 -25.93 13.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.581 1.552 . . . . 0.0 114.361 169.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -164.66 102.79 0.81 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.639 1.176 . . . . 0.0 110.113 -176.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -90.61 162.35 15.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 0.0 111.432 169.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -21.69 12.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.264 2.226 . . . . 0.0 115.975 -176.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -114.72 -1.47 13.27 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.463 1.505 . . . . 0.0 114.235 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.42 -95.33 0.34 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.811 1.672 . . . . 0.0 110.711 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -134.28 -33.29 1.01 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 173.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.49 111.98 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 129.586 3.155 . . . . 0.0 114.912 -171.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.79 22.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.391 -0.818 . . . . 0.0 112.513 175.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -64.67 -16.16 62.42 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.36 1.864 . . . . 0.0 114.839 178.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -84.8 -17.04 39.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 0.0 113.413 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -172.22 2.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.843 1.657 . . . . 0.0 110.025 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.03 115.0 5.62 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.532 -1.355 . . . . 0.0 109.893 172.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD21 ' H ' ' B' ' 154' ' ' GLN . 3.7 pp -105.76 -6.75 18.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -124.95 -7.3 7.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.411 1.885 . . . . 0.0 113.919 -175.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -125.71 84.07 61.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.36 1.864 . . . . 0.0 110.14 -174.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.44 154.44 55.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.755 2.304 . . . . 0.0 112.686 -176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.38 -24.84 15.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.794 1.238 . . . . 0.0 111.989 175.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -149.41 146.89 27.7 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.061 1.744 . . . . 0.0 110.181 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -137.53 154.38 49.85 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.723 0.809 . . . . 0.0 111.407 165.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.17 -139.99 3.12 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.438 -174.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -120.9 145.72 47.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.56 2.344 . . . . 0.0 110.181 -174.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.25 134.68 42.83 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.122 0.969 . . . . 0.0 110.719 177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -118.85 141.62 48.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.553 1.141 . . . . 0.0 110.104 152.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 mt -121.49 124.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 164.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.1 p -128.85 169.35 14.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.377 1.071 . . . . 0.0 111.122 -176.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -151.44 127.87 10.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.563 1.545 . . . . 0.0 112.303 -177.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -92.92 23.86 3.98 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.363 1.865 . . . . 0.0 112.273 167.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 121.54 0.5 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.243 1.877 . . . . 0.0 112.479 -177.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 58.29 -7.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.181 2.192 . . . . 0.0 116.349 -174.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 114.93 16.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.593 1.557 . . . . 0.0 108.333 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.74 159.3 15.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 110.43 173.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -132.5 111.84 11.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.75 111.78 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 169.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -115.73 121.2 41.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.792 0.837 . . . . 0.0 111.241 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.34 132.57 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.372 1.069 . . . . 0.0 109.927 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.36 152.76 49.42 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.601 1.16 . . . . 0.0 112.887 -165.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.38 136.39 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 110.906 177.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -66.45 -9.35 33.25 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -173.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.26 -39.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.266 1.827 . . . . 0.0 111.421 -171.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.78 -2.45 5.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -170.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.73 11.7 69.53 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.033 0.825 . . . . 0.0 115.02 178.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -70.96 140.8 51.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.54 1.17 . . . . 0.0 111.551 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -71.21 123.19 21.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.68 -0.638 . . . . 0.0 112.037 -172.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -85.29 -52.09 6.14 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.67 1.588 . . . . 0.0 111.149 169.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.16 160.5 38.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.95 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -138.88 139.46 38.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.669 0.787 . . . . 0.0 113.07 170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.86 116.26 26.27 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.106 1.762 . . . . 0.0 111.232 178.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 142.97 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.646 2.897 . . . . 0.0 112.404 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.97 134.54 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.299 1.44 . . . . 0.0 113.116 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.53 5.76 9.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.66 1.184 . . . . 0.0 112.99 175.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 129.59 5.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.547 1.939 . . . . 0.0 110.368 -175.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' HD2' HG13 ' A' ' 82' ' ' VAL . 20.8 t80 -133.32 128.09 20.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.717 1.207 . . . . 0.0 112.181 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -64.59 159.76 70.15 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 119.998 1.035 . . . . 0.0 112.749 -9.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.79 -162.12 20.32 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.74 0.686 . . . . 0.0 113.98 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 tp -76.42 -25.8 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.744 -0.857 . . . . 0.0 111.346 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.42 -22.51 54.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 77' ' ' TYR . 2.1 p -161.54 120.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.599 1.56 . . . . 0.0 109.598 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.54 151.07 51.67 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.907 1.683 . . . . 0.0 111.001 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -96.67 95.85 8.22 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 86' ' ' THR . 1.5 m 12.12 -70.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 129.759 3.223 . . . . 0.0 116.577 164.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 85' ' ' VAL . 10.4 p -139.02 -53.12 0.57 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 111.318 158.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.61 -69.76 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.134 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -46.89 138.98 5.87 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.212 0.914 . . . . 0.0 113.411 166.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -113.82 39.75 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.849 1.26 . . . . 0.0 112.846 178.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -75.77 -24.56 56.03 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.129 154.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.06 158.88 31.17 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.882 1.673 . . . . 0.0 112.026 -176.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -141.43 171.21 14.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.234 1.413 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.12 129.51 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.841 1.257 . . . . 0.0 108.469 163.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.67 149.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.616 0.766 . . . . 0.0 111.806 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.12 101.17 12.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.125 1.37 . . . . 0.0 109.019 173.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.6 pt -87.63 165.7 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.566 1.146 . . . . 0.0 111.217 173.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -89.04 146.14 25.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.928 -0.482 . . . . 0.0 111.653 153.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -84.98 -2.48 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.9 89.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.119 1.342 . . . . 0.0 115.245 174.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.3 p -113.8 13.66 18.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.612 1.565 . . . . 0.0 113.329 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 14.38 53.78 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.325 1.441 . . . . 0.0 113.886 -173.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -133.21 172.85 12.11 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.911 1.684 . . . . 0.0 113.55 -176.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -117.87 157.76 26.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 112.992 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.15 33.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.062 1.345 . . . . 0.0 111.975 173.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -98.64 131.78 44.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.01 170.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.6 pt -124.38 141.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.06 0.944 . . . . 0.0 111.663 170.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.57 147.97 31.73 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 161.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.04 143.49 37.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.034 1.334 . . . . 0.0 108.146 173.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.25 130.59 5.04 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.501 1.048 . . . . 0.0 111.163 169.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -94.08 151.97 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.155 0.979 . . . . 0.0 112.608 178.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -66.45 -33.67 76.22 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.438 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -114.88 137.02 52.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.217 1.407 . . . . 0.0 112.26 175.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 45.7 tpt85 -57.08 -34.84 68.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.858 1.263 . . . . 0.0 112.309 173.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.37 -27.23 66.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.279 1.419 . . . . 0.0 114.234 177.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -74.17 -38.83 63.58 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.187 1.493 . . . . 0.0 111.517 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.83 -34.4 73.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 169.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.66 -36.32 78.41 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.416 -1.428 . . . . 0.0 112.32 172.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -70.96 -32.51 69.4 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.063 -1.023 . . . . 0.0 112.043 173.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.73 -41.73 87.11 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.873 0.761 . . . . 0.0 111.135 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -66.62 -50.96 61.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.708 0.803 . . . . 0.0 112.514 170.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.66 -32.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.367 0.985 . . . . 0.0 112.389 -175.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -58.93 -25.56 63.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.787 0.835 . . . . 0.0 113.097 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.89 -35.88 11.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.253 1.021 . . . . 0.0 112.329 175.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.66 -51.52 66.95 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.274 0.943 . . . . 0.0 110.85 173.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.89 -7.67 55.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -84.86 -38.29 19.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.877 0.871 . . . . 0.0 111.584 170.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -89.63 -15.51 32.55 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -27.61 67.26 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -102.32 4.65 39.3 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.138 1.375 . . . . 0.0 114.073 -177.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.44 -154.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 127.636 2.374 . . . . 0.0 109.265 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptp 63.65 16.05 9.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.259 2.224 . . . . 0.0 116.455 168.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 59.81 23.23 12.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.063 2.145 . . . . 0.0 114.789 171.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 114.545 -175.255 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 111.265 0.098 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 62.86 -47.95 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.812 2.845 . . . . 0.0 116.96 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.08 157.89 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.095 1.358 . . . . 0.0 112.266 178.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -72.68 129.29 37.89 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.536 1.135 . . . . 0.0 112.279 174.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 21.8 p -170.21 105.25 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.013 1.325 . . . . 0.0 111.841 171.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . 0.521 ' H ' HD21 ' A' ' 38' ' ' LEU . 28.9 mt-30 59.1 171.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.4 2.68 . . . . 0.0 115.735 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.22 127.79 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -149.02 -18.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.804 1.193 . . . . 0.0 115.389 -169.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -72.72 -17.38 61.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.416 1.108 . . . . 0.0 113.55 174.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.33 -36.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.23 43.44 92.98 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 124.152 0.882 . . . . 0.0 113.808 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.08 -148.3 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.087 1.755 . . . . 0.0 113.891 -167.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -144.29 169.61 17.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.111 1.764 . . . . 0.0 111.697 -143.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.679 174.848 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 73.0 m -63.22 151.96 85.66 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.352 1.061 . . . . 0.0 112.797 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.31 -14.09 28.22 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 114.585 -174.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -142.68 164.6 29.66 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.508 1.523 . . . . 0.0 111.158 176.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 38.2 t -129.67 146.25 51.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.751 1.62 . . . . 0.0 111.483 176.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt -101.17 2.45 40.12 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.907 1.283 . . . . 0.0 113.749 -175.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.11 -19.77 64.75 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -175.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.1 p -97.74 -7.39 30.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.032 1.733 . . . . 0.0 113.836 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -97.66 160.04 14.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.105 1.762 . . . . 0.0 112.362 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . 0.306 0.3 OUTLIER -75.07 16.58 0.3 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 170.758 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -55.73 135.05 51.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.117 1.367 . . . . 0.0 112.031 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -150.24 178.67 8.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -164.38 135.13 4.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.142 2.177 . . . . 0.0 108.639 166.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.9 m -99.16 132.35 44.53 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.703 1.601 . . . . 0.0 111.5 -177.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.2 t -62.08 133.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.386 0.994 . . . . 0.0 111.857 -175.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -109.88 -42.51 4.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.917 1.687 . . . . 0.0 112.5 175.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 t -149.06 147.08 28.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.23 1.012 . . . . 0.0 111.998 -176.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.81 131.2 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.864 1.665 . . . . 0.0 108.891 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.87 140.78 38.61 Favored Pre-proline 0 N--CA 1.479 1.022 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 175.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 -23.83 13.33 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.628 3.552 . . . . 0.0 114.527 -166.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -143.39 134.36 25.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.156 0.982 . . . . 0.0 111.679 175.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.44 140.6 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 109.415 172.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -120.1 144.53 47.57 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.603 1.161 . . . . 0.0 112.67 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.64 133.93 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.418 1.087 . . . . 0.0 111.987 -170.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.06 -10.88 17.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -167.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 43.35 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 127.853 2.461 . . . . 0.0 114.0 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.9 pt -87.85 148.17 42.88 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.057 1.343 . . . . 0.0 114.194 -158.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -74.36 -42.89 0.58 Allowed 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 122.948 2.432 . . . . 0.0 117.324 173.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -82.35 166.97 15.8 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.995 2.463 . . . . 0.0 114.008 -173.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -120.1 -27.78 5.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.731 1.613 . . . . 0.0 115.123 170.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.23 108.01 1.25 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.802 0.81 . . . . 0.0 111.924 -177.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -98.28 162.19 13.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.454 1.502 . . . . 0.0 110.814 160.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -22.3 37.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.522 1.929 . . . . 0.0 114.833 178.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -103.56 -5.04 23.11 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.229 1.411 . . . . 0.0 113.981 175.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.65 -102.94 0.76 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.595 1.569 . . . . 0.0 111.668 -173.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -129.65 -32.62 1.9 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.66 108.97 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.452 3.101 . . . . 0.0 115.136 -169.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.63 52.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.795 -1.191 . . . . 0.0 113.49 174.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 p -68.53 -18.01 64.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.893 2.077 . . . . 0.0 114.532 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -82.22 -32.6 29.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.478 1.111 . . . . 0.0 112.811 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -112.08 -156.61 0.59 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.301 2.24 . . . . 0.0 110.68 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -66.34 109.62 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.668 -1.27 . . . . 0.0 111.12 174.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.26 -31.69 24.83 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.24 -177.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.67 19.92 1.31 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -127.44 79.51 73.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.554 1.542 . . . . 0.0 111.077 -170.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 152.65 58.4 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.407 2.738 . . . . 0.0 113.671 -173.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.58 -25.83 16.01 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.571 1.148 . . . . 0.0 111.937 169.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -137.99 146.39 43.07 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.247 1.419 . . . . 0.0 111.328 174.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 p -138.01 149.18 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.304 1.442 . . . . 0.0 111.257 172.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.19 -134.32 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.911 -176.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -129.11 143.6 50.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.151 2.18 . . . . 0.0 110.654 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.7 139.73 31.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.225 1.01 . . . . 0.0 110.493 177.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -142.26 90.99 2.29 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.248 1.019 . . . . 0.0 110.477 170.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.95 135.94 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.06 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -136.62 171.71 14.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.114 1.766 . . . . 0.0 110.412 -175.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -157.7 137.84 12.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.221 1.409 . . . . 0.0 113.616 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -96.83 15.55 21.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.009 2.123 . . . . 0.0 112.528 171.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.45 121.47 2.05 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.339 1.923 . . . . 0.0 112.153 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tttm 54.2 -21.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 128.879 2.872 . . . . 0.0 116.833 -165.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -110.52 105.74 14.8 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.091 -1.006 . . . . 0.0 108.49 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.4 154.57 27.6 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.387 165.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -131.35 115.57 16.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -74.01 110.05 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -98.14 144.13 27.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.334 0.97 . . . . 0.0 109.413 166.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.9 mt -118.4 131.43 56.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.417 1.087 . . . . 0.0 109.503 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -122.45 148.72 44.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.328 1.451 . . . . 0.0 112.236 -168.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -71.13 131.88 44.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 169.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -69.08 -10.71 58.98 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.28 -38.21 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.945 1.698 . . . . 0.0 111.039 -174.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -129.23 -3.18 5.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -170.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.81 11.93 70.11 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.372 0.987 . . . . 0.0 114.611 -179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.425 1.113 . . . . 0.0 111.69 -175.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.09 123.01 21.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.153 0.581 . . . . 0.0 111.999 -174.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.4 -52.65 5.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.236 1.414 . . . . 0.0 111.319 170.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.2 163.57 39.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.031 1.332 . . . . 0.0 111.516 178.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -142.28 136.89 30.23 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 113.071 171.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.67 122.58 26.47 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.931 1.292 . . . . 0.0 111.928 176.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.71 143.18 14.73 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.782 2.988 . . . . 0.0 111.977 172.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.59 127.33 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.493 1.117 . . . . 0.0 112.598 175.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -109.87 -9.09 14.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.693 1.197 . . . . 0.0 113.466 177.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.55 143.68 17.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.941 1.696 . . . . 0.0 112.042 174.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CD1' HG13 ' A' ' 82' ' ' VAL . 10.7 t80 -132.4 131.04 22.08 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.619 1.968 . . . . 0.0 110.809 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.78 156.56 58.98 Favored 'Cis proline' 0 CA--C 1.541 0.872 0 CA-C-N 120.483 1.208 . . . . 0.0 112.533 -12.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.68 -164.55 23.54 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.936 0.779 . . . . 0.0 113.763 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.69 -25.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.083 0.953 . . . . 0.0 111.643 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.31 -19.98 55.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.1 p -159.2 118.07 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.668 1.587 . . . . 0.0 109.479 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.57 152.12 51.71 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.844 1.658 . . . . 0.0 110.924 -177.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -107.26 71.26 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 109.848 176.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m 43.77 -71.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 128.787 2.835 . . . . 0.0 117.786 158.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.1 p -137.09 -47.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.875 1.27 . . . . 0.0 111.044 155.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -159.51 -62.49 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.529 ' HB2' ' H ' ' B' ' 156' ' ' TPO . 0.2 OUTLIER -55.91 136.95 51.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.487 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.463 ' H ' ' NH2' ' A' ' 113' ' ' ARG . 94.5 p -112.47 13.53 20.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -157.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -58.45 -31.79 68.12 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 118.949 0.795 . . . . 0.0 110.759 161.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.95 155.4 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 112.982 -175.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -141.28 171.73 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.262 1.425 . . . . 0.0 110.312 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -130.3 134.18 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.666 1.186 . . . . 0.0 108.692 163.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 152.72 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.679 0.791 . . . . 0.0 112.36 175.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 93.77 5.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.37 1.468 . . . . 0.0 110.169 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 pt -83.04 157.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.513 1.525 . . . . 0.0 112.535 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -85.08 149.17 25.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.63 -0.669 . . . . 0.0 111.819 159.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -92.54 0.01 57.38 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.176 0.991 . . . . 0.0 113.279 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 17.7 79.92 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.63 1.11 . . . . 0.0 115.154 178.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . 0.257 9.6 t -141.95 33.94 1.57 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 19.23 61.91 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.199 1.381 . . . . 0.0 113.88 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.45 178.81 7.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.883 1.673 . . . . 0.0 113.03 -171.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.6 p -145.59 162.74 36.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.61 156.26 42.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.849 2.06 . . . . 0.0 112.153 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.47 132.14 40.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 111.291 170.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.2 pt -121.77 134.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.192 0.997 . . . . 0.0 111.973 167.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.04 142.6 20.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 166.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -122.77 146.93 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.314 1.445 . . . . 0.0 109.543 -177.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.94 137.64 9.47 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.883 1.23 . . . . 0.0 112.507 164.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.1 158.53 15.4 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.259 1.024 . . . . 0.0 113.311 177.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 t -79.89 -23.59 41.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.037 0.935 . . . . 0.0 113.001 178.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.59 141.81 45.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.738 1.615 . . . . 0.0 111.575 177.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.463 ' NH2' ' H ' ' A' ' 89' ' ' SER . 7.8 tpp180 -61.45 -35.99 79.13 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.672 . . . . 0.0 112.106 175.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.34 80.65 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.19 0.9 . . . . 0.0 112.934 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -66.68 -36.7 83.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.164 0.982 . . . . 0.0 111.385 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.58 -37.46 71.03 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 173.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.75 -29.42 70.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.983 -1.073 . . . . 0.0 111.403 175.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.25 -32.05 55.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.116 -0.99 . . . . 0.0 112.269 172.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.51 -36.92 77.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.15 0.887 . . . . 0.0 111.176 168.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -72.23 -55.95 6.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 112.743 172.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -66.62 -30.79 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.979 -1.075 . . . . 0.0 112.863 -170.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.9 p -65.62 -24.71 67.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.094 0.861 . . . . 0.0 113.285 172.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.7 mt -83.57 -37.79 22.49 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.924 0.784 . . . . 0.0 112.193 166.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -59.17 -52.2 66.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.59 1.086 . . . . 0.0 111.611 176.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.86 -16.34 63.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.057 1.343 . . . . 0.0 113.025 177.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -86.49 -28.1 23.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.865 1.266 . . . . 0.0 112.526 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 130' ' ' VAL . 42.3 m-85 -98.74 -18.89 17.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.22 -33.59 12.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 129.676 3.19 . . . . 0.0 114.912 177.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -105.54 8.75 33.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.516 1.526 . . . . 0.0 114.3 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -133.72 -163.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.903 2.081 . . . . 0.0 110.298 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp 69.13 12.19 8.44 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 162.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 54.73 22.42 4.11 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.824 2.05 . . . . 0.0 115.182 174.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.718 1.607 . . . . 0.0 113.157 178.873 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -73.2 155.05 39.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 112.368 176.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 42.1 mm -120.5 147.75 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.083 1.753 . . . . 0.0 110.124 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -79.04 148.43 32.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.029 1.332 . . . . 0.0 113.172 -177.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -122.0 62.19 0.95 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.42 . . . . 0.0 111.54 -177.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.32 157.01 6.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.386 1.875 . . . . 0.0 113.112 -176.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 88' ' ' SER . 1.4 t -67.85 147.92 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.767 0.794 . . . . 0.0 109.496 171.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.529 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.39 19.99 0.47 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.006 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -146.28 -38.19 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -169.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.96 -34.36 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.858 0.753 . . . . 0.0 112.962 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.0 44.26 94.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.506 1.051 . . . . 0.0 113.513 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -108.79 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.285 1.834 . . . . 0.0 113.893 -164.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.14 158.48 25.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.361 2.664 . . . . 0.0 112.417 -175.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.835 2.054 . . . . 0.0 112.931 -168.873 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 85.7 p -76.79 164.27 60.39 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.4 1.08 . . . . 0.0 112.969 178.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -59.55 -21.15 60.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.349 2.699 . . . . 0.0 114.608 173.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -91.33 -5.45 54.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.115 1.366 . . . . 0.0 113.356 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.0 t -65.92 145.63 55.68 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.232 -0.917 . . . . 0.0 112.364 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm 59.06 7.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.991 2.116 . . . . 0.0 116.033 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.68 -3.8 58.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.665 1.186 . . . . 0.0 113.751 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -84.08 53.43 2.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.3 1.84 . . . . 0.0 113.83 -170.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.38 152.66 27.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.101 1.36 . . . . 0.0 110.523 166.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.52 -45.89 81.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 39.37 45.55 1.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.411 2.285 . . . . 0.0 113.305 -177.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -79.99 175.68 10.42 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -166.21 123.12 1.35 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.308 1.443 . . . . 0.0 109.159 169.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -95.2 128.38 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.63 133.09 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.061 -1.024 . . . . 0.0 111.604 -174.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -107.24 -47.52 3.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.675 1.59 . . . . 0.0 112.21 178.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.2 t -146.56 135.39 22.33 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.415 1.086 . . . . 0.0 111.091 -178.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.48 137.14 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.461 1.104 . . . . 0.0 109.523 171.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -129.85 132.46 24.17 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.203 1.001 . . . . 0.0 112.634 173.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -77.11 -26.51 7.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.893 3.062 . . . . 0.0 114.364 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -141.83 130.98 23.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.994 1.318 . . . . 0.0 110.802 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.76 143.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 109.77 -178.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.4 p -117.98 141.81 48.05 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.479 1.112 . . . . 0.0 112.186 176.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.25 142.14 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.107 1.363 . . . . 0.0 111.39 -172.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -133.32 96.47 3.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.188 1.795 . . . . 0.0 109.782 -173.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -54.76 126.11 22.75 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 119.929 -1.732 . . . . 0.0 110.862 166.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 pt -111.17 141.1 23.62 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -73.75 -43.19 0.66 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 122.883 2.389 . . . . 0.0 116.847 171.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 163.76 22.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.816 2.344 . . . . 0.0 114.089 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -115.56 -44.8 2.94 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.448 1.899 . . . . 0.0 113.279 174.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.86 93.88 1.6 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.374 1.083 . . . . 0.0 111.721 -169.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 t -88.15 162.36 16.77 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.077 162.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -21.86 32.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.438 1.895 . . . . 0.0 114.789 178.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.33 -7.53 19.9 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.215 1.406 . . . . 0.0 114.109 175.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.88 -107.92 1.17 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.568 1.556 . . . . 0.0 111.694 -173.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -122.25 -34.18 3.35 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.96 110.55 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 129.568 3.147 . . . . 0.0 115.027 -170.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.33 -34.7 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.879 -1.138 . . . . 0.0 112.262 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -61.92 -17.12 55.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.437 2.695 . . . . 0.0 115.728 174.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.29 -33.06 22.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.671 1.188 . . . . 0.0 113.067 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -161.76 0.8 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.664 1.985 . . . . 0.0 110.298 178.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -63.17 114.17 3.6 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.487 171.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -94.71 -26.08 16.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.846 2.058 . . . . 0.0 111.887 -176.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.29 9.14 1.63 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.195 1.398 . . . . 0.0 114.021 -176.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -123.18 79.61 52.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.095 1.758 . . . . 0.0 111.074 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 155.16 63.36 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.52 2.814 . . . . 0.0 114.723 -169.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -93.58 -27.82 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.028 1.731 . . . . 0.0 111.932 174.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -148.21 150.53 33.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.626 1.57 . . . . 0.0 110.754 172.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.0 p -138.9 148.93 44.24 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.965 1.306 . . . . 0.0 111.286 172.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.92 -131.26 1.92 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.758 -175.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -129.17 153.96 47.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.087 2.155 . . . . 0.0 110.374 -172.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.97 138.86 51.89 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.983 171.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -135.41 98.57 3.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.789 0.804 . . . . 0.0 111.093 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.3 mt -67.26 132.38 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.284 1.434 . . . . 0.0 108.814 171.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -132.91 173.11 11.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.098 1.359 . . . . 0.0 110.557 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 t -154.33 135.11 13.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.784 1.234 . . . . 0.0 112.733 171.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -90.24 27.71 1.59 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.407 1.883 . . . . 0.0 112.135 169.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.71 122.58 0.31 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.707 2.099 . . . . 0.0 112.497 -176.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 59.67 -18.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.663 2.385 . . . . 0.0 116.718 -175.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -115.78 113.63 23.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.812 1.245 . . . . 0.0 108.72 170.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.02 157.31 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.411 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.36 117.0 18.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.658 1.583 . . . . 0.0 108.321 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.5 76.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.282 1.033 . . . . 0.0 109.124 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -86.37 109.16 18.82 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.17 131.51 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.868 1.267 . . . . 0.0 109.81 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -129.45 151.76 49.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 112.278 -166.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.78 132.4 45.28 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.03 -1.043 . . . . 0.0 110.009 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -65.2 -13.77 59.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.768 1.227 . . . . 0.0 113.693 -174.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.82 -38.51 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.096 1.758 . . . . 0.0 111.338 -172.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -128.85 -2.92 5.25 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -169.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.53 12.07 69.41 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.253 0.93 . . . . 0.0 114.802 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.23 140.45 48.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.384 1.092 . . . . 0.0 111.623 -175.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.27 124.9 25.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.017 0.527 . . . . 0.0 112.095 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -90.38 -52.98 4.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.44 1.496 . . . . 0.0 111.278 170.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.15 161.47 42.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.012 1.325 . . . . 0.0 111.271 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -143.35 136.48 27.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.725 0.81 . . . . 0.0 111.305 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.76 118.53 40.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 170.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.22 139.9 15.19 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.988 2.458 . . . . 0.0 111.048 172.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.33 131.6 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.786 1.234 . . . . 0.0 112.149 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -116.68 -0.96 12.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.724 1.209 . . . . 0.0 112.798 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 141.96 12.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.317 1.847 . . . . 0.0 110.999 177.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -130.48 126.34 22.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.27 1.028 . . . . 0.0 112.322 175.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -66.29 163.34 69.38 Favored 'Cis proline' 0 CA--C 1.544 0.989 0 CA-C-N 119.564 0.88 . . . . 0.0 112.601 -10.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.38 -153.6 7.66 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.364 0.983 . . . . 0.0 113.789 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -85.68 -26.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.894 0.878 . . . . 0.0 112.104 175.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.12 -21.1 60.79 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.77 127.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.671 1.588 . . . . 0.0 109.865 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 154.1 45.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 111.785 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -102.46 88.76 3.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.135 0.974 . . . . 0.0 108.703 176.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 m 24.99 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 129.5 3.12 . . . . 0.0 116.841 160.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -130.58 -50.54 1.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.785 0.834 . . . . 0.0 111.548 154.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -154.59 -71.57 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -165.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -50.23 142.52 9.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 172.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.1 p -117.37 48.09 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.751 1.22 . . . . 0.0 112.958 -172.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -80.57 -26.72 37.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.658 0.783 . . . . 0.0 111.341 150.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -123.84 161.56 25.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.161 1.384 . . . . 0.0 112.83 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.25 174.54 10.52 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.859 1.664 . . . . 0.0 110.559 170.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.7 t -127.82 135.11 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.644 1.577 . . . . 0.0 108.392 162.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.23 153.84 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.985 0.914 . . . . 0.0 112.149 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 90.0 4.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.225 1.41 . . . . 0.0 110.539 178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 pt -82.37 162.21 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.825 1.25 . . . . 0.0 113.036 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -79.33 138.3 37.66 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.86 -0.525 . . . . 0.0 110.589 145.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -86.41 5.38 35.27 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.7 87.89 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.21 1.386 . . . . 0.0 115.217 175.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -124.69 14.87 8.72 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.147 1.379 . . . . 0.0 113.769 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 15.34 57.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.053 1.311 . . . . 0.0 113.962 -175.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -133.77 176.97 8.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.342 1.857 . . . . 0.0 112.729 -176.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.1 p -124.12 156.5 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.359 1.064 . . . . 0.0 113.721 170.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.28 152.89 39.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.884 1.673 . . . . 0.0 111.429 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -92.26 132.33 36.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.81 0.444 . . . . 0.0 110.287 166.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 pt -123.97 140.27 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.043 0.937 . . . . 0.0 110.253 168.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 150.69 42.76 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 158.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.65 141.99 44.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 124.906 1.283 . . . . 0.0 108.175 172.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.63 132.4 7.25 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.044 1.307 . . . . 0.0 111.428 167.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 54.6 m-85 -95.97 157.02 16.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.188 0.995 . . . . 0.0 112.665 175.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -74.4 -28.33 61.04 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.172 0.989 . . . . 0.0 112.401 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.54 142.93 51.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.377 1.471 . . . . 0.0 112.61 176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -61.32 -35.92 78.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.236 1.015 . . . . 0.0 112.94 173.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.96 -34.14 76.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.631 0.651 . . . . 0.0 113.029 174.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -66.06 -41.82 90.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.364 1.082 . . . . 0.0 111.422 176.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -73.92 -39.01 64.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.82 -31.84 72.11 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.302 -1.499 . . . . 0.0 111.631 176.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.82 -26.64 44.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.683 1.193 . . . . 0.0 112.719 175.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -57.81 -43.77 85.91 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.062 0.847 . . . . 0.0 110.606 166.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -49.91 65.56 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.273 1.029 . . . . 0.0 112.186 173.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.2 t -66.25 -31.33 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 112.138 -176.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.0 t -58.25 -25.21 61.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.995 0.918 . . . . 0.0 112.979 171.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.12 -34.23 11.77 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.026 0.93 . . . . 0.0 112.438 174.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -55.44 -53.79 51.93 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.632 1.105 . . . . 0.0 111.143 171.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.01 -7.78 55.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.67 -40.26 16.36 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.462 -0.774 . . . . 0.0 111.775 171.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -87.69 -14.13 40.71 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -27.44 66.26 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -103.23 4.36 36.62 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 114.355 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -168.22 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.544 1.938 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 tptt 63.05 14.08 7.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 178.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 53.92 24.86 4.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.814 2.046 . . . . 0.0 114.938 -178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.332 1.053 . . . . 0.0 113.801 174.544 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.8 40.99 32.18 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.505 1.522 . . . . 0.0 114.157 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 83.1 mt -78.08 138.25 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.647 1.179 . . . . 0.0 109.803 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.6 p -70.03 146.33 51.09 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.381 1.072 . . . . 0.0 113.081 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.4 m -83.54 51.62 2.05 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -43.78 144.09 0.91 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.18 2.192 . . . . 0.0 113.581 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.49 119.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.687 0.676 . . . . 0.0 109.297 -176.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.94 -18.47 0.02 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.633 1.587 . . . . 0.0 115.187 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -65.7 -20.18 66.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.395 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.8 tp -123.67 -33.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.393 . . . . 0.0 113.299 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.85 59.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.326 0.965 . . . . 0.0 114.198 172.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.54 -143.54 0.21 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.514 1.526 . . . . 0.0 113.192 -168.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -134.78 -161.65 1.17 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.504 1.522 . . . . 0.0 111.748 -149.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.105 1.362 . . . . 0.0 113.156 168.327 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 42.0 m -66.55 148.81 98.53 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 124.485 1.114 . . . . 0.0 112.853 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.27 155.11 64.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.312 2.675 . . . . 0.0 112.641 178.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.71 -32.52 67.89 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.129 0.972 . . . . 0.0 112.826 176.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.2 m -132.42 170.31 15.3 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.423 1.489 . . . . 0.0 112.383 -164.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -74.95 74.64 2.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.51 1.524 . . . . 0.0 111.402 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.23 53.61 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.617 1.567 . . . . 0.0 114.851 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -81.09 58.05 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.082 1.753 . . . . 0.0 112.749 -177.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.94 175.82 9.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.815 1.646 . . . . 0.0 113.157 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.61 86.39 6.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.402 169.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.06 65.68 0.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.346 1.459 . . . . 0.0 112.071 -178.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -143.01 -178.45 5.84 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.636 1.174 . . . . 0.0 112.496 176.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 134.67 3.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.497 2.319 . . . . 0.0 108.487 166.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.7 m -91.31 134.82 34.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 110.696 177.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.8 134.77 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 120.724 -1.235 . . . . 0.0 112.24 -177.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.9 mt -113.66 -44.7 3.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.166 1.387 . . . . 0.0 112.272 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 t -148.0 154.59 40.49 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.14 131.11 36.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.496 1.918 . . . . 0.0 108.87 169.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -124.43 140.16 34.58 Favored Pre-proline 0 N--CA 1.481 1.119 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 -31.72 9.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.294 3.329 . . . . 0.0 115.09 -160.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -145.74 133.45 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.38 1.072 . . . . 0.0 111.158 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.45 143.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.143 1.377 . . . . 0.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -121.64 145.47 47.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 111.278 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.78 142.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.241 1.416 . . . . 0.0 111.293 -173.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.53 85.19 2.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.816 2.046 . . . . 0.0 109.097 -170.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -48.77 134.0 16.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.519 -1.363 . . . . 0.0 112.196 173.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.3 pt -119.51 143.93 35.65 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -74.14 -49.84 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.246 2.631 . . . . 0.0 116.939 169.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.46 171.74 13.26 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.078 2.519 . . . . 0.0 113.856 -167.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -125.58 -33.91 2.72 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.79 103.42 1.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.088 0.947 . . . . 0.0 113.47 -173.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.6 t -89.56 165.76 14.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 109.703 153.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -19.43 63.33 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.892 -1.13 . . . . 0.0 112.208 172.004 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -86.93 -17.35 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.667 1.187 . . . . 0.0 113.04 171.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.37 -101.94 0.59 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.288 1.423 . . . . 0.0 112.103 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -124.99 -29.04 3.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.26 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.152 2.981 . . . . 0.0 115.43 -171.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -33.88 29.23 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.235 -0.916 . . . . 0.0 112.922 171.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -65.23 -15.37 62.4 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.941 2.096 . . . . 0.0 114.88 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.91 -32.0 21.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.065 1.346 . . . . 0.0 113.008 176.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -108.6 -154.38 0.53 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.012 2.125 . . . . 0.0 110.192 174.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -74.43 103.0 4.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.923 1.344 . . . . 0.0 110.999 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.0 tp -79.11 -29.76 43.41 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.272 2.629 . . . . 0.0 112.377 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -136.87 -0.05 2.36 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.909 1.684 . . . . 0.0 114.535 -167.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -120.72 87.07 41.64 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.653 1.581 . . . . 0.0 110.897 -172.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.49 155.2 55.35 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.183 2.588 . . . . 0.0 113.366 -175.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.23 -28.02 10.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.95 1.7 . . . . 0.0 112.611 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -146.57 149.96 34.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.159 1.784 . . . . 0.0 109.974 174.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -137.2 156.0 48.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.786 0.803 . . . . 0.0 111.854 165.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.32 -134.96 1.95 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.647 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -131.1 144.5 51.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.841 2.456 . . . . 0.0 109.672 -174.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.95 136.23 35.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.755 0.822 . . . . 0.0 110.062 176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt85 -123.48 149.86 44.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.022 146.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.79 130.7 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 107.387 170.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.4 p -133.63 171.72 13.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.843 1.257 . . . . 0.0 110.215 -177.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.9 p -152.31 124.38 8.07 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.301 -0.874 . . . . 0.0 113.11 175.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -89.2 68.7 8.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.896 1.278 . . . . 0.0 109.716 168.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -125.05 6.77 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.514 1.531 . . . . 0.0 112.181 -175.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -72.73 11.9 0.58 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.483 1.913 . . . . 0.0 114.736 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 m -126.68 118.5 24.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.901 1.28 . . . . 0.0 110.05 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.35 20.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.058 0.943 . . . . 0.0 111.137 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.18 121.62 16.12 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.455 1.102 . . . . 0.0 108.047 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.0 mm -81.64 111.14 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -115.51 110.59 19.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.955 . . . . 0.0 110.98 -178.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.5 mt -93.03 132.93 36.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.696 1.198 . . . . 0.0 110.667 -174.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.04 147.87 47.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 112.059 -167.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.5 131.64 42.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.672 -1.267 . . . . 0.0 109.926 173.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -73.84 0.37 13.45 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.99 -38.6 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.014 1.726 . . . . 0.0 111.174 179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.5 m -126.08 -7.05 6.58 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -171.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 12.14 70.59 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.472 1.034 . . . . 0.0 114.455 -175.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.54 145.94 40.9 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.226 1.013 . . . . 0.0 112.087 -174.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.62 119.83 17.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.015 0.436 . . . . 0.0 111.638 -173.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -83.72 -52.72 6.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.289 1.435 . . . . 0.0 111.183 170.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 160.1 39.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.742 1.217 . . . . 0.0 111.526 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -138.37 135.72 35.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.594 0.758 . . . . 0.0 112.299 171.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.66 120.57 31.57 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.843 1.257 . . . . 0.0 111.148 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.57 125.29 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 111.666 176.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.68 126.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.308 1.843 . . . . 0.0 109.795 -178.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -122.97 7.31 9.27 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.274 -0.891 . . . . 0.0 113.262 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.02 142.85 15.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.931 1.692 . . . . 0.0 110.603 177.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 82' ' ' VAL . 6.5 t80 -136.68 124.65 14.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 0.0 112.841 174.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.15 160.03 35.08 Favored 'Cis proline' 0 CA--C 1.541 0.844 0 CA-C-N 119.947 1.017 . . . . 0.0 114.132 -10.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.31 -158.51 9.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.79 0.71 . . . . 0.0 114.105 178.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -87.49 -29.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.4 -20.09 37.78 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 77' ' ' TYR . 3.7 p -145.23 131.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.547 1.539 . . . . 0.0 110.253 166.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.04 152.98 41.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.385 1.474 . . . . 0.0 111.953 177.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -100.07 90.47 4.39 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 91' ' ' TYR . 1.7 m 24.19 -76.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.776 2.83 . . . . 0.0 116.479 157.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.5 p -137.7 -55.81 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 110.703 156.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -149.7 -64.21 0.22 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.74 0.816 . . . . 0.0 112.968 -166.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -63.52 108.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.8 p -83.69 17.62 2.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -63.43 -25.21 68.17 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.251 0.932 . . . . 0.0 112.044 164.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' HG21 ' A' ' 85' ' ' VAL . 19.3 m-85 -112.16 160.76 17.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.732 1.213 . . . . 0.0 112.47 175.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.17 175.0 10.21 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.816 1.646 . . . . 0.0 110.23 169.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.2 t -128.0 135.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.6 1.56 . . . . 0.0 108.197 163.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.0 pt -129.9 151.87 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.669 0.788 . . . . 0.0 111.838 175.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 92.49 4.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.167 1.387 . . . . 0.0 110.104 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 pt -82.62 159.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.144 1.378 . . . . 0.0 112.601 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -84.02 146.77 27.79 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.687 -0.633 . . . . 0.0 111.429 155.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.79 0.49 56.98 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.29 11.35 85.08 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.905 1.241 . . . . 0.0 115.176 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.5 t -142.9 53.52 1.38 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 123.237 1.494 . . . . 0.0 111.542 -177.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.36 16.07 80.02 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.594 1.569 . . . . 0.0 114.8 172.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -149.66 176.57 10.55 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.877 1.271 . . . . 0.0 113.448 -164.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -141.43 160.47 40.07 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.18 38.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.156 1.782 . . . . 0.0 112.176 -176.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.87 132.13 38.6 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.544 0.738 . . . . 0.0 110.932 169.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 pt -126.18 142.34 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.243 1.017 . . . . 0.0 111.141 169.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.34 151.2 37.97 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 160.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mt -122.99 145.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.73 129.68 4.59 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.088 1.328 . . . . 0.0 111.304 167.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -89.15 164.68 14.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -175.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 t -71.53 -25.93 62.45 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.124 0.97 . . . . 0.0 112.616 172.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.17 144.82 36.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.367 1.467 . . . . 0.0 112.552 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -57.8 -39.78 78.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.559 1.143 . . . . 0.0 112.049 172.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -36.54 70.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.393 0.997 . . . . 0.0 113.128 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.01 -33.14 75.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.158 0.979 . . . . 0.0 111.781 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.49 48.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.135 0.974 . . . . 0.0 113.209 173.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.0 -28.15 69.61 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.35 -1.469 . . . . 0.0 111.42 173.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -74.7 -32.63 62.22 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.351 1.06 . . . . 0.0 112.03 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -59.31 -40.66 86.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.816 1.189 . . . . 0.0 110.737 170.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.78 -57.05 12.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.954 0.902 . . . . 0.0 112.157 169.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.8 t -62.33 -32.21 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.942 -1.099 . . . . 0.0 112.756 -174.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.3 m -59.71 -24.25 63.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 113.386 173.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.97 -34.15 10.22 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.923 1.289 . . . . 0.0 111.968 176.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -56.52 -54.22 48.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.335 0.971 . . . . 0.0 110.468 172.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.07 -12.84 58.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.676 1.591 . . . . 0.0 113.133 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -86.76 -32.2 20.51 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 174.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.8 -18.33 18.01 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.885 0.766 . . . . 0.0 112.731 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -44.03 -35.81 2.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.724 2.81 . . . . 0.0 115.314 172.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -110.58 7.32 22.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 114.587 -175.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.17 -161.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.046 2.138 . . . . 0.0 109.081 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 63.79 -6.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.216 2.606 . . . . 0.0 117.846 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 52.18 35.72 17.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.531 2.332 . . . . 0.0 113.072 177.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.413 1.885 . . . . 0.0 112.519 -177.873 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -137.21 156.34 48.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.952 1.701 . . . . 0.0 111.188 -173.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.4 mt -116.08 137.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.169 1.788 . . . . 0.0 109.733 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.3 p -102.69 125.27 49.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.794 0.838 . . . . 0.0 112.435 175.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 49.4 m -143.92 42.14 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.492 1.917 . . . . 0.0 111.248 -178.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -48.67 144.98 3.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.462 1.905 . . . . 0.0 115.282 -159.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.19 137.46 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 159.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.554 HG21 HG22 ' B' ' 159' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.9 -25.56 0.99 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.619 2.056 . . . . 0.0 114.252 175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 -27.74 3.75 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -166.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.554 HG22 HG21 ' B' ' 156' ' ' TPO . 20.8 tt -79.48 -33.31 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 120.234 1.379 . . . . 0.0 112.614 -177.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.59 49.39 56.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.185 0.897 . . . . 0.0 113.146 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -104.91 -166.46 1.24 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.045 2.138 . . . . 0.0 111.103 -172.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . 0.275 34.9 mmt180 56.55 37.11 28.55 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 162.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 128.103 2.561 . . . . 0.0 113.686 179.442 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 60.5 p -146.43 153.71 48.15 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.372 1.469 . . . . 0.0 112.167 -178.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.64 154.17 59.68 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.456 2.77 . . . . 0.0 112.64 178.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -85.0 114.33 22.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.174 0.99 . . . . 0.0 111.315 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -64.86 -16.08 62.71 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm -89.61 -13.47 37.09 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.476 1.11 . . . . 0.0 113.109 175.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.19 -17.61 32.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 p -83.85 55.15 3.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.553 1.541 . . . . 0.0 112.934 -176.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.43 140.0 32.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.096 1.758 . . . . 0.0 111.124 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.23 1.02 7.81 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.072 1.749 . . . . 0.0 112.555 173.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 53.48 39.24 29.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.652 1.981 . . . . 0.0 113.824 -178.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -93.48 -177.47 4.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.23 1.412 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -169.07 128.31 1.05 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.668 2.387 . . . . 0.0 109.084 169.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -91.01 130.24 36.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.109 1.364 . . . . 0.0 110.937 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.07 137.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.763 -1.211 . . . . 0.0 111.225 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -113.95 -44.51 3.15 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.66 . . . . 0.0 112.706 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.3 t -144.39 152.76 41.15 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.978 0.894 . . . . 0.0 112.756 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.04 129.4 20.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.261 1.824 . . . . 0.0 108.058 170.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -122.11 141.09 33.55 Favored Pre-proline 0 N--CA 1.482 1.136 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.4 -12.45 22.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.966 3.777 . . . . 0.0 114.342 -171.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -141.25 150.92 43.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.607 1.563 . . . . 0.0 110.927 174.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -163.0 131.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.977 1.311 . . . . 0.0 108.554 162.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -115.69 139.87 49.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.055 0.942 . . . . 0.0 111.475 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 133.79 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.162 1.385 . . . . 0.0 111.047 -173.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -115.66 -1.19 12.76 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -162.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 42.29 90.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 128.499 2.719 . . . . 0.0 114.97 170.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.5 pt -94.93 146.08 30.7 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.0 1.32 . . . . 0.0 113.937 -161.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.24 -44.43 0.56 Allowed 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 122.802 2.334 . . . . 0.0 117.015 173.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.18 163.1 15.33 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.948 2.432 . . . . 0.0 114.041 -173.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.39 -28.76 8.41 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.429 1.491 . . . . 0.0 114.948 168.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.63 103.19 0.92 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.609 0.719 . . . . 0.0 111.513 -172.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -93.29 162.71 13.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.612 1.165 . . . . 0.0 110.961 160.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -21.9 31.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.767 2.027 . . . . 0.0 114.934 179.075 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -104.66 -6.11 20.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.167 1.387 . . . . 0.0 114.149 175.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.97 -105.02 0.81 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.406 1.479 . . . . 0.0 111.336 -171.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.06 -31.88 2.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.62 108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.563 3.145 . . . . 0.0 114.909 -169.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.39 -37.33 56.21 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.14 -0.975 . . . . 0.0 112.643 175.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.2 m -57.95 -18.89 26.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.842 2.057 . . . . 0.0 114.958 174.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.16 -21.54 39.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.044 1.338 . . . . 0.0 113.236 176.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -129.24 -160.44 1.03 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.492 1.917 . . . . 0.0 110.811 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -72.23 104.03 3.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.806 -1.184 . . . . 0.0 110.967 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.36 -2.76 35.5 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.99 -9.29 3.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.433 1.493 . . . . 0.0 114.206 -173.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -126.3 92.52 45.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.246 1.418 . . . . 0.0 111.404 -176.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.11 156.63 42.54 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.652 2.234 . . . . 0.0 112.267 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.09 -23.12 13.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.327 1.451 . . . . 0.0 112.511 175.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -144.29 146.76 32.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.892 1.677 . . . . 0.0 110.411 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.8 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.404 1.082 . . . . 0.0 111.69 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.52 -132.06 1.57 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.455 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -130.07 146.6 51.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.286 2.234 . . . . 0.0 110.697 -171.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 tp -99.81 140.48 33.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.006 0.922 . . . . 0.0 111.316 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.74 137.99 53.84 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.978 1.311 . . . . 0.0 110.184 156.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.7 mt -123.89 133.58 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.0 p -131.42 172.27 12.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.077 1.751 . . . . 0.0 109.999 -178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 87.8 p -152.45 128.91 10.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.811 1.244 . . . . 0.0 111.872 169.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -84.2 -28.51 27.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.932 0.893 . . . . 0.0 111.985 170.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.37 -122.09 0.7 Allowed Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.576 1.084 . . . . 0.0 110.545 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -60.38 -18.85 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.269 1.027 . . . . 0.0 113.398 167.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.72 125.58 42.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.064 0.946 . . . . 0.0 111.982 173.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -97.95 160.47 14.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.583 1.153 . . . . 0.0 110.403 161.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.38 116.53 17.67 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mm -76.04 116.06 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 167.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -112.9 124.74 53.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.466 1.507 . . . . 0.0 110.476 173.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.2 128.31 50.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.611 0.764 . . . . 0.0 110.194 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -120.54 148.12 44.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.286 1.434 . . . . 0.0 112.148 -167.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.94 143.12 57.0 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.216 172.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -71.94 -11.22 60.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.51 -29.0 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.101 1.36 . . . . 0.0 114.048 -176.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.2 m -102.97 -13.34 16.93 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.868 0.758 . . . . 0.0 112.87 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.08 9.17 46.64 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.463 1.03 . . . . 0.0 114.745 -174.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.92 146.62 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.707 1.203 . . . . 0.0 112.2 -174.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.48 120.03 19.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -171.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -80.98 -51.14 8.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.598 1.559 . . . . 0.0 111.302 170.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.96 165.21 35.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.264 1.426 . . . . 0.0 111.111 176.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -142.47 147.91 36.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 165.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.85 115.8 20.7 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.489 1.516 . . . . 0.0 110.98 176.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.94 135.05 12.22 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.141 2.561 . . . . 0.0 111.653 172.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.12 129.16 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.974 1.31 . . . . 0.0 112.283 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -117.37 0.24 12.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.057 0.943 . . . . 0.0 113.291 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.68 140.24 15.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.966 1.706 . . . . 0.0 111.523 174.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD1' HG13 ' A' ' 82' ' ' VAL . 8.0 t80 -131.15 130.16 22.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.609 1.164 . . . . 0.0 111.468 174.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -60.66 156.68 50.85 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 CA-C-N 120.375 1.17 . . . . 0.0 112.941 -11.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.16 -163.6 21.3 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.296 0.951 . . . . 0.0 113.02 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.66 -21.52 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.76 -0.847 . . . . 0.0 111.93 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.81 -15.03 53.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 77' ' ' TYR . 2.5 p -161.12 124.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.872 1.269 . . . . 0.0 110.913 169.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.17 150.8 46.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.319 1.848 . . . . 0.0 111.303 -175.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 96.58 8.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.113 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 86' ' ' THR . 2.6 m 13.58 -71.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 129.549 3.14 . . . . 0.0 116.331 160.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.454 ' H ' HG23 ' A' ' 85' ' ' VAL . 9.4 p -144.86 -53.89 0.31 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.587 1.955 . . . . 0.0 110.566 156.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -148.37 -59.17 0.24 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -161.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.469 ' HB3' HG23 ' B' ' 155' ' ' VAL . 40.4 t -55.63 121.71 9.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.61 1.55 . . . . 0.0 111.37 167.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -99.47 33.3 2.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.097 1.359 . . . . 0.0 111.152 177.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -82.81 -21.98 34.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.223 1.409 . . . . 0.0 111.731 157.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -119.57 159.9 23.48 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.669 1.588 . . . . 0.0 112.831 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -143.15 172.82 12.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.129 1.372 . . . . 0.0 111.064 170.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.69 133.07 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.707 1.203 . . . . 0.0 108.822 162.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.14 142.92 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.25 1.02 . . . . 0.0 109.985 174.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.07 113.88 25.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 167.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.3 pt -95.0 158.65 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.928 1.691 . . . . 0.0 111.376 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.76 141.73 37.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.937 0.495 . . . . 0.0 110.208 158.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.35 -1.18 57.74 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 170.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.78 81.16 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.073 1.32 . . . . 0.0 115.353 175.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -136.0 28.35 3.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.653 1.181 . . . . 0.0 113.466 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.75 18.41 56.52 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.216 1.388 . . . . 0.0 113.892 178.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -144.65 160.05 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -172.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.3 m -126.99 156.79 41.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.41 1.084 . . . . 0.0 113.266 -176.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.63 150.09 43.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.976 1.71 . . . . 0.0 111.791 -179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.65 130.34 38.31 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.575 -0.703 . . . . 0.0 110.862 173.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.48 134.25 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.805 0.842 . . . . 0.0 111.899 168.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 138.42 17.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 167.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.1 146.63 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.533 1.533 . . . . 0.0 108.963 -178.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.66 138.42 9.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.202 1.382 . . . . 0.0 111.195 164.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 13.6 m-85 -97.13 154.28 17.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.859 0.838 . . . . 0.0 111.236 173.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -23.68 63.12 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.065 0.546 . . . . 0.0 111.669 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -121.31 142.0 50.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 112.776 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -39.78 77.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.711 1.205 . . . . 0.0 112.354 172.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.57 85.02 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.307 0.956 . . . . 0.0 113.041 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.84 -33.36 73.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.273 1.036 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -72.77 -44.19 61.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 167.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.66 -26.68 68.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.294 -1.504 . . . . 0.0 112.062 178.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.59 -29.11 45.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.067 1.347 . . . . 0.0 112.278 173.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.33 -32.65 73.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.195 0.907 . . . . 0.0 111.075 166.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -55.95 8.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.733 0.813 . . . . 0.0 111.793 166.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.25 -34.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.068 1.304 . . . . 0.0 113.161 -171.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 p -63.0 -22.89 67.17 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 173.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 82' ' ' VAL . 85.2 mt -91.9 -34.46 14.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.23 1.012 . . . . 0.0 112.444 169.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.944 1.247 . . . . 0.0 110.921 174.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.22 -11.13 60.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -83.68 -34.14 25.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.573 -0.704 . . . . 0.0 111.709 170.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -98.0 -8.01 28.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -28.07 69.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.221 1.373 . . . . 0.0 113.876 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.06 5.01 47.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.54 1.536 . . . . 0.0 113.125 177.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 131' ' ' LYS . 38.9 t -110.58 -176.58 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.631 2.773 . . . . 0.0 108.392 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' N ' HG12 ' A' ' 130' ' ' VAL . 22.7 tttm 68.49 10.9 8.14 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 151.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 57.11 29.02 15.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.94 2.096 . . . . 0.0 114.702 172.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.58 1.552 . . . . 0.0 113.315 178.372 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.56 -37.44 71.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.026 0.93 . . . . 0.0 111.375 173.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.82 146.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 125.438 1.495 . . . . 0.0 108.862 164.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.1 173.43 6.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.318 1.447 . . . . 0.0 112.833 177.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 26.0 m -77.9 35.92 0.21 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.056 1.342 . . . . 0.0 114.363 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -48.12 136.23 12.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.621 1.968 . . . . 0.0 113.06 -174.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 88' ' ' SER 0.254 4.1 p -65.3 128.96 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.823 1.297 . . . . 0.0 110.286 -172.688 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.468 ' H ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.32 -2.24 0.1 OUTLIER Glycine 0 C--N 1.298 -1.578 1 C-N-CA 132.317 4.77 . . . . 0.0 115.713 176.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -57.11 -20.19 24.17 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 149.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 20.1 tt -154.47 -42.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.81 51.79 22.93 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.186 0.898 . . . . 0.0 114.682 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -140.42 0.33 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.538 1.935 . . . . 0.0 114.084 -173.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -135.52 -176.2 4.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.373 1.469 . . . . 0.0 112.968 -149.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.15 0.98 . . . . 0.0 112.97 166.826 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 96.8 p -80.14 155.32 74.81 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.424 1.09 . . . . 0.0 112.901 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.69 -10.84 28.63 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.248 2.632 . . . . 0.0 113.609 175.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.4 -1.31 49.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.199 1.4 . . . . 0.0 113.469 178.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.4 t -135.97 160.99 36.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.666 1.587 . . . . 0.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -81.09 39.75 0.52 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.071 -177.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.3 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.241 1.416 . . . . 0.0 114.297 -176.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.4 p -82.01 -11.17 58.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.16 1.784 . . . . 0.0 114.028 177.119 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.6 136.22 52.69 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.557 1.143 . . . . 0.0 112.046 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.1 24.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.521 1.529 . . . . 0.0 113.468 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.06 133.22 47.8 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.978 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 13.7 p90 -150.32 176.22 11.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -163.32 135.41 5.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.35 2.26 . . . . 0.0 108.66 163.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -93.69 127.1 39.23 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.713 1.205 . . . . 0.0 110.844 -178.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.45 136.13 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 111.495 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -114.42 -42.89 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.809 1.643 . . . . 0.0 112.601 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.5 t -149.18 148.83 30.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.988 0.915 . . . . 0.0 112.107 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.95 123.21 24.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.818 1.647 . . . . 0.0 109.07 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 3.9 mptp? -115.24 133.94 22.64 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.102 0.961 . . . . 0.0 111.622 178.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.66 -26.62 33.11 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.508 3.472 . . . . 0.0 115.08 -168.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -143.71 139.23 29.39 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.389 1.076 . . . . 0.0 111.514 175.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.86 141.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.194 1.397 . . . . 0.0 109.666 176.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.8 p -118.32 144.49 45.81 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.448 1.099 . . . . 0.0 112.31 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.84 142.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.355 1.462 . . . . 0.0 111.441 -170.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -135.27 88.82 2.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.632 1.973 . . . . 0.0 108.984 -172.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -50.73 132.24 26.14 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.289 -1.507 . . . . 0.0 111.555 171.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 pt -121.41 138.55 28.36 Favored Pre-proline 0 N--CA 1.484 1.256 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -76.46 -39.48 0.76 Allowed 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 122.95 2.433 . . . . 0.0 117.248 167.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.05 163.61 30.59 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.889 2.393 . . . . 0.0 114.279 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -127.95 -26.32 2.92 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.316 1.846 . . . . 0.0 115.171 176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.4 110.1 1.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.703 0.763 . . . . 0.0 112.133 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.1 p -105.1 171.37 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.2 1.0 . . . . 0.0 111.035 154.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -66.84 -19.9 65.82 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -87.93 -37.88 16.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.06 1.344 . . . . 0.0 111.843 173.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.54 -103.76 0.31 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.801 1.667 . . . . 0.0 110.312 172.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -113.97 -30.27 6.76 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 35.35 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 129.954 3.301 . . . . 0.0 115.59 -178.355 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.76 -27.82 13.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.81 1.244 . . . . 0.0 114.164 -177.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -71.26 -11.83 61.13 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.856 1.663 . . . . 0.0 114.072 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.23 -40.17 38.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.381 1.073 . . . . 0.0 112.994 174.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.59 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.716 2.006 . . . . 0.0 110.912 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -61.34 120.21 9.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.729 1.252 . . . . 0.0 110.99 171.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' B' ' 154' ' ' GLN . 28.2 tp -98.51 -28.71 13.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.236 2.214 . . . . 0.0 111.869 -172.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -142.83 7.41 1.65 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.151 1.781 . . . . 0.0 114.399 -176.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -121.4 79.7 37.13 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.564 1.946 . . . . 0.0 110.985 -175.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.94 159.71 49.63 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.537 2.825 . . . . 0.0 114.173 -173.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -99.32 -25.41 14.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.637 1.975 . . . . 0.0 112.36 177.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -149.67 150.25 31.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.87 1.668 . . . . 0.0 110.485 173.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 p -136.43 152.68 50.86 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.671 0.788 . . . . 0.0 111.877 166.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.79 -135.65 2.02 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.086 -174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -131.87 139.6 48.85 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.469 2.308 . . . . 0.0 109.604 -171.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.4 tp -88.66 140.3 29.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.797 178.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.54 95.94 3.07 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.632 1.173 . . . . 0.0 110.771 167.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.21 131.53 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 171.164 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.6 p -138.81 175.71 9.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.449 1.5 . . . . 0.0 109.705 -177.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 76.3 p -155.0 125.64 6.95 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.765 -1.209 . . . . 0.0 113.235 174.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 7' ' ' TYR . 26.2 ttmt -90.01 67.77 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.124 1.37 . . . . 0.0 109.836 168.137 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.48 -127.1 7.95 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.727 1.632 . . . . 0.0 112.48 -177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -71.93 9.67 0.88 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.242 1.817 . . . . 0.0 114.652 178.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -124.14 117.59 24.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 110.196 177.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.86 156.97 24.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.599 0.76 . . . . 0.0 110.966 169.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -133.44 117.99 17.86 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.918 1.287 . . . . 0.0 107.67 172.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mm -79.81 103.45 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 167.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.1 139.67 41.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.039 0.936 . . . . 0.0 108.584 178.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -120.42 127.97 52.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.887 0.875 . . . . 0.0 110.013 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -116.98 147.09 42.6 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.33 1.452 . . . . 0.0 111.658 -169.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.72 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.898 -1.126 . . . . 0.0 110.27 174.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.67 -0.06 9.95 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -175.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.35 -39.11 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.07 1.748 . . . . 0.0 111.32 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.7 m -130.88 -3.05 4.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -169.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.74 73.97 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.425 1.012 . . . . 0.0 114.956 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.25 145.47 41.9 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.354 1.077 . . . . 0.0 111.915 -175.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -71.77 120.33 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.677 -0.639 . . . . 0.0 111.842 -175.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.01 -51.64 6.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.624 1.57 . . . . 0.0 111.373 171.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.39 39.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.182 1.393 . . . . 0.0 111.164 179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -143.83 141.28 30.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 166.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.71 115.11 32.36 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.274 1.43 . . . . 0.0 110.896 174.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -72.26 131.29 17.56 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.264 2.642 . . . . 0.0 111.6 171.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.6 t -123.68 127.11 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.75 2.02 . . . . 0.0 109.352 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -122.93 7.45 9.3 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 177.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.98 143.48 16.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.238 1.815 . . . . 0.0 109.918 174.069 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -131.43 126.41 21.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.38 167.48 32.17 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.006 0.681 . . . . 0.0 112.82 -16.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.3 -156.03 8.43 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.952 0.787 . . . . 0.0 114.028 175.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 tp -76.18 -31.09 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.833 -0.804 . . . . 0.0 111.137 173.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.27 -23.41 40.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.097 -0.954 . . . . 0.0 113.536 -176.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.45 125.7 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.546 1.139 . . . . 0.0 110.228 169.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.03 159.39 42.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.314 1.846 . . . . 0.0 111.785 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -113.95 92.7 4.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.793 1.237 . . . . 0.0 108.729 178.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.0 m 25.6 -80.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.141 2.576 . . . . 0.0 115.341 155.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 p -136.93 -55.15 0.72 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.137 0.975 . . . . 0.0 111.609 161.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.84 -68.82 0.2 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -164.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' B' ' 156' ' ' TPO . 0.9 OUTLIER -56.41 158.04 4.6 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.831 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.4 t -120.14 56.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.618 1.567 . . . . 0.0 111.176 -172.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.23 -32.61 15.0 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.64 0.776 . . . . 0.0 111.359 148.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -120.09 159.35 24.98 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -166.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.62 173.17 11.76 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.529 1.532 . . . . 0.0 110.366 168.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.1 t -126.46 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.278 1.431 . . . . 0.0 108.353 163.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -130.3 152.63 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.546 0.738 . . . . 0.0 112.274 177.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -100.02 92.65 5.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.554 1.541 . . . . 0.0 110.408 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.0 pt -88.22 163.43 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.987 1.315 . . . . 0.0 113.451 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -76.32 129.31 36.44 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 146.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.4 0.65 48.64 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.05 86.95 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.21 1.386 . . . . 0.0 115.493 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.8 p -110.11 13.63 23.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.552 1.541 . . . . 0.0 113.207 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.37 54.22 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.33 1.443 . . . . 0.0 113.932 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.15 169.54 17.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.064 1.745 . . . . 0.0 113.094 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.4 p -105.47 152.6 22.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.501 1.12 . . . . 0.0 111.742 167.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.8 152.03 40.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.397 1.079 . . . . 0.0 112.776 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -89.49 132.61 34.96 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.896 -0.502 . . . . 0.0 110.335 162.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 pt -124.07 140.42 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.782 0.833 . . . . 0.0 110.549 168.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.26 150.27 41.91 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 157.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.43 145.42 32.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.82 171.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.28 132.01 6.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.385 1.469 . . . . 0.0 111.032 168.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 46.5 m-85 -92.2 167.61 11.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.765 -0.844 . . . . 0.0 113.185 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.5 t -79.66 -21.52 44.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.924 0.889 . . . . 0.0 113.089 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -140.33 151.74 45.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.868 1.667 . . . . 0.0 112.252 178.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 -60.9 -35.67 77.25 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.766 -0.584 . . . . 0.0 112.542 171.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.57 -38.98 93.76 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.127 0.876 . . . . 0.0 112.64 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 57.7 m-20 -64.05 -40.31 96.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.082 0.941 . . . . 0.0 112.312 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 110' ' ' PHE . . . -75.01 -43.54 53.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.708 1.203 . . . . 0.0 113.714 171.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -57.79 -30.67 65.87 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.221 -1.549 . . . . 0.0 112.678 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.45 -33.13 62.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.432 1.093 . . . . 0.0 112.667 172.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.02 -43.47 81.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.051 0.841 . . . . 0.0 110.331 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.4 -51.98 56.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.409 1.084 . . . . 0.0 112.726 172.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.72 -31.94 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.696 1.135 . . . . 0.0 112.441 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -55.06 -35.17 64.24 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.575 0.75 . . . . 0.0 112.205 170.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.9 mt -85.97 -38.74 17.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 111.849 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -55.19 -51.72 65.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.236 0.926 . . . . 0.0 111.107 172.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.99 -8.55 57.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -83.03 -40.97 19.23 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.51 -0.744 . . . . 0.0 111.449 169.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 79.2 m-85 -88.89 -12.17 42.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -26.92 68.21 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -104.7 4.12 32.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.968 1.307 . . . . 0.0 114.012 -177.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 127' ' ' PHE . 1.7 m -121.94 -156.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 128.137 2.575 . . . . 0.0 109.421 174.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.0 tptp 58.65 19.09 6.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.314 1.846 . . . . 0.0 114.781 177.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 53.38 29.39 8.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.46 1.904 . . . . 0.0 114.168 -173.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 C--O 1.255 1.348 0 C-N-CA 124.988 1.315 . . . . 0.0 113.862 176.413 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.458 0.169 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -75.97 144.46 40.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.805 0.842 . . . . 0.0 111.859 177.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.97 143.94 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.115 1.766 . . . . 0.0 108.886 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 7.8 p -64.97 150.92 47.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.17 0.988 . . . . 0.0 112.653 173.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 22.9 m -79.69 49.36 1.03 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.215 1.406 . . . . 0.0 113.065 178.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . 0.479 ' HA ' HD11 ' A' ' 38' ' ' LEU . 13.4 pt20 -59.48 166.38 2.4 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.096 2.158 . . . . 0.0 114.149 -173.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . . . . . . . . . 4.0 p -64.64 119.69 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 154.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.45 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -154.5 -14.82 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.994 2.235 . . . . 0.0 113.876 176.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -67.38 -13.91 62.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.869 2.067 . . . . 0.0 114.528 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 tp -142.16 -34.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.122 1.369 . . . . 0.0 113.249 174.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.0 44.5 67.09 Favored Glycine 0 N--CA 1.477 1.367 0 C-N-CA 124.304 0.954 . . . . 0.0 113.983 171.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.99 -140.6 0.32 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.376 1.87 . . . . 0.0 114.324 -167.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -134.16 -161.07 1.11 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 112.756 -149.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.839 2.056 . . . . 0.0 112.906 177.134 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.9 m -66.66 152.41 95.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.687 1.195 . . . . 0.0 112.958 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.33 160.59 44.59 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.099 2.532 . . . . 0.0 112.167 172.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -63.62 -35.07 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 111.943 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 48.0 t -153.89 145.27 23.07 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 110.396 164.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -65.75 -13.73 59.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.635 0.774 . . . . 0.0 112.368 171.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.61 57.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.402 1.081 . . . . 0.0 113.833 170.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.9 p -118.88 -24.02 6.75 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -175.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.13 148.7 28.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.705 1.602 . . . . 0.0 110.117 173.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.0 mt -135.26 76.77 1.64 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.041 1.736 . . . . 0.0 107.253 179.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.84 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.28 1.032 . . . . 0.0 113.289 -176.015 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -134.79 179.52 6.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 111.06 159.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.52 132.45 2.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.473 1.909 . . . . 0.0 109.012 164.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -93.34 129.61 39.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.965 1.306 . . . . 0.0 111.563 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.43 140.62 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 120.832 -1.167 . . . . 0.0 112.604 -177.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.0 mt -123.67 -46.22 2.01 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 112.677 -178.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 t -145.5 152.28 39.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.228 1.011 . . . . 0.0 112.583 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.83 136.25 43.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.259 1.823 . . . . 0.0 108.527 169.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -127.15 140.43 37.85 Favored Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -82.09 -14.88 9.47 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.527 3.485 . . . . 0.0 114.982 -166.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -150.97 134.63 16.42 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.972 1.309 . . . . 0.0 110.871 172.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.94 147.24 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.792 1.237 . . . . 0.0 110.167 175.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 p -120.13 151.16 39.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.784 1.234 . . . . 0.0 112.7 176.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.14 143.0 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.241 1.417 . . . . 0.0 111.602 -172.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.7 110.49 13.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.297 1.439 . . . . 0.0 110.279 172.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -59.88 131.0 49.53 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 119.642 -1.911 . . . . 0.0 110.422 163.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.5 pt -122.67 143.36 39.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.412 1.085 . . . . 0.0 113.105 -173.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.87 -36.12 1.62 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.815 2.343 . . . . 0.0 117.928 176.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.18 167.05 22.12 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.795 2.33 . . . . 0.0 113.539 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.36 -26.95 3.84 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.661 1.584 . . . . 0.0 115.078 170.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -162.07 103.73 1.14 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.778 0.799 . . . . 0.0 111.983 -173.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.9 t -97.63 168.59 10.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 0.0 110.672 160.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -27.41 60.71 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.517 1.927 . . . . 0.0 114.825 -176.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mtt85 -108.39 -6.56 16.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.318 1.847 . . . . 0.0 114.809 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.48 -109.78 1.0 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.136 1.827 . . . . 0.0 111.799 -177.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -121.73 -29.93 4.25 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.29 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.141 2.976 . . . . 0.0 114.806 -172.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.11 -35.4 25.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.55 0.74 . . . . 0.0 112.802 175.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -56.81 -18.94 14.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.517 2.327 . . . . 0.0 115.127 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.5 -17.0 33.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.998 1.319 . . . . 0.0 114.066 177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.55 -170.06 2.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.355 1.462 . . . . 0.0 110.957 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.1 101.04 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.903 -1.123 . . . . 0.0 110.501 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.91 0.68 54.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 165.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -123.63 -20.22 5.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.239 1.416 . . . . 0.0 113.83 -172.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -123.3 91.09 50.08 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 111.203 -168.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.17 149.51 52.03 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.132 2.555 . . . . 0.0 113.814 -174.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.28 -23.72 16.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.56 1.944 . . . . 0.0 111.948 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -148.96 152.21 35.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.609 1.563 . . . . 0.0 111.181 171.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.9 p -140.52 149.43 42.44 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.476 1.51 . . . . 0.0 111.67 173.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.28 -130.85 2.0 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.529 0.585 . . . . 0.0 112.419 -175.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.57 158.45 43.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.5 1.92 . . . . 0.0 113.038 -173.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -107.25 139.77 41.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.757 1.623 . . . . 0.0 111.238 -177.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -130.02 125.05 34.37 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.561 1.144 . . . . 0.0 109.784 158.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.94 127.25 62.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -132.21 172.02 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.721 1.608 . . . . 0.0 109.881 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.0 p -152.45 123.03 7.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.399 1.095 . . . . 0.0 113.928 175.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -90.32 71.67 7.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.736 1.214 . . . . 0.0 109.56 167.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.21 -126.09 7.7 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.466 1.508 . . . . 0.0 112.598 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -73.52 25.21 0.07 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.3 2.24 . . . . 0.0 114.576 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -145.95 118.63 8.6 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.215 1.806 . . . . 0.0 108.296 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.24 161.88 14.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.464 0.649 . . . . 0.0 110.788 170.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -134.44 117.34 16.16 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.93 1.292 . . . . 0.0 107.728 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.09 100.95 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -105.62 147.01 28.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.314 1.046 . . . . 0.0 110.714 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.66 130.18 49.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.307 -177.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -123.72 146.67 48.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.029 1.332 . . . . 0.0 112.336 -169.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.16 135.04 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.028 0.931 . . . . 0.0 110.383 173.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -65.35 -17.41 64.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.932 1.293 . . . . 0.0 113.717 -173.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.68 -32.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.838 1.655 . . . . 0.0 111.399 -171.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.6 p -127.62 -14.62 5.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -167.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.06 9.63 71.86 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.956 0.789 . . . . 0.0 114.023 -169.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.98 142.16 52.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.211 1.506 . . . . 0.0 112.19 -176.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.24 121.58 20.56 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.149 0.58 . . . . 0.0 111.772 -173.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -84.12 -53.85 5.24 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.231 1.413 . . . . 0.0 111.269 170.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 163.1 40.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 111.245 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -144.32 141.48 29.79 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 165.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.25 117.36 34.96 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.198 1.399 . . . . 0.0 110.502 173.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 133.72 14.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.881 2.387 . . . . 0.0 110.903 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.21 132.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.095 1.358 . . . . 0.0 111.229 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -120.89 6.49 10.39 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.503 1.121 . . . . 0.0 112.035 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.72 151.01 19.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.602 1.961 . . . . 0.0 109.806 174.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -136.06 127.69 17.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.48 165.5 44.78 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.238 0.764 . . . . 0.0 113.081 -16.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.78 -156.07 8.57 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.156 0.884 . . . . 0.0 114.347 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.26 -32.86 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.825 -0.809 . . . . 0.0 110.844 175.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.44 -17.11 49.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.505 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.02 124.85 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.036 1.334 . . . . 0.0 109.699 171.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.8 151.99 41.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.398 1.479 . . . . 0.0 112.179 -176.318 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -97.4 88.62 4.46 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m 25.63 -76.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.758 2.823 . . . . 0.0 116.319 158.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.7 p -137.57 -53.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.797 1.239 . . . . 0.0 111.531 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.72 -69.37 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.845 -167.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.581 ' HB3' HG23 ' B' ' 155' ' ' VAL . 6.4 t -50.51 139.09 16.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -108.44 43.17 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.031 0.932 . . . . 0.0 112.281 172.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -70.18 -23.77 63.03 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 111.406 152.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -134.23 164.14 28.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 112.204 -170.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -140.32 175.71 9.37 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 110.328 166.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.93 136.07 61.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.228 1.411 . . . . 0.0 108.483 161.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.65 153.08 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.918 0.887 . . . . 0.0 111.744 174.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 92.14 4.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.954 1.302 . . . . 0.0 110.49 177.055 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.07 162.47 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.064 1.346 . . . . 0.0 113.202 -178.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -77.09 133.61 38.99 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 147.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -87.41 4.53 42.82 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.43 7.31 82.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.934 1.254 . . . . 0.0 115.948 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -132.73 25.51 4.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.781 1.29 . . . . 0.0 113.871 -176.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.25 17.01 54.64 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.792 1.187 . . . . 0.0 113.924 178.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -137.88 169.91 16.96 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.95 1.7 . . . . 0.0 112.627 -177.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.5 p -107.74 158.67 17.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.597 0.759 . . . . 0.0 112.33 161.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 151.27 36.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.75 1.22 . . . . 0.0 112.348 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.31 130.26 37.19 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.629 0.772 . . . . 0.0 110.247 166.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.13 138.13 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.725 0.81 . . . . 0.0 110.409 169.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.87 153.04 49.64 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 155.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.4 mt -125.12 141.6 44.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 125.071 1.348 . . . . 0.0 108.502 172.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.45 129.05 5.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.77 1.176 . . . . 0.0 112.08 169.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.48 158.77 15.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.039 0.923 . . . . 0.0 113.08 177.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -75.7 -22.26 56.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.0 112.91 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.14 139.43 45.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.479 1.511 . . . . 0.0 112.096 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -60.19 -32.43 71.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.638 1.175 . . . . 0.0 112.261 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.71 -32.1 59.68 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.721 1.153 . . . . 0.0 114.037 174.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.86 -40.09 87.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.668 1.234 . . . . 0.0 111.008 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.7 64.03 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.69 -30.49 67.43 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.111 -1.618 . . . . 0.0 111.696 173.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -82.83 -25.88 32.22 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.487 1.115 . . . . 0.0 112.969 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.24 -41.74 89.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.233 0.924 . . . . 0.0 110.058 164.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -56.17 19.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.141 0.977 . . . . 0.0 112.037 170.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.82 -34.06 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.803 1.183 . . . . 0.0 112.661 -173.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -55.31 -33.16 63.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.889 0.876 . . . . 0.0 112.518 172.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.7 mt -90.99 -36.88 13.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.658 1.183 . . . . 0.0 112.421 178.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -54.45 -53.25 56.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.16 0.891 . . . . 0.0 110.631 172.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.04 -7.58 55.92 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -84.89 -39.9 17.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.524 -0.735 . . . . 0.0 111.527 170.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -88.11 -15.38 36.35 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 177.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -27.63 66.25 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -177.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -103.58 5.58 36.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.974 1.31 . . . . 0.0 114.138 -176.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.04 -164.9 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.76 2.024 . . . . 0.0 111.019 -177.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 62.22 15.37 7.48 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.071 2.148 . . . . 0.0 115.944 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 54.31 24.98 5.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.224 1.81 . . . . 0.0 114.62 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 124.357 1.063 . . . . 0.0 113.742 173.801 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.516 0.198 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -110.25 5.4 21.73 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.793 1.637 . . . . 0.0 113.179 175.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.53 161.62 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.764 1.626 . . . . 0.0 111.444 -178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -71.84 172.61 9.57 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.577 1.18 . . . . 0.0 113.111 170.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 29.8 m -128.76 27.85 5.43 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.519 1.928 . . . . 0.0 114.199 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -160.55 163.99 32.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.237 1.815 . . . . 0.0 114.404 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 155' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 88' ' ' SER . 3.0 p -78.16 124.26 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 142.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 156' ' ' TPO . . . . . 0.499 ' HB ' ' HB2' ' A' ' 88' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -156.48 -18.23 0.04 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 126.05 1.786 . . . . 0.0 114.523 176.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -66.6 -26.88 67.31 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . . . . . . . . . 9.4 tp -100.24 -34.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.311 1.044 . . . . 0.0 112.266 171.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.17 63.7 3.32 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.938 1.256 . . . . 0.0 112.556 166.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 161' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -141.74 170.59 15.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -153.484 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -165.05 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.275 2.23 . . . . 0.0 110.935 164.215 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.956 2.103 . . . . 0.0 111.351 168.022 . . . . . . . . 0 0 . 1 stop_ save_